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Quote - interdependent interactions in systems
"The systems view looks at the world in terms o f relationships and 
integration. Systems are integrated wholes whose properties cannot be 
reduced to those o f smaller units. Instead o f concentrating on basic 
building blocks or basic substances, the systems approach emphasizes 
basic principles o f organization. Every organism - from the smallest 
bacterium through the wide range or plants and animals to humans is an 
integrated whole and thus a living system. ...But systems are not confined 
to individual organisms and their parts. The same aspects o f wholeness 
are exhibited by social systems- such as an anthill, a beehive, or a human 
family- and by ecosystems that consist o f a variety o f organisms and 
inanimate matter in mutual interaction. What is preserved in a wilderness 
area is not individual trees or organisms but a complex web o f  
relationships between them.
All these natural systems are wholes whose specific structures arise from 
the interactions and interdependence o f their parts. The activity o f  
systems involves a process known as transaction- the simultaneous and 
mutually interdependent interaction between multiple components."
-  Fritjof Capra 
the Turning Point
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Abstract
ARVC is a cardiac disease associated with ventricular cardiomyocyte fibro-fatty 
replacement and sudden death. It presents with incomplete penetrance and variable 
clinical expression. Desmoplakin (DP) and plakoglobin (PG) gene mutations were 
previously identified.
This study aimed: to identify desmosomal (DS) gene mutations in an ARVC cohort 
by DNA sequencing; study the gene transmission and disease expression in affected 
families and determine functional implications of three identified mutations 
(A733fsX740PKP-2, S140FPKP-2 and Q273fsX288DP) using wild-type and mutant 
cDNA plasmid cloning and cell line protein expressions.
Eight PKP-2 mutations were identified of which four were novel: frame-shifts 
disrupting Armadillo domains (ARM) 4, 5 and 8, and a non-sense disrupting ARM 2. 
One missense and two ffame-shift novel DP mutations occurred. Pedigree analysis 
showed incomplete gene penetrance and variable ARVC expression.
Stable cells over-expressing A733fsX740PKP-2 showed increased cellular adhesion 
and apoptosis following mechanical stretch recovery, and absence of cell junction 
Connexin-43 (Cx43) protein without significant change in cell-input resistance. 
Desmosomal lengths were statistically unaltered, but intermittent pale DS coupling 
occurred. Truncated PKP-2 showed reduced PG interaction.
Stable cells over-expressing S140FPKP-2 showed no differences in cell proliferation, 
adhesion, apoptosis following mechanical stretch recovery, and in cell junction Cx43 
protein localization. DS lengths, however, were significantly increased, and missense 
PKP-2 showed reduced p-catenin interaction.
Stable cells over-expressing Q273fsX288 DP showed reduced DS widths, vimentin 
filament retraction, and lower monolayer adhesion. PG and PKP-2 interacted 
normally with truncated DP.
Altered DS morphologies featured prominently in all three mutant protein 
expressions. Reduced inter-protein interactions of truncated and missense PKP-2 
proteins with PG and p-catenin respectively suggests PG and p-catenin signalling may 
be affected. Q273fsX288DP expression lacking DP distal domains correlated with 
loss of DS filament association. These data suggests that expression of mutant 
desmosomal proteins leads to abnormal DS formation, thus providing the substrate for 
arrhythmia and cardiomyopathy.
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Chapter 1 -  Introduction
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1.1 Arrhythmogenic right ventricular dysplasia/ 
cardiomyopathy
1.1.1 ARVC disease, diagnosis and treatment
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary myocardial 
disease1 affecting the heart muscle. The condition was described affecting the right 
ventricle by Dalla Volta et al and later recognized by Fontaine et al as a separate 
condition (ARVD) associated with right ventricular tachyarrhythmias. The World 
Health Organization classification of cardiomyopathies assigned the term ARVC to 
include a broad spectrum of diseases featuring ventricular tachycardia, sharing similar 
basic histology, but having different clinical manifestation and outcomes1,4,5. The 
most common form of this condition, ARVD/C, results in morphological and 
functional abnormalities of the right ventricle. This is a progressive familial disease 
(in up to 50% of cases6), genetically heterogeneous, inherited in a predominantly 
autosomal dominant fashion with incomplete penetrance7 and a major cause of sudden 
cardiac death (SD). Autosomal recessive syndromes such as Naxos disease is a variant 
of the disease. ARVC is characterised by gradual loss of myocytes mainly in the right 
ventricle with transmural substitution of the myocardium with fat and fibrous tissue. 
This pathological process begins from the epicardium and extends to the 
endocardium. Although ARVC affects primarily the right ventricle, the left ventricle 
may also be affected during the course of disease progression, in which case it is 
difficult to distinguish it from Dilated Cardiomyopathy8 (DCM). ARVC affecting 
only the left ventricle is also recognized9’11.
The important morphological change in ARVD/C is a diffuse or segmental absence of 
myocardium in the right ventricular free wall, which undergoes replacement with fatty 
and/or fibrous tissue5,12,13. Two types of ARVD/C (fatty or fibro-fatty) were proposed 
based on histology of the right ventricle ; the fatty form consisted solely of fat 
replacement of the right ventricle. The fibro-fatty type is associated with a mixture of 
fibrotic tissue and fat interspersed in regions of myocyte atrophy, and is accompanied 
by myocardial thinning mainly in the infundibulum, outflow tract and the lateral 
apical regions of the right ventricular wall4,13,14 (referred to as “triangle of dysplasia”), 
and significant secondary aneurysmal dilatation and myocardial lymphocytic
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infiltration. The subtricuspid area, the epicardial left ventricle, and to a lesser extent 
the ventricular septum are all involved in the fibro-fatty ARVC type. In contrast, in 
the purely fatty ARVD form, there is a partial or complete replacement of the right 
ventricular wall with adipose tissue confined to the apex and infundibular regions and 
accompanied by normal or thickened myocardium without fibrosis, myocyte atrophy 
or inflammatory infiltrates4,13'15. The left ventricle and the intraventricular septum are 
very infrequently involved in the fatty ARVD form. The inverse relationship between 
wall stress and wall thickness may explain the increased susceptibility of the thin- 
walled RV, and the predilection of early ARVC for its thinnest portions (triangle of 
dysplasia).
Fontaine5 et al, suggested that the fatty ARVD form could represent an early stage in 
disease progression, and that focal myocarditis with myocyte cell death and 
replacement fibrosis may transform the purely fatty ARVD form to the fibro-fatty 
ARVC. Studies of hearts from fibro-fatty ARVC, fatty ARVD and control patients 
who died from non-cardiac causes were compared by Burke14 et al, this showed that 
patients with fibro-fatty ARVC were younger than those with fatty ARVD, more 
likely to have a family history of premature SD, and to be males. However, they were 
less likely to have coexisting conditions (such as atherosclerosis, diabetes epilepsy, 
asthma mitral prolapse or alcohol abuse) predisposing them to SD. Thiene et al 
however, believed that ARVD with pure fatty replacement as well as fibro-fatty 
cardiomyopathy represented a very significant cause of sudden cardiac death in 
patients less than 35 years of age13.
The assignment of a purely fatty form of ARVC in elderly patients and in obese 
young women requires caution as right ventricular fat infiltration is a frequent (>50%) 
normal finding14,16,17. Sheppard believed that fatty infiltration is an incidental finding 
in many hearts not related to death in many cases, and that this did not represent a 
spectrum of ARVD/C. In the UK ARVD is a very rare condition with only three 
pathologically confirmed cases per 600 sudden deaths found in a recent study16.
Clinical manifestation in ARVC shows phenotypic variation, depending on cardiac 
instability and progressive venous dysfunction. It may present without symptoms, or 
manifest clinically with ventricular or supra-ventricular arrhythmias of right 
ventricular origin ranging from isolated premature ventricular beats to sustained
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ventricular tachycardia (SVT) or ventricular fibrillation (VF) that leads to SD4,13,15. 
SD may be the first clinical manifestation of the ARVC and could be a major cause of 
death in young people18,19. Other clinical symptoms evident include global or regional 
dysfunction with structural alterations of the RV, ECG depolarization/repolarization 
changes (observed in right precordial leads), and progression to right or biventricular 
heart failure mimicking DCM.
ARVC prevalence varies according to the study population and it is estimated to be 1 
in 5,000 individuals, affecting threefold more males than female20,21 and usually 
manifests in adolescents and adults, although paediatric and even in-utero cases have 
also been reported ’ . In addition, the disease shows heterogeneity in relation to age- 
related progression, and an incomplete penetrance (30%23). It has been estimated that 
in the young Italian population 12-25% of SD may be attributed to undiagnosed 
ARVC213,24-26 but this is known to vary (10-40%) in different ethnic populations27,28.
Four clinicopathological phases of ARVC disease are recognised:
1) The early or concealed phase is generally asymptomatic, and may be 
characterised by subtle right ventricular structural changes with or without 
minor ventricular arrhythmias during which SD from arrhythmia may be the 
first manifestation of disease, especially in young people during competitive 
sports or intense physical exercise13.
2) The overt arrhythmic phase (or unstable phase) shows symptomatic ventricular 
arrhythmias generally of left bundle-branch block, possibly leading to cardiac 
arrest and associated with clearly discernible right ventricular morphological 
and functional abnormalities . Patients typically present with palpitation, 
syncope and presyncope29
3) The diffuse right ventricular dysfunctional phase results in extension of 
muscle disease leading to a global right ventricular failure with relative 
preservation of left ventricular function25.
4) The final phase leads to progressive bi-ventricular pump failure caused by 
pronounced left ventricular involvement. This ARVC phase mimics 
biventricular dilated cardiomyopathy of other causes leading to atrial 
fibrillation and thromboembolism.
Clinical diagnosis of ARVC is complicated, as a single diagnostic test alone is not 
sufficient to establish the disease with certainty. A definitive diagnosis of ARVC
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requires histological confirmation showing the presence of transmural fibro-fatty 
replacement of right ventricular myocardium in surgical, autopsy, or in 
endomyocardial biopsy samples. Demonstration of intramyocardial fat is not 
sufficient per se for a diagnosis of ARVC; pure adipose infiltration has been
1 7documented in a significant proportion of normal hearts . However, ARVC diagnosis 
by endomyocardial biopsy has a lower sensitivity (67%) due to the segmental and 
progressive nature of ARVC, and because the intraventricular septum area that is 
usually biopsied (for safety reason), is rarely involved in the disease.
Non-invasive clinical assessment is preferred owing to frequent need for serial studies 
to monitor disease progression, and the growing cohort of asymptomatic relatives 
requiring evaluation. A recommended work-up would involve:
• Full-history is performed with particular focus on cardiac symptoms, compilation of 
detailed pedigree highlighting instances of sudden cardiac death and unexplained 
heart failure.
• A twelve-lead ECG examining non-specific abnormalities including intraventricular 
conduction delay in the right precordial or inferior leads, incomplete RBBB, and 
complete RBBB, and specific abnormalities such as QRS dispersion and inverted T 
waves in VI to V3 (left-sided ARVC may be associated with T wave inversion in V4 
toV6).
• Two-dimensional echocardiography with administration of intravenous contrast if 
required is performed to improve endocardial definition, to visualise structural and 
functional abnormalities.
• Exercise testing to unmask ventricular arrhythmia.
• Ambulatory ECG monitoring, performed usually for 24-48 hours, to detect 
spontaneous arrhythmia. Longer term monitoring may be required in asymptomatic 
patients to capture an event.
• Cardiovascular magnetic resonance imaging (MRI) is a non-invasive tissue 
characterization technique. MRI has been shown to be an important non-invasive 
technique of diagnosing ARVD/C because its ability to detect both morphological and 
structural abnormalities of the right ventricular wall30, however, the diagnostic utility 
needs to be defined due to interobserver interpretation31. Over-reliance on presence of 
intramyocardial fat/wall thinning demonstrated by MRI without complete evaluation 
by Task Force criteria (see Figure 1,) causes a high rate of ARVD/C mis-diagnosis32. 
Thus, no single test can confirm diagnosis of ARVC1,23.
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The diagnosis of ARVC in index cases is established after evaluation of structural, 
histologic, electrocardiographic, arrhythmic, and genetic criteria that were proposed
93by a working group on ARVD/C . These diagnostic criteria (Figure 1.1, adapted from
33Paul et al) are subdivided into several major and minor criteria in each group. 
Diagnosis of ARVC requires that two major criteria, or one major and two minor 
criteria, or four minor criteria are satisfied from different groups. These criteria 
developed from tertiary centre experience with symptomatic index cases and SD 
victims were from the severe end of the disease spectrum. These guidelines are widely 
recognised to be highly specific, but lack sensitivity for early familial forms of the 
disease. The Task force guidelines nevertheless, continue to provide an outline of the 
main clinical findings in ARVC and are pivotal in confirming diagnosis in index 
cases. However, for patients that do not fulfil Task Force criteria, they cannot 
necessarily be reassured that they are unaffected. Since clinical features may develop 
or progress over time34, continued clinical follow-up may ultimately elicit an ARVC 
diagnosis.
Familial ARVC with autosomal dominant mode of transmission implies a 50% 
probability of first-degree relatives carrying the disease-causing mutation. In these 
patients, isolated cardiac abnormalities are much more likely to represent disease 
expression. Accordingly, modifications were suggested to enhance the sensitivity of 
the Task force criteria within the context of familial ARVC. The modified criteria 
target detection of milder forms of the disease and facilitate cascade screening of 
relatives.
SD is often the first manifestation of disease in over 50% of index cases. For this 
reason, surveillance of family members is critical. A periodic evaluation on a 6-12 
monthly basis from early adolescence to adulthood and beyond is advised. The full 
clinical assessment with the recommended work-up should be repeated on each 
occasion as many patients will have abnormalities in a single test but not in others, 
and certain abnormalities may only develop in later life.
Hamid and colleagues6 proposed an extended set of modified ARVC clinical criteria 
(Table 1.1) that increased the diagnostic sensitivity in evaluation of asymptomatic 
relatives of affected patients. The clinical diagnosis of the concealed phase of 
ARVD/C is often more difficult than that of the overt phase of the disease based on
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the Task Force criteria. Two international ARVD/C registries (European and 
American) have been set up to assess diagnostic criteria prospectively from a large 
population, and to integrate the genetic information.
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Figure 1.1 Task Force criteria for diagnosing ARVC
Description of the standardized diagnostic criteria for ARVC as proposed by the 
“Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of 
the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the 
European Society o f Cardiology and of the Scientific Council on Cardiomyopathies o f  
the World Health Organization” in 199423. The diagnosis o f ARVC is fulfilled if two 
major criteria, or one major plus two minor criterion, or four minor criteria from 
different groups (i.e., imaging, ECG, etc.) are present. ECG electrocardiogram; LBBB 
left bundle branch block; L V left ventricle; RBBB right bundle branch block; R V right 
ventricle. *= Detected by echocardiography, angiography, magnetic resonance 
imaging, or radionuclide scintigraphy. Figure obtained from Paul33 et al.
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Table 1.1 Proposed modification of Task Force Criteria
These modified criteria were devised for the clinical diagnosis of familial ARVC. 
Reproduced from Hamid6 et al.
* Previously >l,000/24-hr period in task force criteria.
ARVC =arrhythmogenic right ventricular cardiomyopathy; ECG = electrocardiogram; EF = ejection 
fraction; LBBB = left bundle branch block; RV = right ventricle; SAECG = signal averaged 
electrocardiography; VT = ventricular tachycardia.
ARVC in First-Degree Relative Plus One of the Following:
1. ECG T-wave inversion in right precordial leads (V2 and V3)
2. SAECG Late Potentials seen on signal-averaged ECG
3. Arrhythmia LBBB type VT on ECG, Holter monitoring
or during exercise
Extrasystoles >200 over an 24-hour period*
4. Structural or functional Mild global RV dilatation and/or EF reduction
abnormality of the RV with normal LV
Mild segmental dilatation of the RV
Regional RV hypokinesia
There is no curative treatment of ARVD/C patients. Avoidance of athletics or intense 
physical exercise is recommended as these activities hasten the progression of the 
disease. Thus, anti-arrhythmic drug therapy35'37 with or without class I or class IIIp- 
blockers is the first and frequently used approach directed at patient ventricular 
arrhythmias with a goal to prevent sudden cardiac death and other sustained 
arrhythmias which can cause syncope. The non-pharmacological therapy, including 
catheter ablation and implantable cardioverter-defibrillator (ICD) use is reserved for 
patients with life-threatening ventricular arrhythmias in whom drug therapy is 
ineffective or is associated with serious side effect. ICD is recommended for all 
ARVC patients who have experienced aborted sudden cardiac death or sustained 
ventricular arrhythmias. In ARVD/C patients who have progressed to severe right 
ventricular or biventricular dysfunction, treatment consists of therapy for heart failure 
including diuretics, ACE inhibitors, and digitalis as well as anticoagulant therapy. 
Heart transplantation may become necessary in these patients.
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1.1.2 Mechanisms of ARVC
1.1.2.1 Overview of genetic defects in ARVC
Linkage analysis showed substantial genetic heterogeneity in ARVC with the 
identification of nine chromosomal loci associated with ARVC (section 1.2 and Table
-JO
1.2). Plakoglobin and desmoplakin gene mutations were previously identified ’ as 
causative for a fully penetrant autosomal recessive form of ARVC (PG mutation, 
Naxos disease) characterized by cutaneous and follicular abnormalities, and in 
Caravajal syndrome (desmoplakin mutation), a cardiocutaneous syndrome 
characterized by palmoplantar keratoderma, woolly hair, and diffuse cardiomyopathy 
distinct from ARVC. These two mutations both in desmosomal proteins implicated 
possible involvement of other desmosomal proteins or their binding partners in 
ARVC. Desmoplakin mutations associated with autosomal dominantly inherited 
ARVC and with left ventricular cardiomyopathy were subsequently identified in a 
subset of ARVC cases (section 1.5 and Table 1.4). Studies in PKP-2 null mice (-/- 
PKP2 and -/+PKP2) provided vital clues about the role of this Armadillo protein 
suggesting early embryonic death at E l l  with profound cardiac abnormalities 
resulting from a failure of formation of normal cardiac desmosomes due to 
dissociation of desmoplakin from the abnormal junctions (section 1.7.3). Observations 
from these mice studies established an important role of PKP-2 in heart 
morphogenesis providing a rationale for a study leading to the discovery of twenty- 
five dominant heterozygous PKP-2 gene mutations in a cohort of one hundred and 
twenty ARVC patients40. This discovery highlighted possibility of further mutations 
in genes encoding other major desmosomal proteins to be involved in ARVC 
(sections 1.8.1 to 1.8.5 and Tables 1.5 to 1.7). Genetic screening of a cohort of British 
Caucasian ARVC patients undertaken in the present studies identified further four 
novel plakophilin-2 mutations41 and three novel DP mutations (section 3.5.2 Part 1.3). 
Confirmation of the importance of predominant plakophilin-2 mutations in ARVC 
was provided by numerous subsequent studies examining different ARVC cohorts 
(section 1.8.3 and Table 1.5). Following the discovery of plakophilin-2 mutations, 
other mutations were discovered in ARVC that affected genes encoding desmoglein-2 
and desmocollin-2 (sections 1.8.4 to 1.8.5 respectively) emphasizing the
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predominance of abnormalities in desmosomal proteins to pathophysiological 
mechanisms of ARVC.
1.1.2.2 Pathogenic effects of ARVC gene mutations
Mutations in genes encoding the major proteins of cardiac desmosomes (plakophilin- 
2, desmoplakin, desmogelin-2, desmocollin-2 and plakoglobin,) are believed to exert 
pathogenic effects at three different levels involving desmosome composition and 
function, organisation of junction assemblies in the intercalated disc, and perturbation 
in the Wnt/p-catenin signalling pathway. The observation that plakoglobin fails to 
localise to intercalated discs of myocardial tissue of patients with mutation in 
plakoglobin42, as well as in those with mutation in desmoplakin43 and plakophilin- 
244,45 suggests a “final common pathway” role for plakoglobin in the pathogenesis of 
ARVC45 regardless of the underlying gene mutation. The notion of PG being involved 
in a common pathway in ARVC pathogenesis is discussed further in section 1.1.2.2c. 
The general effect of different types of gene mutations on protein formation, function, 
and cellular consequences are discussed in sections 1.1.4 to 1.1.6. The possible 
pathogenic effects of ARVC gene mutations at the level of the desmosome and ID are 
discussed in sections 1.1.2.2a and 1.1.2.2b respectively
1.1.2.2a Pathogenic effects at level of desmosomes
At the level of the desmosome (section 1.3.3), pathogenic effects of gene mutations 
may result from haploinsufficiency (section 1.1.5) causing insufficient incorporation 
of a normal protein, or abolish essential inter-protein (protein-protein) interactions, or 
in the incorporation of mutant protein disturbing formation/function of normal 
desmosomes (dominant negative effects, section 1.1.4), or in reduction of the numbers 
of functional desmosomes. A recent study of myocardial biopsy ID ultrastructure 
examination of ARVC probands carrier of gene mutations encoding desmosomal 
proteins supported this contention by showing a reduction in the number of 
desmosomes and increased desmosomal length46. Desmosomal impairment might 
induce disruption of these structures resulting in reduced mechanical contacts 
mediated either directly by reduced desmosomal contacts, or indirectly by reduced 
gap junction and adherens junction contacts.
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1.1.2.2b Pathogenic effects at level of intercalated disc
At the level of the intercalated disc, desmosomes arguably protect other junctional 
complexes from mechanical stress, the pathogenic effects of mutant desmosomal 
proteins may result in the structural re-organisation at the ID, as exemplified by 
abnormal small junctions and widening of the intercellular gap in the absence of 
convolution in myocardial tissue of mutation carriers46. Perturbation in gap junction 
turnover may result from destabilisation of cell adhesion complexes at the ID, 
resulting in heterogeneous conduction and a substrate for arrhythmogenesis in 
ARVC42,43,47'49. This mechanical junction remodelling in cardiomyopathies has been 
hypothesized by Saffitz50 and colleagues to disrupt gap junction assembly 
(remodelling of gap junctions). Support for this hypothesis came from EM 
examination of ID and immuno-histochemical staining of ventricular biopsies 
obtained from Naxos disease42 (2bp PG gene deletion), Caravajal syndrome43 (lbp DP 
gene deletion), and autosomal dominant ARVC51 (3bp in-frame PG gene insertion). In 
all three cases disruption of ID junctions with a reduction in the immuno- 
histochemical staining signal of membrane localised Cx-43 protein involving 
reduction in the P2 isoform of CX-43 localising in the junctional pool of Cx-4350 
(discussed in section 1.2.5) occurred. ID remodelling may result in remodelling at the 
ID and under abnormal mechanical stress, for e.g. during intense physical exercise, 
this may cause cardiomyocyte detachment, degeneration, fatty tissue replacement and 
fibrosis.
1.1.2.2c Pathogenic effects arising from Wnt signalling
Certain proteins involved in cell-cell adhesion (section 1.3) such as p-catenin and 
plakoglobin also participate in intercellular signalling via the Wnt/p-catenin pathway. 
This is an evolutionary conserved pathway in metazoan animals that is involved in a 
variety of cellular processes, including cell fate, cell proliferation, differentiation, cell 
survival, apoptosis, cell behaviour and migration during development of tissues and 
organs52. In the canonical Wnt/p-catenin pathway, the hallmark of the pathway is the 
stabilization and nuclear localization of p-catenin. In the absence of Wnt signalling, 
the free cytoplasmic level of P-catenin is tightly regulated by multiple ligands by 
formation of a multi-molecular complex that targets p-catenin for degradation via the
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ubiquitin-proteasome complex (see Figure 1.2A). Active Wnt signalling (from soluble 
Wnt proteins) results in stabilization and cytoplasmic accumulation of p-catenin 
leading to its nuclear translocation and association with Tcf/Lef family of 
transcription factors involved in regulating gene expression . The binding of p- 
catenin to an N-terminal domain of Tcf/Lef facilitates the assembly of multimeric 
complexes containing transcription co-activators such a CBP/p300, BCL9/LGS, and 
pygo, which activates transcription of target genes54. Wnt signalling is a dynamic and 
complex process that hinges on four complexes, the first is the Wnt receptor complex 
in the membrane, the second is the p-catenin destruction complex, the third is the 
nuclear TCF/LEF/p-catenin transcriptional activator complex, and the fourth is the 
nuclear TCF/LEF transcriptional repressor complex. A simplified view of canonical 
Wnt/p-catenin signalling is that in the absence of Wnt signalling, the p-catenin 
destruction complex assembles and consequently, Tcf/Lef assembles repressor 
complexes at target genes. Binding of Wnt ligands assembles receptor complexes with 
the disruption of P-catenin destruction complex; as a consequence p-catenin is able to 
form transcription activation complexes with Tcf/Lef in the nucleus54.
PG competes with p-catenin in the canonical Wnt/p-catenin pathway55 by reduction of 
the signalling through Tcf/Lef transcription factors (see illustration in Figure 1.2B). 
Plakoglobin and p-catenin can interact antagonistically at multiple levels including 
nuclear localisation, binding to Tcf/Lef transcription factors, ubiquitination, 
phosphorylation, binding to axin and adenomatous polyposis coli, incorporation into 
adherens junctions and desmosome assembly.
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Figure 1.2 Wnt pathway and influence of PG signalling
Influence of P-catenin and plakoglobin in the Wnt signalling pathway. (A) P-Catenin (b) and 
plakoglobin (Pg) can bind, independently, to the cytoplasmic tail of cadherin adhesion receptors in 
adherens junctions (AJ). Via a-catenin (a), they mediate cadherin association with the actin 
cytoskeleton. When Wnt signaling is inactive, free P-catenin is degraded by a multi-molecular complex 
including the tumor suppressor APC, axin and glycogen synthase kinase (GSK), which phosphorylates 
P-catenin (PP). This complex associates with the ubiquitin-proteasome system via the Ubiquitin Lygase 
P-TRCP, which, together with Cull and Skpl, mediates the ubiquitination (Ub) of P-catenin and 
targets it for degradation by the proteasome. The binding of Wnt to the Frizzled (Frz) receptor activates 
Wnt signaling, and disheveled (Dsh) inhibits P-catenin turnover by suppressing GSK activity. This 
results in the accumulation of P-catenin in the nucleus, complex formation with TCF family 
transcription factors, and activation of target gene expression. (B) Plakoglobin can interact with the 
same proteins as P-catenin but, in addition, binds to the desmosomal cadherins desmocollin and 
desmoglein in desmosomes (DES), mediating their interaction, via desmoplakin (Dsp) and plakophilin 
(Pip), with intermediate filaments (IF). Plakoglobin is believed to result in a reduction in the trans­
activation of target genes in complex with TCF (shown by i  in Figure 1.2B). Figure modified from 
Zhurinsky55.
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An atrial myocyte cell line (HL-1) siRNA inhibition of desmoplakin expression 
resulting in desmosome dysfunction in this cell line was accompanied by the 
delocalisation and nuclear translocation of plakoglobin. This resulted in competition 
between plakoglobin and P-catenin leading to suppression of canonical Wnt/p-catenin 
signalling through Tcf/Lef transcription factors and upregulation of genes implicated 
in adipogenesis and generation of new collagen and accumulation of fat droplets56. 
Using Cre recombinase driven by a-MHC gene promoter with a floxed desmoplakin 
allele, cardiac-restricted desmoplakin deletion resulted in the elimination of 
desmoplakin expression in homozygous mice showing embryonic lethality at E l l 56. 
Heterozygous cardiac DP null mice developed age-dependent multichamber cardiac 
enlargement and dystrophic myocardium with excess adipocytes and fibrosis, 
increased myocyte apoptosis and cardiac dysfunction. Increased cardiomyocyte 
nuclear plakoglobin localisation and ventricular arrhythmias were observed in 
heterozygous cardiac DP null mice56. Thus, cardiac desmoplakin deficiency results in 
inhibition of canonical Wntp-catenin signalling switching cellular fate away from 
myogenesis and towards adipogenesis/fibrosis. In conclusion, current insight in 
ARVC pathogenesis suggests a common final pathway with plakoglobin 
delocalisation proposed as a key event57. Delocalisation and nuclear translocation of 
plakoglobin occurs with suppression of Wnt/p-catenin signalling. The specific 
interactions between plakoglobin and P-catenin that lead to suppression of canonical 
Wnt/p-catenin in ARVC are presently unknown. Additional transcriptional regulators 
of adipogenesis such as the Rho family of small GTPases and GATA transcription 
factors may also be involved in pathogenesis of ARVC.
Direct effects of mutations in genes encoding desmosomal proteins is probably one of 
the mechanisms involved in ARVC pathogenesis. Alternative or parallel mechanisms 
of ARVC may involve the effects of modifier gene mutations encoding other non- 
desmosomal proteins. Mutations present in the 5’ and 3’ UTR regulatory regions of
f  Q
TGFp gene and recently described missense mutation in the gene encoding 
transmembrane protein 4359 emphasize the potential role of these other gene 
mutations in ARVC. Comparison of cardiac biopsies of genotype positive individuals 
for ARVC gene mutations (including those encoding the five major desmosomal 
protein components) and of individuals with confirmed ARVC clinical diagnosis 
albeit genotype negative (lacking mutations in any of the five major cardiac 
desmosomal proteins) showed that abnormalities at the ID were present in both
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genotype positive and negative individuals. This strongly suggested that other still 
unknown disease-causing genes are likely to be involved in ARVC pathogenesis46 and 
that a broad spectrum of ARVC forms would be required to be considered as 
intercellular junction cardiomyopathies arising from predominance of cell junction 
abnormalities at the ID.
A naturally occurring canine model of ARVC with autosomal dominant mode of 
inheritance arising in Boxer dogs shares similarities with human ARVC2 including 
presentation of concealed phase, overt, and myocardial dysfunctional phases of the 
disease, sudden cardiac death, ventricular tachyarrhythmias of RV origin, syncope, 
RV myocyte loss, fibro-fatty infiltrate found predominantly in the RV, myocarditis, 
and apoptosis60. This canine model of ARVC showed substantial loss of Cx-43 
protein gap junctions as well as remodelling of other intercalated disc structures61 and 
examination of DP, DSG-2, PKP-2, PG, and Cx-43 genes did not reveal causative
£1 f*)mutations in the coding and flanking regions of these genes ’ . However, of the “big 
five” genes encoding desmosomal proteins it still remains to determine whether 
mutations in DSC-2 gene could account for ARVC in this animal model61.
1.1.3 ARVC apoptosis and replacement fibrosis
Other basic mechanisms of ARVC include apoptotic cell death and inflammation 
ranging from acute myocarditis to fibrous healing which in severe form of ARVC 
may affect both ventricles leading to congestive heart failure mimicking DCM7,15.
ARVC was initially suggested to be a milder form of Uhl’s anomaly, a congenital 
hypoplasia of the right ventricular myocardium where incessant apoptosis was 
believed to cause a partial or complete loss of the myocardium65. ARVC pathogenesis 
is thought to differ from that of Uhl’s anomaly by episodic focal apoptosis occurring 
at any time in life, resulting in myocyte cell death and islands of residual conducting 
myocytes interspersed with fibro-fatty areas. This provides the arrhythmogenic 
substrate accounting for the delay in intraventricular impulse transmission, persistence 
of electrical depolarization during diastole (late potentials) and onset of re-entrant 
circuits with premature ventricular beats and ventricular tachycardia of left bundle- 
branch block morphology. Thus, cardiomyocyte apoptosis may be involved in
32
arrhythmias and sudden cardiac death. Apoptosis would culminate in replacement 
fibrosis superimposed on fatty replacement during repair as terminally differentiated 
cardiomyocytes have a limited capacity for cellular proliferation.
Various studies have shown apoptotic cell death in ARVC associated with 
cardiomyocyte loss in the myocardium63,64,66'71, but it remains unresolved whether 
apoptosis in ARVC is a cause or effect of the disease. The study of Mallat et al 
showed that myocyte apoptosis was frequently found in areas which have not 
undergone fibro-fatty replacement and very rarely in areas already affected. This 
suggested that apoptosis might be a primary process preceding fibro-fatty 
replacement. Recent EM examination of ARVC patient cardiac biopsies provided 
evidence of early expression of myocyte apoptosis46 indicated by the presence of
79convoluted nuclei previously described .
1.1.4 Cellular consequences of gene mutations
Gene mutations are predicted to lead to either loss of function (proteins have reduced 
or no function) or result in gain of function (proteins may do something positively 
abnormal). For heterozygous autosomal dominant mutations, 50% of normal level of 
the protein may not be sufficient for normal function, and haploinsufficiency 
produces an abnormal phenotype from an autosomal dominant inheritance. 
Sometimes also, a non-functional mutant polypeptide interferes with the function of 
the normal allele in a heterozygous individual, giving a dominant negative effect. 
Gain of function mutations usually cause dominant phenotypes, because the presence 
of a normal allele does not prevent the mutant allele from behaving abnormally. This 
may often involve a control signalling system behaving inappropriately -  signalling 
when it should not, or failing to switch off a process when it should.
Mutations at the gene level arise from a wide variety of sequence variations; they may 
be missense/nonsense mutations resulting in a single nucleotide change causing a 
codon to encode for a different amino acid from the one encoded in the normal wild 
type sequence, or for a codon to result in unscheduled termination (TAA, TAG, or 
TGA). Missense mutations could be disruptive to protein structure (exerting affect on 
folding of secondary structures) if the amino acid replacement results in a change of
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character (hydrophobic: non-polar, polar: hydrophilic, charged: negative, charged: 
positive) of the substituted amino acid compared to the amino acid normally found. 
Missense mutation may also disrupt a site involved in inter protein-protein 
interactions (for example, desmoplakin missense mutation R2834H disrupts the 
interaction between DP and desmin intermediate filament). Missense mutations could 
also result in gain of function if  it affects potential phosphorylation sites on serine, 
threonine, and tyrosine amino acid residues modified post-translationally, which may 
be involved in signalling function of the protein. Missense gene mutations disrupting 
an exonic spicing enhancer may also cause ffameshift resulting in premature 
termination codon; that would lead to nonsense mediated mRNA decay (discussed 
further in sections 1.1.5 and 1.5.3) motif. Splice site mutations resulting in single 
nucleotide change affecting a donor splice (ds) site or an acceptor splice (as) located 
within introns may cause aberrant splicing with the retention of an intron sequence in 
pre-mRNA, exon skipping, or activation of cryptic splice site on an exon resulting in 
incorporation of a truncated exon. For examples of the effects of these splice site 
mutations in PKP-2, DSG-2, and DSC-2 see Table 1.5 (section 1.5.3), Table 1.6 
(section 1.5.4), and Table 1.7 (section 1.5.5) respectively. The nomenclature for 
assigning splice site mutations are covered in chapter three (section 3.4.1 Part 1.1 and 
Figure 3.1) Mutations affecting 5’ UTR or 3’UTR gene sequence could affect 
regulation at the level of gene expression. These UTRs may contain regulatory 
elements important in determining the level of gene expression, and mutations found 
in the regulatory regions of TGFp58 underline the effects of such mutations in ARVC. 
Small deletions (microdeletion < 20 bp) or small insertions (microinsertion < 20 bp) 
may result in out of frame (ffameshift) mutations leading to insertion of aberrant 
amino acids followed by PTC or sometimes in the extension of translation frame 
resulting in the addition of novel additional amino acids at the end of the normal 
protein sequence. Gross deletions may result in deletion of an entire exon, deletion of 
several exons, or even deletion of an entire gene. Gross insertions may result in 
duplication of single exon, multiple exons or even duplication of an entire gene. A 
vast majority of mutations affecting genes encoding for desmosomal proteins result in 
ffameshift or nonsense mutations -  these cause premature termination codons (PTCs) 
which would result in formation of truncated protein or polypeptides with deleterious 
functions. Specific mechanism exists to eliminate mRNA containing PTCs as a means 
of preventing formation of these deleterious proteins. These mechanisms are 
discussed in the next section.
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1.1.5 Nonsense-mediated mRNA surveillance
Nonsense-mediated mRNA decay (NMD) is an evolutionary conserved quality 
control pathway existing in all eukaryotes examined . This pathway selectively 
targets the degradation of mRNAs harbouring PTCs more than 50-55 nucleotides
•J A nO
upstream of a splicing generated exon-exon junction ' , however there are 
exceptions to this rule. Approximately 33% of inherited and acquired diseases are 
attributable to PTCs that truncate the open reading frame (ORF) and precludes the 
synthesis of full-length protein79. NMD blocks the translation of these mRNAs 
thereby preventing truncated proteins with dominant-negative or deleterious gain-of- 
function activities from forming.
PTCs arise in variety of ways including alteration to germ-line or somatic DNA 
resulting in random ffameshift and nonsense mutations that are subsequently 
transcribed into mRNA. Frameshift mutations that are insertions or deletions not of 
multiple-of-three base pairs within an ORF can result in PTCs. Single base mutation 
that converts a sense codon into a nonsense codon also generates a PTC. Mutations at 
intron and exon boundaries that result in inefficient or inaccurate intron removal from 
pre-mRNA can create an intron-derived PTC or a shift in the ORF and a PTC 
downstream of the shift80,81. Another common source of PTCs is errors in RNA 
splicing, including aberrant alternative splicing73,79,82,83.
Mechanistically, NMD is a complex process with the initial signal marking mRNA 
transcript for rapid decay requiring an intron downstream of a PTC for mRNA 
degradation to occur by the NMD machinery. The second signal targeting the 
transcript for NMD results from the deposition of a dynamic multi-protein complex 
(containing at least ten proteins, with the core NMD components consisting of three 
trans-acting factors, called upframeshift proteins (UPF)) 20-24 nucleotides upstream 
of exon-exon junctions on mammalian mRNAs during splicing, which defines a stop 
codon as a PTC. Interaction between this exon-junction complex (EJC) and NMD 
factors assembled at the upstream stop codon triggers a series of steps that ultimately 
lead to rapid mRNA decay.
Most mammalian mRNAs are down regulated by NMD in the nucleus or soon after 
entering the cytoplasm. Normal transcripts escape NMD because all EJCs are
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deposited upstream of the stop codon, permitting the ribosomes to displace them. 
Aberrant transcripts harbouring PTCs, in contrast, have at least one EJC downstream 
of the PTC, thereby triggering NMD. Figure 1.3 illustrates the mechanism of NMD of 
transcript harbouring PTC and explains how mRNA transcripts containing genuine 
termination codons escape NMD. Figures 1.4-1.5 illustrates the downstream 
molecular processes involved in NMD. PTC-harbouring mRNA decay is elicited if 
factors that constitute the second signal (such as the EJC) are allowed to interact with 
factors bound at the stop codon. This does not occur in normal transcripts because the 
second signal factors are probably all stripped off by the ribosome. NMD is a highly
TXconserved pathway that exists in all eukaryotes examined .
Recent studies have shown the existence of three alternative branches of the NMD 
pathways. The first that is independent of UPF2, the second that is independent of 
EJC core proteins instead depending on alternative RNA-binding proteins and a third 
that is independent of the UPF3a and UPF3b EJC factors. Some novel NMD second 
signals may exist as in some mammalian transcripts, such as human p-hexosaminidase 
and mouse Ig-p, NMD occurs efficiently even when an exon-exon junction does not 
follow the PTC.
1.1.6 Nonsense-associated altered splicing
In addition to triggering NMD, premature termination codons are also found to alter 
the splicing pattern often leading to skipping of the PTC-containing exon The term 
“nonsense-associated altered splicing” (NAS) is used to describe such changes in 
splicing caused by PTCs. In many cases, NAS is induced because of the destruction of 
an exonic splicing enhancer (ESE, discussed further in section 1.5.3) by the PTC- 
generating nonsense or ffame-shift mutation. However, for a few genes, NAS appears 
to be PTC specific indicating that premature termination of the translational reading 
frame affects splicing.
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Figure 1.3 Recognition of mRNA transcript destined 
for NMD
Mammalian nonsense-mediated mRNA decay (NMD) occurs because of PTC recognition during a 
unique “pioneer” round of translation. NMD is specifically triggered when up-ffameshift protein 1 
(UPF1, labelled 1) is allowed to interact with UPF2 (2), which is bound to UPF3b (3b). UPF2 and 
UPF3b are both part of the EJC, which is recruited to exon-exon junctions (not shown) during mRNA 
splicing. In an aberrant transcript {left panels), there is typically at least one EJC deposited downstream 
of the premature stop codon, allowing it to interact with UPF1 recruited by cap-binding complex 
(CBC) and the eukaryotic release factors eRFl and eRF3 (eRF). The interaction between UPF1 and 
UPF2 is enhanced by CBC, which is bound to the 5’ cap of mRNAs undergoing the pioneer round of 
translation. In contrast, a normal transcript {right panels) avoids NMD because all of the EJCs (only 
one is shown) are upstream of the stop codon and are thus displaced by the ribosome before UPF1 is 
recruited. After surviving this proofreading step, normal transcripts exchange proteins at both their 5’ 
and 3’ ends and proceed to bulk translation. Reproduced from Chang74 et al.
37
Figure 1.4 Early molecular events initiating NMD
Early molecular events preparing an mRNA to be degraded by nonsense-mediated mRNA decay 
(NMD). Translation of an mRNA during the pioneer round of translation (step 1; also see Figure 1.3) 
leads to recognition of the stop codon by the eukaryotic release factors eRFl and eRF3, which recruit 
the NMD factor UPF1 (labelled 1; step 2). UPF1, in turn, recruits the protein kinase SMG-1 (SI), 
which together with the eRFs forms a transient complex called SURF (step 3). In an aberrant mRNA 
like the one shown, the SURF complex interacts with an EJC downstream (step 4). This interaction 
may be an obligate requirement for SMG-1 phosphorylation of UPF1 (step 5), which then probably 
triggers subsequent steps that ultimately degrade the mRNA (see Figure 4) and recycles release factors 
and the 40S and 60S ribosomal subunits (step 6). Abbreviations: CBC, cap-binding complex; EJC, 
exon-junction complex; SI, protein kinase SMG-1; SMG-1, suppressor with morphogenetic effect on 
genitalia-1; SURF complex, the SMG-1, UPF1, eRF complex; UPF1 (labelled 1), UPF2 (labelled 2), 
UPF3b (labelled 3b), up-ffameshift proteins. Reproduced from Chang74 et al.
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Figure 1.5 Late molecular events culminating NMD
Late molecular events in nonsense-mediated mRNA decay (NMD) that ultimately degrade the mRNA. 
The phosphorylation of UPF1 recruits the SMG-5/SMG-7 heterodimers (labelled S5 and S7, 
respectively) and the phosphatase PP2A (steps 1 and 2). It is uncertain whether PP2A is initially 
associated with SMG-5/SMG-7 (as shown) or recruited at a later stage. Unknown events (perhaps P- 
body recruitment) trigger PP2A de-phosphorylation of UPF1 (step 3), which is likely to lead to the 
dissociation of PP2A and SMG-5/SMG-7 from the mRNP (step 4). Also unknown is what specific 
event leads to loss of the mRNA 5’ cap by Decapping enzymes (Dcp, step 3). Decapping may be 
triggered by the recruitment of SMG-7, which is sufficient to elicit mRNA decay when artificially 
tethered to an mRNA. Alternatively, Decapping may be triggered by UPF1 de-phosphorylation. 
Regardless, once Decapping occurs, the mRNA body is susceptible to rapid decay by 5’-to-3’ 
exonucleases (Xm, step 4). Abbreviations used were CBC, cap-binding complex; EJC, exon-junction 
complex; SI, protein kinase SMG-1; UPF1 (labelled 1), UPF2 (labelled 2), UPF3b (labelled 3b), up- 
frameshift proteins. Reproduced from Chang'4 et al.
39
1.2 Genetics of ARVC
This section provides an overview of the genetics of ARVC; gene mutations affecting 
desmosomal proteins are covered in section 1.3. Several chromosomal locations were 
recognized by linkage studies in various kindreds with ARVC. Thus, nine separate 
chromosomal loci 57,84 were identified on chromosomes 1, 2, 3, 6, 10, 12 and 14, with 
two separate loci found each on chromosomes 10 and 14. These resulted in 
classification of eight ARVC subtypes (ARVC 1 to 8) and an associated recessively
O'}
inherited condition called Naxos disease (Table 1.2, modified from Paul et al).
In ARVC1, most frequently found in Northern Italy region, fourteen families were
or
diagnosed with this disorder. Rampazzo and Colleagues screened four candidate 
genes within the ARVC1 locus, including TGFP3, but did not find mutations within
C O
the coding regions of the four genes examined. Beffagna and colleagues, however 
reported mutations in the 5’ and 3’ untranslated regulatory sequences of TGFP3 
purportedly causing an over-expression of TGFP3. The lack of TGFp3 mutations in 
two kindreds with ARVC1 linkage and absence of confirmation of TGFP3 over­
expression in cardiac biopsy samples from affected patients in this study makes 
significance of the molecular role of TGFP3 mutations in ARVD1 uncertain. This 
gene mutation was not directly associated with adherens or desmosomal cell junction 
(discussed in section 1.2) components; a possible link between TGFp3 over­
expression and TGFp3-induced fibrosis in vivo in ARVC however, was made in this 
study. It was also speculated that TGFp3 over-expression may indirectly affect cell­
cell junction stability via a possible modulation of cell adhesion molecules, known to 
occur in the case of TGFpl exposed cardiac fibroblasts86 and brochial epithelial87 
cells where increased levels of plakoglobin gene expression and of desmoplakin I and 
II protein occurred respectively.
The cardiac ryanodine receptor gene RyR2 has been shown to be involved in the 
pathogenesis of familial ARVC288 which is now known to have features typical of 
stress-induced catecholamine-dependent ventricular tachyarrhythmia syndrome rather 
than ARVD. The RyR2 gene product encodes a 565 KD monomer that interacts with 
four 12 KD FK-506 binding proteins (FKBP12.6) playing a crucial role in calcium 
regulation and excitation-contraction coupling88. RyR2 induces Ca2+ release from the
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sarcoplasmic reticulum into the cytoplasm, and has been shown to be responsible for 
catecholamine induced ventricular tachycardia89,90.
In 13 out of 37 members of three unrelated families of Italian, Slovenian and Belgian 
descent examined by Severini91 et al, ARVC3 (provisionally referred to as ARVC2 by 
the authors) was mapped to the 14ql2-q22 on chromosome 14. In three Italian 
families examined a new ARVD4 locus was mapped to 2q32.1-q32.3. Linkage 
analysis in an extended eight generation family from a genetically isolated population
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of the island of Newfoundland, Canada identified ARVD5 on 3p23. The laminin 
receptor-1 gene (LAMR1) was implicated in a mouse model for AVRD94. The 
LAMR1 gene mapped to 3p21.3 was implicated as a possible candidate gene in 
ARVD5. However, the gene responsible for ARVD5 mapped at 3p25 in fifteen 
unrelated families from a genetically isolated population of the island of 
Newfoundland, Canada was identified to encode a transmembrane protein 43 
(TMEM43 protein)59. In a North American family spanning 5 generations and having 
12 affected individuals with early-onset ARVC (> lOyears age) and high penetrance, 
an ARVD6 locus was mapped to 10pl2-pl495. In a linkage study of 12 patients from a 
Swedish family96 with desmin-related myopathy and ARVC, an ARVD7 locus was 
mapped to 10q23.3. Several of these patients had episodes of chest pain or 
palpitations, and three affected males showed ARVC with non-sustained ventricular 
tachycardia, atrial flutter, and dilatation mainly of the right ventricle. A recent study97 
has shown mutations in the ZASP gene (LDB3) in patients with myofibrillar 
myopathy, some of whom had cardiac involvement. This study raises the possibility 
that the ZASP gene located on 10q22.3 might be a candidate gene in the Swedish 
family studied by Melberg96 et al. In an Italian family study39, the ARVD8 locus was 
mapped to 6p24 and a causative mutation (S299R) identified in exon 7 of the gene 
encoding desmoplakin.
A similar phenotypic expression occurs in all ARVC subtypes (with the exception of 
ARVC7) with left bundle branch block, T wave inversion in the right precordial leads, 
and presence of late potentials in signal averaged electrocardiography23,98.
In the late nineties, positional cloning identified mutations in genes encoding DP in 
ARVC8, RyR2 in ARVC2, and PG in Naxos. Thus, at the start of the work described 
in this thesis (January 2004), the above two aforementioned genes encoding
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desmosomal proteins were known to be involved in dominant ARVC8 and recessive 
Naxos disease. This raised the possibility that further desmosomal gene mutations 
may be involved in ARVC. In September 2004, Gerull40 et al described twenty five 
novel PKP-2 mutations in one hundred and twenty unrelated Caucasian ARVC 
patients. TGF-P mutations affecting the untranslated region of the gene discovered in
co
ARVC1 were reported in the year 2005 showing involvement of a second non- 
desmosomal protein in ARVC . In the following two years after discovery of PKP-2 
mutations further mutations in genes encoding DSG-2 and DSC-2 were identified 
independently in different ARVC cohorts46,99'104. All three mutations affecting PKP-2, 
DSG-2, and DSC-2 genes were thus, identified by DNA screening approach. The 
genetic screening work described in this dissertation supports the involvement of DP 
and PKP-2 genes in familial ARVC with the discovery of further four novel mutations 
in plakophilin-2 and another three novel mutations in desmoplakin (section 3.4.1 
Parti). Mutations in genes encoding all five cardiac desmosomal proteins (PKP-2, 
DP, DSG-2, DSC-2, and PG) indicate that ARVC is a multigenic disorder caused by 
abnormal cell-cell adhesion resulting from defects in desmosomes (section. 
Identification of genes at other ARVC loci may be hampered by difficulties in 
accurate ARVC clinical diagnosis and incomplete penetrance of the disease even 
between members of the same family. The discovery of a mutation (c.1073C>T) in 
the TMEM43 gene causing a missense protein sequence change (p.S358L TMEM43) 
in ARVC5 in March 200859 supports the suggestion that other non-desmosomal 
proteins may be involved in the pathogenesis of ARVC. Although little is known 
about the function of the TMEM43 gene it contains a responsive element for PPARy, 
an adipogenic transcription factor, which may explain the characteristic fibro-fatty 
replacement of the myocardium seen in ARVC.
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Table 1.2 ARVC chromosomal loci and identification of causative genes
? = not determined or not known. Table modified from Paul33 et al. Highlighted in yellow are causative genes (PKP2, DSG-2 and DSC-2 and PG) identified by DNA 
screening o f various ARVC cohorts.
Type Chromosomal Loci LOD
score
Mode of inheritance Penetrance Gene Author/Reference
ARVC1 14q23-q24 5.4 Autosomal dominant High 5’&3' UTR 
mutations TGFp3
Rampazzo105
Beffagna58
ARVC2 1 q42-q43 4.0 Autosomal dominant High RyR2 Rampazzo106
ARVC3 14q12-q22 4.7 Autosomal dominant ? ? Severini91
ARVC4 2q32.1-q32.3 3.5 Autosomal dominant ? ? Rampazzo92
ARVC5 3p23 6.9 Autosomal dominant Fully penetrant TMEM43 Ahmad93, Memer59
ARVC6 10p12-p14 3.9 Autosomal dominant High ? Li95
ARVC7 10q22.3 3.1 Autosomal dominant ? ? Melberg96
ARVC8 6p24 4.32 Autosomal dominant -50% Desmoplakin Rampazzo39
ARVC/PKP2 12p11 Autosomal dominant 
Autosomal recessive
Incomplete Plakophilin-2 Gerull40, Syriss41, Van Tintelen107, 
Dalai108, Nagaoka109, Antoniades110, 
Kannankeril111, Lahtinen112
Awad113
ARVC/DSG-2 Autosomal dominant High Desmoglein-2 Pilichou104, Syrris101, Awad100, Basso46
ARVC/DSC-2 Autosomal dominant Incomplete Desmocollin-2 Syrris102
Heuser103
ARVC/PG Autosomal dominant Plakoglobin Asimaki51
Naxos disease 17q21 3.6 Autosomal recessive 100% Plakoglobin Coonar114, McKoy38
1.3 Cell-Cell Adhesion
1.3.1 Intercellular Junctions overview
Intercellular junctions include morphologically distinct types mediating cell-cell 
interactions. Adhering junctions are cadherin-containing intercellular junctions, which 
contribute to the mechanical strength of tissues and enable morphogenetic changes 
during development. They are characterised by a 10-30nm thick dense cytoplasmic 
plaque where bundles of cytoskeletal filaments are inserted. Two different types of 
junctions can be distinguished based on morphology and molecular composition: the 
desmosomes (DS, maculae adherentes) and the adhaerens junctions (AJ, zonula 
adhaerens, fascia adhaerens, punctum adhaerens) are found in variety of tissues, 
including epithelia. The molecular assemblies in these two types of junctions are 
illustrated schematically in Figure 1.6b-c. Other types of specialized adhaerens 
junction forms occur in certain vascular and lymphatic endothelia (cinctus adhaerens 
and complexus adhaerens), in lens cells (cortex adhaerens) granule cells of the 
cerebellar glomerulli (contactus adhaerens). DS and AJ are clearly distinguished by 
the type of inserting cytoskeletal filament and the cadherin molecules participating in 
these junctions (Table 1.3 & illustration in Figure 1.6). Cadherins are single-pass 
transmembrane proteins that mediate Ca -dependent adhesion. The extracellular 
domains of cadherins on opposing cell surfaces interact with one another, while their 
cytoplasmic domains are linked to the cytoskeleton, thereby mechanically coupling 
the cytoskeleton of adjacent cells. Classical cadherins such as E-, N-, P-, M- and VE 
participate mainly in homophilic interactions in AJ’s, whereas in DS two different 
cadherins, the desmogleins (four subtypes DSG1-4) and desmocollins (three subtypes 
DSC 1-3) participate in homophilic (DSG-DSG or DSC-DSC) or heterophilic (DSG- 
DSC) interactions. Desmocollin 1-3 additionally exists in two splice variant isoforms 
referred to as a-form and b-form, resulting in a shorter cytoplasmic cadherin domain 
for the b-form, which lacks the PG-binding site. Desmosomal cadherin subtype or 
isoform expression is tissue-type specific and is tightly regulated during 
morphogenesis and differentiation.
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Table 1.3 Molecular distinction between Adhering 
Intercellular Junctions
Cell-Cell
junction
T ransmembrane 
linker
Extracellular
connection
Intracellular
connection
Intermediate
binding
molecules
Adherens
Junctions
‘Classical’ 
Cadherins, Type I 
or Type II
Cadherin on the 
other cell 
Mostly 
homophilic 
interactions
Microfilaments, 
e.g. Actin
a  & P-catenin, 
a-actinin, 
vinculin, 
plakoglobin, 
pi 20 catenin
Desmosomes Desmosomal 
Cadherins, 
Desmoglein and 
Desmocollin
Cadherin on the 
other cell. 
Heterophilic 
interactions
Intermediate 
filaments e.g. 
Desmin, 
Vimentin, 
Keratin
Desmoplakin, 
plakoglobin, 
plakophilins & 
other ‘minor’ 
components, e.g. 
Desmocalmin, 
Pinin, etc
1.3.2 Adherens Junction
The adherens junctions found near the apical surface of polarized epithelial cells 
contain Type I or II cadherins (type I distinguished by histidine, alanine, valine, 
(HAV) tripeptide present in EC1 repeat region), which promote mainly, but not 
exclusively homophilic interactions. At the cytoplasmic face of the junction, p-catenin 
or plakoglobin interacts directly with the core region of 30 amino acids within the C- 
terminus of the cadherin cytoplasmic domain115,116. Both proteins are part of the ARM 
repeat family of proteins, sharing 65% homology and are thought to directly substitute 
for one another as structural components of AJ I17‘119. Both proteins consist of N- and 
C- terminal tails flanking a central twelve ARM repeat domain consisting of 
approximately 42 amino acids per ARM domain that mediates binding to the cadherin 
cytoplasmic domain. Huber120 et al showed that the 3-D structure of P-catenin 
consisted of three alpha helices per ARM repeat that are packed against one another to 
form a super helix featuring a positively charged grove, that interacts with the C- 
terminal 100 amino acid residue of the cadherin cytoplasmic domain121.
a-catenin, a protein structurally related to vinculin, provides a direct link to the actin 
filament cytoskeleton by binding to the N-terminal region of either P-catenin or 
plakoglobin122. Both the N- and C- terminus of a-catenin participate in connecting the 
cadherin complex to the cytoskeleton123. a-catenin interacts with actin filaments both
indirectly through actin-binding proteins such as a-actinin, vinculin, VASP and ZOl, 
and directly through interactions with actin filaments. In addition to P-catenin and 
plakoglobin, p i20 catenin, another member of the armadillo protein family has been 
shown to bind the highly conserved juxtamembrane domain of cadherin124. Catenin 
p i20 does not participate structurally in the junctional complex, but it is thought to 
participate in regulating cadherin adhesive activity. Numerous splice variants of p i20 
catenin exist and homologues of p i20 catenin, including ARVCF (armadillo repeat 
gene-deleted in Velo-Cardio-Facial Syndrome), 8-catenin and p0071 (plakophilin 4) 
are also localised to adherens junctions and may function in a similar manner to p i20 
catenin.
1.3.3 Desmosomes
Desmosomes are intercellular junctions that are particularly prominent in tissues 
experiencing mechanical stress, such as the heart and epidermis. Desmosomes link IF 
to desmosomal cadherins and by tethering these stress-bearing cytoskeleton filaments 
to the plasma membrane, they serve as integrators of the IF cytoskeleton throughout 
the tissue, resulting in the formation of a supracellular network, which is critical for 
imparting mechanical integrity to tissues. Disease and animal models targeting 
desmosomal components underline the importance of desmosomes in development 
and tissue integrity, while down regulation of individual protein components in cancer 
metastasis and wound healing suggests their importance in cell homeostasis.
The desmosome is a symmetrical structure comprising two adjacent plasma 
membranes that sandwich a 30-nm intercellular space bisected by a central dense 
stratum or midline and are flanked by mirror-image tripartite electron-dense 
plaques124. Each half plaque comprises a total width of up to 50 nm. The core of the 
desmosome, containing the plasma membrane and intervening material, contains 
transmembrane and extracellular domains of desmosomal cadherins. The outer dense 
plaque (ODP), a 15- to 20-nm thick electron-dense region adjacent to the plasma 
membrane, is separated by less than lOnm from a 20 nm thick inner dense plaque 
(IDP), the later of which is intimately associated with a meshwork of intermediate 
filaments (Figure 1.6d-e). The ODP and IDP contain the cytoplasmic tails of the 
transmembrane cadherins and associated cytoplasmic proteins125.
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Figure 1.6 Adherens junction & desmosome structure
Electron micrograph (a) showing desmosome (asterisk) and adherens junction 
(arrow) in keratinocytes and the schematic illustration of association of molecular 
components in AJ (b) and DS (c). In the lower figure, (d) shows protein composition 
(standard abbreviations used) in various regions identified in electron micrograph of a 
typical desmosome (e). Reproduced from review articles126,127.
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Figure 1.7 Schematic Illustration of heart muscle and the intercalated disc
Illustration on the left is a schematic diagram o f  the ultrastructure o f  the heart muscle in the region o f  an intercalated disk. Contact between cells is 
accom plished by interdigitation in the vertical region and is smooth in the horizontal plane (HP). On the right the intercalated disc: Two regions can be 
identified in the stepwise junctions: A transverse portion which runs across the fibres at right angles and a lateral portion running parallel to the myofilaments. 
The junctional specializations m aking up the intercalated disk com prises fascia (A) adherens in the transverse portion o f  the disk, which serves to anchor actin 
filam ents o f  the terminal sarcom eres to the plasma lemma. The desm osom es (B) found primarily in the transverse portion o f  the disk, binds cells together, 
preventing their separation during contraction cycles. The gap junction (C) restricted to the lateral portion o f  the disk (that area subjected to least stress) 
ionically couples cells and provides for spread o f  contractile depolarization. The significance o f  ionic coupling is that chains o f  individual cells behave as a 
syncytium, allowing the signal to pass from one cell to the other. Reproduced from M arshall128
DS are present in epithelia of many tissues, within the intercalated disks of the heart, 
follicular dendritic cells of the lymph nodes, and in the arachnoid plexus of the 
meninges129. DS can be associated with keratins (in epidermal keratinocytes), 
vimentin (in mesenchymal cells, for e.g., dendritic reticulum) or desmin (in 
cardiomyocytes) IF’s, demonstrating their versatility in IF-binding. The molecular 
composition of desmosomal plaque and core components varies among tissues and 
within complex stratified epithelial tissues. A related structure, the complexus 
adhaerentes, is found in the lymphatic endothelium and in the sinus of lymph nodes. 
This structure is unique, containing a classical cadherin and the desmosome
icomponents desmoplakin and plakoglobin .
The extracellular domains of both types of desmosomal cadherins, desmogleins, and
“ji
desmocollins are necessary for initiating Ca -dependent cell-cell adhesion through
their heterophilic interactions. Their cytoplasmic tails associate with proteins
belonging to the armadillo family of proteins: plakoglobin and plakophilin, which link
to desmoplakin. Desmoplakin in turn binds to the IF cytoskeleton131,132, affording
strength to the desmosomal junction. Different IF proteins interact with desmoplakin
1 ^via distinct sequences in different IF domains . Besides desmoplakin, other proteins 
found in the inner dense plaque include plectin, envoplakin and periplakin, all part of 
the plakin family of proteins134,135. Little is known about the spatial organisation of 
other minor protein components of desmosomes such as desmocalmin, pinin, 
keratocalmin134, desmoyokin and erbin136.
1.3.4 Intercellular junctions in cardiomyocytes -  the 
intercalated disc
Large intercellular junction complexes known as intercalated discs (ID) that play a 
critical role in both electrical and contractile functions of the heart connect individual 
ventricular cardiomyocytes. Cardiomyocytes are highly differentiated bipolar cells 
that are almost completely filled with contractile elements, the myofibrils. Two 
classes of junctions are believed to assemble in the ID, the first are the plaque bearing 
adhering junctions and the second type is the gap junctions. Until very recently, it was 
assumed that two quite distinct and separate types of adhering junctions were 
assembled in the ID. The first type consisted of fasciae adherentes (or adherens 
junction, AJ) which anchor the contractile myofibrils with N cadherin enabling
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transmission of contractile force, and the second type are the desmosomes (DS) which 
provides anchoring sites for desmin intermediate-filament to the desmosomal 
cadherins (DSG2 and DSC2) imparting the cohesiveness, resilience and integrity to 
the tissue. Finally, the gap junctions (GJ, discussed in the following section) 
constituting the non-plaque bearing intercellular junction found in the ID are 
responsible for the electrical coupling and transfer of small molecules between 
myocytes. All three types of junctions, AJ, DS, and GJ are believed to assemble as 
shown in Figure 1.7. The schematic structures of the adhering type of cell-cell 
junctions are shown in Figure 1.6.
However, the assumption that two discrete adhering type junctions are present in the
117 ncID was challenged in recent studies ’ . Examination of mammalian (human,
bovine, rat and mouse) and non-mammalian (chicken, amphibia and fish) cardiac 
tissue by immunoelectron microscopy suggested that desmosomal proteins 
(desmoplakin, plakophilin-2, plakoglobin, desmocollin-2, and desmoglein-2) were not 
restricted to desmosome-like structures, but they also occurred in many, perhaps all, 
of the other adhering junctions of ID, thus occupying a very large proportion of the ID 
membrane. Furthermore, immunofluorescence and immunoelectron microscopic 
examination of myocardia of diverse mammalian species (human, cow, rat and 
mouse) established desmoplakin and other desmosomal proteins to occur in these 
adhering junctions in close proximity or even co-localise with N-cadherin, cadherin- 
11, a-catenin, p-catenin, vinculin, afadin, pl20ctn, ARVCF, p0071, and ZO-1. Thus, 
it was concluded that the predominant type of adhering junctions present in ID is a 
unique ‘hybrid’ junction type termed area composita that is characterized by an 
unusually high molecular complexity with an intimate association of molecules of 
both ensembles, the desmosomal one and of ih&fascia adhaerens category137.
1.4 Cardiac gap junctions and connexin-43
Gap junctions (GJ) are intercellular channels 1.5-2 nm in diameter. These permit the 
free passage of ions and small molecules between the cells, up to a molecular weight 
of about 1KD and allow the conduction of action potentials between cardiac myocytes 
leading to synchronized electrical propagation ensuring the rhythmic pumping of the
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heart. Gap junctions are also involved in metabolic coupling between cells and are 
important in intercellular communication during organogenesis.
Figure 1.8 Ultrastructure of rat ventricular myocyte ID
Thin-section electron micrograph of rat ventricular myocytes intercalated disk 
illustrating the organization of desmosomes (d)), fascia adherentes junctions (fa), and 
the gap junctions (gj). Fasciae adherentes junctions mechanically couple the 
myofibrils (contractile apparatus) o f the adjacent cells; desmosomes serve as anchor 
points for the desmin cytoskeleton. Gap junctions are situated in the membrane 
segments between the fasciae adherentes. Scale bar = 1 pm. Reproduced from 
Severs139.
Gap junctions, adhaerens junctions, and desmosomes are spatially organized at the 
intercalated disks. The disks join abutting myocytes in a step-like structure so that the 
myofibrils of consecutive cells are mechanically joined in series at the fasciae 
adherentes junctions, i.e., in the vertical segments o f disk steps. The gap junctions are 
located predominantly in the longitudinal segments o f the steps. Desmosomes, which 
link to the desmin intermediate filament cytoskeleton, are found in association with
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both the gap junctions and the adhaerens junctions. The organization of these cell-cell 
junctions in the ID of rat ventricular cardiomyocytes is illustrated in Figure 1.8 in a 
thin section of ventricular tissue.
The connexon (hemi-channel) is the functional unit of a gap junction; it is composed 
of six copies of membrane spanning connexins. A gap junction is composed of two 
juxtaposed connexons assembled by docking of two separate connexons derived from 
adjacent cells. The GJ encompass a central continuous pore providing permeability 
for ions and small molecules. There are at least 21 connexin isoforms expressed in 
humans140 that are encoded by a large gene family representing structurally conserved 
proteins varying in size between 25 to 62 KD resulting from variation in length of the 
carboxy terminal region.
Multiple Connexin subtypes are expressed in the heart such as connexin-43, 
connexin-40 and connexin-45 that are found in distinctive combinations and relative 
quantities in different, functionally specialized subsets of cardiomyocyte141'143. 
Connexin-43 is the main connexin isoform expressed in ventricular cardiomyocytes at 
the intercalated disc144. An alteration in gap junction organization and Connexin 
subtype expression is a consistent feature of acquired human heart disease, which can 
give rise to conduction disturbances that may contribute to arrhythmogenesis.
Two overlapping forms of remodelling occur in heart disease including structural 
remodelling, which involves changes in the arrangement or organization of gap 
junctions (redistribution of gap junctions), and remodelling of Connexin expression, 
in which the amount or subtype of Connexin expression is altered. These forms of 
remodelling are now a well documented feature of human cell-cell junction 
cardiomyopathies associated with a high incidence of syncope, ventricular 
arrhythmias and sudden death, and heart disease of other aetiologies 50>144*146. in the 
diseased ventricles, the most consistent quantitative alteration involves heterogeneous 
reduction in connexin-43 expression. Remodelling of myocyte gap junctions and 
alteration in expression of connexin-43 protein have been demonstrated in Caravajal 
syndrome, Naxos disease a cardiocutaneous syndrome of ARVC42’43, and in a 
dominant ARVC caused by an in-frame insertion mutation in plakoglobin51.
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Gap junctions are dynamic structures with connexons being continually added to the 
edges of existing gap junctions, while channels are removed by endocytosis from the 
centre of the gap junction147. Connexins usually have a high turnover rate, with a half- 
life of between 1.5-5h148. During endocytosis of gap junctions, both membranes of 
the junction are internalised into one of the adjacent cells forming a double-membrane 
vacuole called an annular gap junction or connexosome. Endocytosis of gap junctions 
is thought to involve Clathrin. Internalization of gap junctions requires proteasomal 
activity147. However, the precise role of the proteasome in gap junction endocytosis is 
not clear. Following internalization of gap junctions, connexins are degraded in 
lysosomes.
Connexin 43 is phosphorylated at multiple different serine residues during its life 
cycle149. Phosphorylation of connexins regulates multiple steps in the life cycle of gap 
junctions, including connexin trafficking to the plasma membrane, assembly of 
connexons into gap junctions and gating of gap junction channels. There is also 
significant evidence that de-phosphorylation of connexins is important in regulating 
the internalization and degradation of gap junctions. Phosphorylation of connexins 
occurs primarily in the C-terminal tail. Protein kinases are involved in connexin 
phosphorylation include Mitogen-Activated Protein Kinase (MAPK), Protein Kinase 
C (PKC), Protein Kinase A (PKA), cdc2/cyclinB, Casein Kinase 1, v-src, and c-src. 
Connexin-43 is phosphorylated soon after synthesis and its phosphorylation pattern 
changes as it traffics through the endoplasmic reticulum and Golgi to the plasma 
membrane, ultimately forming a gap junction structure. Cx-43 migrates as multiple 
isoforms when analyzed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE), including a faster-migrating form that includes non- 
phosphorylated (PO or NP) Cx-43 and at least two slower-migrating forms, commonly 
termed PI (phosphorylated forms at serine residues: S364/S365) and P2 
(phosphorylated at serine residues: S325/S328/S330). Pulse-chase labelling analysis 
indicates that the Cx-43 isoforms progress from PO to PI to P2 and that the P2 
isoform is associated with junctional gap junctions. When cardiac tissue is analysed 
for Cx-43 by WB analysis, only the low mobility “ phosphorylated” isoforms are 
observed. Myocardial ischemia leads to Cx-43 “ de-phosphorylation” (i.e., loss of PI 
and P2, and gain of PO) and loss of localization from the intercalated disk, which 
probably contributes to contractile failure and arrhythmias. Thus, the membrane
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localization of Cx-43 in gap junctions in disease states appears to be affected by its 
level of phosphorylation.
Modulation in gap junction turnover has been suggested to be an important 
mechanism for regulating GJIC148 and increasing evidence suggests that 
ubiquitination is important in regulating gap junction degradation147.
1.5 Diseases of the desmosomes
The desmosome is a target for autoimmune, infectious, and genetic disorders, 
resulting in common features such as skin blistering and hyperkeratosis. Some genetic 
disorders of the desmosomes, while apparent in infancy, usually become manifest in 
late teens and early adulthood, and are linked with cardiomyopathies (section 1.5.0). 
A summary of diseases of the desmosomes is shown in Table 1.4, adapted from 
review article150.
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Table 1.4 Diseases of the Desmosomes
Adapted from review article150.* Human genome mutation (HGMD) online database: www.hgmd.cf.ac.uk/ac/index.oho. Table 1.5 lists fifty-four novel 
plakophilin-2 mutations reported to the present date (March 2008).
Mutated gene/target 
Antigen
Phenotype References
Genetic Desmoglein 1 Striate palmoplantar keratoderma (SPK) H unt^
Diseases Lesions of the palms & soles exacerbated by mechanical trauma Rickman152
Desmoglein 2 Autosomal dominant right ventricular cardiomyopathy Pilichou104, Basso46
(Table 1.6) Syrris101, Awad100
Desmoglein 4 Autosomal recessive hypotrichosis (LAH). Follicular abnormality 
Loss of hair on scalp, chest, arms, legs and sparse facial hair
Kljuic153
Desmocollin-2 Autosomal dominant ARVC Syrris102, Heuser103,
(Table 1.7) Beffagna"
Desmoplakin Striate palmoplantar keratoderma (SPK)
Armstrong154
Whittock
(haploinsufficiency) Acantholysis with keratin retraction
(939+G>A, IVS7+1G>A)
Desmoplakin 
(C897G, S299R)
Autosomal dominant ARVC Rampazzo39
(I608 609insQSQFT Autosomal dominant biventricular cardiomyopathy
Norgett156DARKI) Keratoderma, wooly hair
Desmoplakin Autosomal recessive ARVC
(G7402C, G2375R) Alcalai157
(C3799T, R1267X) 
Desmoplakin
Autosomal recessive ARVC, Naxos like syndrome Uzumcu158
(C-term  truncation, Autosom al recessive Carvajal Syndrom e
Norgett159(7901 deIG, R2541fsX2559) DCM, SPPK, wooly hair
Desmoplakin Palmoplanter keratoderma Whittock160
(compound heterozygosity) combination of nonsense/missense mutations
Whittock160[T2427A, C809X/T861G, N287K], 
[C1990T, Q664X/C7096T,
Alopecia, hyperkeratosis, acantholysis, keratin retraction
R2366C], & [C5799T, R1934X/ 
& 6090delTT, S2030fsX2059]
Lethal acantholysis epidermolysis bullosa Jonkman161
Table 1.4 (continued)
Mutated gene/target Phenotype References
Antigen
Desmoplakin
Norman162(2034insA, T586fsX594) Autosomal dominant left ventricular ARVC
(K470E, A566T, K1583R, c.542+5G>A) Basso46
(G88A, V30M; A269G, Q90R; Yang163
G699A, W233X; G8501A, R2834H
(G3764A, R1225K; G5324T, R1775I; c.423-G>A, IVS3-1G>A) Bauce164
Various mutations (13 frameshift/nonsense and 4 missense mutations) Sen-Chowdhry165
Plakoglobin Naxos disease (Autosomal recessive ARVC, with PPK & wooly hair) McKoy38
Autosomal dominant arrhythmogenic right ventricular Asimaki
Plakophilin 1 Autosomal recessive ectodermal dysplasia, skin fragility 
Syndrome, hair loss & nail dystrophy
McGrath135, McGrath166 
Whittock167
Plakophilin 2 Autosomal dominant ARVC Gerull40, Syrris41,
S ee  H G M D  w ebsite* V an  T intelen107, D alai108,
Table  1.5 lists 54 PKP-2 N agaoka109, Antoniades110
mutations to date Kannankeril111, Lahtinen112
Autoimmune Desmoglein 1 Pemphigus foliaceus Amagai168
Diseases Blistering of the superficial epidermis 
Circulating autoantibodies directed against DSG1
Nousari169
Desmoglein 1 Paraneoplastic pemphigus Amagai168
Desmoglein 3 Pemphigus vulgaris
Autoantibodies against DSG3 cause blisters in oral cavity 
Antibodies against DSG3 & DSG1 cause blisters in the oral 
Cavity & the deep dermis
Amagai168
Nousar169
Multiple plakin Mucous membrane & skin blistering, variable & severe in PV 
Bronchial epithelial lesions in subset of individuals 
Disease associated with a number of neoplasms
Hashimoto170
Infectious Desmoglein 1 Staphylococcus aureus scalded skin syndrome (SSSS) Amagai171’172
Disease Staphylococcus aureus exfoliative toxin A or B cleaves DSG1
Superficial blister formation
Hanakawa173,174Also known as Ritter disease
1.6 Role of cell-cell adhesion proteins in cellular 
signalling
Besides their role in providing adhesion at intercellular junctions, the armadillo 
catenins: P-catenins, plakoglobin, and plakophilins may also have signalling role in 
the nucleus, whereby they allow the cells to modulate their behaviour in response to
1 75changes in cell adhesion. Wheelock and colleagues were the first to suggest that 
plakoglobin may play a role in signalling apart from their role in desmosome and 
adherens junction assembly.
1.6.1 Beta-catenin signalling
As discussed in section 1.1.2c, beta-catenin plays a pivotal role in mediating the Wnt 
signaling pathway responsible for regulation of differentiation in development176. It 
regulates cellular proliferation via its interaction with TCF/LEF transcription factors 
mediated through its Armadillo repeats. The association of p-catenin-TCF/LEF 
translocates the complex into the nucleus where it activates genes involved in cellular
• 177proliferation . The carboxy terminus of p-catenin was essential for fully activating
I no
the transcription of target genes .
1.6.2 Plakoglobin signalling
A study using cell line lacking functional p-catenin showed that exogenous 
plakoglobin expression caused nuclear accumulation of plakoglobin and binding of 
plakoglobin to TCF-4 or LEF-3, suggesting that plakoglobin can directly activate Wnt 
signalling cascade without interacting with p-catenin179. This suggested that 
plakoglobin could have multiple functions as a transcriptional activator and as a cell 
adhesion molecule. In comparison with P-catenin, plakoglobin is a relatively weak 
transcriptional activator and this was ascribed to the difference in the carboxy termini 
of the two molecules55 (<15% homology present)180. Plakoglobin can also act as a 
signalling molecule by the induction of anti-apoptotic protein Bcl-255, however further
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studies are needed to establish a link between cell-cell junction and intracellular 
signalling pathways.
1.6.3 Plakophilin-2 signalling in ARVC
Precisely how plakophilin-2 might be involved in signalling in ARVC is not presently 
clear. Missense mutations may cause gain-of-function protein activity related to signal 
transduction via post-translational phosphorylation modification of serine, threonine, 
or tyrosine residues. Putative phosphorylation at several of these three amino acid 
residues are predicted by phosphorylation site prediction program (such as NetPhos 
protein phosphorylation site prediction program), to occur in various domains of 
plakophilin-2 protein molecule. One such phosphorylation modification site has been
1 S1identified on serine residue number eighty-two of PKP-2 protein which is 
phosphorylated by C-TAK1 (discussed further in the next section). Other types of 
post-translational modification such as ubiquitination and O-glycosylation occur in 
PG, these types of modifications may potentially regulate the activity of PKP-2.
1.6.4 Nuclear functions of PKP-2
In addition to the role of plakophilin-2 in the desmosomes, it also has, in common 
with other armadillo family proteins, a dual localisation in cell nucleus. The nuclear 
localization of plakophilin-2 was elucidated by Mertens and colleagues182 using 
sucrose density gradient centrifugation showing that PKP-2 associated with RNA 
polymerase III holoenzyme (RPC 155 protein, 155kD). The specific association of 
these two proteins was confirmed by in vitro solid-phase binding assay and co­
localisation experiments. In addition to RPC155, RPC39 and RPC82 were also 
identified as binding partners implicating an association of plakophilin-2 with the 
Polymerase III holoenzyme, but not with the core Polymerase III complex. How 
precisely the dual localization of plakophilin-2 is regulated in the desmosomes and the 
nucleus is not well understood. Plakophilin-2 was identified as a substrate for 
Cdc26C-associated kinase 1 (C-TAK1) implicated in cell cycle regulation and Ras 
signalling181. Phosphorylation of plakophilin-2 by C-TAK1 generates a binding site
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for a  14-3-3 proteins, which contributes to the specific localisation of plakophilin-2 in
the cell. Engineered mutations introduced at serine residue number 82 in plakophilin-
2 (S82A or V82A), around which a putative a  14.3.3 protein-binding site resides,
10-1
exhibits increased nuclear accumulation of the plakophilin-2 . Since the C-TAK1 
generated 14.3.3 binding site was not conserved among the plakophilins, this may 
explain why reduced nuclear localisation of over-expressed plakophilin-2 compared to 
that of plakophilin-1 was found in the study of Chen et al. The precise role(s) of 
nuclear PKP2 is currently unknown184.
1.7 Mice models of knockout genes encoding DS 
proteins
The crucial roles of desmosomal proteins in cardiac morphogenesis were elucidated in 
gene-knockout mice studies. Observations in these mice provided important clues 
about the role of these cell-cell adhesion proteins in the heart, and which provided a 
rationale for the screening of PKP-2, DSG-2, and DSC-2 genes leading to 
identification of mutations in these three genes in human ARVC.
1.7.1 Plakoglobin ablated transgenic mice
Plakoglobin-null mutant mice (plako ) died from embryonic day 10.5 onwards, due 
to severe heart defects coinciding with the onset of heart contraction and mechanical 
stress. Some mutant embryos developed further, especially on a C57BL/6 genetic 
background, and died around birth, presumably due to cardiac dysfunction, and with 
skin blistering (reminiscent of human epidermolytic hyperkeratosis) and subcorneal 
acantholysis. Ultrastructural analysis in these mice embryos, revealed that 
desmosomes were greatly reduced in numbers, and structurally altered with a less 
dense plaque and atypical appearance of their desmoglea185. A related independent 
study of plakoglobin-null mice showed that they die of ventricular rupture and 
consequent pericardial tamponade. The tissue instability correlated with absence of 
desmosomes in the heart (desmosomes were unaffected elsewhere in developing 
epidermis or the gut), but instead extended adherens junctions or ‘mixed type’
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junctions were formed containing desmosomal protein components. This study 
concluded that plakoglobin is indispensable for both the formation of cardiac 
desmosomes and the proper segregation of desmosome & adherens junction 
components to determining the architectural stability of the intercalated disc in 
embryonic mouse heart186.
1.7.2 Desmoplakin ablated transgenic mice
Desmoplakin is a ubiquitous protein molecule expressed in all desmosomes. 
Desmoplakin-null mice showed early embryonic lethality dying beyond embryonic
• * 1 8 7day 6.5 due a loss or instability of desmosomes in extra embryonic tissue . 
Tetraploid rescue in desmoplakin function increased embryonic survival by several 
days, allowing inspection of developing somatic tissues188. Marked abnormalities in 
the heart muscle, neuroepithelium, and skin epidermis were observed, as well as 
abnormalities in the complexus adherens junction in the microvasculature, consistent 
with the widespread importance of DP in tissue integrity during development. Fragile 
skin and cell-cell adhesion defects were apparent and were restricted to cells that 
would normally express desmoplakin. Few desmosomes were observed and those 
present were not linked to keratin filaments. DP-null mutant mice showed greater 
severity in phenotype compared with the PG-null mutant mice suggesting a possible 
functional redundancy of plakoglobin with members of other armadillo proteins, such 
as p-catenin or plakophilins. Plakophilins, plakoglobin and desmoplakin appear to 
play different roles in the desmosome, with desmoplakin performing a dual function 
in linking intermediate filaments (IF) and in providing stability to desmosomes; the 
known interactions of plakophilins and plakoglobin with desmosomal cadherins and 
IF’s alone, it seems not to be sufficient to anchor IF to desmosomes in the absence of 
desmoplakin. Comparison of DP-null mice embryos with that of PG-null mice 
indicated presence of ‘mixed type’ of adhering junctions in the later with DSG2 
diffusely spread over the cell surface, whereas DSG2, DSC2 and PKP2 still appeared 
clustered and co localised, albeit significantly reduced in DP-null mice. In addition, 
the sizes of adherens junctions were increased in PG-null mice, but these junctions 
were unaffected in DP-null mice.
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Conditional ablation of DP in the developing mouse epidermis using a Cre/LoxP 
system under control of keratin 14 promoter showed extreme skin fragility and 
pronounced intercellular separations in the basal and spinous layers of the skin in 
these animals. DS were only slightly reduced in number or size, but they lacked an 
inner plaque and IF attachment. Areas of intercellular separation showed that the 
complete desmosome was linked to one of the two cells, suggesting desmosomal 
cadherin-mediated adhesion was not affected, but rather the entire junction was tom 
out of adjacent cells owing to the lack of cytoskeletal attachment to the plaque. 
Maturation of adherens junctions and associated cortical actin filament network was 
impaired in keratinocytes from these DP-null mice, and exhibited defects in sealing of 
intercellular membranes. Culture of keratinocytes from these DP-null mice showed 
very few DS, but reintroduction of DP N-terminus at least partially rescued effects on 
membrane sealing. Thus, adherens junction maturation appears to require certain 
desmosomal functions, which are dependent on desmoplakin.
1.7.3 PKP-2 ablated transgenic mice
Plakophilin 2-null mice died around mid-gestation (E10.5-11) due to lethal 
alterations in heart morphogenesis and stability characterised by reduced 
trabeculation, disarrayed cytoskeleton, ruptures of cardiac walls, and blood leakage 
into pericardiac cavity. Structures resembling desmosomes seen in cardiac tissue of 
wild type mice were absent in PKP-2-deficient mouse embryos, however adherens 
junction gross morphology was unaffected in this tissue. Immunogold electron 
microscopy examination in PKP-2 mutant mice revealed that desmoplakin had 
dissociated from plaques of adhering junctions connecting cardiomyocytes, instead 
forming granular cytoplasmic aggregates located between myofibrils and desmin 
intermediate filaments, away from the intercalated disc. Absence of PKP-2 caused the 
cytolinker DP to dissociate from plaques of adhering junctions. Double­
immunofluorescence staining revealed that whereas in wild type developing heart 
desmoplakin co-localised with various adhering junctional components such as 
plakoglobin, P-catenin, plakophilin-2, N-cadherin, desmoglein-2, a-catenin, and 
p l20ctn, it did not associate significantly with any of these junctional proteins in the 
PKP-2-deficient mouse embryos, but instead it was dispersed in the cytoplasm away
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from the intercalated disc. Desmoglein 2 could not be localised at significant levels in 
developing heart of PKP2-deficient mice, indicating that PKP-2 is an essential 
stabilising binding partner of desmosomal cadherins. Absence of desmosomes in 
cardiac tissue of PKP2 mutant embryos was tissue-specific as other epithelial tissues, 
such as the developing epidermis and stomach mucosa showed normal AJ and DS 
ultrastructure when compared with PKP-2 wild type mice. Whilst Plakoglobin and 
PKP-2 ablation showed a similar temporal (E10.5-E12) pathological alteration in 
desmosomes in cardiac tissues, an important difference was the firm association of 
desmoplakin in plaques of adhering junctions in the former, but not in the later case.
1.7.4 DSG-2 ablated transgenic mice
While knockout mice data for PG, DP and PKP-2 are available, no data are available 
on cardiac abnormalities in the DSG-2 knockout mice because loss of DSG-2 results 
in early embryonic lethality191. However, the crucial role of desmogleins generally in 
maintaining desmosome ultrastructure is supported by various studies showing 
decreased desmosomal plaque number associated with asymmetry and detachment192' 
194. Examination of myocardial biopsies of three individuals with ARVC carriers of 
DSG-2 gene mutation showed decreased desmosome numbers and widening of the 
intercalated disc gap104.
1.7.5 DSC-2 ablation
There is presently no transgenic mouse study examining the impact of DSC2 ablation 
during embryonic development. However, the role of DSC2 in the heart of a Zebra 
fish model was examined using antisense morpholino oligonucleotides to DSC-2, 
which resulted in marked reduction in the levels of DSC2 mRNA in the morphant 
embryos. The phenotype in these DSC2-targetted fish revealed significant dose- 
dependent bradycardia, chamber dilatation, and abnormal cardiac contractility with 
progressive pericardial oedema103.
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1.8 ARVC Gene mutations encoding desmosomal 
proteins
Several studies have implied that ARVC may be a disease of the 
desmosome39,40,114,157. Five major molecular components are found in cardiac 
desmosomes; these include the desmosomal cadherins (desmoglein-2 and 
desmocollin-2), the ARM-repeat proteins (plakoglobin and plakophilin-2), and the 
plakin family of proteins (desmoplakin). Since the discovery of desmoplakin and 
plakoglobin mutations in ARVC8 and Naxos disease in the late nineties, considerable 
progress was made since 2004 in identifying other causative mutations in ARVC with 
plakophilin-2 mutations shown to be associated with ARVC. Mutations affecting 
major desmosomal proteins have now been reported (Table 1.4) in several diseases, 
but specifically in the context of ARVC, disease causing mutations have now been 
found in all five major cardiac desmosomal components (DP, PG, DSG-2, DSC-2 and 
PKP-2); these findings suggests that ARVD/C is a multigenic disease of cellular 
adhesion195 affecting the desmosome. A detailed analysis of mutations found in these 
cell adhesion molecules now follows.
1.8.1 Desmoplakin mutations in ARVC
The desmoplakin gene is located on chromosome 6 consisting of 24 exons. 
Alternative mRNA splicing forms two transcripts (DPI 2871 amino acid and DPII 
2271 amino acid). DPI is the larger of the two proteins as it contains an additional 600 
amino acid sequence within the coiled coil rod region that is alternatively spliced out 
in DPII isoform; DPI and DPII are abundantly expressed in all types of epithelia, 
while cardiac muscle contains only D P I1%. Desmoplakin belongs to the plakin family 
of proteins in which plectin, envoplakin periplakin, epiplakin, and bullous pemphigoid 
antigen 1 (BPAG1) are structural homologues. Plectin the prototype protein of this 
family consists of a modular organization consisting of four sub domains referred to 
as the actin-binding domain (ABD) consisting of two calponin homology domains, a 
plakin domain found near the N terminus, a central rod domain and a C-terminus 
plakin repeat domain (PRD). The plakin domain of plectin was predicted to form six 
anti-parallel a-helices referred to as NN, Z, Y, X, W, and V based on
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amino acid sequence. The crystal structure of the plakin domain of plectin recently 
determined at 2.05 angstrom resolution showed a tandem pair of spectrin repeats (SR)
107connected by an a-helical linker spanning these two repeats . Protein structure 
prediction analysis of the plakin domain of plectin revealed nine consecutive SR 
organized in an array of tandem modules, with a Src-homology 3 domain inserted in
1 Q7the central spectrin repeat . Homology search in other proteins belonging to the 
plakin family showed that a similar SR modular organization occur in other
1 Q n  |  Q O
representative members of these protein family ’ . Thus, plakins are
evolutionary related to spectrins (spectraplakins), but have diverged to perform 
specialized functions. The modular structure of spectrin repeats found in plakin 
domain of plectin resembles that of p-spectrin and a-spectrin found in erythrocytes 
(Figure 1.9).
Desmoplakin is a spectraplakin with a modular plakin structure similar to that found 
in plectin, but it lacks the ABD and SR 1-2 and 7 (Figure 1.9) repeats. Other domains 
in desmoplakin consist of a central coiled-coil rod dimerization domain and a 
modular PRD consisting of A, B, and C sub-domains involved in binding to desmin 
and vimentin intermediate filament proteins199. The composition of the plakin domain 
as an array of tandem spectrin repeats has profound implications for its function in 
terms of the flexibility, and extensibility of the domain. The elastic properties of 
tandem SR are essential for the function of the proteins that contain such arrays.
All DP mutations discussed here are listed in Table 1.4 these are also represented in 
the illustration in Figure 1.10. A desmoplakin mutation (S299R) in ARVC8 was
I Q
reported to modify a putative phosphorylation site in the N-terminal domain
involved in the binding of plakoglobin. In a study of Muslim-Arab family of twelve
individuals from Jerusalem, with clinical syndrome of sudden death (8/12 family
members), woolly hair, and a pemphigus-like skin disorder (keratoderma), a
homozygous missense mutation (G2375R) in exon 24 of desmoplakin was found157.
The Glycine residue at position 2375 is a highly conserved residue within the plakin
repeat domain (PRD3) of the B segment of desmoplakin C terminus. The PRDs form
a positively charged grove predicted to bind the intermediate filament. Hence, this
mutation destabilized the PRD disrupting desmoplakin-intermediate filament binding.
In another study of three Ecuadorian families159 another homozygous desmoplakin
mutation (c.7901delG, p.S2542fsX2560) truncated the desmoplakin protein molecule
in the C-terminus which resulted in disruption of the IF network;
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Figure 1.9 Modular organization of plakin domains
(a) Schematic representation o f the domain organization o f full-length plectin. The C- 
terminal region contains five type B and one type C plakin repeat domains, (b) Detail 
module organization o f the N-terminal region of plectin and other representative 
plakins including BPAGla/b/n, BPAGle, desmoplakin and periplakin. Spectrin 
repeats (SR) are numbered according to plectin. The repeats o f plectin and BPAG1 
whose crystal structure is known are shown in dark gray. The ABD is formed by two 
calponin homology (CH) domains. The position of the six a-helical-rich regions (NN, 
Z, Y, X, W, and V) described in the plakin domain 14 is indicated above the plectin 
structure, (c) The domain organization o f the erythrocyte isoforms of a and (3-spectrin 
is shown to illustrate the similarities with the plakin domain architecture, noticeably 
the array organization of tandem SR’s, the localization o f the ABD preceding the SRI 
o f (3-spectrin, and the insertion o f an SH3 domain within the ninth SR of a-spectrin.
107Reproduced from Sonenberg et al.
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resulting in a phenotype of palmoplantar keratoderma with woolly hair and DCM. 
Another autosomal dominant mutation caused by a heterozygous insertion 
(c.2034_insA) in desmoplakin resulted in DP truncation (p.T586fsX594) causing a
1 ff)predominantly left-sided ARVC . A 30 base pair insertion in DP exon 14 resulted in
the insertion of ten amino acids (c.608-609_insQSQFTDARKI) causing autosomal
dominant biventricular cardiomyopathy with SPK and Woolly hair156. A homozygous
stop codon mutation in DP exon 23 (c.C3799T) caused a truncation in DP
(p.R1267X) resulting in a DPI isoform specific loss of protein expression. This
nonsense DP mutation caused recessive biventricular cardiomyopathy with
1palmoplantar keratoderma and woolly hair . Three novel DP mutations (p.R1255K 
and p.R1775I and a splice site mutation c.423-lG>A) were identified in four families 
with ARVC164 with the missense mutations affected highly conserved arginine 
residues in different species. Both missense mutations were predicted to destabilize 
the rod domain preventing the formation of the coiled-coil region in DPI. The c.423- 
1G>A mutation altered an acceptor splicing site of intron 3 causing aberrant 
alternative splicing with skipping of exon 4 resulting in a PTC truncating the DP to a 
polypeptide of 200 amino acids. Analysis of sixty-six patients in a North American 
ARVC163 cohort identified four DP variants (p.V30M, p.Q90R, p.W233X and 
p.R2834H). The effects of two missense mutations were examined functionally in 
SCC9 cell line by transient transfection of plasmid vectors encoding a small portion of 
DP N-terminus (DPNTP, first 584 amino acids) as well as full-length desmoplakin 
that incorporated these two missense mutations. These studies highlighted a failure of 
membrane localization of p.V30M and p.Q90R DP variants and their inability to bind
1 A 3  • • •to plakoglobin ; embryonic lethality of cardiac restricted expression of these 
missense DPs in mice corroborated these in vitro finding163. The nonsense p.W233X 
DP mutation examined by transient transfection in SSC9 cells failed to localize at 
cell-cell junctions and analysis of patient mRNA suggested that transcript with this 
PTC was probably degraded by NMD. An elegant demonstration of the effects of 
over-expression of R2834H DP protein in a cardiac restricted transgenic mouse 
showed increased cardiomyocyte apoptosis, cardiac fibrosis, lipid accumulation, and 
defects in cardiac development. R2834H DP in transgenic mice resulted in aberrant 
desmin localization and dissociation of plakoglobin, plakophilin-2, and beta-catenin 
from cell-cell junctions163. Mutation screening of twenty-one unrelated probands46 
revealed four novel desmoplakin mutations (p.K470E, p.A566T, p.K1583R and a
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splice site c.542+5G>A), all three missense mutations occurred in amino acid residues 
highly conserved among species that were located in different domains (p.K470E in 
spectrin repeat SR5, p.A566T in SR6, and p.K1583R in the coiled-coil rod) of DP. 
The splice site mutation altered a donor-splicing site in intron 2, which probably 
affected the normal splicing of exons 2 and 3. Patient mRNA analysis showed no 
aberrant transcripts resulting from this mutation indicating that these transcripts were 
probably degraded by NMD surveillance46.
1.8.1.1 Representative DP mutations illustrated
A schematic representation of location of all mutations affecting the desmoplakin 
protein molecule is shown in Figure 1.10. Two different orientations of the DP protein 
molecule is depicted: the first structure is based on the classical alpha helical 
structures of the amino terminus plakin domain deduced by Kathleen Green’s group 
more than a decade ago (depicted by five boxes in blue, Z, Y, X, W, and V). The 
amino acid residues start positions of these five alpha helical domains identified by 
numbering in orange numbers have been derived relative to the reference DP 
sequence (Ensemble transcript ID: ENST00000211979, transcript size 2871 amino 
acid long) and 5’ sequence of these helices identified by Virata200 et al. This was 
followed by a central coiled coil dimerization region (box depicted in orange, 
numbering in orange according to Alcalai157 et al and Yang163 et al), and a plakin 
repeat domain consisting of three repeat units (depicted by boxes labelled A, B, and C 
in gold, numbering in orange according to Green201 et al) which are important in 
mediating interactions with intermediate filament proteins (vimentin, desmin and 
keratin). The second protein structure of DP is depicted directly below the first to 
contrast the modular organization of the plakin N-terminal domain only based on the 
spectrin repeats identified (Figure 1.9). In this modular plakin domain structure, six 
spectrin repeats are identified (SR 3, 4, 5, 7, 8, and 9) with an insertion of an SH3 
domain in between the SR5 repeat. The numbering of the spectraplakin repeat 
structures in the plakin domain of DP (marked in orange and purple numbers) are 
derived from the work of Sonnenberg197 et al. Figure 1.10 shows the locations of 
twenty-four DP mutations reported in the literature to date (section 1.5, Table 1.4). 
These mutations are identified with an arrow and text (same colour used for both for
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ease of identifying the location of a given mutation). Figure 1.10 also shows the 
locations of three additional novel desmoplakin mutations: Q273fsX288,
M316fsX324 (both of these disrupt spectrin repeat SR4), and S442F (alters a highly 
conserved serine residue in SR5) identified in the genetic screening studies (Chapter 
3, section 3.4.1 Parti). These three novel mutations are shown underlined (Figure 
1.10).
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Figure 1.10 Locations of DP mutations
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Plakin Repeat Domain
S2542fsX2560: recessive Naxos-like ARVC, Norgett159 
G2375R: recessive Naxos-like ARVC, Alcalai157 
1267X: DSP I nonsense mediated mRNA decay -> haploinsufficiency, recessive Naxos-like ARVC, Uzumcu158 
R1255K: R17751: autosomal dominant ARVC, Bauce164
I608_Q609ins_QSQFTDARKI: autosomal dominant Naxos-like ARVC, Norgett156 
T586fsX594 ARVC with left ventricular manifestations, Norman162 
c.542+5G>A K470E: A556T K1583R autosomal dominant ARVC, Basso46
S442F: autosomal dominant ARVC, this study 
Q331X: autosomal dominant striate palmoplanter keratoderma (SPK) -> haploinsufficiency, Armstrong154 
M316fsX324: autosomal dominant ARVC, this study 
S299R: autosomal dominant ARVC, highly conserved PKC phosphorylation site lost by the mutation, Rampazzo39 
Q273fsX288: autosomal dominant ARVC, this study 
W233X: autosomal dominant ARVC, nonsense mediated mRNA decay -> haploinsulficiency, failure of desmosomal localisation in vitro, perinuclear aggregation in vitro, Yang 163 
Q90R: autosomal dominant ARVC, embryonic lethal in mice, failure of desmosomal localisation in vitro, Yang163 
V30M: autosomal dominant ARVC, embryonic lethal in mice, failure of desmosomal localisation in vitro, Yang16’ R2834H autosomal dominant ARVC, Yang163
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= compound heterozygous missense/nonsense mutations, recessive skin fragility/wooly hair syndrome, Whittock160 
= compound heterozygous missense/nonsense mutations, recessive skin fragility/wooly hair syndrome, Whittock160
= compound heterozygous frame-shift/nonsense mutations, neonatal lethal acantholytic epidermolysis bullosa, -> presence of 1933aa nonsense DSPI and 2058aa truncated tDP protein, Jonkman1
1.8.2 Plakoglobin mutation in ARVC
The gene for plakoglobin is located on chromosome seventeen at loci 17q21. It is 
encoded by fourteen exons with the first exon of PG not being translated. PG protein 
consists of thirteen imperfect ARM repeats flanked by N-terminus and C-terminus 
domains. ARM repeats 1-3 are involved in mediating interactions with the 
desmosomal cadherins. Part of the N-terminus domain and the first ARM repeat of 
PG are required for its interaction with a-catenin. ARM repeats 6-8 of PG are 
involved in the interaction between PG and the classical cadherins. ARM repeats 7-11 
are thought not to be involved in interaction with other junctional components, but 
appear to target PG to cell-cell contacts and stabilise desmosomal interactions. PG 
binds to the N-terminal domain of desmoplakin targeting it to cell-cell junctions.
A two-base homozygous mutation PG gene deletion (c.2157del2) was associated with 
Naxos disease38. This disease originally clustered around the Greek island of Naxos 
showing complete penetrance with a phenotype of palmoplantar keratoderma, woolly 
hair association with a recessively inherited ARVC. PG is a common component of 
two different types of intercellular cell adhesion junctions, (section 1.2) the adherens 
junction (AJ) and desmosomes. PG interacts with (3- and a- catenin to mediate cell­
cell adhesion in cardiac and dermal-epidermal junctions. The PG mutation in Naxos 
disease resulted in C-terminal premature termination of translation of this protein, 
which is shorter by 56 amino acid residues, compared to wild type protein.
Apart from the homozygous PG mutation reported in Naxos disease, there is only one 
reported PG mutation showing a dominant mode of inheritance in ARVC identified 
recently in a German family 51. This resulted in a heterozygous three base pair gene 
insertion (118_119insGCA) causing an in-frame insertion of a single Serine 
(p.S39_K40insS) amino acid residue in the PG protein molecule. Functional in vitro 
expression of S39_K40insS PG protein in HEK293 cells showed that the mutant PG 
protein was apparently ubiquinated and localised preferentially in the cytoplasm 
targeting it for proteosomal degradation. Markedly decreased immunostaining of 
plakoglobin, desmoplakin, and Cx-43 proteins was localised at ID in cardiac biopsy of 
a patient with this PG mutation. Cell lines expressing the mutant PG formed smaller
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and fewer desmosomes; these data suggests that expression of mutant PG protein 
accompanies alteration of the structure and distribution of mechanical and electrical 
junctions.
1.8.3 Plakophilin-2 mutations in ARVC
The PKP-2 gene is located on chromosome four and encoded by fourteen exons 
(Figure 1.11). Two PKP-2 protein isoforms are translated from two alternatively 
spliced mRNA transcripts, transcript 2b (long form consists of all fourteen exons 
being translated, 881 amino acid long) and transcript 2a (short form, with exon six not 
being translated, 837 amino acid long) respectively. Although several additional 
isotypes of plakophilin exist (PKP-1, PKP-3 and p007) in humans, PKP-2 is the 
predominant protein isotype expressed in heart where both the short and long form 
of the proteins are present. The structure of PKP-2 protein is composed of a head 
domain of 348 amino acids where the vast majority of inter protein-protein 
interactions are known to take place183, followed by ten imperfect ARM repeats, and a 
short C-terminus (Figure 1.11). Although the ARM repeats found in plakoglobin are 
known to mediate binding activity, the precise function of ARM repeats found in 
plakophilin-2 remains unclear.
Since the work of Gerull40 and colleagues published in 2004 describing twenty-six 
PKP-2 mutations there are fifty-four novel plakophilin-2 mutations reported to date 
(March 2008) providing compelling evidence for a major role of PKP-2 in 
pathogenesis of ARVC with a divergent role of these mutations in distinct ethnic 
population. Plakophilin-2 occupies a central position as a stabiliser of myocardial 
desmosomes supported by studies performed in plakophilin-2 ablated transgenic mice 
(section 1.4.3).
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Figure 1.11 Structure of PKP-2 gene & protein
Structure of the plakophilin-2 gene and protein illustrated schematically. For the gene 
structure, the clear boxes represent the 5’ and 3’ UTR of the gene, the black boxes 
represent each of the fourteen exons, ATG represents the initiation codon, and TGA 
represents the stop codon. The protein structure shown for the 2b isoform (transcribed 
from long form of the mRNA transcript) contains a head domain of 348 amino acid 
followed by ten imperfect ARM repeats (-42 amino acids/repeat). The C terminus 
domain of PKP-2 is quite short
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A chronological compilation of all plakophilin-2 mutations discovered to date is listed 
in Table 1.5. All PKP-2 mutations are transmitted in an autosomal dominant mode, 
except for a single mutation (c.2484C>T/c.2484C>T, p G828G, Table 1.5) that is 
transmitted in an autosomal recessive manner. Although PKP2 mutations appear to be 
common in ARVC and affects all three domains o f the protein molecule, precisely 
how these mutations could cause ARVC is unknown. This section will explore 
possible mechanisms by which plakophilin-2 mutations might cause ARVC. The vast 
majority o f plakophilin-2 mutations fall in the category of small insertion/deletions 
(<20 bp, Table 1.5, 37%) that are predicted to cause a frameshift (when the 
insertion/deletion are not a multiple o f three bases) followed by a PTC. Many of these 
mRNA transcripts containing PTC would undergo degradation by NMD; however, if
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some mRNA transcripts containing PTCs were to evade NMD surveillance then 
expression of truncated plakophilin-2 would lead to dominant negative effects if 
incorporated into desmosomes. Nonsense mutations account for nearly 24% of all 
plakophilin-2 mutations (Table 1.5), many of the mRNA transcripts with these PTCs 
would be expected to undergo NMD resulting in haploinsufficiency, or in exon 
skipping if NAS (see section 1.1.6) occurs. However, if NMD is bypassed then 
dominant negative effect will ensue if truncated plakophilin-2 polypeptide or protein 
were formed.
The missense mutations in plakophilin-2 comprise nearly 24% of all mutations 
whereas a smaller proportion of mutations arise from splice donor/acceptor site 
mutations (9%), insertion/deletions (indels, 2%), large insertion/deletion (>20bp, 2%) 
and entire deletions of several exons (deletion of exons 1-4 & promoter region, 2%, 
Table 1.5). Missense mutations may cause gain of function activity if amino acid 
substitutions involve serine, threonine, and tyrosine amino acid residues that might be 
involved in post-translational modification of plakophilin-2 with associated signalling 
functions. Missense mutations may disrupt protein-protein interactions of plakophilin- 
2 (particularly in the head domain where the vast majority of interactions are known 
to occur) if an amino acid residue substituted formed part of an epitope involved in 
the binding activity. Fine mapping studies to define amino acid residues important in 
the binding domains of plakophilin-2 to its diverse protein partners are currently 
unavailable, but the impact of certain highly conserved missense amino acid residue 
substitutions in plakophilin-2 head domain are predicted to be disruptive for this 
reason. The deleterious effects of missense mutations are commonly attributed to their 
impact on primary amino acid sequence and effect on protein secondary structure. 
However, several recent studies have shown that some missense mutations are 
deleterious because they disturb cis-acting splicing elements called exonic splicing 
enhancers (ESEs) that positively encourage the selection of flanking splice sites 
compensating for weak splice sites. Examples of pathogenic missense mutations 
affecting ESEs are well illustrated in other genes encoding hMLHl, hMLH2 and 
BRCA1 which leads to higher propensity for splicing defects202,203.
ESEs are discrete, degenerate motifs of 6-8 nucleotides located inside exons. The 
study of normal splicing suggests that most exons contain at least one functional ESE
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site. ESEs are target sequences for the family of conserved essential splicing factors - 
the serine- and arginine-rich (SR) proteins. ESEs play an important role in exon 
recognition. Missense nucleotide substitutions in ESEs can result in failure of SR 
proteins to bind to the ESE, which leads to failure of splisosome machinery to 
recognize the sequence as exonic causing exon skipping. Each SR protein recognizes 
specific, albeit degenerate and partially redundant, sequence motifs. ESE motifs of 
five members of the SR family (SF2/ASF, SF2/ASF (IgM-BRCAl), SRp40, SRp55, 
and SC35) have been identified. Apart from missense mutations, ESEs can also be 
disrupted by nonsense as well translationally silent point mutations (synonymous 
mutations). Aberrant exon skipping resulting from missense, nonsense, or 
translationally silent single-base substitutions is frequently, if not always, caused by 
disruption of a critical ESE. Disruption of an ESE may result in the pre-mRNA 
transcript to splice incorrectly, effectively deleting an entire exon-encoded segment of 
the protein. Mutations in one exon sometimes could cause skipping of multiple 
consecutive exons. If the length of the skipped exon(s) is not a multiple of three 
nucleotides, a frameshift may cause down regulation of the aberrantly spliced mRNA 
by NMD.
In addition to ESEs there are exonic splicing silencer (ESS), these are cfr-regulatory 
elements that inhibit the use of adjacent splice sites, often contributing to alternative 
splicing (AS). ESSs often act through interactions with members of the heterogeneous 
nuclear ribo-nucleoprotein (hnRNP) family204. The molecular mechanisms by which 
ESSs inhibit splicing are just beginning to be uncovered. Presence of a higher density 
of ESEs in authentic exons than in pseudoexons may contribute to recognition of the 
correct exons, while presence of ESSs in pseudoexons may suppress their splicing205. 
Although ESSs are prevalent in the human genome they are a relatively less studied 
aspect of splicing compared to ESEs.
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Table 1.5 Plakophilin-2 mutations in ARVC
PKP-2 mutations in autosomal dominant ARVC reported in various cohorts. * = mutations seen in previous studies. * = only PKP2 
homozygous mutation documented causing a recessively inherited ARVC. Highlighted in yellow are the mutations discovered in genetic
screening work described in section 3.5/ Part 1 that have since been pulWished41. Mutations listed are as re]ported until March 2008.
Nucleotide alteration Amino Acid alteration Type of mutation References /No. probands
145 148delCAGA S50fsX110 Small deletion frameshift Gerull40/120
216insG Q74fsX85 Small insertion -> frameshift
235C>T R79X Nonsense
534 535insCT C179fsX190 Small insertion -> frameshift
419C>T S140F Missense
1369 1372delCAAA Q457X Small deletion nonsense
1631 1632insTT L544fsX563 Small insertion -> frameshift
1642delG V548fsX562 Small deletion -> frameshift
1844C>T S615F Missense
1912C>T Q638X Nonsense
1948delA V650fsX655 Small deletion -> frameshift
1951C>T R651X Nonsense
1960A>C K654Q Missense
2076 2077delAA C693fsX741 Small deletion frameshift
2088insA K696fsX742 Small insertion -> frameshift
2095C>T Q699X Nonsense
2146-1G>C (IVS10 acceptor site) N/A Aberrant splicing
2176C>T Q726X Missense
2203C>T R735X Missense
2386T>C C796R Missense
2393 2401 delCATTGAACA N798fsX879 Small deletion frameshift
2424insA E809fsX826 Small insertion -> frameshift
2489+1 G>A (IVS12 donor site) N/A
Aberrant splicing, retention 56bp 
of intron12 or skipping exon 12
2490-1 G>C (IVS 12 acceptor site) N/A
Aberrant splicing, retention 146bp 
of intron 12 or part skipping exon 13
2509delA V837fsX930 Small deletion frameshift
Nucleotide alteration Amino Acid alteration Type of mutation References /No. probands
145_148delCAGA* S50fsX110 Small deletion frameshift Syrris41/100
C419T* S140F Missense
C1237T R413X Nonsense
1597 1600delATCC P533fsX561 Small deletion -> frameshift
1755 1756insTTGACTCA L586fsX658 Small insertion -> frameshift
1709delC V570fsX576 Small deletion -> frameshift
C1844T* S615F Missense
2146-1G>C (IVS10 acceptor site) N/A Aberrant splicing
2197 2202delCACACCinsG A733fsX740 Indel -> frameshift
235C>T* R79X Nonsense Dalal108/58
145_148delCAGA* S50fsX110 Small deletion -> frameshift
C419T* S140F Missense
1171-2A>G Aberrant splicing
1271T>C F424S Missense
13688delA N456fsX458 Small deletion -> frameshift
1613G>A W538X Nonsense
1642delG* V548fsX562 Small deletion -> frameshift
2011delC P671 fsX683 Small deletion -> frameshift
2146-1G>C (IVS10 acceptor site) N/A Aberrant splicing
2197_2202delCACACCinsG * A733fsX740 Indel -> frameshift
2489+1 G>A (IVS12 donor site) N/A Aberrant splicing
2509delA* V837fsX930 Small deletion -> frameshift
Nucleotide alteration Amino Acid alteration Type of mutation References /No. probands
76G>A D26N Missense Van Tintelen107/96
148 151delACAG T50fsx60 Small deletion -> frameshift
184C>A Q62K Missense
235C>T* R79X Nonsense
258G>T Y86X Nonsense
397C>T Q133X Nonsense
1211 1212insT V406fsX409 Small insertion ->  frameshift
1848C>A Y616X Nonsense
2028G>A W676X Nonsense
2062T>C S688P Missense
2386T>C C796R Missense
2421 C>A Y807X Nonsense
2544G>A W848X Nonsense
2489+1 G>A (IVS12 donor site) N/A Aberrant splicing
C1237T* R413X Nonsense Unsold206/1
145_148delCAGA* S50fsX110 Small deletion -> frameshift Dalal207/9
1271T>C* F424S Missense
1613G>A* W538X Nonsense
1642delG* V548fsX562 Small deletion -> frameshift
2011delC* P671 fsX683 Small deletion -> frameshift
2146-1 G>C (IVS10 acceptor site) * N/A Aberrant splicing
2489+1 G>A (IVS12 donor site) * N/A Aberrant splicing
2509delA* V837fsX930 Small deletion -> frameshift
Nucleotide alteration Amino Acid alteration Type of mutation References /No. probands
2196ins28bp A733fsX740 Large insertion ->  frameshift Kannankeril111/1
V587I Missense Basso46/80
N670fsX683
Q707X Nonsense
c.24840T/c.2484C>T* G828G Aberrant splicing Awad113/1
1728 1729insGATG R577fsX582 Small insertion ->  frameshift Nagaoka109/1
971_980del10bp G324fsX348 Small deletion -> frameshift Antoniades110/23
2509delA* V837fsX930 Small deletion -> frameshift
2568del50bp R857fsX858 Large deletion -> frameshift
176A>T Q59L Missense Lahtinen112/29
184C>A* Q62K
Missense
1839C>G N613X Nonsense
2421 C> A * Y807X Nonsense Otterspoor208/!
Deletion of exons 1-4 & promoter functional null PKP-2 allele large genomic rearrangement Smagt209/82
*
Various mutations Various mutations Seven frameshift/nonsense, three missense Sen-Chowdhry165
Unique small insertions/deletions: 20/54 37% Unique splice site defects: 5/54 9%
Unique Missense mutations: 13/54 24.0% Unique indels: 1/54 2%
Unique Nonsense mutations: 13/54 24.0% Unique large insertion/deletions: 1/54 2%
Large genomic deletion 1/54 2.0%
1.8.4 Desmoglein-2 mutations in ARVC
• # 9 i  n  •Desmoglein-2 is expressed in many tissue including the myocardium . DSG-2 is a
i
type I integral membrane glycoprotein participating in Ca -dependent cell-cell 
adhesion at desmosomal junctions, it is composed of a small signal domain (S) and a 
preprotein (P) domain followed by four highly conserved extracellular subdomains 
(EC1-EC4), a variable extracellular anchor (EA) domain, a single transmembrane 
domain(TM), and an intracellular anchor domain (IA). The DSG-2 cytoplasmic 
subdomains are composed of an intracellular cadherin-typical segment (ICS) a linker 
domain (LD) a repeat unit domain (RUD) containing six repeats and a terminal 
domain (TD). DSG-2 mediates calcium-dependent intercellular adhesion and in 
cardiac tissue it interacts laterally and transcellularly with desmocollin-2.
Following the discovery of plakophilin-2 mutations in ARVC, rapid progress during 
2006-2007 resulted in the identification of DSG-2 mutations that were causative for 
autosomal dominant ARVC. Four separate reports46,100,101,104 identified twenty-one 
(Table 1.6) unique mutations in DSG-2. These mutations are listed in chronological 
order in Table 1.6. The vast majority (67%) of these DSG-2 mutations are missense 
mutation that disrupts highly conserved amino acid residues involved in various 
functional domains of DSG-2. Some of these missense substitutions (p.R45Q & 
p.R48H) disrupt the Furin-recognition motif (RXXR) that is involved in cleavage (by 
subtilisin-like proprotein convertase) of inactive DSG-2 propeptide to mature active 
DSG-2 protein. Other missense amino acid substitutions (p.V56M, p.D154E, 
P.V1588G, p.Y87C, p.GlOOR, p.N266S, p.K294E, p.E331K, & p.V392I) appear to 
disrupt EC1, EC2, EC3, and EC4 domains. Small insertions/deletions comprise 19% 
of all DSG-2 mutations that can lead to a variety of outcomes resulting in frameshift, 
abnormal splicing, and a nonsense mutation (Table 1.6). Nonsense mutations 
comprise about 9% of DSG-2 mutations, some nonsense mutations (p.Q558X, 
p.Q591X) appear to truncate DSG-2 with loss of transmembrane and cytoplasmic 
sites (ICS) where binding sites for plakoglobin and plakophilin-2 are located. So far 
only one splice site mutation in DSG-2 has been reported in ARVC, this causes 
activation of an alternative cryptic splicing in exon 13 resulting in an aberrant mRNA 
lacking 38 bases of exon 13 that truncated DSG-2 protein to 646 amino acids104.
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Table 1.6 Desmoglein-2 in ARVC
Data was derived from genetic screening o f various cohorts. * = mutations seen in previous studies or previously described.
Nucleotide alteration Amino Acid alteration Type of mutation References /No. probands
260A>G Y87C Missense Pilichou104/80
298G>C G100R Missense
797A>G N266S Missense
877A>G K294E Missense
991 G>A E331K Missense
1881-2A>G X646
Aberrant splicing in acceptor site of intron 12 activating 
alternative splicing in exon 13, 38bp downstream -> frameshift
1672C>T Q588X Nonsense
1253 1257insATGA E418fsX419 Small insertion -> frameshift
2036delG G678fsX681 Small deletion -> frameshift
134G>A R46Q Missense Awad100/33
143G>A R49H Missense
915 G>A W306X Nonsense
1517G>A C507Y Missense
2431 G>T G812C Missense
298G>C* G100R Missense Basso46/21
1253_1257insAT GA* E418fsX419 Small insertion -> frameshift
Q558X Nonsense
3G>C M1 (start codon affected) Start codon mutation-> abolishing translation? Syrris101/86
165G>A V56M Missense
473T>G V158G Missense
829 840delCTTGAAGGGATG 227 280delLEGM Small deletion -> Abnormal splicing
1174G>A V392I Missense
1773 1774delTG C591fsX591 Small deletion -> frameshift with
2759T>G V920G Missense
*
Various mutations Various mutations Nine frameshift/nonsense and one missense Sen-Chowdhry165
missense 14/21 = 67% splice sites 1/21 = 5% small inserts/deletions 4/21 = 19% nonsense 2/21 = 9%
1.8.5 Desmocollin-2 mutations in ARVC
Desmocollins are type I membrane glycoproteins mediating Ca -dependent cell-cell
adhesion at desmosomal junctions. Three desmocollin isoforms (DSC 1-3) exists that
are encoded by separate genes clustered on chromosome 18 in humans. Desmocollin-
2 is ubiquitously expressed in tissues forming desmosomes and it appears to be the
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only isoform expressed in cardiac tissue . Similar to Desmoglein-2 protein domain 
structure, desmocollin-2 is composed of a signal domain (S), a preprotein (P) domain 
followed by four highly conserved extracellular subdomains (EC1-EC4) and an 
extracellular anchor domain (EA) at its amino terminus. This is followed by a single 
transmembrane domain (TM) and a cytoplasmic tail at its carboxy terminus which 
consists of an intracellular anchor domain (IA) and an intracellular cadherin specific 
domain (ICS) that is present in desmocollin-2a isoform (long form of protein), but not 
in the desmocollin-2b (short form of protein) isoform.
Three independent studies have examined DSC-2 mutations in ARVC. In the first 
study, seventy-seven Caucasian ARVC probands not carrying gene mutations in 
desmoplakin, plakoglobin, plakophilin-2, or desmoglein-2 showed four affected 
individuals with two heterozygous frameshift DSC-2 gene mutations, c.l430del_C 
and c.2687_2688ins_GA (Table 1.7), resulting in DSC-2 protein truncations 
p.M477fsX480 and p.E896fsX900 respectively; with mutation carriers showing 
incomplete ARVC penetrance102. Mutation p.M477fsX480 is located in the fourth 
extracellular cadherin repeat unit (EC4) of desmocollin-2 and this mutation would be 
pathogenic as it truncates desmocollin-2 with the loss of transmembrane and 
cytoplasmic domains. The p.E896fsX900 mutation truncates desmocollin-2 protein in 
the ICS domain, which displays a high degree of sequence homology with 
desmosomal and non-desmosomal cadherins where a putative binding site for 
plakoglobin is located. How precisely these desmocollin-2 mutations might disrupt 
desmosome function remains speculative, but this may involve either NMD causing 
haploinsufficiency, or if NMD mechanisms are escaped then incorporation of 
truncated desmocollin proteins may cause dominant negative effects. A second study 
examined eighty-eight Caucasian probands for mutations in desmoglein-2 and 
desmocollin-2 genes. A single heterozygous mutation disrupting a highly conserved
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3’ splice-acceptor site in intron 5 (c.613-2A>G) of the DSC2 gene (Table 1.7) caused 
cryptic splicing resulting in skipping of the first 25 base pairs of exon 6 resulting in a 
frameshift and PTC after insertion of ten novel amino acid residues . In a third 
study, a cohort of fifty-four Italian ARVC patients who were negative for mutations in 
DP, PKP-2, DSG-2, and TGFp were examined by dHPLC and DNA sequencing 
analysis of the DSC-2 gene". Two heterozygous mutations were found c.304G>A 
and c.1034T>C (Table 1.7) resulting in missense amino acid substitutions (p.E102K 
located in propeptide domain and p.I1345T located in the EC2 domain respectively). 
Both amino acid substitutions altered the physicochemical properties compared to the 
wild type amino acid residue found. In vitro expression studies of p.E102K and 
p.I1345T DSC-2 proteins in rat neonatal cardiomyocytes and HL1 cells showed that 
these two N-terminal missense DSC-2 mutant proteins affected the normal 
localisation of desmocollin-2 at the cell-cell junction.
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Table 1.7 Desmocollin-2 mutations in ARVC
Found by the genetic screening o f various cohorts. Two-hundred and nineteen probands in three independent studies were examined between these studies. 
Desmocollin-2 mutations appear to contribute a very small percentage o f mutations in ARVC compared to all other gene mutations encoding other desmosomal
ic
proteins. =  Mutations previously described.
oo
OJ
Nucleotide alteration Amino Acid alteration Type of mutation References /No. probands
1430del C M477fsX480 Small deletion -> frameshift Syriss102/77
2687 2688ins GA E896fsX900 Small insertion-^ frameshift
613-2A>G M211fsX221
Aberrant splicing resulting from splice-acceptor site intron 
5 mutation that activates alternative cryptic splice causing skipping 
of first 25 bases of exon6 resulting in a frameshift and PTC 
after insertion o f ten novel amino acids Heuser103/88
304G>A E102K Missense Beffagna"/54
1034T>C I345T Missense
★
Two mutations Two mutations One frameshift and one missense mutation Sen-Chowdhry
1.9 Experimental Aims
A literature review at the beginning of the year 2004 on ARVC genetic studies 
showed that linkage analysis approach was used in identifying loci associated with 
ARVC; this resulted in the identification of three gene mutations by positional cloning 
responsible for ARVC2, ARVC4 and a recessive form of ARVC (Naxos disease) with 
manifestations of palmoplantar keratoderma and woolly hair. Two of genes involved, 
DP in ARVC4 and PG in Naxos disease were desmosomal constituents, whereas 
RyR2, a non-desmosomal component (cardiac sarcoplasmic reticulum calcium release
94-channel) involved in regulating the intracellular Ca levels was the gene involved in 
ARVC2. This led to a hypothesis that mutations in genes encoding other cell-cell 
adhesion proteins may be associated with ARVC. This formed the basis for carrying 
out the genetic screening work in Chapter 3.
The aim of the first part of the genetic screening work (Chapter 3, part 1) was to 
examine a cohort of one-hundred ARVC patients. Peripheral blood samples obtained 
from these patients were extracted to obtain genomic DNA. Template DNA was used 
for exon specific PCR amplification from the genes encoding for plakoglobin, 
desmoplakin, and plakophilin-2, followed by bidirectional DNA sequencing analysis. 
This approach identified mutations covering the entire coding and exon flanking 
regions in each of the three genes examined. The aim in the second part of the genetic 
screening work (Chapter 3, part 2) was to examine mutations identified in individual 
probands to determine the inheritance of the genetic defect in family members. In 
these family studies, genetic screening was performed by DNA sequencing, this 
allowed identification of family members of the probands inheriting a known genetic 
defect; and evaluations were performed applying both Task Force and modified 
ARVC criteria to determine clinical expression of the disease in family members. 
These pedigree studies provided supporting evidence for pathogenicity of sequence 
changes identified at the DNA level.
In the following three parts of this thesis (Chapters 4 to 6), the aims were to examine 
the in vitro functional effects of expression of three separate mutations found. Two 
separate plakophilin-2 gene mutations were analysed by functional studies (Chapters 
4-5) involving mutations resulting in truncated and missense PKP-2 proteins 
respectively. A desmoplakin mutation was also analysed by functional studies
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(Chapter 6) this involved a mutation resulting in truncated DP polypeptide. All three 
gene mutations identified in the genetic screening analysis were likely to be 
pathogenic as they associated with ARVC disease in family studies (Chapter 3, 
section 3.5.4 Parts 2.1, 2.5. and 2.7 respectively). Functional studies were performed 
to determine the consequence of expression of these mutant proteins in vitro, this was 
done using a cell line derivative of the HEK 293 lineage that is widely used to study 
the expression of both soluble and membrane bound proteins. This cell line was 
selected for expression studies of plakophilin-2 and desmoplakin full-length or their 
truncated and missense protein variants because of the high level of transfection of the 
cell line with vectors used. This resulted in a high level of expression and appropriate 
processing of these proteins for membrane targeting in HEK 293 cell system.
In Chapter 4, a mutation found causing an insertion/deletion within exon 11 of the 
plakophilin-2 gene resulted in a truncated protein (A733fsX740 PKP2, nucleotide 
change 2197_2202delCACACCinsG) and the expression of this protein was examined 
by functional studies in Flp-In T-Rex HEK293 stable cell lines to determine the effect 
of expression of this truncated plakophilin in vitro. Cloning of DNA encoding full- 
length and the truncated plakophilin-2 were performed in pcDNA4 and pcDNA5 
plasmid vectors. These plasmids allowed expression of full-length and truncated PKP- 
2 proteins in cell culture experiments. Using pcDNA5 plasmid transfection, stable cell 
lines were established in Flp-In T-Rex HEK293 that expressed full-length and the 
truncated plakophilin proteins. Using induced cell lines expressing these plakophilin-2 
proteins, the cellular proliferation, initial cell adherence and spreading, cell-cell 
adhesion assay and mechanical stretch was examined. The cellular localization and 
expression of plakophilin-2 and of connexin-43 proteins was examined in stable cells 
as remodelling of the later has been postulated to play a possible role in 
arrhythmogenesis in ARVC. Furthermore, the cell-cell electrical coupling in cell lines 
expressing full-length or truncated plakophilin-2 proteins was examined by 
electrophysiology to assess the measured cell input resistances, a measure of how well 
connected these cells are electrically. Non-transfected cell line and stable cells 
expressing full-length or truncated plakophilin-2 were analyzed by transmission 
electron microscopy to determine the effect on the formation of desmosomes in vitro. 
Using pcDNA4 plasmid transfection experiments in HEK 293T cells the interactions 
of truncated plakophilin-2 with desmosomal and adherens junction proteins was 
examined by immunoprecipitation.
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In Chapter 5, a missense mutation causing a single serine to phenylalanine amino acid 
substitution in plakophilin-2 (S140F PKP-2, nucleotide change C419T) was encoded 
into cDNA that were cloned into pcDNA5 and pcDNA4 plasmid vectors. These 
plasmid vectors allowed expression of full-length and missense PKP-2 proteins in cell 
culture experiments. Stable cell line expressing S140F PKP-2 was established in Flp- 
In T-Rex HEK 293 cells using pcDNA5 plasmid transfection. Using induced stable 
cell line expressing missense and full-length PKP-2 proteins the cellular proliferation, 
initial cell adherence and spreading, cell-cell adhesion, and cellular mechanical stretch 
was examined. The cellular expression and cellular localization of missense 
plakophilin-2 and Cx-43 was examined in stable cell line to assess the localisation of 
Cx-43 protein to cell plaques. Non-transfected cell line and stable cells expressing 
either full-length or missense plakophilin-2 were analyzed by transmission electron 
microscopy to determine the effect on the formation of desmosomes in vitro. Using 
pcDNA4 plasmid transiently transfected in HEK 293T cells the interactions of 
missense plakophilin-2 with desmosomal and adherens junction proteins was 
examined by immunoprecipitation.
In Chapter 6, a heterozygous insertion of a single Adenosine nucleotide residue in 
exon 7 of desmoplakin (Q273fsX288 DP, nucleotide change 818_819_insA) resulted 
in truncation of desmoplakin to a polypeptide of 287 amino acids in length. A cDNA 
encoding the above insertion sequence and of a full-length desmoplakin control 
sequence were each cloned into pcDNA5 vector. Plasmid vectors encoding these 
sequences allowed expression of full-length or truncated DP proteins in cell culture 
experiments. Stable cell lines expressing full-length or truncated DP were established 
in Flp-In T-Rex HEK293 cells using pcDNA5 plasmids transfection. Using induced 
stable cell line expressing full-length or truncated DP proteins the cellular 
proliferation, monolayer cell-cell adhesion, and cellular mechanical stretch response 
to apoptosis was examined in these cell lines. The co-localization of truncated or full- 
length DP with either PKP-2 or PG at cell-cell junctions was examined by 
immunofluorescence in cell lines stably expressing full-length or truncated DP 
proteins. The Vimentin intermediate filament network was examined by 
immunofluorescence staining of stable cells expressing full-length or truncated DP 
proteins. Using stable cell lines the interaction of full-length or truncated DP with 
plakophilin-2 or plakoglobin proteins were examined by immunoprecipitation.
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Chapter 2 -Materials and methods
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2.1 Genetic analysis of an ARVC cohort
Blood samples were obtained from one hundred index ARVC patients (probands) who 
were diagnosed by Task Force criteria at the London Heart Hospital, in collaboration 
with Professor William McKenna and a consultant led clinical team after approval by 
the local ethics committee in University College London Hospital and obtaining 
informed patient consent. For Pedigree analysis, further blood samples were obtained 
with consent, from family members of the affected probands and both Task Force and 
modified criteria were applied in clinical assessments of these individuals.
2.1.1 DNA extraction from whole blood samples
QIAamp Mini Kit (QIAGEN) was used to extract DNA from EDTA preserved human 
blood samples. Archived blood samples were thawed to room temperature prior to 
DNA extraction. Protease enzyme supplied was added (20pl, 15pg/pl) to 1.5 ml 
Eppendorf micro-centrifuge tubes. Blood sample (200pl) was added followed by 
200pi AL lysis buffer to each micro centrifuge tube and pulse-vortexing followed by 
incubation at 56°C for 10 minutes. Following the incubation and a brief centrifugation 
of the tubes, 200pl absolute ethanol was added to the samples. Samples were pulse- 
vortexed and the mixture was transferred to spin columns assembled in 2ml collection 
tubes. These were spun at 8000rpm for 1 minute. The filtrate was discarded and the 
spin column assembled in a new 2 ml collection tube. 500pl of AW1 buffer was 
added to the spin column followed by centrifugation at 8000 rpm for 1 minute. The 
filtrate was discarded and the spin column was placed in a clean 1.5ml Eppendorf 
tube. Sterile water 200pl was placed in the spin tube and after standing for 1 minute, 
the DNA was eluted by centrifugation at 8000 rpm for one minute. This procedure 
typically yielded 6pg of pure genomic DNA from 200pl of blood DNA samples were 
stored at 4°C.
2.1.2 Polymerase chain reaction
All PCR reactions were performed in the Gene Amp PCR System 9700 (Applied 
Biosystems) using Thermo-Fast 96-well (ABgene) plates. Optimum primer annealing
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temperature and the number of cycles employed for PCR amplification varied with 
PCR fragments amplified. These were determined separately in experiments to work 
out the best conditions to achieve a high specificity of the PCR reaction. Individual 
exons for sequencing were <600bp and were obtained by PCR using AmpliTaq Gold 
polymerase (Applied Biosystems, UK), otherwise EXL DNA polymerase (Stratagene, 
UK) and AccuTaq LA (Sigma Aldrich, UK) polymerases were used for PCR of 
amplimers between lOOObp -  9,000bp in length. These enzymes were especially 
formulated for amplification of cloned DNA targets up to 48kb with a low error rate 
of mis-incorporated nucleotides (<lbp change per 10,000bp amplified product).
AmpliTaq Gold PCR
AmpliTaq PCR reaction was set up as follows:
2.5 pi 1 Ox PCR buffer containing 1.5mM MgCl2 (Applied Biosystems)
50-100 ng T emplate DNA
*
1.0 pi Forward pnmer (10 picomoles, Invitrogen)
1.0 pi Reverse primer* (10 picomoles, Invitrogen)
1.0 pi dNTP mix, (2.5mM each dATP, dGTP, dCTP and dTTP (Invitrogen)
1.0 pi 25mM MgCl2 (Applied Biosystems), omitted where appropriate
0.1 pi AmpliTaq Gold DNA polymerase (Applied Biosystems, 0.5Units)
PCR grade H20  was added to a final volume of 25pl. The following PCR program was used: 
Segment Cycles Temperature Time
1 96°C 10 minutes
2 X35-40 96°C 30 seconds
45 - 68°C (as appropriate) 30 seconds
72°C 1 minute
3 72°C 7 minutes
4 4°C hold/oo
* Primer sequences are listed in Chapters 4-6.
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EXL Polymerase PCR
EXL PCR was assembled as follows
5.0 pi lOx EXL buffer (Stratagene)
2.5 pi dNTP mix, (lOmM each dATP, dGTP, dCTP and dTTP, Invitrogen)
2.0 pi Forward primer (lOOng/pl, Invitrogen)
2.0 pi Reverse primer (lOOpl ng/, Invitrogen)
0.5 pi DMSO (Stratagene)
1.0 pi Stabilising Solution (Stratagene)
15-60 ng Vector template DNA (non-linearized)
1.0 pi EXL DNA polymerase (Stratagene, 5 Units/pl)
PCR grade H2O was added to a final volume of 50pl. The following PCR program was used:
Segment Cycles Temperature Time
1 92°C 2 minutes
2 X10 92°C 20 seconds
55°C 45 seconds
68°C x min, variable (lmin/kbp length)
3 X15 92°C 20 seconds
55°C 45 seconds
68°C x min +10 seconds additional /cycle
4 68°C 20 minutes
5 4°C hold /oo
* Primer sequences are listed in Chapters 4-6.
AmpliTaq LA PCR was assembled as follows:
5.0 pi lOx AccuTaq LA buffer (Sigma Aldrich)
2.5 pi dNTP mix, (lOmM each dATP, dGTP, dCTP and dTTP, Invitrogen)
1.0 pi Forward primer* (lOOng/pl, Invitrogen)
1.0 pi Reverse primer (lOOpl ng/, Invitrogen)
1.0 pi DMSO (Sigma Aldrich)
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5-50 ng 
0.5 pi
Vector DNA templates (non-linearized)
AccuTaq LA DNA polymerase (Sigma Aldrich, 0.05 Units/pl)
PCR grade H2O was added to a final volume of 50pl. The following PCR program was used:
Segment
1
2
Cycles
X15
Temperature
98°C
94°C
55°C
68°C
Time
1 minute 
20 seconds 
45 seconds
x min, variable (lmin/kbp length)
X15 94°C
55°C
68°C
68°C
4°C
20 seconds 
45 seconds
x min +15 seconds additional /cycle 
10 minutes 
hold /oo
Primer sequences are listed in Chapters 4-6.
GC-rich PCR
GC-rich PCR system (Roche) was used for amplifying genomic targets from a region 
of high G-C content and the PCR reaction was assembled as follows:
5.0 pi GC-rich lOx PCR buffer with DMSO (Roche)
1.0 pi dNTP mix, (2.5mM each dATP, dGTP, dCTP and dTTP, Invitrogen)
lOpmoles Forward primer (Invitrogen)
*
lOpmoles Reverse primer (Invitrogen)
2.5 pi GC-rich resolution solution (Roche)
0.5 ul GC-rich system enzyme mixture (2 Units/pl, Roche)
75 ng Genomic DNA template
PCR grade H20  was added to a final volume of 25pi. The following PCR program was used:
Segment Cycles Temperature Time
1 95 °C 3 minutes
X35 95°C 30 seconds
60 -  68°C (as appropriate) 30 seconds
72°C 45 seconds
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34
72°C
4°C
7 minutes 
hold/oo
* Primer sequences are listed in Chapters 4-6.
2.1.3 Restriction enzyme digests, agarose gel 
electrophoresis and gel DNA extraction
Plasmids obtained in cloning reactions or from SDM, were characterised by analytical 
scale restriction endonuclease digest. This involved either single or double-digest of 
super-coiled plasmid DNA with appropriate restriction enzymes. Restriction 
ffagment-length analysis was performed in 2% (500-1000bp) or 0.8% (500-10,000bp) 
agarose gel electrophoresis allowing screening of large number of plasmid clones to 
verify positive clones containing the expected insert DNA sequence. Single or double 
restriction enzyme digests were performed using manufacturer’s recommended 
protocol (Fermentas UK, New England Biolabs, Invitrogen UK,) employing 
appropriate buffer systems optimized for double-digest reactions. One enzyme unit of 
restriction enzyme in a total volume of ten microliters in xl restriction enzyme buffer 
was used with a maximum amount of plasmid DNA in the digest not exceeding one 
microgram. Restriction digests were incubated for a minimum of four hours at 37°C 
or overnight at the same temperature.
For agarose gel electrophoresis of PCR and digests, liquefied gel solution was mixed 
with ethidium bromide (2.5pg/ml) prior to casting the gel. Loading dye containing 
bromophenol blue and orange G (x6 concentration, Fermentas) was diluted into PCR 
product or digest to x l final concentration and samples were loaded into wells of a gel 
immersed in x l TBE running buffer. The gel was electrophoresed in x l TBE buffer at 
150V until sufficient migration and resolution was achieved. Reference DNA size 
markers (lOkb DNA ladder, Fermentas, UK) were loaded alongside to allow 
verification of the expected size specificity of samples analyzed. A permanent 
photographic record of the gel was obtained under ultraviolet light transillumination 
using a BioRad gel imaging system (Gel documentation system, BioRad, UK).
Specific PCR DNA band was excised from agarose gel exposed under preparative 
ultraviolet transillumination using a sterile scalpel blade. The gel sample containing
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DNA band was weighed prior to performing a DNA gel extraction using the 
QIAquick gel extraction kit (Qiagen, UK). In a 1.5 ml Eppendorf tube for every 100 
mg of agarose gel slice, 0.3 ml of QG was added and solubilisation of the gel in this 
buffer was achieved by incubation at 50°C for 10-15 minutes until the entire gel 
sample was completely dissolved (aided by periodic pulse-vortexing during the 
incubation) in this buffer. The mixture was transferred into a spin column assembled 
on top of a collection tube. The spin column was centrifuged at room temperature at
13,200 rpm for 1 minute and the flow-through was discarded. The spin column was 
assembled on the collection tube and 0.75 ml wash buffer PE was added followed by 
centrifugation at 13,200 rpm for 1 minute. The flow-through was discarded and the 
spin column was centrifuged again at 13,200 rpm for 1 minute to remove traces of 
ethanol residue. Finally, the spin column was assembled on a new sterile 1.5 ml 
Eppendorf tube and 50 pi of EB elution buffer was added, incubated at room 
temperature for 1 minute prior to centrifugation at 13,200 rpm for 1 minute to obtain 
the purified DNA fragment. Gel purified DNA sample was stored at -20°C.
2.1.4 DNA sequencing and data analysis
Removal of unincorporated nucleotides, primers, buffer, and enzyme from the PCR 
reaction was performed prior to bi-directional sequencing using the forward and 
reverse primer respectively.
2.1.4.1 Purification of PCR products
GFX-96 (96-well plate) purification
A GFX-96 plate purification system was used to purify simultaneously ninety-six 
PCR products according to the suggested manufacturer’s protocol (GE Healthcare, 
UK). A GFX plate was assembled on top of a 96-well wash plate and 0.3 ml of 
binding buffer was added to each well. PCR reaction products were checked on an 
agarose gel and the remaining samples were transferred and mixed with binding 
buffer into individual wells of the GFX-96 plate. The plate was centrifuged at room 
temperature at 1800 rpm for 2 minutes and the flow-through was discarded. The GFX 
plate was re-assembled on a 96-well wash plate and ethanol containing wash buffer
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(0.4 ml) was added to each well. The plate was centrifuged at 1800 rpm for exactly 5 
minutes. The flow-through was discarded and the wash plate re-assembled on the 96- 
well wash plate. Following centrifugation at 1800 rpm for 1 minute to remove traces 
of residual ethanol, the GFX-96 plate was assembled on a 96-well collection plate and 
20 pi of PCR grade water was added to each well. Following incubation of the plate 
for 1 minute at room temperature, it was centrifuged at 1800 rpm for 2 minutes. The 
purified PCR products in the collection plate were sealed with a clear plastic adhesive 
sheet to prevent sample evaporation Purified PCR products were stored at 4°C (short­
term) or at -20°C (long-term).
Individual PCR purification
When small numbers of individual PCR products were purified, this was done using 
the QIAquick PCR (Qiagen, UK) purification kit according to manufacturer’s 
protocol. Five times the volume of PB binding buffer was added to one volume of 
each PCR sample. The QIAquick spin column was assembled on a 2 ml collection 
tube and the sample mixture was transferred into the spin column and centrifuged at
13.200 rpm for one minute. The flow-through was discarded and the spin column was 
re-assembled on the collection tube. Wash buffer PE (0.75 ml) was added to the 
column and centrifugation was carried out at 13,200 rpm for another 1 minute and the 
flow through was discarded. Residual ethanol from the wash buffer in the column was 
removed after a final centrifugation at 13,200 rpm for 1 minute. Finally, the spin 
column was placed on clean 1.5 ml Eppendorf tube and 20 pi EB elution buffer was 
added and incubated at room temperature for one minute prior to centrifugation at
13.200 rpm for 1 minute. Purified PCR products were stored at 4°C.
2.1.4.2 PCR reaction for cycle sequencing
The BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems) was used 
according to the manufacturer’s protocol. Briefly, for each DNA sample to be 
sequenced the following were added:
1.0 pi Either forward* sequencing or reverse* sequencing primer (3ng/pl)
1.0 pi BigDye Terminator cycle sequencing mixture
1-5 pi 200 -  600 ng Purified PCR or plasmid DNA template
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PCR grade H2O was added to a final volume o f  lOpl. The following PCR program was used:
Segment Cycles Temperature Time
1 96°C 2 minutes
2 X25 96°C 10 seconds
50°C 5 seconds
60°C 4 minutes
3 4°C hold/oo
* Primer sequences are listed in Chapters 4-6.
2.1.4.3 Cycle sequencing reaction clean up and 
automated DNA sequencing
The DyeEx 96 kit (Qiagen, UK) was used according to the manufacturer’s suggested 
protocol to remove unincorporated fluorescently labelled deoxynucleotides prior to 
DNA sequencing. A DyeEx 96 plate placed on a 96-well collection plate was 
centrifuged at room temperature for 3 minutes at 2600 rpm. The flow-through was 
discarded and the DyeEx 96 plate was placed on top of a Thermo-Fast 96-well plate 
(ABgene). Each sequencing reaction (10 pi) was carefully transferred into the centre 
of the resin of each well of the DyeEx 96 plate followed by centrifugation at 2600 
rpm for 3 minutes. DyeEx purified samples collected in the Thermo-Fast 96-well plate 
were dried down at 70°C for 45 minutes in a thermal cycler block. Formamide (12 
pl/well, Applied Biosystems) was added to each sample well and the plate was then 
sealed with an adhesive clear plastic sheet, briefly vortexed to mix and denatured at 
96°C for 5 minutes followed by rapid cooling to 4°C on a thermal cycler block. DNA 
sequencing was performed in an automated sequencer (ABI 3130XL Genetic 
Analyzer) using DT3100POP6BDv3vl.mob, RapidSeq36_POP6DefaultModule, and 
BC3100POP6RR_SeqOffFtOff.saz as mobility, run, and analysis modules 
respectively. Sequencing data aligned with a synthetic trace generated from a 
reference file was analyzed by Seqscape program (Applied Biosystems, UK). 
Mutations were confirmed by bi-directional sequencing using forward and reverse 
primers complimentary to the fragment being analysed.
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2.2 Cloning PCR amplified fragments
PCR amplified fragments were cloned into the following vectors: 
pcDNA5/FRT/TO/TOPO/TA (Invitrogen) 
pcDNA4/XPress/TOPO/TA (Invitrogen)
For cloning of PCR amplimer into plasmid vectors, the amplimers were either gel- 
purified or unpurified. The vector and PCR fragments were mixed in varying molar 
ratios ranging from 1:1 to 1:4 (vector:amplimer) and ligation was achieved by a 
vector mediated catalysis.
2.2.1 Cloning in pcDNA5/FRT/TO/TOPO/TA
The cloning in pcDNA5/FRT/TO/TOPO/TA (kit from Invitrogen, UK) was mediated 
by topoisomerase enzyme covalently associated with the vector at the cloning sites 
(“activated” vector) in which the energy conserved in phospho-tyrosyl bond between 
the DNA and the tyrosyl residue (Tyr274) of the topoisomerase drives the ligation of 
a PCR product. The EXL or AccuTaq derived PCR product contained 3’ Adenosine 
residue overhangs on complementary DNA strands allowing annealing and ligation to 
the linearized vector containing complementary T residue overhangs at the cloning 
site. PCR product anneals in two possible orientations in either the sense orientation 
or anti-sense incorrect orientation. Cloning in plasmid pcDNA5/FRT/TO/TOPO/TA 
was performed according to manufacturer’s recommended protocol:
1-4 pi Gel purified or unpurified PCR (molar ratio range: 1:1 to 1:4 (vector: insert)
1.0 pi Salt solution (Invitrogen, UK)
Sterile water was added to make the final volume to 5 pi, and then TOPO vector was 
added.
1.0 pi pcDNA5/FRT/TO/TOPO/TA (1 Ong, Invitrogen, UK)
The reaction was incubated at room temperature (22-23°C) for 5 minutes to 1 hour 
dependent on the size of the PCR amplimer cloned. Two microliters of the cloning 
reaction was transformed in TOP 10 E coli cells (section 2.2.3) and single clones were 
selected and screened for correct orientation of the insert in the plasmid (section 
2.2.4).
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2.2.2 Cloning in pcDNA4/XPress/TOPO/TA
EXL PCR products encoding full-length PKP2, S140F PKP2, and A733fsX740 PKP- 
2 DNA were amplified using XPress primers using +2301A pcDNA5, S140F 
pcDNA5, and A733fsX740 pcDNA5 plasmid template DNA in separate reactions to 
obtain respective amplimers that were cloned into pcDNA4/XPress/TOPO/TA as 
follows:
1-4 pi Gel purified or unpurified PCR (molar ratio range: 1:1 to 1:4 vector: insert)
1.0 pi Salt solution
Sterile water was added to a find volume to 5 pi, and then TOPO vector was added
1.0 pi pCDNA4/XPress/TOPO/TA (lOng, Invitrogen)
The reaction was incubated at room temperature (22-23°C) for 1 hour. Two 
microliters of the cloning reaction was transformed into TOP 10 cells (section 2.2.3) 
and single clones were selected and screened for correct orientation of the insert in the 
plasmid (section 2.2.4).
2.2.3 Transformation of cloned plasmids into 
competent TOP10 cells
Chemically competent TOP 10 E coli cells (Invitrogen, 50 pi aliquots) were thawed 
from -80°C on ice for 10 minutes. Cloning reactions (5 pi reaction volume) from 
pcDNA5 or pcDNA4 was added to the competent cells. The transformation reaction 
mixture was mixed gently with the chemically competent cells. After 30 minutes 
incubation on ice, the cells were heat-shocked at 42°C for 30 seconds and transferred 
onto ice for two minutes. Sterile LB broth (1 ml) was added to the transformation 
reaction and this was left in a shaking incubator at 37°C for 1 hr. The bacterial cells 
were centrifuged at 10,000 rpm for 1 min and pellet was re-suspended in 150 pi of 
sterile LB before plating onto LB agar plates containing the appropriate selecting 
antibiotic (ampicillin lOOpg/ml or kanamycin 50pg/ml. The plates were incubated 
overnight at 37°C. Single bacterial colonies were picked with a sterile 10 pi pipette tip 
and inoculated into 5 ml of LB broth containing the appropriate antibiotic and 
incubated in a shaker overnight at 37°C prior to performing a mini-plasmid DNA 
preparation (section 2.4.1). Plasmid obtained from mini-plasmid preparation was
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checked for the presence of recombinant plasmid containing the cloned PCR fragment 
(section 2.24). For midi-plasmid DNA preparation, a single TOP 10 bacterial clone, 
previously characterised, was cultured in 0.5 ml of SOC medium (Invitrogen, UK) for 
one hour and then plated on an LB agar plate containing the appropriate antibiotic and 
incubated overnight at 37°C. A sterile inoculation loop was used to streak across the 
plate to transfer an inoculum of this sample into a 0.5 litre bottle containing 250 ml of 
LB broth with the appropriate antibiotic followed by incubation overnight in a shaker 
at 37°C. The culture supernatant was processed for midi-plasmid preparation as 
described in the second paragraph of section 2.4.2.
2.2.4 Checking plasmids obtained in cloning reactions
Recombinant plasmid (1 pi) was digested with appropriate restriction endonuclease 
enzyme as described in section 2.1.3. This allows identification of recombinant 
plasmids containing the cloned PCR. Direct sequencing using BigDye terminator, 
sequencing primer, and 600 ng of plasmid DNA was performed to further confirm the 
orientation of the PCR fragment in the recombinant plasmid following the procedures 
described in sections 2.1.4.2 and 2.1.4.3.
2.3 PCR mediated site-directed mutagenesis
PCR mediated SDM was used to create specific change in a triplet codon to obtain a 
desired amino acid substitution. SDM allowed a single nucleotide substitution to be 
introduced into plasmid vector encoding a full-length normal protein sequence with 
missense mutation expression. Truncation mutations arising from insertion/deletion of 
specific nucleotide residues were similarly achieved by SDM using primers spanning 
the mutation site that allowed the insertion or deletion nucleotide residues to ‘hairpin 
loop out’ when annealed to full-length normal nucleotide sequence encoded on a 
plasmid vector. The Quick Change II SDM kit (Stratagene, UK) was used to generate 
mutant plasmid of interest from a large double-stranded plasmid.
Three steps were required to obtain the plasmid with a mutated cDNA of interest:
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1. Thermal cycling was performed to denature super-coiled plasmid DNA template, 
annealing of specific mutagenic primers, and extension of PCR product using Pfu 
Ultra high fidelity DNA polymerase.
2. Addition of Dpn I restriction endonuclease digested the parental methylated and 
hemi-methylated plasmid double stranded DNA resulting in parental plasmid DNA 
degradation.
3. Transformation of the mutant plasmid into competent E coli cells for nick repair 
and amplification.
SDM PCR reaction was assembled as follows:
5.0 pi lOx Pfu Ultra HF reaction buffer
10 ng double stranded plasmid DNA template
125 ng Forward primer*
125 ng Reverse primer*
1.0 pi dNTP mix
3.0 pi Quick Solution (Stratagene, UK)
1.0 pi PfuUltra HF DNA polymerase (2.5U/pl, Stratagene, UK)
PCR grade water was added to a final volume of 50 pi. PCR was performed under the 
following conditions:
Segment Cycles Temperature Time
1 95°C 1 min
2 X18 95°C 50s
60°C 50s
68°C 1 min/kb of plasmid length
3 68°C 10 min
4 4°C hold/oo
* Mutagenic primer sequences are listed in Chapters 4-6.
2.4 Plasmid amplification in chemically competent 
TOP10 cells
Plasmid generated from cloning reaction or by SDM was first cultured up in a small 
volume to obtain mini-plasmid (section 2.4.1) preparation. This plasmid DNA
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preparation was characterised by restriction endonuclease digest (section 2.1.3) and 
by DNA sequencing (sections 2.1.4.2 and 2.1.4.2) to identify the orientation of the 
cloned DNA insert and to confirm the expected insert sequence of full-length insert 
sequence, or to confirm presence of a desired mutation introduced by site directed 
mutagenesis. The selected plasmid was transfected into TOP 10 cells and a bulk 
preparation of the desired plasmid was obtained after purification of culture medium 
using a midi-plasmid (section 2.4.2) preparation.
2.4.1 Mini-plasmid DNA preparation
An individual colony of transformed E. coli (TOP 10) bacterium picked from an 
antibiotic selective plate was inoculated in a 10 ml polypropylene culture tube 
containing 5 ml of LB broth supplemented with the appropriate antibiotic (50-100 
pg/pl). The tube was shaken overnight at 37°C at 225 rpm. Culture tube was 
centrifuged at 3,000 rpm at 4°C for 10 minutes. The bacterial pellet was extracted 
using a QIAprep spin plasmid MiniPrep Kit (QLAGEN, UK) according to the 
manufacturer’s recommended protocol. Buffer PI (0.25 ml containing ribonuclease A 
100 pg/pl) was added to each pellet and mixed by pulse-vortexing. The resuspended 
pellet was transferred into 1.5 ml Eppendorf centrifugation tube, 0.25 ml of P2 lysis 
buffer was added, and the tubes inverted gently four to six times. Neutralization buffer 
N3 (0.35 ml) was added and the tubes inverted gently four to six times. After 
centrifugation at 13200 rpm for 10 minutes at 4°C, the supernatant was carefully 
transferred into a spin column assembled on a 2 ml collection tube. The spin column 
was centrifuged at 13200 rpm for 1 min at 4°C and the flow-through was discarded. 
Wash buffer PB (0.5 ml) was added to the spin column and the flow-through obtained 
after centrifugation at 13,200 rpm for 1 minute at 4°C was discarded. Wash buffer PE 
(0.75 ml) reconstituted in ethanol was added to the spin column and the column was 
centrifuged at 13,200 rpm for 1 minute at 4°C. The flow-through was discarded and 
the column was centrifuged again at 13200 rpm for 1 min to remove residual ethanol. 
The column was placed on a sterile 1.5 ml micro-centrifuge tubes and 50 pi of EB 
elution buffer was added, followed by incubation for 1 minute at room temperature, 
and centrifugation at 13200 rpm for 1 minute to elute the plasmid mini-preparation. 
The absorbance at 260nm of each DNA sample was measured in a spectrophotometer
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(Libra S I2, Biochrom Ltd, UK) to calculate the DNA concentration in pg/ml 
assuming a concentration of 50pg/ml for double stranded plasmid DNA at an 
absorbance value of 1.0 at 260nm. DNA from plasmid mini-preparation was stored at 
-20°C.
2.4.2 Midi-plasmid DNA preparation
Plasmid DNA (100-1000 ng) containing cloned cDNA of interest was added to 50 pi 
of TOP 10 chemically competent E. coli cells in a 1.5 ml Eppendorf micro centrifuge 
tube, mixed gently and incubated on ice for 30 minutes. The mixture was heat- 
shocked in a water bath at 42°C for 30 seconds and transferred into ice for 2 minutes 
followed by the addition of 0.8 ml LB or SOC (Invitrogen) medium without antibiotic 
and the micro-centrifuge tube was shaken in a 37°C incubator at 225 rpm for 1 hour. 
The entire sample was transferred into a 0.5 litre flask containing 250 ml of LB broth 
with the appropriate selective antibiotic (50-100 pg/pl). The culture was shaken in an 
incubator at 250 rpm at 37°C for 24 hrs. The content of the flask were centrifuged at 
3200 rpm at 4°C for 60 minutes in several Falcon 50 ml tubes.
The pooled bacterial pellet obtained was processed using a QIAGEN midi-plasmid 
purification kit according to the manufacturer’s recommended protocol. Bacterial 
pellets re-suspended in a total of 4 ml of PI re-suspension buffer were transferred in a 
single 50 ml falcon tube to which lysis buffer P2 (4 ml) was added, this was gently 
mixed by inverting four to six times, and the lysate was incubated at room 
temperature for 5 minutes. Chilled neutralization buffer P3 (4 ml) was added to the 
lysate and mixed gently by inverting four to six times and the mixture was 
immediately poured in a QIAfilter cartridge (QIAGEN, UK) and incubated at room 
temperature for exactly 10 minutes. A QIAGEN-tip 100 column pre-assembled in a 
50 ml falcon tube and was equilibrated in QBT buffer (4 ml) under gravity flow. 
Following a ten-minute incubation of the lysate in the QIAfilter, the cap was removed 
from the cartridge and with the aid of a syringe plunger; the cell lysate in the 
QIAfilter was filtered into the pre-equilibrated QIAGEN-tip 100. The lysate was 
allowed to enter the resin under gravity flow and the flow-through was discarded. The 
QIAGEN-tip 100 was washed twice; each time with 10 ml of QC wash buffer and the
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column was allowed to empty under gravity flow with the flow-through being 
discarded. The QIAGEN-tip 100 was assembled on top of sterile 15 ml falcon tube 
and 5 ml of elution buffer QF was added to the column, which was allowed to empty 
under gravity flow. To the eluted plasmid DNA, isopropanol (3.5 ml) was added and 
after mixing this was centrifuged at 3200 rpm at 4°C for 1 hr to obtain a plasmid 
DNA pellet. The pellet was carefully transferred in a 1.5 ml Eppendorf micro 
centrifuge tube in one ml 70% ethanol followed by centrifugation at 13,200 rpm at 
4°C for 15 minutes. Traces of ethanol were removed from the plasmid pellet and the 
pellet was air-dried at room temperature for 5-10 minutes prior to resuspension in 30- 
50 pi of endotoxin-free Tris/EDTA buffer. The DNA concentration was calculated 
using measured absorbance at 260 nm. Plasmids were stored at -20°C.
2.5 Cell culture
All cell culture media, supplements including penicillin, streptomycin, zeocin, 
hygromycin, and blasticidin, foetal calf serum, and trypsin/EDTA were purchased 
from Invitrogen, UK.
2.5.1 Human embryonic kidney HEK 293T cell culture
HEK 293T cells were cultured in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% foetal calf serum, 50 U/ml penicillin, 50 U/ml streptomycin, 
and glutamine (4 mM). The medium supplemented as above was referred to as 
complete DMEM. The medium was changed every 72 hours until the cells became 
80-90% confluent when they were passaged into fresh complete DMEM. Confluent 
culture flasks or dishes were trypsinized by addition of Trypsin/EDTA solution (0.067 
ml/cm2 area of the culture dish/flask, e.g. 5 ml/T75 or 0.12 ml/well of 24-well plate) 
and incubating at 37°C for two-five minutes until all the cells had detached. Complete 
DMEM (0.06 ml/cm2) was added to neutralise the action of trypsin and the cells 
resuspended uniformly. 1/10* -  1/5* of this was transferred into a fresh culture 
dish/flask with appropriate amount of complete DMEM medium and the dish/flask 
was incubated at 37°C, 5% CO2 in a humidified incubator. Fresh medium was added
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after 72 hours until cell became 80-90% confluent, when they were sub-passaged as 
above.
2.5.2 Transient plasmid transfection of HEK 293T ceils
HEK 293T cell line was transfected to test the transient (24 to 48 hours post­
transfection) protein expression from cloned cDNA of interest in various plasmids, 
low passage number HEK 293T cells (PI-10) were plated in complete DMEM in 
various plate formats 6-well (5 x 105 cells/well), 24-well (3 x 103 cells/well) or 48
o  £1
well plates (1.5 x 10 cells/well), P90 (2 x 10 ) twenty-four hours before the start of the 
transfection experiment. The protocol described is for the 6-well format, but can be 
scaled up for other plate or flask formats. Twenty-four hours after incubation of 5 x 
106 cells in 3 ml of complete DMEM per well at 37°C in 5% CO2, plasmid DNA 
sample (4 pg in endotoxin-free TE buffer) was added to 0.1 ml of incomplete DMEM 
in a 1.5 ml sterile Eppendorf tube. Sterile Polyfect reagent (40 pg, Qiagen) was added 
and pulse-vortexed for 10 seconds and the mixture was incubated at room temperature 
(20-25°C) for 20 minutes for complex formation. During this incubation, 3 ml of 
complete medium from each well was replaced with fresh 1.5 ml of complete DMEM. 
After plasmid-Polyfect complex formation had taken place, 0.6 ml of complete 
DMEM was added to the Eppendorf tube and the content was transferred immediately 
into the well containing cultured HEK 293T cells and mixed by swirling to ensure 
uniform distribution. Transfection controls included vector plasmid DNA without a 
cDNA insert of interest or a no transfection control in which the entire procedure was 
carried out except for the omission of both plasmid DNA and Polyfect reagent was 
performed. Control wells and those containing transfection with the test plasmid were 
incubated for 24-48 hours at 37°C in 5% CO2. For transient transfected cell expression 
of full-length or mutant protein of interest by confocal immunofluorescence 
microscopy, the entire procedure was performed with cells cultured on coverslips 
(Sarsdtedt, 25 mm plastic coverslip) in 6-well plate. Following twenty-four to forty- 
eight hours after transfection, the medium was removed from each coverslip and with 
the coverslip left in situ in the 6-well plate; they were immediately processed for 
immunofluorescence staining as described (section 2.7.2). Where expression of wild 
type or mutant proteins in transiently transfected HEK 293T cells were examined by
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Western immunoblotting technique the cells were processed as described (section 
2 .6.2).
2.5.3 Flp-ln T-Rex HEK 293 cell culture
The Flp-ln T-Rex HEK 293 cell line (Invitrogen, UK) was supplied at a density of 3 x 
106 cells/vial in cell freezing medium containing 90% foetal calf serum and 10% 
dimethylsulfoxide mixture. A vial of Flp-ln T-Rex HEK 293 removed from liquid 
nitrogen was rapidly thawed in water bath at 37°C, and just before the entire vial 
content had fully thawed, the contents were transferred (under sterile conditions) into 
a T75 flask containing 10 ml of complete DMEM (section 2.5.1) and gently swirled to 
mix the contents. The flask was incubated at 37°C in 5% CO2 for 48hrs to allow cells 
to adhere to the culture flask. Thereafter, the medium was removed and 10 ml of fresh 
complete DMEM supplemented with 15 pg/ml blasticidin (Invitrogen, UK) and 100 
pg/ml zeocin was added to the cells to maintain a selective pressure for retaining a 
stably integrated FRT site present in the genome of this cell line. This growth medium 
was replaced every 72 hours until the cells became 80% confluent. The spent medium 
was aspirated and cells were washed in 8 ml sterile PBS to remove excess foetal calf 
serum. Five millilitres endotoxin-free Trypsin/EDTA solution (Invitrogen, UK) was 
added to the flask followed by incubation at 37°C, 5% CO2 for exactly 5 minutes. The 
flask was gently agitated to dislodge the cell clumps from the flask and complete 
DMEM (5 ml) was added to neutralize the action of trypsin followed by uniform 
dispersal by trituration. Cell viability and counts were performed (section 2.7.1). For
• • thpassaging the cell line, 1/10 -1/5 of the resuspended cells were transferred into a 
new T75 flask containing 10 ml of complete DMEM and blasticidin and zeocin added 
to a final concentrations of 15 pg/ml and 100 pg/ml respectively.
2.5.4 Transfection of Flp-ln T-Rex HEK 293 cells to 
establish stable cell line
Flp-ln T-Rex HEK293 cell line allowed rapid generation of a stable cell line 
expressing a protein of interest from a Flp-ln expression vector (pcDNA5/FRT). 
Targeted integration of pcDNA5/FRT expression vector containing a cloned cDNA of
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interest into this cell line allowed high-level protein expression of the cloned cDNA of 
interest upon induction. Co-transfection of the pcDNA5 expression vector containing 
the cDNA of interest, and a Flp recombinase vector (pOG44) into the Flp-ln HEK 293 
cell line was required for targeted integration of the expression vector into a stably 
integrated FRT site at a transcriptionally active genomic locus in every cell. This 
ensured homogenous level of gene expression (Flp-ln T-Rex system handbook, 
Invitrogen, UK) in every cell.
The Flp-ln T-Rex HEK 293 cells were harvested as described (section 2.5.3) and 
1/20 of the cell suspension was transferred in a (100 mm P90 petridish, Sarsdtedt), 
containing 10 ml of selective complete medium. The plate was incubated in a 37°C, 
5% CO2 humidified incubator until the cells became 30-40% confluent. Plasmid 
pcDNA5/FRT/TO vector containing cloned DNA of interest (4pg) and plasmid 
pOG44 (4pg, Invitrogen) which expressed the Flp recombinase gene were added to a 
0.3 ml incomplete DMEM in a 1.5 ml Eppendorf tube. Polyfect transfection reagent 
(80 pi, QIAGEN, UK) was also added followed by pulse-vortexing of the mixture and 
incubation at room temperature for 20 minutes to allow complex formation. Culture 
medium in P% dish was replaced with fresh complete medium (7 ml) containing only 
blasticidin (because targeted integration of pcDNA5/FRT vector containing a cloned 
DNA into the genome of Flp-ln T-Rex HEK 293 cell line resulted in loss of zeocin 
resistance). One ml of complete medium supplemented with blasticidin was added to 
the Eppendorf tube and the mixture was triturated and transferred into the P 9 0  dish. 
The P90 dish was incubated in a 37°C, 5% CO2 in a humidified incubator for 24 
hours.
Twenty-four after transfection culture medium in P90 plate was replaced with 
complete medium supplemented with blasticidin (15 pg/ml) and hygromycin (100 
pg/ml). Cells acquired hygromycin resistance following targeted integration of the 
pcDNA5/FRT plasmid. Selective medium containing hygromycin and blasticidin was 
replaced every 72 hours providing a continuous selective pressure for clone of cells 
containing a stably integrated pcDNA5 with a cDNA of interest. Non-recombinant 
cell clones were hygromycin sensitive and therefore did not survive the selection 
process. When well-separated individual clones of surviving cells were visible (1-2 
mm), individual clones were transferred into separate wells of a twenty-four well
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plate. The growth medium was aspirated from the P90 plate and the cells washed with 
5 ml of incomplete DMEM to wash out the foetal calf serum. Cloning disc (Sigma- 
Aldrich, UK, product Z374431) previously immersed in Trypsin/EDTA solution 
(Invitrogen, UK) was placed gently over each separate clone of cells and the plate was 
incubated for 5 minutes at 37°C. After the cells had detached from the surface of the 
P 9 0  plate onto the disc, each cloning disc was individually transferred (using a sterile 
pair of tweezers) into separate well of a 24-well plate containing 750 pi of selective 
complete medium. The plate was incubated at 37°C, 5% CO2 in a humidified 
incubator. This growth medium was aspirated and replaced with fresh selective 
complete medium every 72 hours until the cells became confluent. Cells in each well 
were washed with 0.75 ml sterile PBS and then trypsinized in 0.1 ml Trypsin/EDTA 
incubated at 37°C for two minutes. Thereafter, 1 ml of complete DMEM was added 
and the entire contents of the well was transferred into a well of a six well plate 
containing 3 ml selective complete DMEM followed by further incubation. Fresh 
selective complete medium was replaced every 72 hrs until cells became confluent. 
Medium was aspirated and cells washed with one ml sterile PBS followed by 
trypsinization in 0.5 ml Trypsin/EDTA at 37°C for 3 minutes. One ml complete 
medium was added and the entire suspension was aspirated and transferred to a T-25 
flask containing 5 ml selective complete medium. T25 flasks were further incubated 
with fresh selective complete medium replaced every 72 hours until cells become 
confluent when they were washed in 2 ml sterile PBS and trypsinized in one ml 
Trypsin/EDTA at 37°C for 3 minutes. Selective complete medium (4 ml) was added, 
and the entire cell suspension was transferred into a T75 flask containing 5 ml 
selective complete medium and T75 flasks were further incubated with medium 
replacement every 72 hours until cells became confluent.
2.5.5 Long-term storage of stable cell lines
Stocks of various stable cells were prepared from T75 flasks reaching 80% 
confluence. Cells were trypsinized in 4ml Trypsin/EDTA for five minutes, 
resuspended in 6 ml complete medium, and a cell pellet obtained after centrifugation 
at xlOOOrpm for 3 minutes. To the cell pellet, 10 ml freezing solution (90% foetal calf 
serum and 10% cell culture grade DMSO) was added and after gentle trituration, 
aliquots of 1 ml were transferred into cryovials. Vials wrapped in polystyrene bubble
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wrap were frozen for 48 hours at -80°C and then transferred into liquid nitrogen for 
long-term storage.
2.5.6 Inducing wild type or mutant protein expression 
in stable cell lines
Induction of proteins of interest (by Western immunoblotting & Immunofluorescence 
staining) in stable cell lines was performed six well plate format. Wells of a six well 
plate were seeded with 4 x 105 stably transfected cells (for analysis by WIB) or onto 
25 mm coverslips (for analysis by immunofluorescence confocal microscopy) in a 
total volume of 3 ml complete DMEM supplemented with Blasticidin and 
Hygromycin (15 pg/ml and 100 pg/ml respectively). One set of wells in triplicate 
were designated non-induced stable cells (3 pi of 70% ethanol was added/well to each 
well) used as assay controls. A second set of triplicate wells were designated induced 
stable cells (3 pi of 100 pg/ml sterile tetracycline in 70% ethanol was added per well 
to give a final tetracycline concentration: 0.1 pg/ml). Both sets of stable cells were 
cultured for 24-72 hours after which cells were processed for either western 
immunoblotting analysis (section 2.6.2) or immunofluorescence staining and confocal 
microscopy (section 2.7.2) examination.
2.5.7 Sub-cellular protein fractionation using the 
Qproteome cell compartment kit
The Qproteome cell compartment kit (Qiagen, UK) was used to obtain sub-cellular 
protein fractions from stable cells. After trypsinization of cells from a T75 flask, they 
were centrifuged at xlOOOrpm for 3 minutes to obtain a cell pellet. The pellet was 
resuspended uniformly in 5 ml complete DMEM and a cell count and viability were 
determined as described in section 2.7.1. For comparison of cellular fractionation 
between different cells, the same numbers of cells (5 x 106) were used in each 
determination. An aliquot of cells in a 15 ml conical tube was pelleted by 
centrifugation at 1000 rpm for 3 minutes. The cell pellet was resuspended in 2 ml ice- 
cold PBS by trituration. The cell suspension was transferred into a 2 ml Eppendorf 
micro-centrifuge tube and a cell pellet was obtained by centrifugation at x 500g for 
ten minutes at 4°C. The cell pellet was washed again in 2 ml ice cold PBS and a cell
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pellet was obtained by repeated centrifugation. To the pellet fraction, one ml of ice- 
cold extraction buffer CE1 (containing lOpl xlOO protease inhibitor) was added and 
cells were resuspended by trituration through one ml pipette tip. The micro-centrifuge 
tube was put on a rotator for at 4°C for 10 minutes. The sample was centrifuged at x 
lOOOg at 4°C for ten minutes and the supernatant fraction (cytosol fraction) was stored 
at 4°C. To the pellet fraction one ml extraction buffer CE2 (containing 1 OjllI xlOO 
protease inhibitor was added and the cells were resuspended by trituration and then 
placed in a rotator at 4°C for 30 minutes. The micro-centrifuge tube was centrifuged at 
x6000g at 4°C for 10 minutes and the supernatant fraction (membrane fraction) was 
stored at 4°C. To the pellet fraction 7 pi of Benzonase nuclease was added followed 
by addition of 13 pi of distilled water and the pellet was resuspended by flicking the 
tube. The pellet was left to incubate at room temperature for 15 minutes. To the pellet 
0.5 ml of extraction buffer CE3 (containing 5pl xlOO protease buffer) was added and 
the pellet was resuspended by trituration and then incubated at 4°C for 10 minutes on 
a rotator. The sample was centrifuged at x 6800g for 10 minutes at 4°C. The 
supernatant (nuclear protein fraction) was stored at 4°C. The pellet fraction was 
resuspended in 0.5 mis of extraction buffer CE4 (cytoskeletal fraction). All four 
protein fractions were desalted and concentrated by the addition of four volumes of 
ice-cold acetone and centrifugation of the samples at x 12000g for 10 minutes at 4°C 
to obtain the protein pellet fraction of each fraction. Each protein fraction was 
resuspended in 100 pi of RIPA buffer containing protease inhibitors. 1/5* of each 
protein fraction was analyzed by western immunoblotting analysis (section 2.6.2).
2.6 Protein expression and protein-protein interaction 
analysis
2.6.1 Total cellular protein assay in cellular lysates
Adherent cells were trypsinized from well plates, T25, and T75 flasks and cell pellets 
were obtained as described before. To cell pellets obtained 0.15, 5, and 10 ml 
respectively of ice-cold RIPA buffer (50 mM Tris-HCl pH 7.4,1% NP-40, 0.25% Na- 
deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VC>4, 1 mM NaF and Roche
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protease inhibitor cocktail: 1 tablet per 7 ml of buffer) was added followed by 
trituration through a P I000 or P200 pipette tip. The lysates were sonicated twice on 
ice for 10 seconds with cooling on ice to prevent excessive sample warm-up. Cell 
lysates were centrifuged at 13,200 rpm for 10 minutes at 4°C to obtain the supernatant 
fraction. Protein concentration was measured in the supernatant using a Biuret protein 
assay reagent (Sigma Aldrich, UK) according to the manufacturer’s instructions.
2.6.2 Western immunoblotting (WB) analysis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis was performed as 
follows: for comparison of samples (for e.g. non-induced & induced or between two 
different samples), the same relative amount of total cell protein lysate (50-100 pg 
protein) was used for each sample. The protein was added into a 1.5 ml Eppendorf 
tube containing 5 pi of reducing and denaturing Laemmli SDS-PAGE sample buffer 
(x5 concentrated, BioRad, UK) and an appropriate volume of distilled water to a final 
volume of twenty-five microliters. Samples were denatured at 95°C for 5 minutes and 
then centrifuging at 13,200 rpm for 30 seconds. Precast Tris-glycine Novex gels 
(Invitrogen, UK) 10% (25 KD-150 KD protein resolution) or 8% (37 KD-250 KD 
protein resolution) of 1.5mm thickness were assembled in a Sure Lock electrophoresis 
gel tank (Invitrogen, UK) with 200ml x l Tris-Glycine-SDS (Invitrogen, UK) placed 
in the upper buffer reservoir and 600 ml in the bottom buffer tank. 25 pi of denatured 
sample was loaded and 20 pi of precision plus protein dual-colour markers (Bio-Rad 
laboratories, UK) were loaded into an adjacent lane for size estimation (KD). The gel 
was run at 125 Volts for approximately two hours until a bromophenol blue tracking 
dye had reached the bottom of the gel.
For western blotting six Whatman 3M sheets ( 6 x 8  cm) and one Hybond nylon ECL 
membrane of the same size (Amersham) were pre-soaked in Tris-glycine methanol 
transfer buffer (TGM, final concentrations: 25 mM Tris base pH 8.3, 192 mM glycine, 
10% (v/v) methanol). On a semi-dry transfer apparatus (Semi-phor, Hoefer Scientific, 
UK) three pre-soaked Whatman sheets were placed on the bottom anode plate 
followed by the nylon membrane, the gel, and further three pre-soaked Whatman 
sheets to complete the assembly. The cathode electrode lid of the semi-phor apparatus
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completed the circuit using a power supply set at 60mA constant current for 90 
minutes.
The blot was removed and placed in a tray containing 25 ml TBST/5% skimmed dried 
milk (5% wt/vol non-fat milk powder, 0.05 M Tris, 0.15 M NaCl, 0.05% Tween-20, 
pH 8.0) and placed on a rocking platform for one hour at room temperature. Blot was 
sealed in a sample bag (GE Healthcare) with 5 ml TBST/milk containing final dilution 
of primary antibody (mouse monoclonal, or rabbit polyclonal or goat polyclonal 
antibodies) at between 1:500 and 1:10,000 as recommended in the supplier’s antibody 
data sheet. The blot was placed at 4°C overnight with the primary antibody. The 
following day the blot was equilibrated at room temperature for one hour and the 
primary antibody solution was removed followed by washing the blot three times (20 
minutes/wash) in 150 ml TBST. Blot was resealed in sample bag with 5 ml 
TBST/milk containing 1.0 pg/ml horseradish peroxidase conjugated secondary 
antibodies (anti-mouse, anti-rabbit, or anti-goat specificities) and was placed on a 
rocking platform for 1 hour at room temperature. Three further TBST washes were 
performed as before after removal of blot from secondary antibody. The blot was 
placed in a sample bag and 0.5 ml ECL reagent 1 followed by ECL reagent 2 (GE 
Healthcare, UK) was added and the bag was sealed and placed in an autoradiography 
cassette with ECL Hyperfilm (GE Healthcare, UK) to obtain exposure for between 
one to twenty minutes. Hyperfilm was developed manually in developer followed by 
incubation in fixer (Kodak reagents, supplied by Sigma Aldrich, UK) for the 
recommended time.
2.6.3 Immunoprecipitation assays
Stable cells cultured in P90 culture dishes were harvested and washed in ice cold PBS. 
All subsequent steps were performed on ice and in a walk-in cold room. Forty eight 
hours after transfection cells were scrapped off the P 9 0  dish using a plastic cell scraper 
into 500 pi of immunoprecipitation (xl IP) buffer (lOmM Tris HC1 pH 7.6, 145mM 
NaCl, 1 mM Na3V04> and 1% triton X-100 and one tablet of Roche protease 
inhibitor/10ml solution). Lysate was triturated six times through a 21-gauge needle on 
ice followed by centrifugation at 14,000 rpm for 30 minutes in a refrigerated
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Eppendorf centrifuge to obtain a soluble whole cell lysate fraction. Protein 
concentration in the soluble lysate was determined by spectrophotometry (section 
2.6.1. Soluble cell lysates (3 mg) were transferred into a sterile Eppendorf tube and 
pre-cleared by addition of 25 microliters of Protein G-Sepharose (Sigma Aldrich, UK) 
followed by incubation at 4°C for 30 minutes on rotator. Protein G-Sepharose was 
pelleted by centrifugation at 10,000g for 0.5 minute at 4°C and supernatant fraction 
was carefully transferred into a new Eppendorf tube making sure not to disturb the 
Protein G-Sepharose pellet. Three microgram of anti-XPress or six micrograms anti- 
DP (mouse monoclonal anti-XPress antibody, Invitrogen, UK, or goat anti-DP, sc- 
18082, Insight Biotechnology, UK, respectively) was added to pre-cleared supernatant 
followed by incubation on a rotator at 4°C for three hours. Control samples used an 
irrelevant antibody (anti-C myc) added to pre-cleared lysate or a no antibody control 
where addition of IP antibody to pre-cleared lysate was omitted. Fifty microliters of 
Protein G-Sepharose was added and the incubation at 4°C was continued overnight. 
Immuno-complexes were pelleted at x 10000 g for 30 seconds and washed thrice in 
low stringency PBS/inhibitor followed by a single wash in xl IP buffer. Immuno- 
complexes were denatured in x3 reducing Laemmli sample buffer at 100°C for ten 
minutes. Following centrifugation at x 13000 g for 1 minute at room temperature, the 
denatured protein samples were electrophoresed on a 10% SDS PAGE gel 
(Invitrogen, UK) and Western immunoblotting analysis was performed as described in 
section 2.6.2.
2.7 Microscopy techniques
Light microscopy was performed in a standard Nikon microscope fitted with stage 
holding six- or twenty-four well tissue culture plates.
Confocal microscopy was performed in a Nikon Eclipse TE300 inverted microscope 
equipped with a motorized focus unit. The microscope was fitted with xlO eyepiece 
and xlO, x20, x40 (oil immersion) and xlOO (oil immersion) objective Nikon lenses. 
The microscope was equipped with a laser scanning system Radiance 2100 scan head 
(BioRad Laboratories, UK). The lasers used in the confocal microscope consisted of 
Red diode (637 nm), Green Helium/Neon (543 nm), Argon (456, 478, 488, and 514 
nm) and a blue diode (405 nm). The lasers controller unit was a Radiance laser 
scanning system 2000 (BioRad Laboratories, UK). A Nikon super high-pressure
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mercury-lamp power supply used located initial fluorescence of sample. The thickness 
of the section examined equalled a stack of six. After initial observation of the 
fluorescence image through the microscope unit the image was analysed using 
BioRad Zeiss laser sharp 2000 software that allowed acquisition of confocal images 
from the microscope. Scale size bar on images were fitted using Laserpix software 
(BioRad Laboratories, UK).
A Philips 201 transmission electron microscope equipped with a digital camera 
examined ultra-thin sections of Flp-ln T-Rex HEK 293 stable cells over-expressing 
various desmosomal full-length or mutated proteins.
2.7.1 Cell number and viability determination
Trypsinized stable or transiently transfected cell lines were resuspended in complete 
DMEM. A Neubaur haemocytometer was assembled with a coverslip in place. A 
uniformly resuspended cell sample 10 pi was mixed with 10 pi sterile Trypan blue 
solution (Sigma Aldrich, UK). Ten microliters of this mixture was transferred 
between the coverslip on the Neubaur counting chamber and viewing under a light 
microscope (Nikon) with x40 objective lens in place, the number of cells in the centre 
twenty-five squares flanked by triple lines was counted. This number was multiplied 
by 2 x 104 to give the number of cells per ml in the original cell sample. Visual 
Trypan blue exclusion showed the percentage cell viability (number of cells not 
taking up Trypan blue/total number of cells counted in the field x 100). Trypsinization 
routinely gave >95% cell viabilities.
2.7.2 Immunofluorescence staining and confocal 
microscopy
Cells cultured in 6-well plates (section 2.5.2 & 2.5.6) were prepared for 
immunofluorescence staining and confocal microscopy examination. The medium 
was gently aspirated and with coverslips in situ, they were washed once in sterile 
PBS. Cells on coverslips were fixed in situ with 4% formaldehyde for 5 minutes at 
room temperature and after washing twice in PBS, they were permeabilised in
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PBS/0.1% Triton X-100 for 5 minutes. Cells were washed twice with PBS and 
blocked in PBS/10% foetal calf serum for 30 min at room temperature. The primary 
antibody was diluted in PBS/1 % foetal calf serum and cells were left covered in this 
solution for one hour at room temperature. Following three PBS washes, secondary 
antibody conjugated with Alexa fluor-546 (red fluorescence, Invitrogen, UK) was 
diluted at the recommended dilution factor in PBS/10% foetal calf serum. This 
solution was left covering the cells in the dark for one hour at room temperature. 
Following three PBS washes, the cells were incubated in DAPI (4’, 6 diamidino-2- 
phenylindole, nuclei fluoresce blue) solution for 5 min. After a brief wash in PBS, the 
coverslips were mounted on to microscope slides in 95%glycerol/PBS solution with 
cells face down in contact with the glass slide. Slides were stored at 4°C in the dark 
until visualised by confocal microscopy. Alexa conjugated-fluorochromes have 
enhanced stability in the dark at 4°C, and therefore do not require the use of anti­
fading reagents.
For triple staining with FM 1-43 FX membrane dye (Invitrogen, UK, emitting a green
•  *y-4- *y ifluorescence), coverslips were first exposed to this reagent 5 pg/ml in Ca and Mg 
free HBSS medium for exactly 1 minute, prior to fixing in 4% paraformaldehyde. The 
rest of the staining procedure was essentially performed as previously described.
2.7.3 Gap junction intercellular communication (GJIC) 
measurement using Lucifer Yellow
Gap junction intercellular communication was assessed by confocal microscope 
following scrape loading of Lucifer Yellow dye and transfer of the fluorescent dye 
into adjacent cell layers. Tetracycline-induced confluent monolayer of stable cells 
cultured in a P30 dishes was gently rinsed in PBS. A fine linear incision was made in 
the monolayer using a 0.25mm thin silver wire. A solution of Lucifer Yellow (final 
concentration 5% dissolved in incomplete DMEM) was incubated with the scraped 
monolayer for exactly 5 minutes to allow uptake and transfer of the dye. Excess dye 
was washed off in PBS solution and the monolayer was then fixed in 5% 
formaldehyde. The uptake and extent of transfer of Lucifer Yellow from the scrape 
line was assessed by fluorescence microscopy using the Helium/Neon laser at 534nm
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(green fluorescence) using the dark non-fluorescing nuclei as a count to asses the 
number of layers through which the dye was transferred.
2.7.4 Electron microscopy to determine desmosomal 
morphology
Stable cells cultured on Thermanox plastic coverslips (BD Bioscience, UK) were 
used, as they are specially adapted for ease of processing for examination by 
transmission-electron microscopy. Coverslips supplied were treated on one side to 
allow adherence of cultured cells. Stable cells were cultured under tetracycline- 
induced condition for 48-72 hours to allow expression of respective cell adhesion 
protein or mutant protein. For comparison with non-transformed Flp-ln T-Rex HEK 
293 cells, these were cultured similarly as stable cells. Culture medium was carefully 
removed from the coverslip in a twenty-four well tissue culture plate (BD Bioscience 
UK) and this was replaced with a standard Kamosky-style fixative and left in situ to 
fix the cells overnight at 4°C. The cells were processed further by a series of 
incubations involving three washes in PBS for 5 minutes each, fixation in osmium 
tetroxide for 20 minutes and three washes in purified water for 5 minutes. Stepwise 
dehydration was achieved in 10% IMS for 5 minutes, 30% IMS for 5 minutes, 50% 
IMS for 5 minutes, two washes in 70% IMS for 15 minutes each, two washes in 90% 
alcohol for 15 minutes each, two washes in 100% IMS for 15 minutes each, and a 
final wash in 100% IMS for 20 minutes. Samples were processed overnight in 50: 50 
alcohol: Lemix™ on a rotator, followed by processing in Lemix™ on a rotator the 
following day. Pieces were cut out of the coverslips, small enough to fit the base of 
individual polythene embedding moulds (TAAB). These were placed in the TAAB 
moulds, orientated cells down (now visibly blackened by the osmium tetroxide). After 
the pieces had sunk to the bottom, they were with GREAT CARE pressed to the 
bottom (flush for cutting an insubstantial monolayer). Semi thin sections (Reichart 
Ultracut ultramicrotome at a nominal thickness of 0.5pm) mounted on glass slides 
were stained with Toluidine Blue for examination by light microscopy to confirm 
presence and quality of preparation, and then the Reichart Ultracut™ ultramicrotome 
was used to cut ultra thin sections, (nominally 70nm) directly onto water in the trough 
of a Diatome™ diamond knife. These were picked up on copper EM grids (300 mesh, 
high transmission, Gilder™). Sections were stained consecutively with saturated
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Uranyl Acetate (50% ethanolic), then alkaline lead citrate (5 minutes each), with a 
good drop wise purified water wash after of each staining. A Philips 201 electron 
microscope equipped with a digital camera was used to examine desmosomes in 
different random fields. Electron micrographs were interpreted by an electron 
microscopist unaware of the identity of cell adhesion molecule expressed in 
desmosomes examined. Morphometric analysis of desmosomal widths and length 
were performed from electron micrographs (at x70000 magnification) and 
measurements in nm were derived from scale bars obtained from microscope internal 
size calibration at different magnifications.
2.8 Cellular adhesion, proliferation, and apoptosis 
analysis
2.8.1 Measuring initial cell-cell contact adhesion
The initial cell contact adhesion of stable cells was determined using a Vybrant Cell 
Adhesion Assay kit (Molecular Probes, UK) that is widely used in assessing cell-cell 
adhesion in vitro. A non-fluorogenic dye, calcein acetoxymethyl ester (calcein AM) 
produces Calcein a fluorescent product after the substrate is cleaved by esterase 
enzymes in live cells. Calcein absorbance (494 nm) was detected in a confocal 
microscope. Stable cells lines were cultured under tetracycline-induced conditions on 
25 mm coverslips (2.0 x 103) until they were fully confluent. Sable cells (cultured 
separately under tetracycline-induced conditions) were harvested and re-suspended in 
pre-warmed DMEM at 3.6 x 106 cell/ml and 5 pi of calcein AM stock dye solution 
(final calcein AM concentration of 5 pM) was added to the cells. After 30 min 
incubation at 37°C/5% CO2 in a humidified incubator, excess calcein AM was 
removed from these cells by washing thrice in sterile PBS and cells were resuspended 
to a density of 3.6 x 106 cells/ml in DMEM. An aliquot of labelled cells (100 pi) were 
layered on top of the fully confluent adherent cells on the coverslips. After incubation 
in 5% CO2 humidified incubator at 37°C for five hours, all non-adherent labelled cells 
were carefully removed by washing with pre-warmed DMEM. Cells on the coverslips 
were fixed in 4% formaldehyde for ten minutes, washed once with PBS,
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permeabilised in 0.1% Triton X-100/PBS, stained with DAPI (300 nM) solution and 
mounted in PBS/95% glycerol upside down on a glass microscope slides. Labelled 
cells were observed in a confocal microscope where the calcein-labelled cells 
appeared green (emission at 523 nm) versus a background of total cells labelled blue 
with DAPI (emission at 461 nm). The number of green cells relative to the blue cells 
in a given field of view were quantified and expressed as a percentage to indicate 
initial cell contact adhesion (% = no of green fluorescing cells/no of blue fluorescing 
cells x 100). The percentage of initial cell contact adhesion is a measure of initial cell­
cell adherence, and the mean values obtained using stable cells expressing full-length 
cell adhesion proteins were compared with the value obtained in stable cells 
expressing mutant cell adhesion proteins. The % initial cell adhesion values obtained 
from six independent experiments were averaged to obtain a mean value and a 
student’s t-test was used to make a statistical comparison of mean initial cell adhesion 
of stable cells expressing full-length and mutant cell adhesion molecules.
2.8.2 Dispase-based monolayer dissociation adhesion 
assay
This assay measures the adhesive strength of a highly confluent monolayer of cells in 
vitro subjected to controlled mechanical stress. The protocol is widely used to assess 
cell-cell adhesion in confluent monolayer of cells and was essentially carried out as
•  0 1 'Jdescribed by Huen et al. Stable cells were cultured in P6o mm Nunc plastic culture 
dishes in penicillin, streptomycin, foetal bovine serum, blasticidin and hygromycin 
supplemented DMEM (Invitrogen 19308-025) in the presence of 0.1 pg/ml 
tetracycline until cells were highly confluent. Cells were carefully washed in PBS and 
one ml of 2.4 U/ml Dispase II (Roche, Cat No 10295835001) was added to the dishes 
followed by incubation at 37°C for 30 minutes. Dispase II released the entire 
monolayer intact from the plastic tissue culture surface without dissociating individual 
cells. The monolayer was carefully rinsed twice in PBS without agitation and finally 
resuspended (one to five ml) in PBS. Gentle shearing (using predetermined and a 
controlled number of rotations on a tabletop rocker platform) or relatively more 
vigorous shearing (by triturating six times) through a P I000 pipette tip was applied to 
the monolayer. The sheared monolayer was photographed under Epi-white light
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illumination using a BioRad Gel Documentation system (gel doc XR) and the image 
was captured using Quantity One version 4.6 image analysis program (BioRad 
Laboratories, UK). Cluster size of the sheared fragments provided a visual measure of 
the adhesive strength of the monolayer sheet of cells, wherein a large cluster size 
indicated an increased resistance to disruption by shearing force. A quantitative 
measurement of Dispase-based cell dissociation adhesion was carried out by counting 
under a light microscope the number of cluster of a predefined size (e.g. cluster size of 
> 100) following disruption of cell monolayers.
2.8.3 Cellular proliferation assay
Cellular proliferation was measured using the CellTiter 96 AQueous One Solution 
reagent (Promega Corporation, UK) according to manufacturer’s suggested protocol. 
This assay is an inexpensive non-radioactive alternative method widely used to assess 
cellular proliferation. The assay reagent contains Owen’s compound, which is bio­
reduced by live cells into a coloured formazan product. The amount of formazan 
produced was measured spectrophotometrically and was directly proportional to the 
number of surviving cells.
Cell proliferation assays were performed in a 6-well plate with an initial seeding 
density of 30,000 cells per well. Cell Titre AQueous One Solution reagent (80pl) was 
added to the medium in each well and plates were incubated for exactly 1 hour in the 
tissue culture incubator. The entire medium from each individual wells assayed was 
transferred into separate wells of a fresh plate and the absorbance at 490 nm was read 
in a Libra S12 spectrophotometer (Biochrom Ltd, UK). A plot of absorbance versus 
time elapsed after plating the cells was done on a single graph depicting stable cell 
lines over-expressing full-length or mutant cell adhesion proteins under induced or 
non-induced conditions for direct comparison of the cellular proliferation.
2.8.4 Cellular apoptosis assay
Caspase-3 activity is an index of cellular apoptosis and was measured using a 
colorimetric CaspACE Assay System (Promega Corporation, UK). A substrate (Ac-
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DEVD-pNA) containing the chromophore /7-nitroaniline (pNA) is cleaved by 
DVEDase in cells undergoing apoptosis, the action of which releases pNA. Free pNA 
produces a yellow colour detected spectrophotometrically at 405 nm. The amount of 
yellow colour produced was proportional to the amount of DVEDase activity in the 
sample.
Stable cells seeded at 400,000 cells/well in a 6-well plate were cultured in 3 ml 
complete DMEM supplemented with 15 pg/ml blasticidin, 100 pg/mg hygromycin, 3 
pi 70% ethanol (triplicate wells, non-induced condition) or 0.1 pg/ml tetracycline 
(triplicate wells, induced conditions) until cells were nearly confluent. Stable cells 
were subjected to mechanical stretch (section 2.9.1) and were harvested to obtain a 
cell pellet by centrifugation at xlOOO rpm for 2 minutes. The cell pellet lysis was 
performed using sonication for 10 seconds in lysis buffer. The supernatant obtained 
after centrifugation at 13,200 rpm for 5 minutes was assayed for total cell protein 
(section 2.6.1). The assay was performed in 96-well plate by adding the following to 
each well for every sample analysed: 64 pi assay buffer, 4 pi dimethylsulfoxide, 20 pi 
100 mM dithiothreitol 60 pi protein lysate (148-480 pg protein), 48 pi sterile water 
and 4 pi DVED-pNA substrate. A blank was prepared as above except protein sample 
was omitted and total volume made up to 200pl with sterile water. The 96-well plate 
covered in foil was incubated for four hours at 37°C. Standards of pNA in the range 0- 
400 pM were prepared by diluting from a stock solution (supplied in the kit) in a 200 
pi final volume containing a 10th dilution of DMSO. After four hours, the absorbance 
of each sample was read at 405 nm against a blank tube, and using the standard curve 
generated from the absorbance readings of pNA standards (0-400 pM); the pM pNA 
released per pg protein lysate was calculated for each sample so that direct 
comparison between the samples could be made. Values of specific DVEDase activity 
(pM pNA/pg protein) for each of the triplicate samples in non-induced and induced 
conditions were plotted on a single graph depicting cell lines expressing full-length 
and mutant proteins.
2.9 Exposure of stable cell lines to mechanical cell- 
stretch
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The effects of induced expression of full-length or mutant cell adhesion proteins in 
stable Flp-ln T-Rex HEK 293 cell lines on programmed cell death following exposure 
to mechanical cell stretch was determined using the FlexerCell apparatus (FlexCell 
International Corporation). Each cell line was cultured on FlexerCell 6-well plates 
either in non-induced (without over-expression of protein of interest) or tetracycline- 
induced (resulting in induced over-expression of proteins of interest) conditions and 
they were subjected to controlled cyclical stretch in the FlexerCell apparatus for a 
defined time of exposure and magnitude of cell stretch. This was followed by 
recovery of the cells subjected to stretch prior to performing apoptosis assay on cell 
lysate obtained.
2.9.1 Mechanical cell-stretch of stable cells
To allow for observed difference in growth characteristic of stable cell line cultured 
on gelatine-coated silicon membrane insert and those cultured on tissue culture 
plastic, 0.5-1.5 x 106 cells were seeded per well in the FlexerCell 6-well plate. As 
before, the medium was 3 ml complete DMEM with blasticidin and hygromycin 
supplementation at 15 pg/ml and 100 pg/ml respectively, and either 3 pi 70% ethanol 
(control non-induced wells) or 3 pi tetracycline (0.1 pg/ml final concentration, 
induced wells) was added to the appropriate wells. Tetracycline induction was for the 
full duration of cell culture until they were nearly confluent. The FlexerCell 6-well 
plate was coated with type I gelatine, which allowed stable cell lines to adhere to the 
silicon membrane support. When cells were nearly confluent, plates were placed in a 
tissue culture incubator (humidified and set at 37°C with 5% CO2) in a FlexerCell 
loading platform allowing assembly of four separate FlexerCell 6-well plates. Each 
plate was sealed in place on the platform with special silicon grease supplied, so that 
an airtight seal was made between the FlexerCell 6-well plate and a rubber gasket on 
the platform. The loading platform was linked to a computer-controlled vacuum pump 
so that precision suction at the desired strength (amplitude) and rate (frequency in Hz) 
could be applied to the FlexerCell 6-well plates assembled on the platform. Cyclical 
stretch at between 4-6% amplitude and 1 Hz frequency was applied to the plates for 
varying time between three to four hours. Cells were allowed recovery in the 
incubator for three hours after application of mechanical stretch. Plates were carefully 
disassembled from the platform and cellular pellets were obtained from each well
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using standard trypsinization procedure, but all washings were pooled to retain any 
cells that had detached off the membrane insert. Cell pellets were stored at -80°C until 
processed for cellular apoptosis assay using the CaspACE assay system. FlexerCell 6- 
well plates were reused by washing in mild detergent followed by UV irradiation 
sterilisation, and silicone membranes of plates reused were recoated with sterile 
gelatine (Sigma, 0.2 mg/ml in complete DMEM, overnight incubation) and rewashing 
of wells in complete DMEM prior to plating stable cell lines for further stretch 
experiments.
2.9.2 Measuring apoptotic response of stable cell lines 
to mechanical cell-stretch
Cell pellets were processed for the CaspACE assay as described in section 2.8.4.
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Chapter 3 -  Genetic screening of ARVC patient
DNA
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3.1 Introduction
When studies in this chapter commenced in 2004, three gene mutations were 
identified in ARVC and its variant: the first was RyR2 in ARVC2, the second was 
desmoplakin in ARVC4, and the third was plakoglobin in Naxos disease. Apart from 
mutations reported in the untranslated regions of TGFp in ARVC1 (discovered in 
August 2004) no other gene mutations were known until then in the remaining five 
ARVC loci (TMEM43 gene responsible for ARVC5 was reported in March 2008) as 
identification of causative genes were hampered by incomplete penetrance and by a 
lack of accurate ARVC clinical diagnosis.
3.2 Hypothesis and Experimental Aims
As two of the mutations identified previously were in genes encoding proteins 
involved in cell-cell adhesion it was hypothesized that further mutations in genes 
encoding other cell-cell adhesion proteins could be present in this disease. This 
formed the basis for performing the genetic screening work.
The working hypothesis was that mutations in genes encoding desmosomal proteins 
involved in cell-cell adhesion would disrupt various domains or sub-domains 
associated with these proteins and abnormalities manifested clinically may be 
determined by the location of mutations within the same protein or by mutations in 
different proteins resulting in structural or functional abnormalities.
Two experimental aims were set in these studies
1) The aim in the first part of the study was to screen one hundred index cases 
(probands) for mutations using a DNA screening approach to examine genes 
involved in desmosomal cell-cell adhesion. Three genes encoding desmosomal 
proteins were examined; these were derived from different families of 
proteins: one of these belongs to a member of the plakin family (desmoplakin), 
a second belongs to an Armadillo (ARM) family of proteins related to P- 
catenin (plakoglobin), and the third belongs to an ARM family of proteins 
related to the pl20ctn sub-family of proteins (plakophilin-2). Both DP and PG
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genes were known candidates involved in ARVC, but this was not the case for 
the PKP-2 gene. However, as plakophilins are associated with desmosomes, 
and PKP-2 is a predominant isotype expressed in the cardiac tissue, it was 
included as one of the genes in genetic screening studies.
2) The aim in the second part of the study was to perform pedigree analysis, this 
is a family study where the transmission of the inherited genetic defect 
(identified in a proband) is investigated in siblings, offspring, and relatives of 
the proband and the clinical expression of ARVC symptoms are evaluated in 
family members using modified & Task Force criteria. Seven out of the eleven 
mutations identified in the first part of the study were selected for pedigree 
analysis to determine transmission of the disease causing allele and clinical 
expression across the spectrum of ARVC disease phenotype manifestations.
3.3 Materials and methods
A consultant lead clinical team at the London Heart Hospital in collaboration with 
Professor William J McKenna performed the clinical evaluation of patients referred at 
the ARVC clinic, and which formed part of the British ARVC registry. Blood samples 
were collected (preserved in EDTA) after local ethics committee approval by the UCL 
Hospitals NHS trust and obtaining informed consent from one hundred patients who 
fulfilled ARVC clinical diagnostic criteria assessed under the Task Force guidelines. 
Blood samples were stored at -20°C prior to analysis and were thawed to room 
temperature prior to use. Blood samples were also collected after obtaining informed 
consent from first, second, third, etc. generation relatives of each proband for 
performing pedigree analysis when this was permitted. Both the Task Force and 
modified clinical ARVC diagnostic criteria were applied for evaluating family 
members of the proband.
DNA was extracted from preserved peripheral whole blood samples as described 
previously (section 2.11). Primers flanking the coding region and the immediate 
adjacent intron flanking sequence in each of these three genes (DP, PG, and PKP-2) 
were used in PCR reactions (section 2.1.2) to amplify overlapping DNA fragments
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covering all exons and the immediate flanking intron regions of each of these three 
genes. Each amplified DNA fragment was sequenced bi-directionally using Big Dye 
chain-terminating chemistry (Applied Biosystems, UK) in an ABI 3100XL genetic 
analyser (sections 2.1.3 to 2.1.3.3). DNA sequence data was analysed using Seqscape 
software (Applied Biosystems, UK) that aligned sequences against a synthetic trace 
generated by the software using the appropriate reference sequence (Accession 
numbers: plakophilin-2, NM_004572.2; plakoglobin, NM 002230; desmoplakin, 
NM 004415) obtained from the Genebank database. This allowed identification of 
mutations in the coding regions and immediate flanking intron regions of each gene 
analysed. Nucleotide sequence variants identified were checked in public domain 
databases (for example, ensemble genome browser and NCBI SNP database) to 
ascertain whether the sequence variant had been previously reported. Reference 
sequences used were for the long-form transcripts of plakophin-2, plakoglobin, and 
desmoplakin. The numbering of all mutations, polymorphisms, and other unknown 
sequence changes (not falling in the previous two categories) were relative to the 
nucleotide numbering in the reference sequence for each transcript with the first 
Adenine nucleotide in the ATG initiation codon designated as nucleotide number 1.
PCR primers designed manually with reference to the published gene sequences, 
utilised intron flanking regions (whenever possible) so that primer pairs amplified 
overlapping PCR fragments allowing complete sequence read through to be obtained. 
Amplimers were restricted to less than 600bp in size, primers contained 50-60% total 
GC content and were checked to exclude significant self complementarity or inter­
primer complementarity (< four consecutive nucleotide runs). The theoretical melting 
temperature of each oligonucleotide primer was calculated using an established 
formula:
Tm = 81.5°C + 16.6°C x (Log i0 [Na+] + [K+]) + 0.41°C x (%GC) -  75/N 
Where [Na+] = sodium ion molar concentration, percentage GC = total percentage of 
G and C residues, N = length of the oligonucleotide primer, [K+] = potassium ion 
molar concentration.
The AmpliTaq enzyme PCR buffer used in the PCR reactions contained 50mM Na+, 
but it did not contain any KCL and therefore the [K+] did not feature in the formula
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used for calculating the theoretical melting temperature. The PCR annealing 
temperature was varied ± 5-10°C on either side of the calculated Tm, and/or MgCk 
concentration (2-2.5 mM) was varied in the PCR optimization reactions to work out 
the best conditions for obtaining a single amplimer of the expected size. The primer 
sequences and PCR conditions optimised for PG, PKP-2, and DP are listed in Tables 
3.1 -  3.3. Amplification of targets in G-C rich region was performed using a G-C rich 
PCR kit (Roche, UK) according to the manufacturer’s instructions (GC rich PCR, 
section 2.1.2).
The desmoplakin gene is encoded in twenty-four separate exons. Although each of the 
individual exons 1 to 22 was amplified in its entirety in a single PCR reaction, this 
was not feasible with exons 1, 23, and 24 as these exons were quite large. Therefore, 
overlapping fragments (two fragments for exon 1, seven fragments for exon 23 and 
nine fragments for exon 24) were amplified for these exons. Overlapping fragments 
allowed the entire sequence of exons 1, 23, and 24 to be assembled and their sequence 
confirmed by Seqscape analysis. For plakophilin-2 exon 3 was also quite large 
therefore, this particular exon was amplified in two overlapping fragments (3 A and 
3B). Exon 12 of PKP-2 was amplified using two sets of primers pairs as upstream of 
exon 12 a sequence of ten consecutive thymidine residues cannot be amplified intact 
by AmpliTaq enzyme resulting in double peaks during sequencing of the PCR 
fragment with PKPexl2F primer. Downstream of the exon there is a naturally 
occurring deletion in many samples which makes the PKPexl2R primer useless too. 
Therefore, to overcome these problems the two internal primers (see Table 3.2) were 
used for sequencing.
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3.4 Results
3.4.1 Part 1: Screening of ARVC cohort for mutations 
in Desmoplakin, Plakoglobin and Plakophilin-2 genes
Table 3.1, 3.2, and 3.3 lists the PCR primer sequences and the conditions used for PG, 
PKP-2, and DP PCR respectively. In each table primer sequences in 5’ to 3’ 
orientation are listed in pairs indicated by gene name, exon number, and an F or R 
suffix to indicate the forward and reverse primers respectively. Where multiple primer 
pairs were used to cover the PCR of a large exon (for example DP exon 23) then these 
primer pairs were further identified by additional numbering of the fragments after the 
exon amplified (for e.g. for the seven fragments of DP exon 23 these are labelled as 
DPex23.1 to DPex23.7). The sizes in base pairs of each exon and of the PCR product 
obtained are stated in the next column. The optimal primer annealing temperature 
(deduced from preliminary experiments) and special conditions required (such the use 
of a GC-rich system or a employing a non-standard concentration of MgCb) are stated 
in the next column. The sequencing primer used to obtain an initial sequence read-out 
was indicated in each table, this could be either the forward or the reverse primer. 
Mutations, polymorphisms or other unknown sequence changes identified were 
confirmed by bi-directional sequencing using the complementary PCR primer to 
confirm the suspected sequence alteration.
3.4.1 Part 1.1 Classification of mutations
For the purpose of this study, mutations were classified based on nucleotide sequence 
changes that led to the following:
1) Truncation of protein during translation of mRNA transcript compared to the wild 
type resulting from frame-shift nucleotide sequence change (either short sequence 
insertions, short deletions or combination of insertion and deletions referred to as 
‘indels’) causing a PTC to be encountered further downstream of the insertion or 
deletion. Alternative to protein truncation is rare, but sometimes 
insertion/deletions can cause addition of extra residues extending the overall 
reading frame, this can happen, when insertion or deletions occur in the last exon
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of the gene. Frame-shift mutations identified in these studies resulted only in 
protein truncation.
2) Splice junction variants (affecting the donor splice site or the acceptor splice 
present in the flanking intervening intron sequence) may result in exon skipping, 
or in aberrant splicing causing retention of only a part of an exon or the retention 
of an of intron. The nomenclature for assigning splice site sequence changes 
(Figure 3.1) are illustrated using two hypothetical mutations in donor and acceptor 
splice sites respectively. The first ten nucleotides in the donor and splice sites 
were considered essential for normal splicing to occur.
3) Single nucleotide changes that cause a nonsense sequence change (TAA, TAG, 
and TGA) leading to a PTC.
4) A single nucleotide change causing a missense sequence variant not listed as a 
known SNP and not detected in 400 normal control DNA samples. This missense 
sequence variant was assumed a mutation if it was associated with the clinical 
expression of ARVC in family studies. These missense mutations identified were 
analysed using web based programs such as SIFT (sorting in-tolerant from tolerant 
amino acids), POLYPHEN (Po/ymorphism P/zeftOtyping), and RUSSEL analysis 
to determine the severity of missense amino acid substitutions on protein structure 
and function. This results in classifying missense protein variants as benign, most 
likely benign, most likely pathogenic, or certainly pathogenic. SIFT predicts 
whether a naturally occurring non-synonymous amino acid substitution affects 
protein function based on homology and the physical properties of amino acids. 
SIFT returns predictions for what amino acid substitutions will affect protein 
function. SIFT is a multi-step analysis which searches for and chooses similar 
sequences, makes an alignment of these sequences, and calculates scores based on 
the amino acids appearing at each position. Polyphen is another tool, which 
predicts possible impact of an amino acid substitution on the structure and 
function of human proteins using both physical and comparative considerations of 
an amino acid change. SIFT and Polyphen analysis of missense mutations found 
in the genetic screening of the ARVC cohort are described in a later section 
(section 3.4.1 Part 1.7). Russel allows comparison of substituted amino acid 
residue with the wild-type amino acid residue based on their physicochemical 
properties. Another tool used for analysis of missense mutations affecting 
substitutions of serine, threonine, and tyrosine residues is a phosphorylation
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prediction program called NetPhos. NetPhos predicts potential phosphorylation 
sites in serine and threonine residues based on homology search of conserved 
motifs found in these amino acid residues at known phosphorylation sites found in 
other proteins. NetPhos examines protein o f interest and predicts putative 
phosphorylation sites based on conserved motifs used by various phosphorylation 
enzymes. Another tool used in the analysis o f missense amino acid substitutions is 
a program called ESE finder. ESE finder predicts the effect of a nucleotide variant 
(encoding a missense mutation) on exon splicing enhancer sequence (discussed in 
section 1.8.3) found within an exon.
Figure 3.1 Nomenclature of donor and acceptor splice 
site mutation explained using a hypothetical example
Illustrated below is a hypothetical example of two different splice site mutations. The 
last nucleotide o f exon 10 and first nucleotide in exon 11 are numbered 2145 and 
2146 respectively (according to the numbering relative to a reference sequence). The 
horizontal line identifies intron 10 with twelve consecutive nucleotides shown for 
simplicity. The donor site is close to the intron sequence adjacent to exon 10 while the 
acceptor site is close to intron sequence adjacent to exon 11. The numbering o f the 
nucleotide residues in intron 10 is as shown with even number of residues closest to 
exon 10 being numbered with + sign while those closest to exon 11 are numbered 
with -  sign. The red arrow marks an acceptor site mutation (c.2146-lG>C) while the 
blue arrow marks a donor site mutation (c.2145+5C>T).
c.2145+SOT c.2146-1 G>C
2145 2146
Intron 10
+1 +2 +3 +4 +5 + 6 -6 - 5 - 4  -3 -2 -1
Exon 10 Exon 11
A C T  G C A C C T  G A G
> T >C
Donor splice site Acceptor splice site
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Table 3.1 PG primers and conditions used for PCR
Plakoglobin PCR primer sequences, annealing temperatures, and the expected sizes of the PCR 
amplimers. All PCR were performed between 35-40 cycles using a final concentration of 2 mM MgC12 
in the buffer supplied with AmpliTaq Gold DNA (Applied Biosystems) polymerase enzyme.
Primer Sequence (5’-3’) Exon/PCR 
size (bp)
PCR-
Annealing
temperature
°C
Sequencing
primer
JUPexlF CTTGGCTGTCAGGTCTCTTCGC 111/201 - -
JUPexlR TCTGTCCCCAACGATACCTGCG
JUPex2F CTGGGCCAGGTGACTTCCTGCT 216/323 65 R
JUPex2R TCTCTCCAGGACCCAGGCAGGT
JUPex3F AGTGTCTGCCCAGCCCACTGC 260/392 67 F
JUPex3R ACAATGTCCCTCCCCTGAGGACATCT
JUPex4F GCCTCTCCTTAGTGCTCACGTC 239/344 58 R
JUPex4R AGGGGAGAGGCCCAAGTGAGAG
JUPex5F GCTCACATGTATGCCAGGCCTC 202/323 60 F
JUPex5R GC AGG AT AG AAG ATGGCGC AAG
JUPex6F CCCGCGCTTCCTTGTTCCTGTCA 145/295 62 F
JUPex6R CATCAGCCACGGGGAGCATGGCT
JUPex7F CCATTGTGGAGGCTGGTGAGTATG 104/310 65 F
JUPex7R AGATGCCCAGACAGGAGGCTGGAT
JUPex8F TGGAGTTGGCTGCTCCCTGAC 339/434 62 R
JUPex8R ACCTAAGCCTGCTGCAGGGTG
JUPex9F AAGCTGGGATCCTTCAGATGTC 156/289 55 R
JUPex9R ATTCACACACACACCCACAGAG
JUPexlOF CATTCGGCTGTCATGGGGAGGA 120/266 55 F
JUPexlOR CTGGGACTCCTAACCTTGCCCT
JUPexl IF TGTCCGGCCTGCCTCACCCCTT 151/276 65 F
JUPexllR ACGTCGGCCAGCCTCCATCGTG
JUPexl 2F CACGATGGAGGCTGGCCGACGT 122/234 65 R
JUPexl2R CCATGGGCAGTGCCCAACTTGC
JUPexl 3F AGAAGCATCTCTCCCTGCCCAC 40/223 55 F
JUPexl 3R CCTCTGGCCCCGGAGACATAAT
JUPexl4F GACTGCTCCCTGCAGGGTAGCT 166/288 58 R
JUPexl4R GAGGGCCTCCAACAGAAGGAGG
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Table 3.2 PKP-2 Primers and conditions used for PCR
PKP-2 PCR primer sequences, annealing temperatures, and the expected sizes of the PCR amplimers. 
All PCR were performed between 35-40 cycles using a final concentration of 2 mM MgCl2 in the 
buffer supplied with AmpliTaq Gold (Applied Biosystems, UK) enzyme, unless otherwise indicated.
Primer
Sequence (5’-3’) Exon/PCR 
size (bp)
PCR-
Annealing
temperature
°C
Sequencing
primer
PKP2exlF ACTCGAGCGGGGCGGGGCTCG 248/414 68, GC rich kit F
PKP2exlR ACTCCCAGCACGCGGGGTGAG 0.5mM GC 
resol sol
PKP2ex2F T ACTTGTTCTTGGCCTTC ATT AC 113/332 55 F
PKP2ex2R ACTTGGG A AAAGT A A AC ACTC
PKP2ex3AF AGTCCTCAGCAAAGTTGAAATTTG 698/423 53 F
PKP2ex3AR GTCAAAAACGGTGTCGCTAACAGA
PKP2ex3BF C AC AT ACC AC AG AC AGT ACC AG 698/443 58 R
PKP2ex3BR TGTGCTGGCAATGACTGAACTG
PKP2ex4F AGT ATTCGCTG AGTCGTCTCT 136/291 55 F
PKP2ex4R GCAAAGTCACCATAATAGAAG
PKP2ex5F G AA AGGTT AT AGTC AGC ATC AG 208/413 55 F
PKP2ex5R CATCAATCATTTGCTCCAGGA
PKP2ex6F TTGCTGTGTTCATAAAGGAGCC 132/258 55 F
PKP2ex6R ATT ACAGGCGCAGACCACGACA
PKP2ex7F TTCAGCGGTCATTTTGGTCCCA 178/305 55 F
PKP2ex7R TGACTTCCTTGGGGCT ACCTAA
PKP2ex8F CAAAGACCTGTTGGATACACA 118/250 55 F
PKP2ex8R CC AAGCGGCT ATCTT A AG AAT
PKP2ex9F T ATC AC ACCTGC AAGG AT ATC 165/324 58 F
PKP2ex9R GCCGAT ATAT ACC A AGTACTT
PKP2exlOF GTGA A ATT AT AGCC ATC ACCTG 174/303 55 F
PKP2exlOR CTG A ATTG A ATGT AGGT A AGTC
PKP2exllF CATCTTCATCAACCTCTGGTA 154/322 58 F
PKP2exllR GGTG AT AC AG AC AAC ATTTC A
PKP2exl2F TGGGATCTTGGGATTAAGAAAC 190/259 65 R
PKP2exl2 TT ACGC ATCGCCTGC ACTA ATG
PKP2exl2 AAGAAACTCTCCCTGATTTGGT 190/274 62 (1.5mM 
MgCl2)
F
PKP2exl2R CATGACCGCACATTCACAACCGG
PKP2exl3F AGGCCGCATCCAGAAGCCTCA 88/224 55 F
PKP2exl3R TTCCCAGGGTCAAGTCAAGTGG
PKP2exl4F CCACTTGACTTGACCCTGGGAA 1639/246 58 F
PKP2exl4R GGTTTCTTGGGCTGGGTAGTAG
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Table 3.3 DP Primers and conditions used for PCR
Desmoplakin PCR primer sequences, annealing temperatures, and the expected sizes of the PCR 
amplimers. All PCR were performed between 35-40 cycles using a final concentration of 2 mM MgCl2 
in the buffer supplied with AmpliTaq Gold DNA (Applied Biosystems) polymerase enzyme.
Primer Sequence (5’-3’) Exon/PCR 
size (bp)
PCR-
Annealing
temperature
°C
Sequencing
primer
DPexl.lF AAGAAACCGGCCAGGTGTGG 449/393 - -
DPexl.lR TCATGCGGCCCAGAGTGTTGATC
DPexlF AGGTAGCGAGCAGCGACCTCG 449/361 65 R
DPexlR AGTCGTCCAGAGGAGGACGGT
DPex2F GGTAAAGGGTCTCACAGGAGTGGT 103/325 55 R
DPex2R GTGAAAG AGGTC AGTG AAT AGGCC
DPex3F CTTGCTTCCATTAATGCCCATGAA 149/291 60 F
DPex3R AGTGTAACTGGTTATGAGGAGTTC
DPex4F CCAGAACGGGTTTTCATAGGC 175/314 55 R
DPex4R CACACAAACACATGGGCTGAC
DPex5F GGTGTGCGTAAGTGAAACAGGT 129/260 55 R
DPex5R GTAATTACACGATCCTTCGGTAG
DPex6F AGGAGGCTTAGAAGGGCCACTC 51/218 55 F
DPex6R TCCCCGCCAGGATGTGCTTGAT
DPex7F CAGAGAACACCAGTCACTGCA 162/282 60 F
DPex7R CCAGCTCTTCAAGGCAACAGG
DPex8F AACAGCGTGATTCTTTGGCA 105/386 50 F
DPex8R CCAACCCCTGGTGTAGGGTA
DPex9F TGGTGTTCATGCATCTGTACAA 96/214 50 F
DPex9R CAAAAGATTAGGTATTAAGACC
DPexlOF CTACTAGATGAAATTGCTCAT 126/254 55 F
DPexlOR TCCAAGGCATGTGTTTTATCT
DPexllF TGCAGGTTGAAAATCTCCTCT 153/302 55 F
DPexllR AATGTTGCTTTCTTGATGGAC
DPexl2F CATCTCTGTTTCCATCATTGAG 155/313 55 F
DPexl2R TATAAACACCTGCCCTCTTCCT
DPexl3F TCCCATTTGGGATGAAGTGTG 127/263 60 F
DPexl3R AACTGTTGGACACAGGCACTG
DPexl4F CTCTTCTTGATTGCATTGTGG 202/340 55 F
DPexl4R AGTTTTATGCAAACTCCCTTC
DPexl5F TAGCACCTTGATACCTAGGTAT 227/377 60 R
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DPexl5R GCCTACAAACATTTAAACCAGG
DPexl6F CAGCATATTGTACACCTTAAAT 167/340 55 R
DPexl6R AGAAACTGTAAGGCAAGCATCT
DPexl6F CAGCATATTGTACACCTTAAAT 167/340 55 R
DPexl6R AGAAACTGTAAGGCAAGCATCT
DPexl7F GTGAGAGGCAAATCTTCACAGA 139/270 55 F
DPexl7R TGGGAGCTCAGATCTGAATTAG
DPexl8F AGTGTAGCATACAATGGGAGAA 194/319 55 R
DPexl8R GACATTATCTTGTGAACAACCA
DPexl9F TCAAGTGAATTTCTGGGTGA 163/386 55 F
DPexl9R AAGCCTTCACAAAATGGGTT
DPex20F AAGGGTACAAATAACAGTGGTA 84/246 52 F
Dpex20R ATCAGCAAGTCATGCAGTTAAT
DPex21F GTGGAACTGTAGCTGTTAGTGA 108/265 55 F
DPex21R GAAAAGGGAAGAGGCAGGAGAC
DPex22F ATCGGTC AAATT AC AT AGG ACT 99/257 48 F
DPex22R CCAAATCCATGTTATAATGTGG
DPex23.1F CTTCTTTCTTGGAATGTGAGGT 2295/420 55 F
DPex23.1R ACATTGCCTTGCTTTCTGCAGT
DPex23.2F GACCAACAGAAGAATGACTATG 2295/381 60 F
DPex23.2R CTGCTCAGTGGCCTGCAAGAT
DPex23.3F GGATGAAATTGTCAGGCTCAA 2295/415 58 F
DPex23.3R TATCCTCTTCCTTCTGCATGG
DPex23.4F ACCAAGACCACCATCCACCAG 2295/416 55 F
DPex23.4R TGGACCCTTTGTAATCTCGCG
DPex23.5F ACCGGAAATGCCTGGAAGATG 2295/397 55 F
DPex23.5R CTCTTCTTAACAATGGATGCC
DPex23.6F ATCACCAACCTGACCCAGCAG 2295/351 55 F
DPex23.6R CCTCAGGTTCCGCAGTTCTTC
DPex23.7F CTCACAGAGAACCTGACCAAG 2295/333 58 R
DPex23.7R GAGCACAGTTCAGATGAGATA
DPex24.1F GTTAAGTCGTGATAGTAATATG 3931/420 55 F
DPex24.1R CTTGATCTCTGCTTGGAGTCTT
DPex24.2F GAAGAACAGTCTTAGGAGTGA 3931/409 55 F
DPex24.2R TCCTTAGGAGAAGCAGATGCT
DPex24.3F CCTTCTGGGTGCAGGATCTAT 3931/466 60 F
DPex24.3R TCGGGGATCATTCAGGGATCG
DPex24.4F GTAGACCCTGTGAACAGTGTC 3931/417 65 F
DPex24.4R CGGAAGCTTCTGTTTTGTGGT
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DPex24.5F CAAGCTGCATAGCAGGCATAT 3931/410 55 F
DPex24.5R CTTATATGCTATGTCAACTGG
DPex24.6F ATTGACCCAAAGGAGAGCCAT 3931/406 55 F
DPex24.6R CATCTGATCCCGTGATGGTTA
DPex24.7F TGTGAGCAGGAATGTGAATGG 3931/413 55 F
DPex24.7R GTAATGGAGATTTTCTCCAGG
DPex24.8F TTGCAGCCATCTTTGACACAG 3931/416 60 F
DPex24.8R ATCTATGAACCCCTTCCGGAT
DPex24.9F AGGATAAGCACCGAAGAAGC 3931/480 60 R
DPex24.9R CTGCAAGCACCGGGATTTTCT
3.4.1 Part 1.2 Classification of Polymorphisms
A given single nucleotide sequence change was considered a potential polymorphism 
under the following criteria:
1) A single nucleotide was reported to occur at a defined position (in the SNP 
database, Single Nucleotide Polymorphism, these are referred to as listed 
polymorphisms and usually have a SNP number, for example, I305F in the DP 
gene is a known SNP with an assigned SNP number of rs17604693.
2) If a similar sequence change was found present in 400 healthy control subjects, 
but the polymorphism was not listed in the literature then this could be regarded as 
an unreported polymorphism.
3) If the single nucleotide sequence change resulted in a third-base change that did 
not cause an amino-acid change (synonymous amino acid substitution) and 
therefore, this was a silent polymorphism.
3.4.1 Part 1.3 Desmoplakin mutations found
Desmoplakin mutations found are summarised in Table 3.4. All three mutations found 
were novel, as they were not reported in the literature. Two of these desmoplakin 
mutations resulted in sequence insertions within exon 7 (c.818-819insA) and exon 8 
(c.946_947insATACGCA) of the desmoplakin gene, causing a PTC to be encountered 
in both mRNA transcripts formed that would result in truncation in the translated
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proteins (p.Q273fsX288 and p.M316fsX324 DP). The third DP mutation resulted in 
single nucleotide substitution in exon 11 of desmoplakin (c.C1604T) causing a 
missense mutation (p.S442F). An analysis of the effect of p.S442F DP mutation on 
protein structure and function using SIFT, Polyphen was performed, and results of 
these analyses can be found in section 3.4.1 Part 1.7.
3.4.1 Part 1.4 Plakophilin-2 mutations found
Plakophilin-2 mutations found are summarised in Table 3.4. They consist of eight 
mutations, of which four (p.413X, p.P533fsX561, p.L586fsX658, and p.A733fsX740) 
were novel as they were not previously described in the literature. These four 
mutations resulting from gene insertion, c.l755_1756insTTGACTCA 
(p.L586fsX658)); deletion, c.l597_1600delATCC (p.P533fsX561); and an indel, 
c.2197_2202delCACACCinsG (p.A733fsX740) caused reading frameshift resulting in 
PTCs in mRNA transcripts formed, and a nonsense mutation, C.C1237T, p.R413X 
resulted in a PTC in the mRNA transcript formed. Four other PKP-2 mutations found 
were previously reported by Gerull and colleagues40. These included a frameshift 
mutation c.l45_148delCAGA (pS50fsX110), two missense mutations C.C419T 
(p.S140F) and C.C1844T (p.S615F), and an intervening sequence splice acceptor site 
mutation c.2146-lG>C causing abnormal splicing. The splice site mutation was 
reported to result in the activation of cryptic splice acceptor site in intron 12 with 
retention of 160bp of the intron, or alternatively the activation of another cryptic 
splice acceptor site in exon 13 resulting in the loss of 17bp in exon 13 (see 
supplementary information40). All eight plakophilin-2 mutations discovered in the 
present genetic screening are illustrated in Figure 3.2 to define changes at the 
nucleotide and protein level.
3.4.1 Part 1.5 Identification of families for pedigree 
analysis
Table 3.4 also identified nine families (families A to I) in which pedigree analysis 
investigating mutations: p.A733fsX740 PKP-2 (families A, B, and C), p.L586fsX658 
PKP-2 (family D), p.R413X PKP-2 (family E), p.S615F PKP-2 (family F), p.S140F
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PKP-2 (family G), p.S50fsX110 (family H) and p.Q273fsX288 DP (family I) were 
performed (section 3.4.1 Part 2).
3.4.1 Part 1.6 Identification of Polymorphisms
Several polymorphisms found in the genes encoding plakoglobin, plakophilin-2, and 
desmoplakin are listed in Table 3.5. Some of these are listed polymorphisms, whereas 
others are presumed to be polymorphisms as they were also present in about 4 in 200 
DNA samples obtained from normal individuals. One variant (c.C1577T, p.T526M in 
PKP-2) found in proband A116 has been included as a probable polymorphism as 
SIFT and Polyphen analysis predicted that this missense amino acid was tolerant and 
predicted to be benign (data not shown). The consequence of this presumed PKP-2 
polymorphism in A116 on desmosomes is expected to be of minimal functional 
importance as an insertion desmoplakin mutation was additionally presented in this 
proband (Table 3.4).
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Table 3.4 Mutations found in genes for DP and PKP-2
Mutations found in desmosomal genes encoding desmoplakin (DP) and plakophilin-2 
(PKP-2) in a cohort o f 100 ARVC cases. Families A to I identified here were 
examined in the second part o f this study (section 3.4.2 Part 2). Highlighted in blue 
identifies the seven novel mutations found in DP and PKP2 genes. The asterisks 
denote mutations that were already reported in the literature. HGVS nomenclature 
was followed for assigning mutations.
Gene Exon Proband  
& (family
M utation at nucleotide 
level
M utation at 
protein level
Predicted Effect 
on Protein
DP 7 A 116 (I) c.818-819insA p .Q 273fsX 288
Disruption of SR4 
Spectrin repeat, loss 
off rod & C- 
terminus. Loss of IF 
aggregation
8 A53 c.946_947insATACGCA p .M 316fsX 324
Disruption of SR4 
Spectrin repeat, loss 
off rod & C- 
terminus. Loss of IF 
aggregation
11 A27 
& A58
C.C1604T p .S442F
Conserved Serine 
residue altered in 
SR5 Spectrin 
repeat
PKP-2 1 A 165 (H) c. 145_148delCAGA
*
p.S50fsXl 10
Severe N-terminus 
truncation with loss 
of all ARM repeats 
& C-terminus
3 A 104 (G) C.C419T
*
p.S140F
Conserved Serine 
residue altered in 
N-terminus
5 A 144(E) C.C1237T p.R 413X
ARM repeat 2 
disrupted, loss of C- 
terminus
7 A150 c.l597J600delATCC p.P 533fsX 561
ARM repeat 4 
disrupted, loss of C- 
terminus
8 A9 (D) c.l755_1756insTTGACTCA p.L 586fsX 658
ARM repeat 5 
disrupted, loss of C- 
terminus
9 A18 (F) C.C1844T
*
p.S615F
Conserved Serine 
residue altered in 
ARM repeat 6
11 A48 (A), 
A145 (B )&  
A39 (C)
c.2197_2202delCAC ACCinsG p .A 733fsX 740
ARM repeat 8 
disrupted, loss of C- 
terminus
11 A108 c.2146-lG>C, abnormal 
splicing
*
Activated 
cryptic splicing in 
exon 13
ARM repeat 8 
disrupted, 
truncation in the C- 
terminus
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Table 3.5 Polymorphisms in PG, PKP-2 & DP genes
Polymorphisms found in Plakoglobin (PG), Plakophilin-2 (PKP-2) and Desmoplakin 
(DP) in a cohort of 100 ARVC patients. The nomenclature for splice site 
polymorphisms uses the + sign to describe donor splice site and the -  sign to describe 
acceptor splice site polymorphisms. Abbreviation: dup = duplicated nucleotide and 
IVS = intron or intervening non-coding sequence flanking two exon sequences (for 
example, IVS 11 is the intervening sequence immediately following exon 11 and 
located between exons 11 and 12.
Gene Exon/
Intron
Proband Sequence altered at the 
nucleotide level/Protein level
Comments
PG 3
A3, A32, A58, 
A62, A128& 
A152
C.C425A/p.Rl 42H
Variant present 
in six 
probands
PKP-2 7 A116 c.C1577T/p.T526M
Variant 
predicted 
tolerant and 
benign by SIFT 
& Polyphen
8 A l l c.G1772T/p.R591I
Seen in ~ 4/200 
normal control 
samples
IVS7 A142 c.l689-8dupT
Seen in ~ 4/200 
normal control 
samples
9 A145 c.T1941G/p.C647W
Seen in ~ 4/200 
normal control 
samples
IVS 11 A103 c.2299+14A>C
Seen in ~ 4/200 
normal control 
samples
IVS 11 A144 c.2299+7C>T
Seen in ~ 4/200 
normal control 
samples
DP 1
A138, A ll, 
A144
A32, A ll, 
A152, A19.3
c.G3 84A/p.G3 5G 
C.T405C /p.Y42Y
Synonymous
polymorphism
Known SNP: 
rs36087964
7 A35.6, 
A32, A137, 
A109, A19
c.A1192T/p.I305F Known SNP: 
r s l7604693
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Figure 3.2 Schematic illustration of PKP-2 mutations
The PKP-2 gene structure shows open boxes representing untranslated 3’ and 5’ 
regions o f the gene, the filled boxes representing fourteen exons, and the horizontal 
line between two exons representing an intron. The vertical lines mark the positions of 
eight gene mutations found with affected nucleotide numbering indicated by text in 
black. Corresponding protein changes are shown in green with underlining indicating 
the four novel mutations identified. The protein structure o f plakophilin-2 was 
previously discussed (section 1.8.3, Figure 1.11), the location o f C.C419T and 
c.2179_2201delCACACCinsG gene mutations on the PKP-2 protein (p.S140F and 
p.A733fsX740 PKP-2) are identified in blue, and the predicted effect o f these 
mutations on the protein are shown in Table 3.4. A733fsX740 and S140F PKP-2 
proteins expressions obtained in cellular systems determined their functional 
consequences (Chapters 4, and 5) in vitro.
PLAKO PH IL IN  2 GENE STRUC TUR E
S 5 0 fsX 1 10 R 413X  2146*1G>C E xon11  s k ip p in g
C1237T
2197_2202delCACACCinsG
A 733fsX 740
C419T
S 1 40F
1755,1756insTTGACTCA 
IC18¥ I , 5
ATG TGA
HZH 837
S140F A 73  3 fs X 7 4 0
PLAKO PHIL IN  2 PROTEIN STRUC TUR E
3.4.1 Part 1.7 Russel, SIFT, AND POLYPHEN analysis 
of missense PKP-2 and DP mutations found
Out of the eleven mutations found in the genetic screening of the ARVC cohort 
(Table 3.4), three o f these were missense mutations: p.S140F PKP-2 (c.C419T), 
P.S615F PKP-2 (C.C1844T), and p.S442F DP (c.C1604T). In all three mutations, a 
serine amino acid residue substitution with a phenylalanine amino acid residue
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occurred. Russell analysis (http://www.russell.embl-heidelberg.de/aasA) of a serine to 
phenylalanine change indicates that this results in substitution of a polar sulphur 
containing amino acid with an aromatic hydrophobic amino acid; hence, the 
substituted phenylalanine residue has a different physicochemical property from the 
serine residue and this is predicted to be a disfavoured substitution. The predicted 
effects of these three missense mutations were analysed using SIFT and Polyphen 
analysis (pages 140-146)
• For the plakophilin-2 missense mutation p.S140F, SIFT predicts that this amino acid 
substitution should be tolerant with a score of 0.13. Polyphen analysis of SHOF PKP- 
2 substitution predicts this to be benign, with the multiple fragment alignments around 
position 140 showing relative conservation of the serine residue (with phenylalanine 
and threonine as the other two amino acids represented).
• The plakophilin-2 missense mutation p.S615F is predicted by SIFT to affect protein 
function as no other amino acid residue apart from serine is predicted tolerant at 
position 615 in the plakophilin-2 protein. Polyphen analysis of S615F substitution 
predicts this change to be probably damaging, with the multiple fragment alignments 
around position 615 showing an extremely high degree of sequence conservation.
• SIFT analysis of the desmoplakin missense mutation, p.S442F predicts an affect on 
protein function, although there was a lower confidence in this prediction due to a low 
number (n=4) of sequence representation. Polyphen analysis of the S442F DP variant 
predicts the substitution to be possibly damaging with the multiple fragment 
alignments around position 442 showing a high degree of sequence conservation.
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SIFT & Polyphen predictions for S140F PKP-2, S615PKP-2 and S442F DP
Analysis to determine whether plakophilin-2 missense mutations S140F and S615F and desmoplakin mutation S442F are tolerated or not 
tolerated according to the protein prediction algorithm SIFT (Sorting Intolerant From Tolerant)
Web-site link: http://blocks.fhcrc.org/sift/SIFT.html
S I F T  r e s u l t s
o
Predictions for S140F PKP-2
Substitution at position 140 from S to F is predicted TOLERANT with a score of 0.13.
Median sequence conservation: 3.42 
Sequences represented at this position: 11
Predict Not Tolerated Position Seq Rep Predict Tolerated
w 140S 0.61 c m h y i F l p v r g q n k e D A T S
Predictions for S615F PKP-2
Substitution at position 615 from S to F is predicted to AFFECT PROTEIN FUNCTION with a score o f 0.00. 
Median sequence conservation: 3.02 
Sequences represented at this position: 17
Predict Not Tolerated Position Seq Rep Predict Tolerated
y w v t r q p n m l k i h g f e d c a  615S 0.94 S
Predictions for S442F DP
Substitution at position 4 42 from S to F is predicted to AFFECT PROTEIN FUNCTION with a score of 0.00. 
Median sequence conservation: 4.32 
Sequences represented at this position: 4 
WARNING!! This substitution may have been predicted to affect function just because 
the sequences used were not diverse enough. There is LOW  C O N FID EN CE in this prediction.
Predict Not Tolerated Position Seq Rep Predict Tolerated
y w v t r q p n m l k i h g f e d c a  442S 0.67 S
POLYPHEN prediction for S140F PKP-2
Acc num ber Position Description
1 2
148664226 140 S F plakophilin 2 isoform 2b (Homo sapiens]
This variant is predicted to be benign
Prediction Available data  Prediction basis Substitution effect Prediction data
benign alignment alignment N/A PSIC score difference: 0.045
PS1C profile scores for two amino acid variants
M ultiple alignm ent around substitution position
Flanks:
Show alignment
Scorel Score2 O bservations Diagnostics  ---------  Scorc2|    **----
+0.801 +0.756 0.045 9 calculated Sequences:
Mapping o f the substitution site to known protein 3D structures
Database Initial num ber of struc tu res N um ber of s truc tu res
PQS 56 0
Fragment of multiple alignments around PKP-2 position 140:
1 rclTXP S43739.2I
2 reflNP 00I077I98.II
3 rctlXP 0QI363643.il
4 rcflXP 00IQ6524l.il
5 reflNP 080439.11
6 rcflXP 4I6362.2I
7 a b lA A lI7 II I6.ll
8  eblA A I35674.il
9 reilXP 213560.4J
PREDICTED: similar to plakophilin 
2 isoform 2a ...
hypothetical protein LOC537784 
[Bos tau ru s]...
PREDICTED: similar to plakophilin 
2a [Monode...
PREDICTED: similar to plakophilin 
2 [Rattus ...
plakophilin 2 [Mus musculus]
>gi|12835971 |dbj|B...
PREDICTED: similar to plakophilin 
2a [Gallus ga...
MGC81355 protein [Xenopus 
laevis]
Unknown (protein for 
MGC:121717) [Xenopus tropica...
PREDICTED: similar to plakophilin 
2 [Rattus nor...
10 »h!AAH68279.11 Pkp2 protein [Mus musculus]
. TT TYE W T Q Y SSQ  SVEE
.TT TYES W T QYSSQ SVEE
.T TYE W TSQYSSQ SVEE
,STS YENYL E TQYSSQ SVEE 
,VT TY S W T QYSSQ SVEE
,MT TY S W QYSSQ SVEE
S SSYTN W T I Y  MEE
SV YEN—  N VTFNEW S— EC 
YT YEN V' N VTFSEW S— EC
L H L L E I S  D S S  E H Y T H SD .
L Q L LEIS DSS E IHYSH D.
F Q L LEIS DSS E QY HSE.
Q Q L LEIS SSS E VHY HSD.
W Q L LEIS DSS E HY HSE.
W Q L LEIS DSS E HY HSE.
Q Q L LEVS Q E L  YVSND,
T TL DVS E EV LS F .
T TL DVS E E E VSWS .
11 reflXP 696460.11 PREDICTED: hypothetical protein [Danio rerio] SSCQISSSSSL SLHL TFSVNHE ^ST -SL MVD S SME LFH Y S
POLYPHEN prediction for S615F PKP-2
Acc num ber Position ----  ----
I 2
148664226 6I5 S F
Prediction
Description
plakophilin 2 isoform 2b [Homo sapiens]
This variant is predicted to be probably damaging
Prediction Available data Prediction basis Substitution effect Prediction data
probably  alignment alignment' N/A PSIC score difference: 2 .149
d am agin g
PSIC profile scores for two amino acid variants
M ultiple alignm ent around  substitution position
Show alignment
Score I Scorc2 ^^o re2 i O bservations Diagnostics
i 1.525 -0.624 2.149 II calculated
Sequences:
Mapping o f the substitution site to known protein 3D structures_____________
Database Initial num ber of struc tu res N um ber of struc tu res
PQS 56 0
Fragment of multiple alignments around PKP-2 position 615:
-t*.
0 QUERY:
1 rcllXP 543739 '’ I PREDICTED: similar to plakophilin
IL •' 1 i 2  isoform 2 a ...
2 rcllNP 001077198.11
3 rcllXP 001363643.11
4 rcllXP 00106324111
5 rcllNP 080439.11
6 rcllXP 416362.21
7 u b lA A II7 IM 6 .il
8 ub|AAI35674.l|
9 rcllXP 213560.41
hypothetical protein LOC537784 
[Bos tau ru s]...
PREDICTED: similar to plakophilin 
2a [Monode...
PREDICTED: similar to plakophilin 
2 [Rattus ...
plakophilin 2 [Mus musculus]
>gi|12835971 |dbj|B...
PREDICTED: similar to plakophilin 
2a [Gallus ga...
MGC81355 protein [Xenopus 
laevis]
Unknown (protein for 
MGC:121717) [Xenopus tropica...
PREDICTED: similar to plakophilin 
2 [Rattus nor...
10 uh[AAI I68279.11 Pkp2 protein [Mus musculus]
11 rcllXP 696460.11
PREDICTED: hypothetical protein 
[Danio rerio]
.V  T I  DYQ DD TENC VCILH N L
.V TI DYQ DD TENCVCILHNL
.V TI- DYQ DD TENCVCILHNL
.V TI- DYQ DD TENCVCILHNL 
.V TI' DYQ DD TENCVCILHNL 
,V TI DYQ DD TENCVCILHNL 
,IQ 1/ DHE ND TENCVCILHNL 
, I SI/ DY DD TENCVCILHNL 
. T SI' DY DD TENCVCILHNL
V TI; DYQ DD TENCVCILHNL
V TI DYQ DD TENCVCILHNL 
I TI DY DD TENCVCILHNL
YQLE E L  E Y S Q N IY IQ N  N IQ T D
YQLE EL D YSQSIYIQN TIQTD
YQLE EL E YSQSIYIQN NIQ D
YQLE EL E YSQSNYIQN NIQT 
YQI.E EL E YSQSI YMQN NIQTN 
YQLE EL E YSQSIYMQN NIQTN 
YQLEVEL ESY QSIYTQ NIST-
YQLE EL SSYTQFIY SS D- E 
YQLE EL TYTQSIY S
YQLE El E YSQSIYMQN N QTN 
YQLE EL E YSQSIYMQN N :QTN 
Y FDCEV - VDS V Q QTHTE
POLYPHEN prediction for S442F DP
AA AAAcc num ber Position --------------------------------------------   Description
I 2
P I5924 442 S F Desmoplakin (DP) (250/210 KD paraneoplastic pemphigus antigen). LENGTH: 2871 AA
This variant is predicted to be possibly damaging
Seauence features o f the substitution site
Prediction Available data Prediction basis Substitution effect 
possibly FT
dam aging alignment alignment N/A
Prediction data
PSIC score difference: 1.773
PSIC profile scores for two amino acid_variants
M ultiple aliiinm cnt around substitution position
Flanks:
Show alignment
Score I Score2 l^ corc  ^ O bservations Diagnostics 
  ---------  Score2| -------------------  ----------------
+ 1.245 -0.528 1.773 9 Pre-computed
Sequences:
Mapping o f the substitution site to known protein 31) structures_____________
Database Initial num ber of struc tu res N um ber of struc tu res
PQS 56  0______________________________________________
Fragment of multiple alignments around DP position 442:
, Q I  ELE E E I LEY QVQNLVN S
,QI ELE E E ILEY QVQSLVN
.QI ELE E E [LEY QVQNLVN
■QI ELE E E IIEY QVQNLVN
QI ELE E E IIEY QVQNLVN
QI ELENE E ILEY QVQSLVN
.QI ELE E E ILEY QVQNLVN
.QI ELE E E ILEY QVQSLVN
QI ELE E E IIEY QVQNLVN
.QI ELENE E ILEY QVQSLVN
IV Q L  N  DY SN  I I L  L C ,
IVQL N DY SN IIL LC.
IIQL N DY SN IIL LC.
IVQL N DY SN IIL LC,
IVQL N DY SN IIL LC,
IVQL N DY SN IIL LC,
IVQL N DY SN IIL LC,
IVQL N DY SN IIL LC,
IVQL' N DY SN IIL LC,
IVQL N DY SN IIL LC,
0 QUERY:
1 r -HYP ^ 1 9 7  ^ PREDICTED: similar to desmoplakin
   J isoform II is...
j  rcllXP 00137797 PREDICTED: similar to desmoplakin 
8. 11 [Monodelph...
nvM, ,v * m . *** ,, PREDICTED: similar to desmoplakin3 re X P 917 76.2 . ,  , .■ 1  —1 isoform I iso...
n o n  PREDICTED: similar to desmoplakin4 rcl]XI> 980076J1 isoform  , [Mu
PREDICTED: similar to desmoplakin5 rcllXP 418957.2] i s o fo r |n || |s ^
6  (.lbilHAI-06074.il DSP variant protein [Homo sapiens]
7 dhilBAI-:06074.11 DSP variant protein [Homo sapiens]
PREDICTED: similar to desmoplakin 8 rellXP88l3MJ J iso fo rm || is^
o o . - , - , .  PREDICTED: similar to desmoplakin9 rcllXP 3?4JJ isofQrm ||
1 n n ,  4 . - >  . ,  PREDICTED: desmoplakin isoform 2
0  I 90I4^ -'J [Mus musculus]
1 nn, 4 ,> PREDICTED: desmoplakin isoform 2
1 rcllXI>,..9 !)l4 4 M ] [M us m uscu|us]
1 rcllXP 00 123 14 1 PREDICTED: similar to desmoplakin
2 U J isoform II...
3.4.1 Part 1.8a Effect of S140F PKP2 on predicted 
binding of SR protein (SC35) to ESE motif
Accurate removal of introns from pre-mRNA requires multiple cis-elements, 
including the splice sites, poly pyrimidine tract, branch site, and other intronic and 
exonic sequences that have a positive or negative effect on splicing. Positive-acting 
sequences termed exonic splicing elements (ESE) are identified in exons associated 
with regulated splicing. These exons are typically adjacent to introns with weak 
intronic splicing signals and require ESEs for their inclusion. Deletion of an ESE 
often causes exon skipping, or in the case of terminal exon, suppresses removal of the 
last intron.
The effect of the missense plakophilin-2 mutation (p.S140F, C.C419T in exon 3) was 
checked to establish whether this mutation affected a potential exonic splicing 
enhancer-binding site. The entire wild type PKP-2 exon 3 and that of the mutant 
nucleotide sequences (WT: TCC, mutant: TTC) were analysed using a web-based 
program, fhttp://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=homek ESE 
finder which predicts ESE motifs recognised by five known SR proteins (SF2/ASF, 
SF2/ASF (IgMBRCAl), SC35, SRp40 and SRp55). The program assigns a threshold 
matrix score for each motif that is recognised by a single SR protein and the predicted 
recognition score of each motif in the submitted sequence. The threshold is a value 
above which a score for a given sequence is considered to significant (high score 
motifs). A high score value implies recognition by an ESE element by the respective 
SR protein, but the presence of a high score motif in a sequence does not necessarily 
identify that sequence as an ESE in the native context as a nearby silencer element 
may prevent the SR protein from binding. Using the ESE finder program, the wild 
type nucleotide sequence around Serine residue number 140 was predicted to contain 
a high score motif (value = 4.15371) recognised by human SC35 protein under normal 
splicing condition based on the consensus sequence GRYYcSYR (see next page). The 
exon 3 nucleotide sequence encoding the S140F mutation site was also assigned a 
high score value of 3.92287 for recognition by human SC35 protein.
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ESE finder prediction of SC35 protein motif at the site 
of S140F PKP-2 mutation
Wild type nucleotide sequence of exon 3 and mutant exon 3 sequence encoding the 
S140F mutation were analysed using a web-based program, ESE finder. The URL for 
this program is http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home 
Data shown below were obtained from ESE finder using input sequences as above.
Human SC35 protein binding to consensus motif threshold value = 2.383
Wild Type exon 3 sequence 
Position*/Motif recognition Site/Score
80 (-619)/GGTCCTTG /4 .15371 (TCC is the codon for Serine residue no. 140).
Mutant S140F exon 3 sequence 
Position*/Motif recognition Site/Score
80 (-619)/GGTT( TTG /3.92287 (TTC is the codon for Phenylalanine residue)
The current weighted matrix values (release 3.0) and the consensus motifs obtained 
with sc35 SR protein is shown below; the height o f each letter reflects the frequency 
of each nucleotide at a given position, after adjusting for background nucleotide 
composition. At each position, the nucleotides are shown from top to bottom in order 
of decreasing frequency; orange letters indicate above-background frequencies.
* Both positions from 5'end (through 1) and 3'end (through -1) are given
Protein
SC35
Matrix
H  [1] [2] [3] [4] [5] [6] [7] [8]
A -0.88 0.09-0.06-1.58 0.09-0.41-0.06 0.23
C -1.16-1.58 0.95 1.11 0.56 0.86 0.32-1.58
G 0.87 0.45-1.36-1.58-0.33-0.05-1.36 0.68
T -1.18 -0.2 0.38 0.88 -0.2-0.86 0.96-1.58
Logo
CONCENSUS sequence:
GRYYcSYR
Threshold
2.383
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3.4.1 Part 1.8b Effect of S140F PKP2 on predicted 
phosphorylation of serine residues
The prediction of potential phosphorylation sites on serine, threonine and tyrosine 
amino acid residues in plakophilin-2 protein was performed using a bioinformatics 
approach using a program, NetPhos2 (http://www.cbs.dtu.dk/services/NetPhos/). 
Phosphorylation prediction sites only on serine residues were examined as PKP-2 
mutations in genetic screening affecting only serine residues (p.S140F and p.S615F) 
were encountered. The result of NetPhos analysis shown in Table 3.6 lists all serine 
residues (with a score >0.85) which are predicted as putative phosphorylation sites. 
NetPhos predictions in Table 3.6 shows that there is a clustering of putative 
phosphorylation sites around residue 140 highlighted in red. Serine residue 140 in 
PKP-2 protein is predicted a potential phosphorylation site with a score of 0.873. 
Other Serine residues in close proximity of serine 140 were also predicted to be 
potentially phosphorylated (for example serine residues 132, 135 and 151 and 154 are 
all high score putative phosphorylation site predictions). Serine residue at position 
615 was not predicted by NetPhos to be a potential phosphorylation site, whilst a 
serine residue at position 82 reported to be phosphorylated was correctly identified as 
a potential phosphorylation site by NetPhos.
3.4.1 Part 1.9 Electropherograms of mutations found
The wild type and mutant DNA sequence electropherograms of three DP mutations 
and eight PKP-2 mutations are depicted in Figures 3.3-3.13. In each figure, the 
relevant part of the electropherogram shows in the top part the normal sequence 
derived from unaffected normal controls and the bottom part identifies the probands 
displaying genetic defect with the arrowhead underneath each mutant sequence 
marking the point where nucleotide sequence change begins. All sequences shown are 
obtained from the forward sequencing direction and nucleotide numbering are derived 
relative to the numbering in the reference sequences in accession numbers: 
plakophilin-2, NM 004572.2; plakoglobin, NM 002230; and desmoplakin, 
NM 004415 with the first Adenine residue in the ATG initiation codon designated 
position.
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Table 3.6 NetPhos predictions for phosphorylation of 
Serine residues in PKP-2
All serine residue that are predicted to be putative phosphorylation sites with a score 
of >0.85 are included. Serine residue number 615 in plakophilin-2 substituted by 
phenylalanine in a PKP-2 mutation studied in family F (Figure 3.15) was not 
predicted to be a putative phosphorylation site. Serine residue number 140 was 
predicted to be a potential phosphorylation site, shown highlighted in red.
Sequence Serine residue No Context Score Prediction
*S* = putative 
phosphorylation
gi_14866422 44 LAGSSGRGG 0.866 *S*
gi_l4866422 53 QTVKSLRIQ 0.929 *S*
gi_14866422 71 KGRSSVGNG 0.996 *s*
gi_l4866422 82 HRTSSVPEY 0.981 *s*
gi_14866422 132 AQYSSQKSV 0.982 *s*
gi_l4866422 135 SSQKSVEER 0.997 *§*
gi_14866422 140 VEERSLRHP 0.873 *s*
gi_l4866422 151 RLEISPDSS 0.981 *s*
gi_14866422 154 ISPDSSPER 0.964 *s*
gi_l4866422 155 SPDSSPERA 0.997 *s*
gi_14866422 225 YQHGSVSDT 0.980
gi_l4866422 286 QNRASRSSW 0.992 *s*
gi_l4866422 289 ASRSSWHQS 0.997 *s*
gi_l4866422 297 SSFHSTRTL 0.923 *s*
gi_14866422 313 AVDSSGRRA 0.935 * s *
gi_14866422 358 ERAVSMLEA 0.995 *s*
gi_14866422 693 LIAKSVRNY 0.968 *s*
gi_14866422 744 VGDPSVKKT 0.973
gi_l4866422 826 IMAISAGDA 0.968 *s*
gi_l4866422 833 DAYASNKAS 0.967
gi_l4866422 878 KAYHSLKD- 0.997 *s*
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3.4.1 Part 1.9a Desmoplakin mutations
Figure 3.3 Desm oplakin M utation: p .0273fsX 288
Wild Type DP Exon 7 sequence
T G G  A C G T G G C C T G  A A T G  A T G T T C T
f,k mAMHMS!
G C A G C T G
fmtf
T C G C
iaI W
A G
A116 Mutant DP exon 7 sequence: c.818-819het ins A,
T G G  A C G T G G C C T G  A A T G A T G T T C
iMwUMMM
T N G H N N T I
W U
G C C C
U M a
A I
H
A
Figure 3.4 Desm oplakin M utation: p.M 316fsX324
Wild type DP Exon 8 sequence
A T T T C T T  C A T  T C A C A G  A T  A C G C A T G  A G T C A A C T G G  A A G
A53 Mutant DP Exon 8 sequence: c.946_947het_insATACGCA
A T  T T  C T  T C A T  T C A C A G  A T  A C G C A T G  A C  T C A T N H G  N N  A <
▲
Figure 3.5 Desm oplakin M utation: p.S442F
Wild Type DP Exon 11 sequence
A27 & A58 Mutant DP Exon 11 sequence: het C.C1604T
3.4.1 Part 1.9b Plakophilin-2 mutations
Figure 3.6 Plakophilin-2 M utation: p.S50fsX110
Wild type PKP2 Exon 1 sequence
’ G G C G G G G A G C A G C G G C C G C G G C G G C C A G A C A G T C A A  
A165 Mutant PKP2 Exon l sequence: c.145 148het_delCAGA
G G C G G G G  A G C A G C G G C  C G C G G C G G C C  A G  A C A A N A N N !
/V /^ ]vV W W % Y V W W ^
▲
Figure 3.7 Plakophiiin-2 Mutation: p.S140F
Wild Type PKP2 Exon 3 sequence
A 104 Mutant PKP2 Exon 3 sequence: het_c.C419T
Figure 3.8 Plakophilin-2 Mutation: p.R413X
Wild Type PKP2 Exon 5 sequence
: G T T C A G C G  A G C T G T G T G T G G G G C C T T G  A G  A A A C T  T A <
A 144 Mutant PKP2 Exon 5 sequence: het_c.C1237T
G T T C A G N G  A G C T G T G T G T G G G G C C T T G  A G A A A C T T  A G
▲
152
Figure 3.9 Plakophilin-2 M utation: p.P533fsX561
Wild Type PKP2 Exon7 sequence
T G C T T A C G C  T G  A C G G  A G  A A T A
WtJfiWM.
r  C A T
u
C A T C C C C T T
MM
■ T T C
W v\
A150 Mutant PKP2 Exon7 sequence: c.l597_1600het_delATCC
T G C T T A C G C T G  A C G G  A G  A A T  A T  C A T
/VWVvvw\/Vv M l A w i W
C C N N  T N N  N
kmd
T G T C
m
▲
Figure 3.10 Plakophilin-2 M utation; pL586fsX658
Wild Type PKP2 Exon8 sequence
G A A G A T G T G A C G G  A C T C A T T G A C T C A C T G  G T C C A T  T A T
A9 Mutant PKP2 Exon 8 sequence: c.1755 1756het_insTTGACTCA
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Figure 3.11 Plakophilin-2 M utation: P.S615F
Wild Type PKP2 Exon 9 sequence
G T G C  A T  T C  T T C A T A A C C  T C  T C C T A C C A G  C T
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A18 Mutant PKP2 Exon 9 sequence: het C.C1844T
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Figure 3.12 Plakophilin-2 M utation: p.A733fsX740
Wild Type PKP2 Exon 11 sequence
A G  A A G G  A A A G T  G G C C T G C  A G C A C A C  C C G  A A A G A T  G C T
A48, A145 & A39 Mutant PKP2 Exon 11 sequence: c.2197_2202het_delCACACCinsG
A G A A G G A A A G T G G C C T G  C A G N N C  A C C N  A N  G C T N T  G T G
▲
Figure 3.13 Plakophilin-2 Mutation: Abnorm al splice acceptor site (Exon 11 skipping)
Wild Type PKP2
G A T  A T  G T C T C A C  A A A A C A G  A T G C C G  A C A T C A G  T G  G C  T
A108 mutant PKP2 IVS10 c.2146G-lG>C (ATG immediately after mutation = start of exon 11)
G A T  A T  G T C  T C  A C  A A  A A C  A C  A T G  C C G  A C A T C A G  T G G C T i
A
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3.4.1 Part 2: Pedigree Analysis (Single family genetic 
and clinical analysis)
Nine families were identified in Table 3.4 (families A to I) based on probands 
presenting with seven different mutations in plakophilin-2 and desmoplakin genes. 
These families consented for pedigree analysis and individuals in each family were 
evaluated by genetic screening (which was performed by myself) and by modified and 
Task Force clinical criteria. The objective of the family study was to determine which 
members carried a given heterozygous mutation, and to determine the extent to which 
carriers of a given genetic defect expressed ARVC disease phenotypes. Clinical 
evaluation was performed at the London Heart Hospital by a consultant led clinical 
team, this included family history, SAECG with a 40Hz filter, transthoracic echo, 
contrast echo (where appropriate), 12-lead ECG, 24-hour ambulatory ECG, and in 
some cases cardiac magnetic resonance imaging. As the disease expression within a 
family can show a variable penetrance, the clinical evaluation of first-degree relative 
in a family with proven ARVC showing a positive SAECG, or an otherwise 
unexplained ECG, Holter or echo abnormality was considered to be suggestive of 
disease expression. For interpreting the pedigree analysis of families A to I (Figures 
3.14 -  3.17), the symbols used in those figure are explained in Table 3.7.
3.4.1 Part 2.1 Pedigree analysis of three families, A, B 
and C with p.A733fsX740 PKP-2 mutation
The Plakophilin-2 mutation, p.A733fsX740 was found in three unrelated families 
(families A, B, and C, Figure 3.14):
• Family A was a very large Scottish family consisting of one hundred and forty five 
individuals, only the relevant part of the pedigree is illustrated (family A, Figure 
3.14). This shows that the genetic defect was detected in five individuals, showing an 
autosomal dominant inheritance pattern through three generations with six individuals 
clinically affected by ARVC. The proband 111:2 died suddenly with no previous 
cardiac history; ARVC was only confirmed on post-mortem. The proband’s brother 
111:1 presented with recurrent ventricular tachycardia but ARVC was only confirmed
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after the proband’s death. Out of a possible thirteen immediate family members 
consenting to evaluation, three (111:4, 111:6 and IV:3) fulfilled clinical diagnostic 
criteria and were confirmed to carry the mutation. Three family members (111:3,111:9 
& 111:10) did not fulfil Task Force Criteria, but aroused suspicion of incomplete 
ARVC penetration based on the following observations: precordial T-wave inversion 
(111:3), mild RV enlargement on echo (111:9), and >1000 ectopic beats on 24-hour 
Holter monitoring (111:10). All of these three individuals fulfilled modified criteria, 
but only 111:3 carried the c.2197_2202delCACACCinsG genetic defect.
• In family B, the p.A733fsX740 PKP-2 mutation was detected in the proband 111:1 
who died suddenly at twenty-one years of age. With six of the immediate family 
consenting to genetic screening, only his mother, 11:2 carried the heterozygous 
c.2197_2202delCACACCinsG genetic defect, but she only fulfilled the modified 
ARVC criteria with an abnormal T-wave inversion in VI-V3 on ECG.
• In family C, the p.A733fsX740 PKP2 mutation was detected in the proband 111:1 
who died suddenly at fifteen years of age, he had previously presented with syncope 
at seven years of age and a clinical diagnosis of ARVC was confirmed at eight years. 
Out of the ten possible immediate family members spanning through three 
generations, only three (11:1, 11:2 and 11:2) were available and gave consent to 
evaluation. None had evidence of clinical ARVC disease expression. However, a first- 
degree relative of the proband, 111:3 had previously died suddenly and she was found 
to have fibroelastosis on post-mortem examination. DNA sample was available only 
from the proband, which was found to carry the c.2197_2202delCACACCinsG 
genetic defect in PKP-2.
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Table 3.7 -  Explanation of symbols used in Pedigree 
Analysis
Symbols used in pedigree analysis of families A to I (Figures 3.14 -  3.17) are 
explained below____________ _____________________________________________
Symbol Explanation
Square Males
Circle Females
Solid symbol Meeting Task Force Criteria or confirmed affected at 
Post-Mortem
Grey symbol Deceased individual who did not undergo clinical 
evaluation and was considered probably affected due 
to sudden death (<40yrs), or by their position in the 
pedigree as an obligate gene carrier
Shaded symbol Meeting only the Modified Criteria
Dotted symbol Mutation Carrier not fulfilling ARVC diagnostic 
Criteria
Open symbol Unaffected by ARVC
Underlined Roman numeral Individual undergoing clinical evaluation
Slanted bar symbol Deceased individual
+ symbol Carrier of the gene mutation
-  symbol Individual free of the gene mutation
Arrow symbol Index case or Proband
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Figure 3.14 Pedigree analysis examining p. A733fsX740 PKP-2 (families A, B, & C)
Transmission of PKP-2 gene mutation c.2197_2202_delCACACC_insG was examined in three separate families A, 
B, and C. Symbols are explained in Table 3.7.
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Figure 3.15 Pedigree analysis examining p.L586fsX658 PKP-2 (family D)
Transmission of PKP-2 gene mutation c.l755_1756_insTTGACTCA was examined in family D. Symbols are 
explained in Table 3.7.
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Figure 3.16 Pedigree analysis examining p.R413X, p.S615F, p.S140F, and 
p.S50fsX110 PKP-2 (families E, F, G, and H respectively)
Transmission of PKP-2 gene mutations: C.C1237T, C.C1844T, C.C419T, c.l45_148delCAGA were examined in 
families E, F, G, and H respectively. Symbols are explained in Table 3.7
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Figure 3.17 Pedigree analysis examining p.Q273fsX288 DP (family I)
Transmission of DP gene mutation c.818_819insA was examined in family I. Symbols are explained in Table 3.7.
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3.4.1 Part 2.2 Pedigree analysis of family D carrying 
p.L586fsX658 PKP-2 mutation
The plakophilin-2 mutation p.L586fsX658 was examined in family D. This was a 
family with forty-three members spanning through three generations. Part of the 
pedigree reproduced (Figure 3.15) illustrates twenty-six of these individuals, and in 
out of nineteen of these family members consenting to evaluation, five individuals 
met either the Task Force (11:2,11:8) or the modified ARVC clinical criteria (11:4,111:3 
& 111:5) and all five of these individuals carried the c.l755_1756insTTGACTCA 
PKP-2 genetic defect. The proband’s sister (111:12) and a further two individuals of 
first (111:8) or second (IV:3) degree relative of the proband were found to carry the 
genetic defect, but none of them fulfilled ARVC diagnostic criteria, demonstrating 
that inheriting the mutant gene alone is not sufficient for phenotypic ARVC disease 
expression. This is an important point to note as it shows evidence of incomplete 
disease penetrance. Possible mechanisms for the incomplete penetrance are discussed 
in section 3.5.4.
3.4.1 Part 2.3 Pedigree analysis of family E carrying 
p.R413X PKP-2 mutation
The plakophilin-2 mutation p.R413X PKP-2 was examined (Figure 3.16) in family E. 
The proband (111:2) aged forty had an episode of cardiac arrested while playing 
hockey, but he was successfully resuscitated. The proband had precordial T-wave 
inversion, an enlarged hypokinetic right ventricle, and a positive SAECG. He had 
inherited the C.C1237T gene mutation from his mother (11:2); she had normal ECG 
and no evidence of arrhythmia, but had an aneurysmal segment in the right ventricular 
outflow tract on echocardiography. Three other additional individuals who consented 
to testing (11:1,111:1 & IV: 1) were asymptomatic and found not to carry the C.C1237T 
gene mutation.
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3.4.1 Part 2.4 Pedigree analysis of family F carrying 
p.S615F PKP-2 mutation
The plakophilin-2 mutation, p.S615F was examined in family F. In out of forty-one 
immediate members spanning four generations, nineteen consented for evaluation 
(only a part of the pedigree is illustrated in Figure 3.16). The proband died suddenly at 
15 years of age. The proband’s three sisters (11:2,111:3 & 111:4) met Task Force criteria 
and together with the proband all four individuals carried the C.C1844T gene 
mutation. Both of the proband’s parents met the modified criteria, but only his father 
(11:1) carried the C.1844T gene mutation, which he inherited from his mother (1:2). 
None of the proband’s maternal lineage carried this PKP-2 genetic defect.
3.4.1 Part 2.5 Pedigree analysis of family G carrying 
p.S140F PKP-2 mutation
The plakophilin-2 mutation, p.S140F was examined in family G (Figure 3.16). The 
proband (1:2) died suddenly at the age of 36 years and ARVC diagnosis was 
confirmed at post-mortem. Out of seventeen family members spanning through three 
generations, five consented for evaluation. Three individuals (11:2, 111:1 & 111:2) met 
Task Force criteria and carried the C.419T gene mutation, whilst a relative (11:3) 
satisfying the modified criteria, did not carry the genetic defect.
3.4.1 Part 2.6 Pedigree analysis of family H carrying 
p.S50fsX110 PKP-2 mutation
The plakophilin-2 mutation, p.S50fsX110 was examined in family H (Figure 3.16). 
The proband (11:1) carried the c.l45_148delCAGA gene mutation. Whilst sixteen 
family members spanning four generations were present in the family only the 
proband’s parents consented to evaluation, and although his father (1:1) carried the 
gene mutation, he did not fulfil ARVC diagnostic criteria. The proband’s mother was 
asymptomatic and she did not carry the genetic defect.
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3.4.1 Part 2.7 Pedigree analysis of family I carrying 
p.Q273fsX288 DP mutation
The desmoplakin mutation, Q2733fsX288 was evaluated in family I (Figure 3.17). 
Seven members were evaluated clinically and in genetic screening. The proband 
(III.2) aged 43 years had incurred two episodes of aborted sudden death presumably 
related to ARVC. Although the proband did not meet Task force Criteria (only two 
minor criteria satisfied: non-sustained VT plus 1000 ectopics/24hr period and LV and 
RV enlargement with preserved systolic function on echo), genetic screening was 
carried out taking into consideration her arrhythmia far exceeded what would be 
expected in DCM with her cardiac function. She was found to carry the desmoplakin 
p.Q273fsX280 mutation. The proband’s mother (11:2) had no cardiac symptoms (no 
arrhythmia on exercise testing or Holter monitoring, and SAECG was negative, but 
she showed an abnormal ECG with QRS dispersion (major criterion) and a contrast 
echo with RV and LV wall motion abnormality (minor criterion); she carried the 
desmoplakin c.818_819insA gene mutation. The proband’s brother 111:4 also carried 
the genetic defect, he had syncopal episodes in childhood and clinical evaluation at 
the age of 35 years showed an abnormal ECG pattern and conventional echo showed 
borderline LV enlargement with normal systolic function and right ventricle. SAECG 
was negative and there was no arrhythmia on exercise testing. Further evaluation 
(contrast echo and Holter monitoring) was pending on 111:4 and in his daughter, IV: 3 
aged 6 years. The proband’s son (IV:2) carried the genetic defect, but his lack of 
clinical findings (normal ECG, no evidence of arrhythmia) at age 7 years were not 
surprising; his sister (IV: 1) did not have ARVC and was genotype negative for the 
desmoplakin mutation. The proband’s maternal aunt 11:3 lived abroad and available 
clinical details suggests a history of palpitations. She satisfied ARVC diagnostic 
criteria based on repolarization and right ventricular structural abnormalities and she 
carried the c.818_819insA desmoplakin genetic defect. II:3’s daughter, 111:6, who also 
lived abroad inherited the desmoplakin gene mutation and had a history of 
palpitations, but her clinical details were not available.
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Two other mutations found in proband A108 (c.2146-lG>C mutation affecting 
consensus splice acceptor site in plakophilin-2) and in proband A150 (p.P533fsX561, 
c.l597_1600delATCC in PKP-2) in Table 3.4 could not be characterised by pedigree 
analysis, as additional family members of both probands declined further clinical 
investigations.
3.5 Discussion
3.5.1 Genetic screening of ARVC cohort
Genetic screening of a cohort of one-hundred ARVC probands identified fourteen 
probands carrying mutations in the genes encoding for DP and PKP-2 (Table 3.4). 
Eleven different mutations were identified; three of these were in desmoplakin and 
eight were in plakophilin-2. No mutations were found in the gene for plakoglobin in 
the ARVC cohort examined and this appears to be consistent with observations 
indicating the presence of only two mutations in plakoglobin have been found to date, 
one causing a recessively inherited Naxos disease38 and the second causing an 
autosomal dominant ARVC51.
3.5.1a Desmoplakin mutations
Desmoplakin is an obligatory cytolinker protein essential in desmosome formation 
where it is involved in linking the outer dense plaque region of desmosomes to sites of 
intermediate filament attachment within the inner dense plaque. Desmoplakin protein 
(SDS PAGE apparent migration sizes of 210 or 220 KD) exists in two alternatively 
spliced isoforms. The protein forms a homo-dimer within desmosomes by self 
association within the coiled coil rod region and the N-terminal head domains 
interacts with plakoglobin and plakophilins within the outer dense plaque of 
desmosome. The plakin repeat domains within the C-terminus region of desmoplakin 
establish association with keratin, desmin, or vimentin intermediate filament within 
the inner dense plaque of desmosome. Desmoplakin tethers desmosomes to 
intercellular intermediate filament networks between two adjacent cells, and by this
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mechanism, it imparts adhesive strength to a structure formed by condensation of 
DSG2 and DSC2 desmosomal cadherin proteins.
Three desmoplakin gene mutations were found in the cohort examined that were 
absent in 400 control DNA samples. Two of these mutations arise from nucleotide 
sequence insertions in exon 7 (c.818_819insA, p.Q273fsX288) and exon 8 
(c.946_947insATACGCA, p.M316fsX324) causing reading frame shift that were both 
predicted to disrupt within spectrin repeat, SR4 in the plakin domain of desmoplakin 
protein molecule. A third mutation seen in two unrelated probands was a nucleotide 
change encoding a missense change in exon 11 (c.C1640T, p.S442F) resulting in 
alteration of a serine residue in SR5 of desmoplakin (Table 3.4). The two DP gene 
mutations resulting in the formation of truncated DP proteins was speculated to 
compromise desmosomal function by disrupting sites of intermediate filament 
attachment within the inner dense plaque. The S442F mutation affected a serine 
residue highly conserved in chimpanzee, monkey, dog, mouse, rat, cattle and fowl 
desmoplakin. Pedigree analysis of the S442 missense mutation was not possible as 
family members declined consent for genetic and clinical evaluations.
None of three DP mutations found in the genetic screening work were previously 
reported in the literature. The location of these three mutations on DPI isoform of the 
protein is illustrated (Figure 1.10) where it is evident, the two truncating mutations 
disrupt modular assembly of the plakin domain of desmoplakin with the loss of the 
rod and the plakin repeat domains. The missense desmoplakin mutation causes the 
substitution of a highly conserved serine residue within the SR5 spectrin repeat in the 
plakin domain. The effect of the missense desmoplakin mutation on protein structure 
and function analysed by SIFT and Polyphen predicted that this mutation affected 
protein function with damaging consequences based on physical and comparative 
considerations of the amino acid change.
All three DP gene mutations found in the present screening work affected the N- 
terminus domain of the protein. However, there does not appear to be mutational hot 
spots in the DP gene, as generally in ARVC, gene mutations affecting the N-terminus, 
rod and the C-terminus functional domains of DP protein are equally represented 
(Figure 1.10). Furthermore, in a recent study of two-hundred ARVC patients 
(conducted between January 2003 to June 2007) in which forty-three families with
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two or more affected individuals were examined found seventeen different DP gene 
mutations, with fourteen resulting in chain termination and four causing primarily 
missense amino acid substitutions (see online-only data supplement165).
3.5.1b Plakophilin-2 mutations
Eight plakopophilin-2 mutations were found by genetic screening of the ARVC 
cohort. These were predicted to disrupt different domains in the plakophilin-2 protein 
(Table 3.4). Plakophilin-2 is an essential protein in cardiac tissue localising both in 
desmosomes as well as in the nuclei playing an essential role in cell signalling134,183. 
In the desmosomes, plakophilin-2 appears to function by stabilising the lateral 
connections between the desmosomal plaque proteins in the outer dense plaque. It is 
closely related to an Armadillo pl20ctn family of proteins and structurally it contains a 
globular N-terminal head domain followed by ten imperfect amino acid repeats (ARM 
repeats) and a short C-terminal tail134.
Genetic screening of the ARVC cohort identified 8/100 or 8% of probands who were 
carriers of PKP-2 mutations. This was a relatively small cohort of ARVC patients 
examined to arrive at an accurate figure for the prevalence of PKP-2 mutations in the 
population studied. Examination of several other ARVC cohorts from different 
geographic locations have shown that PKP-2 mutation carriers could account 14% in 
an Italian cohort of eighty patients104, 27% in a Western European cohort of one- 
hundred and twenty patients40 and 43% in a North American cohort of fifty-eight
• 10R , _ ,patients . The most striking finding was in a Dutch study in which 70% of a cohort 
of twenty-three patients107 with demonstrable familial disease had PKP-2 mutations, 
suggesting that plakophilin-2 is the major determinant of familial ARVC in the 
Netherlands107. The varying prevalence of PKP-2 mutation carriers may be due to 
small sample size of the cohorts, varying ethnicities of the population, and patient 
selection bias. In most referral centres individuals with asymptomatic arrhythmia of 
right ventricular origin account for majority of index cases, while in the UK a greater 
proportion of cases were identified by familial evaluation after death of the proband 
from pathologically proven ARVC probably resulting in a selection bias. A wide 
spectrum of plakophilin-2 mutations were identified in the present genetic screening
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work including missense, insertions, deletions, indel and splice sites mutations; this 
was consistent with observations in other cohorts examined40,107,108,207.
Of the eight plakophilin-2 mutations found, four of these were previously described40. 
Two of these mutations resulted in a single nucleotide substitution in exon 3 
(c.C419T) and exon 9 (c.C1844T) resulting in the substitution of a serine residue with 
a phenylalanine residue in both cases (p.S140F and p.S615F respectively). The third 
mutation involved nucleotide sequence deletion in exon 1 (c.l45_148delCAGA) of 
the PKP-2 gene causing a PTC in the mRNA transcript formed with a potentially 
severely truncated protein (p.S50fsX110) translation. The fourth mutation was an 
intervening sequence splice acceptor site mutation c.2146-lG>C causing an abnormal 
splicing with retention of 160bp of the intron 12, or the loss of a 17bp sequence of 
exon 13 due to activation of a cryptic splice site40. This splice site PKP-2 mutation is 
an example of a recurrent mutation ’ .
The p.S50fsX110 plakophilin-2 mutation reported in other studies40,108,207 is a second 
example of a recurrent mutation in ARVC. The nucleotide change 
(c.l45_148delCAGA) encoding this change leads to the formation of an mRNA 
transcript containing a PTC. This mRNA transcript probably was degraded via the 
NMD machinery causing PKP-2 haploinsufficiency. Plakophilin-2 mutations p.S615F 
and c.2146-lG>C, previously described40, lead to disruption of a conserved serine 
amino acid residue within Arm repeat 6, and an abnormal splicing disrupting ARM 
repeat 8 respectively40. The p.S615F mutation resulted in substitution of a serine 
residue highly conserved in dog, mouse, rat and fowl plakophilin-2 All eight 
plakophilin-2 mutations described in Table 3.4 were absent in 400 control DNA 
samples examined.
The p.S140F is a third example of a recurrent mutation that is found in other cohorts 
examined40,108 this disrupted a conserved serine amino acid residue. Although this 
mutation was predicted to be tolerant and probably benign by SIFT and Polyphen 
analysis respectively, family study (Figure 3.16, family G) showed that transmission 
of this mutation was associated with the clinical expression of ARVC in three other 
family members (individuals 11:2, 111:1 and 111:2). DNA sequence analysis program, 
ESE finder indicated that a potential exon splicing enhancer sequence was present at 
the site of the p.S140F missense substitution. However, the C.C419T nucleotide
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change did not result in the abolishment of an ESE element in exon 3 of plakophilin-2 
recognised by SC35 protein, as a high score motif was still recognised after the 
nucleotide change. This suggested that it was unlikely that this nucleotide could affect 
the normal splicing involving exon 3. However, bioinformatics analysis of the PKP-2 
protein using NetPhos phosphorylation algorithms predicted several putative serine 
residue phosphorylation sites (Table 3.6) indicating that there was a clustering of 
putative phosphorylation sites around the serine residue at position 140. Although 
there is no literature evidence supporting the functional relevance of phosphorylation 
at any of these serine residues including serine 140, some of these serine residues may 
conceivably partake in signalling activity of PKP-2. One such serine residue at 
position number 82 in PKP-2 protein was reported to be phosphorylated by CTAK1
j O j  • • •in vitro that generated a binding site for a  14-3-3 proteins affecting the nuclear 
localization of PKP-2 was correctly identified by NetPhos as a phosphorylation site 
(score of 0.981, Table 3.6). Expression of S140F PKP-2 protein in Flp-In T-Rex HEK 
293 cells was achieved to determine functional consequence of its expression 
(Chapter 5).
Four PKP-2 mutations found were novel having not been described in the literature 
before. The mRNA transcript resulting from one of these mutations (c.C1237T, 
p.R413X PKP-2) might have been predicted to undergo NMD and cause PKP-2 
haploinsufficiency, this mutation was subsequently identified in a large German 
family206, and using mRNA expression analysis and sequencing transcription of the 
defective allele leading to a presumed truncated PKP-2 was indicated. Family 
members of the proband in this study were reported to display a severe ARVC 
phenotype with frequent occurrence of SD at young age (5 cases at age 14-29) 
occurring mostly during physical exercise. The age of onset of arrhythmia in the 
family was significantly lower compared to patients with ARVC due to other PKP-2 
mutations, and the penetrance was strongly sex-dependent with all carrier males 
developing the disease, but only 30% of carrier females developed ARVC. Clinically 
affected patients LV biopsy showed pathological nuclei, hypertrophied 
cardiomyocytes, reduced myofibers, and fibrosis. EM examination showed abnormal 
mitochondria and dilated ID. A mouse model over-expressing R413X PKP-2 was 
reportedly established, but functional studies using this animal model has not 
appeared in the literature to date. Although a definitive demonstration of the truncated 
protein in cardiac tissue of affected individual was not reported in this study, the
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structural changes in the ID reported by EM examination suggests the truncated 
R413X PKP-2 protein could be inserted causing dominant negative effect.
Three of the other novel plakophiln-2 mutations p.P533fsX561, p.L586fsX658 and 
p.A733fsX740 were localised within conserved ARM repeat domains causing protein 
truncations resulting in plakophilin-2 proteins lacking seven, six or three out of the ten 
ARM repeats respectively; it is possible that some of these three mutations might 
result in PKP-2 haploinsufficiency as mRNA transcripts containing PTCs may 
undergo NMD. However, if small amounts of these transcripts escaped NMD then the 
formation of these truncated plakophilin-2 proteins lacking these ARM repeat 
structures may compromise PKP-2 protein function via a dominant negative effect if 
these proteins were inserted into desmosomes.
3.5.2 Family studies of PKP-2 mutation carriers
Studies of plakophilin-2 pedigree analysis represent for the first time a systematic 
analysis of genotype-phenotype correlation in families carrying plakophilin-2 genetic 
defects which were not examined in detail in a previously reported study40. 
Heterogeneous phenotypic expression (variable expressivity) was observed among 
individuals carrying the same mutation in a given family. The Task Force criteria 
facilitated ARVC diagnosis, but lacked sensitivity for early diagnosis of disease when 
clinical findings are often subtle. The modified ARVC criteria6 applied to relatives of 
the probands, in the context of family screening because of incomplete disease 
expression, increased the diagnostic yield, but this reduced the specificity. This was 
shown by several examples: 111:9 & 111:10 (Figure 3.14, family A), 11:2 (Figure 3.16, 
family F), and 11:3 (Figure 3.16, family G) where these individuals were found to be 
genotype negative for the respective PKP-2 mutation identified in the proband in each 
family, but all of them fulfilled some of the modified ARVC diagnostic criteria. 
Pedigree analysis allowed the identification of asymptomatic family members who 
had inherited a particular genetic defect identified in the index case patient. This 
information was relevant for clinical management and continued surveillance of these 
individuals who were at risk of developing overt ARVC at some point during their 
lifetime, or who were at an increased risk of sudden cardiac death as a first clinical 
symptom of the disease. Conversely, family members of the proband who do not have 
demonstrable cardiological abnormalities and who do not carry the genetic defect
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identified in the proband can be reassured and dismissed from lifelong periodic 
follow-up cardiological screening allowing scarce clinical resources to be targeted to 
proven gene-positive mutation carriers. Pedigree analysis is also useful for cascade 
screening of relatives who are at risk of developing ARVC for identifying 
transmission of a genetic defect identified in the proband. Pedigree analysis may 
result in reclassification of sequence variant of unknown clinical significance as a 
mutation if the transmission of the identified genetic defect (resulting in a missense 
amino acid substitution) is associated with expression of clinical symptoms, but this 
approach may not always be successful due to variable expressivity of ARVC clinical 
symptoms and reduced penetrance of the disease. The p.S140F PKP-2 mutation is a 
good example of a missense sequence change being classified as a mutation following 
pedigree analysis.
Haplotype analysis of index cases with four apparently recurrent PKP-2 mutations 
(C.C235T; p.R79X, C.C397T; p.Q133X, C.T2386C; p.C796R, and c.2489+lG>A) in a 
Dutch cohort revealed allele sharing which was consistent with founder effects. 
However, in other studies of Western European40 and North American108 ARVC 
cohorts no evidence of founder effects were found for recurrent mutations. In the 
absence of founder effects, however, the proportion of common or recurrent mutations 
in the ARVC population is too limited to be useful as a first-line genetic screening 
approach. The vast majority of PKP-2 mutations found in the present screening study 
and in other studies are ‘private’ mutations that are associated in specific families. 
Thus although as many as fifty-four PKP-2 mutations are known to be associated with 
familial ARVC (Table 1.5), the vast majority of these may be specific only in certain 
populations or present in single families, thereby limiting their usefulness in genetic 
testing in the general population. The implication of frequent private mutations is that 
some of these may be novel mutations for which limited information is available 
regarding their pathogenicity. For deletions, insertions, and splice site mutations 
involving frame shift and nonsense mutation resulting in PTC, a causative role in 
ARVC may be assumed. However, for missense mutations involving single amino 
acid substitution its absence from ethnically matched control subjects must be verified 
followed by the screening of other family members to establish causality through 
correlation of clinical and genetic findings. A detailed search of the effect of a 
missense mutation using literature search, public and diagnostic mutation databases, 
SIFT, Polyphen, Russell and splice site analysis are required to determine whether the
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unclassified variant could be tolerant and benign or intolerant and probably 
pathogenic.
An important observation from examination of other PKP-2 mutation carriers is that
113an important minority of ARVC patients are homozygous for PKP2 mutations or 
double heterozygous. For example, screening the parents of a proband of sixteen years 
of age who died from SD, found that the mother carried a nonsense mutation in exon 
5 of PKP-2 gene while the father carried a pathogenic missense mutation in exon 15 
of the desmoglein-2 gene165.
3.5.3 Importance of missense mutations in ARVC
Generally, missense mutations are difficult to prove as causative for a disease unless 
supportive evidence indicates a functional or structural change in the protein 
concerned. In other non cardiac diseases, such as hereditary non-polyposis colon 
cancer (HNPCC), missense mutations can be found that affect the levels of the 
expression of proteins involved in DNA mismatch repair (MMR, proteins: hMLHl, 
hMSH2, and hMSH6). Supportive evidence for pathogenicity of these gene mutations 
resulting in missense protein formation can be derived by examining the levels of 
proteins by immuno-histochemical staining of tumour tissue where they can be 
associated with knockdown in the expression levels of MMR proteins. Three missense 
mutations were found in the cohort of ARVC patients examined. All three missense 
mutations affected serine residues in desmoplakin (p.S442F DP) and plakophilin-2 
(p.S140F & p.S615F PKP-2) substituted by phenylalanine residues. Using pooled data 
derived from all ARVC gene mutations (DP mutations: Table 1.4, PG mutations: 
section 1.8.2, PKP-2 mutations: Table 1.5, DSG2 mutations: Table 1.6, and DSC2 
mutations: Table 1.7), ninety-six novel mutations were identified in ARVC. Out of 
these, thirty-six (38.0%) were missense mutations indicating that single amino acid 
substitutions constitute an important class of mutations involved in the pathogenesis 
of ARVC. DSG-2 had the greatest proportion of missense mutations with 66.7% 
(14/21), followed by desmoplakin with 57% (8/14) and PKP2 with 24.0% (13/54).
Precisely how missense mutations might cause ARVC is not fully understood, but for 
some missense mutations, such as in desmoplakin (p.V30M & p.Q90R), the head
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domain of DP protein was affected by the missense substitution disrupting the binding 
of DP to PG and affecting its membrane localization. Similarly, in the case of 
desmoglein-2 missense mutations (p.V56M, p.D154E, p.V1588G, p.Y87C, p.GlOOR, 
p.N266S, p.K294E, p.E331K, & p.V392I) these appear to disrupt specific 
extracellular domains in DSG-2 (EC1, EC2, EC3, and EC4) protein. One identified 
PKP-2 missense mutation (p.S140F PKP-2) was examined in a stable Flp-In T-Rex 
HEK 293 cell line to determine the functional consequence of cellular expression of 
this protein.
3.5.4 Incomplete penetrance and variable disease 
expression in pedigree analysis
Pedigree analysis of families A - 1 in section 3.4.1 Part 2 showed evidence of variable 
phenotypic expression and incomplete penetrance of ARVC in families examined. 
Variable phenotypic expression in ARVC implies that family members carrying a 
given gene mutation encoding a desmosomal protein will always express clinical 
symptoms of the disease, but the severity of clinical presentation will vary (mild to 
severely affected) amongst family members inheriting that genetic defect. Some of 
these individuals may fulfil Task Force ARVC diagnostic criteria; others may not 
achieve diagnostic scores to fulfil Task Force criteria, while others may only fulfil 
some of the modified set of ARVC diagnostic criteria. Incomplete penetrance (or 
reduced penetrance) implies that although the genetic defect has been characterised in 
a given family, the transmission of this genetic defect alone will not always 
accompany the expression of ARVC clinical symptoms in all family members. A 
good example of incomplete penetrance was seen in pedigree analysis of family D 
where three individuals (111:12, 111:8, and IV:3, Figure 3.15) related to the proband 
inherited the c.l755_1756_insTTGACTCA genetic defect, but none of these three 
individuals fulfilled any of the ARVC diagnostic criteria (modified or Task Force 
ARVC criteria). Hence, in a family based investigation only a percentage of 
individuals carrying a genetic defect will express ARVC disease. Dominant ARVC 
with PKP-2 mutations in this study showed a reduced penetrance in about 47%41 of 
cases examined. Incomplete penetrance in ARVC results from the following factors:
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• Age-related reduced penetrance seen in pedigrees with PKP-2 mutations carriers 
demonstrates normal or mild disease phenotypes even at the age of beyond seventy. 
Dalai207 et al performed the clinical screening of twenty six PKP-2 mutation carriers 
related to nine probands with pathogenic PKP-2 mutation and found 31% of these 
individuals fully fulfilled Task Force ARVC criteria while 35% had at least some 
Task Force criteria apart from a family history of ARVC. The penetrance of 
symptoms, diagnosis of ARVC (meeting Task Force criteria), occurrence of 
ventricular tachycardia and death in these individuals were all shown to be age- 
dependent207. Due to age-related penetrance of ARVC estimates of penetrance must 
be linked to the age of the target population studied, acknowledging that younger 
individuals without phenotypic expression may later develop this condition. The 
accurate analysis of penetrance of ARVC mutations based on age is important in order 
to allow proper counselling for mutation carriers at young ages to estimate their 
lifetime risk.
• Gender-related penetrance in ARVC is higher in men than women, with an
• • 1 'X .approximate ratio of 3:1 . The penetrance of ARVC has been reported to be between
62-67% in men6,207,214. Analysis of measures of severity of disease between the two 
genders indicated an influence of the male gender on phenotypic manifestations of 
ARVC with men more likely to have late potentials on SAECG, frequent ventricular 
extrasystoles on a 24-Holter monitor, and right ventricular dilatation on imaging207. 
The lower penetrance of ARVC among women may be due to lesser exposure to 
environmental factors such as viral agents causing inflammation or sustained vigorous 
athletic activity.
• Reduced penetrance may result from biological differences, for example, myocyte 
apoptosis is believed to play a role in the pathogenesis of ARVC, and myocardial cell 
apoptosis was inhibited by the effects of oestrogen in vitro and in vivo via the 
activation of phopho-inositol-3 kinase/AKT signalling. This may explain the lower 
incidence of ARVC in women.
• Other environmental factors such as viral triggers and aerobic activity may 
predispose men to the effects of these on ARVC. Men may also be at a higher risk to 
environmental factors influencing disease outcomes. The importance of 
environmental factors influencing the rates of ventricular arrhythmia and severity of 
structural right ventricular dysfunction was emphasized in the work of Dalai and
0(Y1colleagues who examined two sets of monozygotic twins with ARVC and showed 
discordant severity of disease.
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3.5.5 Limitations of genetic screening and future 
studies
The limitation of the present study are five-fold: firstly, that only a very small sample 
of ARVC probands (one-hundred index cases) was studied to gather enough 
information about how different mutations affecting plakophilin-2 or desmoplakin 
may be involved in the pathogenesis of ARVC. Secondly, the number of individuals 
consenting to participate in the clinical and genetic screening limits the pedigree 
information that is available from each family study. Thirdly, only the coding regions 
and immediate flanking intron regions of the three genes encoding desmosomal 
proteins were examined by DNA sequencing, therefore any sequence variants in the 
5’ or 3’ UTR regions of these genes will not be identified using this approach. 
Fourthly, DNA sequencing will not detect the deletion/duplication of single or 
multiple exons or of an entire gene. Detection of such large deletions requires 
alternative methods such as multiplex ligation probe dependent amplification (MLPA) 
analysis. However, a recent report examining one-hundred and twenty ARVC patients 
in a Dutch cohort who were referred for PKP-2 mutation testing, and who had tested 
negative by denaturing gradient gel electrophoresis and sequencing, found only one 
patient by MLPA analysis with deletion affecting the promoter region and exons 1-4 
of the PKP-2 gene resulting in a functional null allele209. Thus, the frequency of large 
genomic deletion in PKP2 gene, which goes unnoticed with sequencing, appears to be 
very low. Lastly, mutation identification studies in the present ARVC cohort 
examined only three of the genes encoding desmosomal protein (DP, PG, and PKP-2). 
Other genes encoding desmosomal cadherin proteins expressed in the heart (DSG-2 
and DSC-2) were not examined in the present studies. In addition, future work may 
involve the identification of other ARVC-related novel genes not yet been screened. 
This may involve examination of additional components such as, for example, plectin, 
other components such as alpha T-catenin, and intermediate filament protein such as 
desmin for encoded gene mutations.
3.5.6 Advent of Genetic Testing in ARVC
The discovery of large number of mutations in the “big three genes” (plakophilin-2 
desmoplakin and desmoglein-2, Tables 1.5 -  1.6 and Figure 1.10) encoding
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desmosomal proteins has opened up the possibility of genetic testing for ARVC in the 
clinical setting. Three scenarios seem amenable to genetic testing in ARVC:
1) Confirmatory and predictive testing in relatives with or without clinical 
features of ARVC is a relatively straightforward relying on bi-directional 
DNA sequencing of all known genes and DNA sequencing of the affected 
exon containing the genetic defect being. Confirmatory testing is defined as 
the use of genetic testing to corroborate clinical suspicion of ARVC in an 
index case. In line with most other cardiovascular diseases, ARVC is 
genetically heterogenous and therefore, would appear to be less amenable to 
genetic testing. However, confirmatory genetic testing may play an increasing 
role in ARVC due to the unique challenges of establishing a clinical diagnosis. 
Predictive testing is defined as the genetic testing to exclude or verify the 
presence of a known mutation in relatives of a family.
2) Pre-symptomatic diagnosis of ARVC, particularly in the setting of sudden 
cardiac death in >50% of index cases provides the strongest argument in 
favour of adapting a proactive approach to familial evaluations6,214. This 
approach emphasizes the need for a timely diagnosis of the concealed phase of 
ARVC, during which a dearth of symptoms may belie significant arrhythmic 
risk.
3) Cascade Screening where the presence or absence of an identified genetic 
defect is investigated by DNA sequencing in extended relatives of an index 
case. This type of genetic testing has an upshot of reassuring gene-negative 
relatives constituting 50% of individuals tested, and allowing targeted use of 
scarce clinical resources on gene-positive individuals.
However, there are several obstacles affecting the utility of genetic testing of ARVC 
in the general population:
• The major obstacle of using a sequencing approach in genetic testing is that despite 
its reliability, this is a labour-intensive and cost-intensive process. The comprehensive 
screening of all known five genes (PKP-2, DP, DSG-2, DSC-2, and PG) and flanking 
intron regions of each exon involves the coverage of a large genomic region of 
approximately 40Kb. Nevertheless, as emerging techniques such as whole genome 
amplification (WGA) overcome problem of reliability and prohibitive present costs
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come down, then it is foreseeable that clinical benefits of a genetic analysis in ARVC 
may eventually outweigh the technical limitations.
11^• Since an important minority of ARVC patients are homozygous , double 
heterozygous165 or compound heterozygous100, digenic inheritance with a gene-dose 
effect in ARVC underscores the importance of screening every coding region of all 
known disease-causing genes, even after isolation of a putative pathogenic mutation.
• Allelic heterogeneity precludes the use of genetic probes in genetic diagnosis. Thus, 
DNA sequencing appears to be the mainstay of genetic screening or testing in ARVC.
• Although PCR restriction ffagment-length polymorphism analysis approach is 
amenable as a relatively inexpensive approach, its utility is limited to mutations that 
fall within restriction sites.
• It has been suggested that some of the numerous missense sequence changes found 
in ARVC may be pathogenic only when accompanied by additional genetic 
polymorphism165.
• Results of genotype-phenotype correlation studies104,165 examining the “big three 
genes” in ARVC estimate a pick-up rate of between 30-40% of successful genotyping 
of all ARVC patients215. Since ARVC is a familial disease in 50% of cases, it implies 
that the remainder of the cases will not show mutations in the known genes, but they 
may possibly harbour mutations in genes not yet implicated.
• Silent gene mutation carriers are individuals who, at any point in time, lack 
evidence of clinically penetrant disease, but retain the capacity to transmit the disease 
to their children. Silent carriers are frequent in ARVC and may give a false 
impression in small families of a sporadic disease.
3.5.7 Impact of p.S140F PKP-2, p.A733fsX740 PKP-2 
and p.Q273fsX288 DP mutations
Two plakophilin-2 mutations (p.S140F and p.A733fsX740) and one desmoplakin 
mutation (p.Q273fsX280) were selected for further functional studies. The p.S140F 
PKP-2 mutation was examined by functional studies because it resulted in the 
substitution of a relatively conserved serine residue in human PKP-2 with an aromatic 
phenylalanine amino acid residue within the N-terminus head domain of PKP2. The 
head domain of plakophilin is involved in the vast majority of the protein-protein
• 183interactions previously reported . This serine residue is highly conserved in several
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species (human, cat and mouse plakophilin-2) and is only replaced by an analogous 
threonine residue at this position in chicken plakophilin-2 or a phenylalanine in 
bovine plakophilin-2. Although SIFT and Polyphen analysis predicted the p.S140F 
missense change to be tolerant and benign, pedigree analysis of family G showed that 
this genetic defect was clearly pathogenic as the transmission of this single nucleotide 
change (c.C419T) was associated with clinical expression of ARVC. Since C.C419T 
PKP-2 mutation did not appear to cause loss of an ESE within exon 3 of PKP-2 
recognised by the SC35 splicing protein, no effect on the normal splicing of PKP-2 
was predicted. Examination of putative phosphorylation sites within the PKP-2 
protein, however, indicated that serine residue at position 140 may be potentially 
phosphorylated clustering around other adjacent serine residues also with high 
likelihood of being phosphorylated.
Functional study of A733fsX740 PKP-2 protein expression was performed as this 
truncated protein was the largest of all PKP-2 protein truncations found in this genetic 
screening work, this protein molecule retained the N-terminus head domain and seven 
ARM repeat units with loss of the final three ARM units and C-terminus region. 
Study of this mutation was considered important because Chen183 and colleagues 
examining functional properties of different domains of PKP2a isoform in vitro did 
not attribute any inter-protein interaction of the C-terminus portion of PKP-2a, 
although the elimination of all ten ARM repeat units in PKP-2a reportedly led to a 
reduction in the amount of plakoglobin binding in immunoprecipitation analysis183.
Expression of A733fsX740 protein was examined in functional study (Chapter 4) as 
compelling evidence was established for the pathogenic nature of this indel nucleotide 
sequence change in three independent families (Figure 3.13, families A, B, and C) 
probably indicating alteration of some property of desmosomes.
The desmoplakin mutation p.Q273fsX280 was examined by functional studies as a 
predicted truncated (33 KD) N-terminus head-domain DP polypeptide formed might 
compete with full-length desmoplakin for insertion into desmosomes. The amino- 
terminus of desmoplakin domain is important for association with the desmosomal 
junctional plaque through interactions with plakoglobin and plakophilin216. A study 
supporting a role of desmoplakin in intermediate filament attachment in desmosomes 
was provided by protein expression work in A431 epithelial cells in which an N-
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917terminus 70KD desmoplakin peptide, referred to as the DNTP peptide was over­
expressed. This truncated desmoplakin polypeptide was recruited to the desmosomal 
plaque region; however, it displaced endogenous full-length desmoplakin from cell­
cell contacts and disrupted intermediate filament attachment to the cell surface.
The Q273fsX280 DP polypeptide truncates within the SR4 spectrin repeat in the 
plakin domain and this may disrupt interactions with PG and PKP-2. This truncated 
DP polypeptide lacks the coiled coil rod region and the C-terminus essential for DP 
self-dimerization and interaction with the intermediate filament network respectively. 
Thus, expression of induced Q273fsX288 DP polypeptide achieved in vitro in Flp-In 
T-Rex HEK 293 stable cells established its functional consequence.
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Chapter 4 
Functional Studies of A733fsX740 
Plakophilin-2 protein expression in tPKP2 cells
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4.1 Introduction
Genetic screening of an ARVC cohort and pedigree analysis of three unrelated 
families A-C (Figure 3.14) showed an autosomal dominant mode of transmission of 
ARVC with incomplete penetrance caused by an insertion/deletion (c2197- 
2202_delCACACC_insG) sequence within exon 11 of the PKP-2 gene. This resulted 
in PKP-2 protein truncation (p.A733fsX740 PKP-2). The p.A733fsX740 PKP-2 
mutation was reported in a total of six unrelated probands; three of these were from 
probands in the present cohort examined41 and subsequently another three unrelated
I AQ #
probands were identified in a North American ARVC cohort suggesting that this 
mutation could be a possible recurrent mutation. Another novel mutation involving a 
28 nucleotide insertion (at position 2196, reference sequence NM 004572.2) within 
exon 11 of the plakophilin-2 gene 111 resulted in a frame shift causing truncation of 
PKP-2 with an identical effect on the protein (p.A733fsX740) as the 
c.2197_2202delCACACC_insG mutation found in the present genetic screening. 
Given the prevalence of p.A733fsX PKP-2 mutation and lack of literature data on 
functional significance of the region implicated by this PKP-2 mutation, the truncated 
PKP-2 protein was expressed in Flp-In T-Rex HEK 293 stable cells to examine its 
effect on cellular characteristics compared to a control cell line expressing full-length 
PKP-2 protein.
Plakophilin-2 mutation p.A733fsX740 resulted in premature protein translation 
termination within the eighth Armadillo repeat unit. However, the truncated PKP-2 
protein retains nearly 85% of the full-length sequence of the plakophilin-2a isoform; 
nonetheless, this truncated protein undoubtedly affected structural or functional 
properties of PKP-2 protein as pedigree analysis of three unrelated families showed 
expression of ARVC clinical symptoms with the inheritance of the genetic 
(c.2197_2202_delCACACC_insG) defect.
4.2 Experimental approach to investigate functional 
effects of A733fsX740 PKP-2 protein expression
The mRNA transcript formed during transcription from the PKP-2 gene encoding the 
indel mutation (c.2197_2202delCACACCinsG) contains a PTC and therefore the
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transcript should undergo NMD resulting in PKP-2 haploinsufficiency. The problem 
with frame shift mutations is that the protein product might be expressed, and if so, 
this could be dominant negative. Thus even if NMD occurs, small amounts of the 
transcript might escape NMD mechanism and protein translation would result in 
formation of a truncated PKP-2 that could act in a dominant negative fashion if 
inserted into desmosomes. Two stable cell lines expressing full-length and truncated 
PKP-2 proteins were generated to investigate this proposition.
Cloning of full-length and A733fsX740 PKP-2 DNA was performed in pcDNA5 and 
pcDNA4 vectors that permit stable cells to be established and inter-protein interaction 
to be examined using an anti-XPress immunoprecipitation approach using these two 
vectors respectively. Using pcDNA5 plasmids, Polyfect-mediated cationic 
transfection allowed selection of stable clones expressing either full length or 
truncated PKP-2 proteins in an established tet-on system in Flp-In T-Rex HEK 293 
cells. Several studies were performed using stable cells expressing full-length 
(designated wPKP2 cells) and truncated PKP-2 (designated tPKP2 cells) proteins:
1) Expressions of full-length or truncated PKP-2 proteins were confirmed by 
confocal microscopy and western immunoblotting in wPKP2 and tPKP2 cells. 
The distribution of full-length and truncated PKP-2 proteins expressed in 
wPKP2 and tPKP2 cells were examined in different cellular compartments (in 
cytosol, membrane, nuclear, and cytoskeletal fractions) using a commercial 
cell fractionation kit.
2) Properties of wPKP2 and tPKP2 cells were examined to compare cellular 
proliferation rate and initial cell-cell contact adhesion using commercial kits 
measuring cell growth characteristics and intercellular adhesion using a 
colorimetric (bio-reduction of substrate to produce a coloured formazan 
product) and a fluorescence assay (cellular esterase enzyme cleavage of 
substrate to release calcein, a fluorescent product) respectively. Another assay 
measured adhesive strength of monolayer to compare wPKP2 and tPKP2 cells 
using an enzyme-based adhesion assay that releases confluent monolayers 
followed by controlled exposure to shear stress and visualization of the 
monolayer fragments formed212. In this monolayer adhesion assay, Dispase II 
enzyme released monolayer from the plastic culture surface without disrupting 
intercellular adhesion (cell-cell contacts preserved), and then the released 
monolayer was subjected to controlled shear stress. Fragments formed were
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assessed with larger monolayer fragments indicating better cell-cell adhesion 
(resistance to fragmentation) while smaller fragments indicate weaker cell-cell 
adhesion (increased susceptibility to fragmentation).
3) Stable cells exposed to controlled mechanical cell stretch were allowed to 
recover for a short time. Non-induced and tetracycline-induced wPKP2 and 
tPKP2 cells treated in this manner were compared for their response to 
specific apoptosis activity measured using a commercial CaspACE assay kit 
that measured colorimetric release of a yellow product from a colourless 
substrate cleaved by caspases enzymes (caspases were activated by cleavage 
during induced apoptosis following mechanical stretch) in these stable cells. 
This procedure measured the extent of apoptosis in wPKP2 and tPKP2 cells 
subjected to cellular stretch to determine whether expression of truncated 
PKP-2 influenced the degree of apoptosis.
4) Cx-43 protein was examined in stable cells as this gap junction protein is the 
major connexin expressed in the heart ventricles, and it has been recently 
implicated as a possible mechanism for arrhythmogenesis in heart diseases. 
The level of Cx-43 protein in soluble cell lysates and cell membrane localized 
Cx-43 protein was compared in non-induced and induced wPKP2 and tPKP2 
cells using western immunoblotting and confocal microscopy analysis 
respectively.
5) Electrophysiology performed using a single electrode recording changes in 
potential differences of induced wPKP2 and tPKP2 cells to injected step 
pulses of electrical current enabled the cell input resistance (ri) of each stable 
cell line to be determined. The ri values obtained provide a measure of how 
well each stable cell line is connected to one another in a cluster. The ri value 
in stable cells without cell surfaced localized Cx-43 protein is expected to be 
greater than the ri value in stable cells that express Cx-43 in their gap 
junctions, as presence of Cx-43 gap junctions would facilitate the flow of 
current through the cell cluster. The cell input resistance values obtained from 
wPKP2 and tPKP2 stable cells were compared by student’s t-test. An 
independent measure of the extent of functional coupling between induced 
wPKP2 and tPKP2 cells was assessed using Lucifer Yellow dye transfer 
providing a measure of gap junction intercellular communication (GJIC)218.
6) Desmosomes formed in vitro in induced wPKP2 and tPKP2 cells examined by 
electron microscopy were compared with desmosomes formed in non-
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transfected Flp-In T-Rex HEK 293 cells to determine the effect of truncated 
PKP-2 protein expression on the morphology of desmosomes.
Lastly, using pcDNA4 vectors HEK 293 T cells were transfected to obtain transient 
expressions of full-length and A733fsX740 PKP-2 N-terminally XPress epitope 
tagged proteins. These PKP-2 proteins were immunoprecipitated using a mouse 
monoclonal antibody reactive to the XPress epitope allowing the extent of interaction 
of these two PKP-2 proteins with other endogenous desmosomal proteins to be 
determined.
4.3 Experimental Aims
Seven overall objectives were set in this part of the study. The first was to clone wild 
type PKP-2a DNA into an expression vector pcDNA5/FRT/TO/TOPO/TA. The 
second was to construct expression mutant c.2197_2202_delCACACC_insG PKP2 in 
pcDNA5/FRT/TO/TOPO/TA using site directed mutagenesis. The third was to make 
stable cell lines in Flp-In TRex HEK 293 and verify expressions of PKP2 and 
A733fsX740 PKP2 in these stable cells. The fourth was to examine the proliferation 
rates, cell adhesion, and the effect of mechanical cell stretch to measured apoptosis 
following recovery of wPKP-2 and tPKP-2 stable cells to an exposure to mechanical 
cell stretch. The fifth was to examine connexin-43 protein levels in wPKP-2 and 
tPKP-2 stable cell lines, and to ascertain whether electrical conduction properties (ri 
values) were affected and the extent of gap junction intracellular communication 
occurring in a stable cell line. The sixth was to examine desmosomes formed in 
induced wPKP-2 and t-PKP-2 stable cell lines and to compare them with desmosomes 
formed in non-transfected control Flp-In T-Rex HEK 293 cells. The seventh was to 
clone DNA encoding full-length PKP-2 and A733fsX740 PKP-2 into 
pcDNA4/XPress/TOPO/TA expression vector to achieve transient transfection in 
HEK 293T cells for examining protein-protein interaction of these expressed PKP-2 
proteins using anti-XPress antibody immunoprecipitation (IP) analysis.
4.4 Materials and Methods
All plasmid vectors were purchased from Invitrogen (Invitrogen, UK). Antibodies 
were purchased from various suppliers such as Invitrogen, Becton Dickinson (BD
184
Bioscience), Abeam (Abeam Pic, UK), Sigma Aldrich (Sigma Aldrich, UK), and 
Santa Cruz antibodies were purchased from Insight Biotechnologies, UK. Cell culture 
media and supplements such as penicillin, streptomycin, Zeocin, blasticidin, 
hygromycin, and bovine foetal calf serum were purchased from Invitrogen.
4.4.1 Cloning of PKP-2 in pcDNA5/FRT/TO/TOPO/TA
Both plakophilin-2a and plakophilin-2b isoforms are expressed in the human heart. 
The 2a isoform lacks a 46 amino acid ARM repeat unit encoded by exon 6 in the 
PKP-2 gene, which is alternatively spliced out. Mutation screening (Chapter 3) of an 
ARVC cohort did not reveal any mutations within the sequence encoded by exon 6 of 
plakophilin-2, and other studies examining PKP-2 mutations in various other ARVC 
cohorts did not find any mutations within this spliced out region. Hence, a pakophilin- 
2a DNA sequence obtained by PCR amplification was cloned in a plasmid vector 
pcDNA5/FRT/TO/TOPO/TA, the cloned plasmid permitted PKP-2a protein 
expression in mammalian cell systems in vitro.
An IMAGE plasmid clone of plakophilin-2 (product TCI 17285, Origene, USA) 
encoding a PKP-2a DNA sequence was the template DNA used for amplifying a 
2662bp PCR fragment of PKP2a using EXL DNA polymerase (section 2.1.2). PCR 
was carried out using primers spanning an ATG start and TAG stop codons and 
containing a Kozak recognition sequence (for correct protein translation in HEK 293 
cell) preceding the ATG start site. EcoR V restriction sites flanked the 5’ and 3’ ends 
respectively. The restriction sites incorporated in the amplified PCR fragment 
provided an alternative cloning strategy within the multiple cloning site of the plasmid 
vector. However, pcDNA/FRT/TO/TOPO/TA topoisomerase catalyzed ligation 
successfully cloned the PKP2a PCR fragment in this study. The primer sequences 
(Table 4.1) were used to amplify a 2662bp PCR product that was cloned into 
pcDNA/FRT/TO/TOPO/TA using the method described (section 2.2.1). The map of 
pcDNA5 plasmid (Figure 4.1) shows the T-A overhang positional cloning of a PCR 
amplified DNA insert (encoding a gene of interest) using vector-mediated 
topoisomerase catalysed reaction to obtain a plasmid containing a cloned gene of 
interest. Using this cloning strategy the 2662bp PCR product encoding PKP2a was 
cloned in pcDNA5 to obtain a plasmid designated -2301A pcDNA5 (Table 4.1).
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Plasmid -2301A pcDNA5 would fortuitously express a truncated plakophilin-2a 
(p.S747fsX753) in Flp-In T-Rex HEK 293 cell transfection. A single Adenosine 
residue was missing at nucleotide position 2301 (numbering relative to PKP2b 
reference sequence in accession number NM 004572.2) in the cloned PKP2a DNA. 
Hence, PCR mediated site-directed (section 4.4.2) mutagenesis was used to re­
introduce the missing Adenosine residue at position 2301 to obtain a pcDNA5 
plasmid correctly encoding full-length PKP-2a.
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Table 4.1 PCR Cloning of PKP-2a in pcDNA5 using an IMAGE clone of plakophilin-2
Cloning of a PCR fragment amplified from a PKP-2a IMAGE clone (Origene technologies, Inc., USA Cat No TC300868) in 
pcDNA5/FRT/TO/TOPO/TA plasmid. PCR primers PKP2 for and PKP2 rev generated a 2662bp fragment using the IMAGE clone as 
template DNA. The PKP2a PCR amplified fragment contained a Kozak recognition sequence preceding an ATG translation start site. A 
termination stop codon, TGA, was incorporated in the reverse primer. The resulting plasmid designated -2301A pcDNA5 was sequenced 
to confirm nucleotide-coding sequence of the cloned PKP 2a DNA. Sequencing verified a missing Adenosine nucleotide residue at 
position 2301 (reference sequence: NM 004572.2). The missing Adenosine nucleotide residue was not a PCR-mediated amplification 
artefact, but occurred in the PKP2a Origene IMAGE clone purchased. The manufacturer of the IMAGE clone (Origene, USA) 
independently verified the missing Adenosine residue in the plasmid supplied.
Primer
Pairs
Sequence (5’-3’) PCR size 
(bp)/ 
Enzyme 
used/ 
Template
Destination vector 
containing cloned 
PCR product
Plasmid
obtained
PKP2 for AAAGATATCGAAATGGCAGCCCCCGGCGCCCCAGCT 2662/EXL/Origene 
IMAGE PKP-2a 
DNA
pcDNA5/FRT/TO/TOPO/TA -2301A pcDNA5
PKP2 rev AAAGATATCTCAGTCTTTAAGGGAGTGGTAGGC
Figure 4.1 pcDNA5 plasmid map for cloning PKP-2
Cloning o f full-length PKP2a and A733fsX740 PKP2a polymerase chain reaction 
DNA amplified fragments into pcDNA5/FRT/TO/TOPO/TA vector used in stable 
(inducible) protein expressions o f these PKP2a proteins in Flp-In T-Rex HEK 293 
cells. The map shows the strategy for cloning a PCR product into the 
pcDNA5/FRT/TO/TOPO/TA vector; the T/A site cloning approach was used which 
relied on vector catalyzed Topoisomerase reaction. The vector map is reproduced 
from the vector handbook (Invitrogen, UK).
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4.4.2 Site Directed Mutagenesis to obtain full-length 
and A733fsX740 plakophilin-2 encoded in pcDNA5 
vector
Plasmid -2301A pcDNA5 DNA was used in SDM (section 2.3) PCR to obtain 
plasmid +2301A pcDNA5 that encodes full-length PKP2a (mutagenic primers listed 
in Table 4.2,). +2301A pcDNA5 maintained the correct reading frame for expression 
of full-length PKP-2a protein in Flp-In T-Rex HEK 293 cells. Both plasmids -2301A 
pcDNA5 and +2301A pcDNA5 were sequenced to verify entire nucleotide sequences 
of the cloned DNA. The sequencing primers (Table 4.3,) verified the insert nucleotide 
sequences of the above two plasmids. Site-directed mutagenic primers (Table 4.2) 
were used to prepare plasmid A733fsX740 pcDNA5 using the method in section 2.3; 
this plasmid encoded a truncated plakophilin-2 (A733fsX740 PKP-2) verified by 
sequencing to confirm correct orientation and nucleotide coding sequence for the 
presence of the insertion/deletion (c.2197_2202delCACACC_insG).
4.4.3 Cloning in pcDNA4/XPress TOPO/TA
Plasmid pcDNA4/XPress/TOPO/TA enables protein expression from a cloned gene of 
interest preceded by short peptide sequences encoding poly-histidine (His6) and an 
XPress epitope tag, this result in expression of a fused protein from a gene of interest. 
Antibody directed against a peptide tag (anti-XPress monoclonal antibody was used) 
enables examination of the in vitro protein-protein binding interaction (by 
immunoprecipitation technique) of endogenous desmosomal protein with either full- 
length or mutant PKP-2 proteins in pcDNA4 transfected HEK 293T cells.
The XPress primers (Table 4.4) and templates +2301A pcDNA5 and A733fsX740 
pcDNA5 (Table 4.2) were used to obtain PCR amplified DNA encoding full-length 
and A733fsX740 plakophilin-2 that were cloned in pcDNA4 plasmid as described 
(section 2.2.2). Plasmids pcDNA4 PKP2 and pcDNA4 A733fsX740 PKP2 obtained 
were sequenced (using primers in Table 4.3) to verify the correct orientation and the 
reading frames of full-length and A733fsX740 PKP-2 nucleotide sequences of the 
insert sequences in these plasmids.
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Table 4.2 SDM to obtain pcDNA5 encoding full-length and truncated A733fsX740 PKP-2
Site-directed PCR mutagenesis to obtain +2301A pcDNA5 and A733fsX740 pcDNA5 plasmids which are suitable for in vitro transfection studies in 
Flp-In T-Rex HEK 293 cells to obtain tetracycline-induced expressions of full-length PKP-2 and A733fsX740 PKP-2 proteins respectively. The 
Plasmid -2301A pcDNA5 containing an out of frame coding sequence of PKP2a (Table 4.1) was mutated by site directed mutagenesis to obtain 
+2301A pcDNA5 plasmid that correctly encoded the full-length PKP2a coding sequence. Plasmid A733fsX740 pcDNA5 containing the nucleotide 
coding sequence for the mutant A733fsX740 PKP2a was generated from +2301A pcDNA5 by site directed mutagenesis using the primers shown. 
Resulting plasmids obtained were sequenced to verify the entire protein encoding nucleotide sequences in these plasmids.
Purpose of Site 
Directed 
Mutagenesis
Forward primer 
Sequence (5’-3’)
Reverse primer 
Sequence (5’-3’)
Plasmid
Mutated
Resulting
plasmid
Obtained
Create a plasmid 
encoding full-length 
PKP2a in pcDNA5
PKP2 Mut2301A for
TTGGTGACCCAAGTGTGAAAAAGACA
GCCATCTCGCTGCTGAG
PKP2 Mut2301A rev
CTCAGCAGCCAGATGGCTGTCTTTTT
CACACTTGGGTCACCAA
-2301A 
pcDNA5
+2301A pcDNA5
Create a plasmid 
encoding A733fsX740 
PKP2a in pcDNA5
PKP2 A733fsX740 for
CAGAAGGAAAGTGGCCTGCAGGCGAA
AGATGCTGCATGTTGGT
PKP2 A733fsX740 rev
ACCAACATGCAGCATCTTTCGCCTGC
AGGCCACTTTCCTTCTG
+2301A 
pcDNA5
A733fsX740
pcDNA5
Table 4.3 PKP-2 primers for verifying sequence of 
cloned PKP-2
Sequencing primers for verifying the full-length PKP-2 and A733fsX740 PKP-2 DNA 
cloned into pcDNA5/FRT/TO/TOPO/TA vector. These primers were used to amplify 
either a PCR from each of the cloned inserts followed by sequencing using the 
respective forward or reverse, or they could be used directly in cycle sequencing 
reactions with plasmid templates containing the above inserts. For PCR amplification, 
an annealing temperature of 55°C was used with 1.5mM MgCk concentration and 
35cycles using lOng plasmid preparation. PCR product sizes referred to amplification 
of wild type plakophilin-2 insert cloned into pcDNA5/FRT/TO/TOPO/TA. For the 
A733fsX740 plakophilin-2 insert cloned into pcDNA5/FRT/TO/TOPO/TA, the PCR 
product obtained using the primer pair Y forward/Y reverse is shorter by five bases 
because of the deletion/insertion. The P forward and Z reverse lie upstream and 
downstream of the insert cloned within the pcDNA5/FRT/TO/TOPO/TA vector.
Primer
Pair
Sequence (5’-3’) PCR size (bp)
P forward TTAGTGAACCGTCAGATCGCC 395
P reverse AGGTT GT AG AC AT ACTC AGG A
Q forward AGATCCTGGGACAACTGGACA 450
Q reverse CACGGACTTCTGGGAGCTGTA
R forward TGACATGCTAAAGGCTGGCAC 340
R reverse GTACTGTCTGTGGTATGTGTC
S forward TATGCTCGTTCCGAGATCGTG 359
S reverse CTGGAATCCACGGCGACACTG
T forward CACTCAGAACAGGGCTTCCAG 271
T reverse TTCTGGAAGCACTCGTGCTGT
U forward ACAGCACGAGTGCTTCCAGAA 320
U reverse TCAGCGTAAGCAATGCTTCTG
V forward AGCAAACCAGAGACTTGGAGA 295
V reverse TTTGGGTAGTCTCCTTCAGGC
W forward CAGAAGCATTGCTTACGCTGA 357
W reverse CTTTTGTTGTTGTCAGTCTGG
X forward TAACCTCTCCTACCAGCTGGA 418
X reverse CGAGATGGCTGY CTTTTTC AC
Y forward TCAGTGGCTCAGACAGTTGTC 350
Y reverse TTGTTGGAGGCATAGGCATCG
Z forward ACCAGAATGCACGCGACCTTC 367
Z reverse AGGCACAGTCGAGGCTGATCA
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Table 4.4 Cloning of PCR amplified DNA encoding either full length or truncated PKP-2 into 
pcDNA4
Cloning of PKP-2 and A733fsX740 PKP-2 into pcDNA4/XPress/TOPO/TA vector suitable for in vitro transfection studies to obtained XPress- 
tagged expression of full-length and A733fsX740 PKP-2 protein expression in HEK 293T cells. Transient expression of these XPress-tagged 
PKP-2 proteins in HEK 293T transfected cells can be immunoprecipitated using an anti-XPress antibody. Plasmids +2301A pcDNA5 and 
A733fsX740 pcDNA5 (Table 4.2) were used as PCR templates with EXL DNA polymerase to obtain amplimers that were cloned in 
pcDNA4/XPress/TOPO/TA. Primer pairs PKP2 XPress for and PKP2 XPress rev amplified PCR fragments encoding either full-length PKP-2 or 
A733fsX740 PKP-2 DNA that was cloned in pcDNA4/XPress/TOPO/TA preceded by vector encoded sequences for poly-histidine and an 
XPress tag (amino acid sequence: DLYDDDK). The cloned PKP-2 DNA maintained the proper reading frame for protein translation with an 
ATG translation start site used from the host vector. A stop codon for protein translation termination was contained in the amplified cloned DNA 
inserts. PKP-2 or A733fsX740 PKP-2 proteins expressed in HEK 293T transfected cells contained N-terminal fused 6XHis tag and an XPress 
epitope adding 3.9 KD to the size of each PKP2 expressed.
Primer
Pairs
Sequence (5’-3’) PCR size 
(bp)/ 
Enzyme 
used / 
Template
Destination vector PCR 
product cloned into
Plasmids
obtained
PKP2 
XPress for
ATGGCAGCCCCCGGCGCCCCAGCT 2517 &
2522*
/EXL/**
pcDNA4/XPress/TOPO pcDNA4 
A733fsX740 
PKP2 or 
pcDNA 
PKP2
PKP2 
XPress rev
GCTCTAGATCAGTCTTTAAGGGAGTGGTAGGC
*  PCR fragment sizes 2522 and 2517bp were for ftill-length PKP-2, and A733fsX740 PKP-2 amplimers respectively. 
* *  Templates used A733fsX740 pCDNA5 and +2301A pcDNA5 respectively.
4.4.4 Preparation of stable transfected cell lines
Stable cell lines were established in Flp-In T-Rex HEK293 cells using pcDNA5 PKP2 
and pcDNA5 A733fsX740 PKP2 plasmids as per procedure described previously 
(section 2.5.4) to obtain full-length PKP-2 and A733fsX740 PKP2 protein expressions 
upon tetracycline-induction. At least five different clones of each stable cell line 
established were selected and clonally expanded, and a best clone showing strong 
stable tetracycline-induced protein expression by western blotting (section 2.6.2) and 
immunofluorescence staining (section 2.7.2) were selected for functional studies 
based on the above criteria: clone wPKP2 expressed full-length PKP-2 and clone 
tPKP2 expressed A733fsX740 PKP-2 under tetracycline-induction respectively.
4.5 Results
4.5.1 Characterization of plakophilin-2 expressions in 
wPKP2 and tPKP2 stable cells
Full-length PKP-2a was expressed in tetracycline-induced wPKP2 stable cells that 
localised as punctate staining at cell-cell junctions (Figure 4.2A) and this was detected 
as a strongly induced 98.7 KD band (Figure 4.3A) by SDS PAGE/westem 
immunoblotting analysis, which correlated with the predicted size of PKP-2a. Using 
confocal microscopy examination of PKP-2 staining procedure (protocol omitting 
detergent treatment step) that preserved nuclear PKP-2 staining, but not of membrane 
PKP-2182, induced PKP-2a was shown to be present in the nucleus (Figure 4.4A) of 
tetracycline-induced wPKP2 cells. Sub-cellular fractionation of tetracycline-induced 
wPKP2 cells (Figure 4.5A) confirmed nuclear presence of PKP-2a protein. The 
antibody used in these localization studies was a mouse anti-plakophilin-2 recognising 
an epitope located within the N-terminus between amino acid residues 19 to 183. A 
predominant localisation of full-length PKP-2a occurred in the cytoplasm, membrane, 
and cytoskeletal fractions of tetracycline-induced wPKP2 cells, whereas a smaller 
amount of this protein was associated with the nuclear fraction examined by sub- 
cellular fractionation and distribution studies (Figure 4.5A). A human heart 
ventricular lysate (lOOpg protein) was analysed by SDS PAGE and western
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immunoblotting analysis that showed expressions of both PKP-2a and PKP2b proteins 
in the lysate (Figure 4.2C).
Truncated plakophilin-2 (A733fsX740 PKP-2) expressed in tetracycline-induced 
tPKP2 cells was localised by confocal microscopy in punctate staining at the cell-cell 
contacts (Figure 4.2B). The truncated PKP-2 was detected as a 77.1 KD band by SDS 
PAGE and western immunoblotting analysis (Figure 4.3B) that correlated with the 
predicted size of this truncated PKP-2 protein. Endogenous full-length PKP2 was also 
present in tKPK2 cells, which migrated at an expected position on the SDS PAGE gel. 
Using confocal microscopy examination of PKP-2 staining procedure (protocol 
omitting detergent treatment) that preserved nuclear PKP-2 staining, but not of 
membrane PKP-2182, induced A733fsX740 PKP-2 was shown to be present in the 
nucleus (Figure 4.4B) of tetracycline-induced tPKP2 cells. Sub-cellular distribution 
studies of induced tPKP2 cells (Figure 4.5B) showed strong expression of a truncated 
PKP-2 in cytoplasm and cytoskeletal fractions with roughly equal amount of an 
endogenous PKP-2 and truncated PKP-2 compartmentalizing in the cytoskeletal 
fraction. Both truncated and endogenous PKP2 appeared in the membrane 
compartment, but with more endogenous PKP-2 localising in this fraction. In the 
nuclear fraction, roughly equal amounts of endogenous and truncated PKP-2 were 
present. The sub-cellular fractionation Qproteome cell compartment kit is used to 
fractionate proteins specific for the cytosol, membrane, nuclear and the cytoskeletal 
compartments of HEK 293 and other cells 219’220. However, the validity of this kit has 
been verified by examining specific protein marker distribution in the four protein 
fractions obtained from a different stable cell line expressing truncated DP protein 
(fractionation of tDP stable cells verified in Figure 6.5).
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Figure 4.2 Immuno-localisation of full-length and A733fsX740 
PKP-2 in wPKP2 and tPKP2 cells by confocal microscopy
Localization of expressions o f full-length PKP-2 and A733fsX740 PKP-2 to the cell membranes of 
tetracycline-induced wPKP2 and tPKP2 stable cell lines respectively. Immunofluorescence images 
showing blue fluorescence signal resulting from DAPI nuclear staining, green fluorescence resulting 
from FM 1-43FX membrane dye staining, red fluorescence resulting from full-length PKP2 or 
A733fsX740 PKP2 staining with anti-PKP2 antibody (610788, BD Bioscience) followed by anti­
mouse Alexa 546 and merge representing composite staining (all panels on the far right) with all 
signals superimposed. A punctate staining o f each plakophilin indicates a staining reminiscent of 
desmosomal reactivity. The size bar on each image in the green channel represents 8pm.
A) wPKP2 cells non-induced
DAPI M embrane PKP-2 Merge
wPKP2 cells tetracycline-induced
DAPI M embrane PKP-2 Merge
B i l l !
B) tPKP2 cells non-induced
DAPI M embrane PKP-2 Merge
tPKP2 cells tetracycline-induced 
DAPI M embrane PKP-2 Merge
H S 1 1 1
m
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Figure 4.3 Western blot analysis of the expressions of 
PKP-2 & A733fsX740 PKP-2 in wPKP2 & tPKP2 cells 
and of PKP-2s in human heart ventricular lysate
Analysis o f expressions o f full-length PKP-2 and A733fsX740 PKP-2 in non-induced 
(NI) or tetracycline-induced (IND) wPKP2 (A) and tPKP2 (B) stable cells determined 
by western blotting technique. A mouse monoclonal antibody to human PKP-2 
(1:500, BD Bioscience, product 610788) was used followed by a goat anti-mouse 
HRP conjugate (1:5000 dilution, Abeam). Blots were exposed to ECL reagents (GE 
Healthcare) and developed using Kodak reagents. Human heart ventricular lysate 
western blotting analysis (C) showed expression of both PKP-2a and PKP2b isoform 
expression; PKP-2a was expressed in induced wPKP2 cells. The migration o f protein 
markers (Precision Plus protein standards, BioRad Laboratories, UK) are indicated on 
the left hand side o f the blots
A - wPKP2 cells B - tPKP2 cells
NI IND NI IND
150 KD->
100 KD-*
75 KD-» -7 U* /
KD 77.1 KD 
A733fsX740 
PKP2a
50 KD-»
37 KD->-
C -  Heart lysate
150 KD-»
100 KD—>■ PKP2b
75 KD-> PKP2a
50 KD-*
37 KD->
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Figure 4.4 Demonstration of nuclear presence of full- 
length and truncated PKP-2 in wKPP2 and tPKP2 
induced cells
Nuclear staining o f full-length PKP-2 and A733fsX740 PKP-2 demonstrated in 
tetracycline-induced wPKP2 and tPKP2 stable cells respectively using confocal 
microscopy. Cells were cultured on glass coverslips in the presence o f O.lpg/ml 
tetracycline to induce the expressions of the respective PKP2 isoforms in each stable 
cell line. Seventy-two hours after induction, cells were fixed in -20°C methanol for 
five minutes followed by incubation in acetone for 30 seconds. After rinsing the cells 
in PBS, they were incubated in 10% FBS/PBS solution for thirty minutes, followed by 
incubation in 1:200 dilution o f mouse anti-plakophilin-2 (BD Bioscience, 610788) for 
thirty minutes at room temperature. Coverslips were washed gently twice in PBS and 
incubated in 1:200 dilution o f goat anti-mouse Alexa fluor-546 antibody for one hour 
at room temperature. Coverslips were washed in PBS followed by mounting on glass 
slide in Glycerol/PBS solution and observation of fluorescence in a laser scanning 
confocal microscope. Under this detergent-free staining conditions, membrane 
staining of plakophilin-2 is abrogated, but exclusive intense nuclear staining is
9 9 1  •seen , probably due to masking o f the plaque-bound form of the protein. The red 
immunofluorescence signal localized each PKP-2 staining inside the spherical nuclei 
(where the presence o f dark outline o f nucleoli can be seen inside some of these 
nuclei). The presence o f truncated PKP-2 in the nuclear protein fraction was 
confirmed by sub-cellular fractionation studies (Figure 4.5B). The size bar on each 
image represents 5 pm.
A) Induced wPKP2cells B) Induced tPKP2 cells
Figure 4.5 sub-cellular localization of full length & 
truncated PKP2 in wPKP2 and tPKP2 stable cells
Sub-cellular distribution o f A) full-length PKP-2, or B) A733fsX740 PKP-2 in 
cytosolic (CYT), membrane (MEM), nuclear (NUC) and cytoskeletal (CSK) protein 
fractions obtained from tetracycline-induced (48hrs) wPKP2 or tPKP2 stable cells 
respectively. Sub-cellular protein fractions were obtained from 5x106 cells from each 
cell line using the Qproteome cell compartment kit (Qiagen, UK). Each protein 
fraction obtained was precipitated in four volumes o f ice-cold acetone and the pellet 
was resuspended in lOOpl RIPA buffer containing protease inhibitor cocktail (Roche).
th
1/5 o f each protein fraction was electrophoresed in a 10% SDS PAGE gel and 
transferred onto a Hybond ECL membrane. Following blocking o f blot in TBST/5% 
milk, it was incubated with 1:500 mouse monoclonal anti-plakophilin-2 (610788, BD 
Bioscience) for one hour in TBST/5% milk at room temperature. Following washing 
of the blots in TBST, they were exposed to 1:3500 dilution o f anti-mouse HRP 
conjugate in TBST/5% milk for one hour at room temperature. After washing the 
blots in TBST, they were incubated in ECL reagents (GE Healthcare) followed by 
exposure to ECL Hyperfilm (GE Healthcare).
A) Induced wPKP2 cells
CYT MEM NUC CSK
<e 98.7 KD full-length 
PKP2a and 
endogenous PKP2
B) Induced tPKP2 cells
CYT MEM NUC CSK
<r 98.7 KD PKP2a
<r 77.1 KD A733fsX740
PKP2a
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4.5.2 Properties of wPKP2 and tPKP2 stable cells
Cellular proliferation of wPKP2 and tPKP2 cells did not alter substantially as the 
values of the slopes obtained by regression analysis were similar in these cells upon 
tetracycline induction to obtain expressions of full-length or truncated PKP-2 
respectively (Figure 4.6). The initial cell-cell adhesion of induced calcein-labelled 
wPKP2 or tPKP2 cells plated onto homologous confluent monolayers of induced 
wPKP2 and tPKP2 cells cultured on plastic coverslips showed that there was 
significantly increased adherence of tPKP2 cells compared to wPKP2 cells (Figure 
4.7). A Dispase-based cell dissociation assay measuring the adhesive strengths of 
highly confluent induced monolayers of wPKP2 and tPKP2 cells showed an increased 
resistance to fragmentation of tPKP2 monolayer versus those of wPKP2 (larger 
fragments seen in tPKP2) monolayer when these were subjected to shear stress 
(Figure 4.8). The increased adhesive strength of tPKP2 monolayer was reflected 
during trypsinization procedure as confluent induced tPKP2 monolayer took a 
consistently longer time (five minutes, data not shown) to come off the culture flask 
compared to confluent induced wPKP2 monolayers that came off earlier (three 
minutes, data not shown). Stable wPKP2 and tPKP2 cells subjected to mechanical 
cell-stretch and then allowed to recover for a short while showed that there was 
approximately a two-fold increased apoptosis measured in tPKP2 cells compared to 
wPKP2 cells (Figure 4.9). During the mechanical cell stretch experiments, cells were 
cultured on gelatine-coated silicon membranes, which did not permit immuno-staining 
in situ to demonstrate apoptosis. However, analysis of whole cell lysates of 
mechanically stretched and non-stretched wPKP2 and tPKP2 cells by western 
immunoblotting showed that cells exposed to mechanical stretch expressed increased 
17KD active caspase-3 protein band (formed by activation of caspases-3), which 
appeared more intense in induced stretched tPKP2 cells (Figure 4.10).
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Figure 4.6 Proliferation of wPKP2 and tPKP2 cells
Cellular proliferation o f stable wPKP2 and tPKP2 cells expressing full-length PKP-2 
and A733fsX740 PKP-2 respectively. 15,000 cells per well were plated in a twenty- 
four well plate and allowed to attach overnight. Cell proliferation was measured 
spectrophotometrically at 490nm by measuring the reduction o f Cell Titer AQ One 
solution (Promega, UK) after incubation of substrate with cells for exactly one hour. 
The seven data points obtained in each treatment were fitted to a linear tread line 
using Microsoft Excel software. The values o f the slopes were: 0.0216, 0.0231, 
0.0231, 0.0236 for wPKP2NI, wPKP2 IND, tPKP2 NI and tPKP2 IND cells 
respectively.
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Figure 4.7 Initial cell-cell contact adhesion assay of 
wPKP2 and tPKP2 cells
Initial cell-cell contact adhesion measured in wPKP2 and tPKP2 stable cell lines 
expressing full-length PKP-2 and A733fsX740 PKP-2 respectively. Both cell lines 
were cultured under tetracycline-induced conditions on 13 mm plastic coverslips to 
obtain a uniform highly confluent monolayer of cells. Separate suspension aliquots (1 
x 106) of each tetracycline-induced cells previously pre-incubated in lOpM Calcein 
AM dye were allowed to adhere to the homologous unlabelled confluent monolayer of 
cells growing on coverslips conditions for five hours at 37°C/5%C02. Coverslips were 
carefully washed four times in complete DMEM medium. Coverslips were fixed in 
4% formaldeheyde/PBS, stained with DAPI and mounted on glass slides, followed by 
examination in a confocal microscope (images shown obtained with xlO objective 
lens) to co-localise the green and blue signals. The number of calcein AM-labelled 
(cells fluorescing green) versus the total number of cells labelled with DAPI (all cells 
fluorescing blue) was expressed as a percentage to quantify the percentage initial cell­
cell contact adhesion of each monolayer. A statistically significant increase in % mean 
initial cell-cell adhesion o f tPKP2 compared with wPKP2 cells was shown using a 
paired student’s t-test. A p-value o f <0.05 was considered statistically significant.
Induced wPKP2 cells Induced tPKP2 cells
G reen = calcein labelled cells Green = calcein labelled cells 
retained on adherent retained on adherent
m onolayer, B lue = DAPI monolayer, Blue = DAPI
staining o f all cells staining o f all cells
% wPKP2 initial cell­
cell adhesion
% tPKP2 initial cell­
cell adhesion
Experiment 1 20.7 39.8
Experiment 2 23.3 41.4
Experiment 3 24.4 37.3
Experiment 4 25.4 33.0
Experiment 5 29.3 46.6
Experiment 6 35.4 44.9
Total number of cells examined 3000 3000
Mean % initial cell adherence 26.050 40.517
SD 4.723 4.957
SEM 1.928 2.024
p value (paired student’s t-test) p= 0.0036
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Figure 4.8 Dispase-based induced wPKP2 and tPKP2 
monolayer dissociation adhesion assay
Monolayer adhesive strength of tetracycline-induced wPKP2 and tPKP2 confluent 
monolayers measured using a Dispase-based cell dissociation assay212. Each cell line 
was cultured in 60 mm Nunc brand plastic culture dishes in penicillin, streptomycin, 
foetal bovine serum, blasticidin and hygromycin supplemented DMEM (Invitrogen 
19308-025) in the continued presence o f O.lpg/ml tetracycline until cells were highly 
confluent. Medium was decanted from each dish and the cell monolayer was carefully 
washed in PBS. One ml o f 2.4U/ml Dispase II (Roche, Cat No 10295835001) was 
added to the dishes followed by incubation at 37°C for 30 minutes. The entire intact 
monolayer lifted off the plastic cell culture dish by Dispase treatment was carefully 
rinsed in PBS and resuspended in five ml of PBS. The cell monolayer was subjected 
to shearing for exactly ten rotations on a rocking tabletop platform. Sheared 
monolayer was photographed under Epi-white light illumination in BioRad Gel 
Documentation system (gel doc XR) using quantity one version 4.6 software for 
image analysis. This adhesion assay showed visually that tPKP2 cells resisted 
fragmentation, resulting in larger fragments after ten rotations compared to control 
wPKP2 cells forming comparatively smaller fragments under the same conditions.
Control wPKP2 stable cells expressing full-length PKP-2
Small monolayer fragments formed in wPKP2 cells by shearing
tPKP2 stable cells expressing A733fsX740 PKP-2
Larger monolayer fragments in tPKP2 cells by shearing -> increased monolayer adhesion 
Arrows indicate presence of large fragments in tPKP2 cells that are not present in wPKP2 cells
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Figure 4.9 Effect of mechanical cell-stretch on 
apoptosis of wPKP2 and tPKP2 stable cells
Effect of mechanical cell stretch on the measured apoptosis determined in wPKP2 and 
tPKP2 stable cells. Student’s paired t-test statistical p value = 0.1448 (wPKP2 NI 
versus wPKP2 Ind) and p < 0.0001 (tPKP2 Ind versus either tPKP2 NI or wPKP2 
Ind). Apoptosis levels are mean values of n = 6 experiments ± standard deviations. 
The CaspACE assay system (Promega, UK) was used to measure the specific activity 
of caspase-3 in cell lysates of cells subjected to mechanical stretch using the Flexer 
cell-stretch apparatus with 4% cell-stretch applied at a frequency of 1Hz for 3.5 hours 
followed by recovery of cells for 3 hours prior to assessing apoptosis. Cell plating 
density was 0.5 x 106 cells/six well plate and these were cultured for 48 hours prior to 
exposure to mechanical stretch. Induced cells were cultured in presence of 0.1p.g/ml 
tetracycline.
Susceptibil ity  of tPKP2 and wPKP2 cel ls  to apoptos is  
fo llowing 4 % cell-stretch for 3.5 hrs at 1Hz
□ Mean Apoptosis
Cell/Treatm ent
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Figure 4.10 Western blot analysis of active caspase-3 
in wPKP2 and tPKP2 cells not exposed or exposed to 
4% mechanical cell-stretch at 1 Hz for 3.5 hrs
Western blot analysis to detect cleaved Caspase-3 in cell lysates of non-stretched and 
mechanically stretched wPKP2 and tPKP2 cells. Cells were subjected to 4%  
mechanical stretch at 1Hz for 3.5hours in the Flexer cell-stretch system. Non­
stretched cells were cultured in a FlexerCell six well plate and handled in an identical 
manner as cells exposed to mechanical cell-stretch except that these cells were spared 
exposure to mechanical cell-stretch. Cell lysates were prepared in RIPA buffer from 
cells that had undergone 4%  mechanical stretch or from cells that were not subjected 
to stretch. lOOpg of cell lysates were electrophoresed on a 15% SDS PAGE gel and 
blotted on ECL Hybond membrane. Following blocking of blots in TBST/5%milk 
they were incubated either in 1:500 rabbit anti-active caspase3 antibody (antibody 
detects a band of 17 KD, Abeam Pic, UK) or in 1:2000 rabbit anti (3-actin antibody 
(Abeam, ab-8227) for one hour. Blot were washed in TBST and incubated in 1:3500 
mouse anti-rabbit HRP conjugate (Abeam) for one hour. Blot were washed in TBST 
and incubated in ECL reagents followed by exposure to ECL Hyperfilm and 
development using Kodak photographic reagents. Top part o f the figure shows 
cleaved active Caspase-3 band while the bottom part shows loading controls staining 
for (3-actin.
Non-stretched 4% stretched
wPKP2 wPKP2 tPKP2 tPKP2 wPKP2 wPKP2 tPKP2 tPKP2
NI IND NI IND NI IND NI IND
Cleaved active Caspase-3 detection 17KD band
Non-stretched 4% stretched
wPKP2 wPKP2 tPKP2 tPKP2 wPKP2 wPKP2 tPKP2 tPKP2 
NI IND NI IND NI IND NI IND
Loading control (3-actin detection 42 KD band
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4.5.3 Connexin-43 protein expression in wPKP2 and 
tPKP2 stable cells
Analysis of non-induced and induced wPKP2 and tPKP2 highly confluent monolayer 
soluble cell lysates by western immunoblotting showed strong Connexin-43 protein 
bands in both cells (Figure 4.11). However, examination of these induced cells by 
confocal microscopy confirmed Connexin-43 protein localization to cell membranes 
of wPKP2 cell membranes (Figures 4.12A and Figure 4.13), but this was consistently 
absent in tPKP2 cell membranes as shown by a representative staining (Figure 
4.12B).
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Figure 4.11 Western blot analysis of whole cell lysates 
of wPKP2 and tPKP2 cells to measure Cx-43 and 
plakophilins
Connexin-43 levels in wPKP2 and tPKP2 cells analyzed by western blotting analysis. 
The top panel shows the levels o f Cx43, middle panel shows PKP-2 and A733fsx740 
PKP-2 levels and bottom panel shows (3-actin as loading control. Stable wPKP2 and 
tPKP2 cells were cultured in the absence (NI) or presences o f 0.1 pg/ml tetracycline 
(IND) for 72 hrs until cells were fully confluent. Cell lysates were prepared in RIPA 
buffer and equal amounts o f cell lysates (100 microgram protein) were separated in a 
10% SDS PAGE system. Gels were blotted onto ECL Hybond membrane and blots 
were blocked in TBST/milk followed by incubation in 1: 2000 rabbit anti-connexin- 
43 (GJA1, Abeam ab-113700), or 1:500 mouse anti-human PKP2 (610788, BD 
Bioscience), or 1:2000 rabbit anti-p-actin (loading control, Abeam, ab-8227). 
Following washing of blots in TBST they were incubated in either 1:5000 anti-mouse 
HRP or 1:5000 anti-rabbit HRP. Blots were washed in TBST and incubated in ECL 
reagents (GE Healthcare) followed by exposure to ECL Hyperfilm and development 
with Kodak photographic reagents.
Detection of Connexin-43 using antibody GJA1 43KD band
WPKP2 NI wPKP2 IND tPKP2 NI tPKP2 IND
43 KD Cx-43
Detection of PKP2a (97 KD) and A733fsX740 PKP-2 (81 KD)
PKP-2 
wPKP2 NI wPKP2 IND
A730fsX740 PKP-2 
tPKP2 NI tPKP2 IND
<- 97 KD PKP-2
81 KD
A733fsX740 PKP-2
Detection of loading control (3-actin 42KD band
wPKP2 NI WPKP2 IND tPKP2 NI tPKP2 IND
<— 42 KD (3-actin
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Figure 4.12 High Magnification immuno-iocalisation of Cx-43 expression in wPKP2 and tPKP2 
stable cells
Localization o f Connexin-43 expression determined by immunofluorescence staining and confocal microscopy examination o f induced wPKP2 and 
tPKP2 stable cell lines. Blue channel records DAPI nuclear staining, green channel records cell membrane staining with FM 1-43FX dye, red channel 
records connexin-43 staining, and composite channel shows all three signals together. Images were obtained using xlOO objective lens. The size bar in 
the green channel represents 10pm. Cx-43 protein localization in cell membranes o f wPKP2 cells occurs, but this is absent in tPKP2 cells.
A -  induced wPKP2 cells B -  induced tPKP2 cells
DAPI M embrane DAPI M embrane
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Figure 4.13 Low magnification immuno-iocalisation of Cx-43 to cellular membrane of 
tetracycline-induced wPKP2 stable cells
Confocal microscopy localization of connexin-43 expression to cell membranes o f induced wPKP2 cells. Red channel shows connexin- 
43 protein staining, green channel shows cell membrane staining with FM 1-43FX dye and merge channel shows both signals 
superimposed. These images were obtained using x40 oil immersion objective lens. Cx-43 protein is present abundantly in these cells and 
localizes within the cellular membrane o f induced wPKP2 cells. The size bar in the green channel represents 7 pm.
Induced w P K P 2  cells
C x-4 3 M em brane M erge
4.5.4 Cell Input Resistance measurement
4.5.4.1 Description of the measurement of the cell 
input resistances of tetracycline-induced wPKP2 and 
tPKP2 stable cell clusters
This electrophysiological technique compares two different monolayer cell 
preparations to determine how well cells in the monolayer connect to each other by 
measuring the flow of an electric current through cell clusters. The rationale for 
employing this technique was to determine whether the difference in connexin-43 
protein localising at cell membranes of induced wPKP2 versus tPKP2 cells 
accompanied a better current conduction in wPKP2 cells compared to tPKP2 
monolayers: the later cells, which did not express connexin-43 protein at cell 
membranes. Cell lines were cultured in 35mm diameter culture dishes in the presence 
of tetracycline (O.lpg/ml) for expression of respective plakophilins (full-length or 
truncated PKP-2). Both cells were highly confluent prior to performing cell input 
resistance measurements. These experiments were performed in collaboration with 
Professor Chris Fry; Dr Rosaire Gray performed the measurements and data analysis.
The cell input resistance measurements were carried out using a single 3M KCl-filled 
borosilicate microelectrode pulled using an automated micropipette puller (P-87, 
Sutton Instruments Co, USA) designed to construct uniform microelectrodes of 
similar resistance. The voltage measured by the microelectrode was compared to a 
reference electrode (a liquid 3M KC1 junction) in contact with the extracellular (cell 
culture medium) fluid. The membrane potential of an individual cell was recorded 
against the reference electrode after inserting the microelectrode into a single cell and 
ensuring a steady state potential difference (p.d) was obtained.
Prior to performing cell input resistance measurements, a steady state value of the cell 
membrane potential recorded on an oscilloscope was rescaled to allow simultaneous 
recording of an injected pulse of electrical current and the elicited potential difference. 
For cell input resistance measurement of each cell preparation, a single experiment 
consisted of two measurements, illustrated in figure 4.14. In this figure, the top part 
shows a schematic diagram of the microelectrode setup for each of the two
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measurements, the middle part shows electrical circuits in each situation, and the 
bottom part showed the p.d. change recorded in each case upon injection of a step 
pulse of an electric current. In Figure 4.14A, the microelectrode was placed in contact 
with culture medium alone that surrounded the cell monolayer. The p.d. measured in 
response to injecting step pulses of varying magnitude of electrical current through 
the microelectrode and into the medium determined the microelectrode resistance rei 
(following Ohm’s law). The time constant of the microelectrode, xei = rei cei, where cei 
= the capacitance of the microelectrode, was extrapolated from p.d. traces recorded on 
a fast time scales (see section 4.5.4.2). The time constant t  was the time required for 
the voltage to reach (1 -  1/e) of its maximum plateau (i.e. about 63%). In Figure 
4.14B, a microelectrode was inserted into a single cell and the change of p.d. was 
recorded following injection of varying step pulses (14 ms duration) of current. The 
voltage recordings in Figure 4.14A and Figure 4.14B were monitored on a slow and 
on a fast time scale to determine the resistance of the cellular preparation, r prep (Figure 
4.14B) or that of the electrode alone rei (Figure 4.14A). The respective time constants 
Tei and Tprep were extrapolated from the fast voltage response traces using curve-fitting 
software of the stored transients. The resistance of the cell was given by the equation 
Tceii = r Prep -  rei ~ n, where r ^ u  = cell input resistance, r prep was the measured resistance 
of the preparation (using Ohm’s law, R=V/I) and rei = resistance of the 
microelectrode. It was assumed that rceii was predominantly determined by r* (the 
intracellular resistivity), rj was in series with the membrane resistance, rm, but rm «  rj. 
The rise in p.d. in response to injection of current in the preparation was given by a 
time constant, Tprep = rprepCprep, where c prep = capacitance of the preparation. The time 
constant of the cell, Tceii =  Tprep- xei, where xprep=  time constant of the preparation and 
xei = time constant of the electrode. The Tceii value was a measure of cellular mass of 
each preparation as it was assumed that cell mass was proportional to cell membrane 
area of unit specific capacitance.
rj values were plotted as a function of xceii when a linear relationship was generally 
observed for each monolayer. The slope of the line was a measure of resistance of the 
preparation (dominated by rj) as a function of unit cell mass. A decrease of slope 
would indicate a unit reduction of rj. n itself was assumed a sum of cytoplasm 
resistance, rc, and intercellular coupling resistance, q. An increase of Connexin-43 
expression would reduce 15, and hence r*, per unit change of xceii -  i.e. the slope of the 
plot would be reduced.
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Figure 4.14 Principles of ceil input resistance measurement
Cell input resistance measurements were made using measurements in two situations: A) electrode in solution and B )  electrode inserted inside a cell.
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4.5.4.2 Results: measurement of the cell input resistances of 
induced wPKP2 and tPKP2 cell clusters
Representative intracellular and extracellular p.d. recordings obtained from individual cell 
input resistance measurements of wPKP2 and tPKP2 monolayers are shown in Figures 4.15 
and 4.16 respectively. The fast p.d. change recordings were analyzed using KaleidographTR 
software to obtain rfast (representing cell input resistances, see Tables 4.5 and 4.6) values, and 
the teen values were calculated after estimating Tprep and Tei values with the aid of this software.
Analysis of clusters of individual wPKP2 and tPKP2 monolayers recordings suggested a small 
difference in coupling between these two cell monolayers as shown by sample data in Figure 
4.17. However, statistical analysis of pooled data obtained from five separate experiments 
measuring cell input resistances in wPKP2 and tPKP2 monolayers (Tables 4.5 and 4.6 
respectively) showed no statistically significant difference between the average rfast/i values of 
wPKP2 and tPKP2 monolayers (mean values derived at end of sixth columns in Tables 4.5 and 
4.6 compared by paired student’s t-test, p = 0.234). The values of average rfast plotted versus 
average t (derived from fourth and fifth columns respectively in Tables 4.5 and 4.6) plotted 
graphically for wPKP2 and tPKP2 cells (Figure 4.18) shows that two separate regression lines 
fit each data set. However, the value of the slopes of these two lines (y = 103.7x for wPKP2 
cells and y = 105.4x for tPKP2 cells) showed only a modestly small reduction in value for 
wPKP2 cells expressing connexin-43 at cell membranes, suggesting there was little difference 
in the cell input resistances, and the degree of electrical coupling between wPKP2 and tPKP2 
cell clusters.
Another technique measuring how well cell clusters are connected to each other involves 
assessing the extent of transfer of Lucifer Yellow in confluent monolayers of cells. This 
measure of GJIC performed in tetracycline-induced wPKP-2 cell clusters (Figure 4.19) showed 
that induced wPKP2 cells were not particularly well coupled to each other as dye transferred 
poorly across a maximum of eight adjacent cell layers from the scrape line. Efficient gap 
junction intracellular coupling (GJIC) in wPKP2 cells would result in more than twenty 
adjacent cells transferring the dye (personal communications with Professor Chris Fry). Similar 
data were obtained in tPKP2 cell GJIC with a maximum transfer across 4-7 cell layers (data not 
shown).
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Figure 4.15 Potential difference recordings in wPKP2 
cells
Traces o f p.d. changes recorded in wPKP2 cells in response to injecting a step pulse 
of current intracellularly and of the extracellular electrode p.d. response with a 
comparable step pulse o f current. In A) trace o f an intracellular recording of a wPKP2 
monolayer performed on a slow time-base, in B) trace of intracellular recording o f a 
wPKP2 monolayer performed on a fast time-base, and in C) extracellular electrode 
recording performed on a slow time-base.
A) WPKP2 B) wPKP2
Intracellular slow time-base Intracellular fast-time base
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Figure 4.16 Potential difference recordings in tPKP2 
cells
Traces of p.d. changes recorded in tPKP2 cells in response to injecting a step pulse o f  
current intracellularly and o f the extracellular electrode p.d. response with a 
comparable step pulse o f current. In A) trace o f an intracellular recording of tPKP2 
monolayer performed with a slow time-base, in B) trace of intracellular recording of  
tPKP2 monolayer performed with a fast time-base, and in C) extracellular electrode 
recording performed with a slow time-base.
A) tPKP2 B) tPKP2
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Figure 4.17 Individual cell input resistance 
measurements in wPKP2 and tPKP2 cells
Representative cell input resistance measurements showing a small difference in the 
measured cell input resistance o f wPKP2 cell clusters compared to that of tPKP2 cell 
clusters. A smaller value of ri per unit time constant (ri = [V/I]/t), ri wPKP2 cells = 
34.1 [68.2 x10'3/2 xlO'9] and ri tPKP2 cells = 40.9 [81.8 x l0 '3/2 xlO'9] megaQ) as in 
wPKP2 versus tPKP2 cells here, suggests a marginally better coupling between 
wPKP2 cell clusters
v tPKP2 tPKP2
vvPKP2
nAmV
5 ms
t = 0.3 ms
wPKP2
nAmV
500 (is
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Table 4.5 Cell input resistance measurements from 
five separate experiments of wPKP2 cell monolayers
Cell input resistance measurements in wPKP2 cell monolayers from twenty-six 
individual cell recordings obtained in five separate experiments.
WPKP2 Cells Average Average Average
x value rfast rfast/x rfast x value rfast/x
Exp 1
0.1304 12.984 99.571 19.653 0.1783 110.2
0.1317 13.301 100.97
0.0833 9.3748 112.54
0.1131 13.033 115.37
0.1671 18.651 111.71
0.3035 33.541 110.52
0.3253 36.076 110.91
0.1726 20.265 117.39
Exp 2
0.0753 6.7301 89.338 21.376 0.2103 101.65
Exp 3
0.0691 8.392 121.63 15.229 0.1618 94.144
0.1956 20.809 106.41
0.0996 11.582 116.31
0.1249 14.444 115.63
0.1979 21.956 110.93
0.1921 10.897 56.755
0.2533 18.522 73.114
Exp 4
0.1643 18.959 115.43 29.841 0.2998 99.542
0.2861 26.681 93.29
0.4151 37.989 91.54
0.3458 32.632 94.38
0.4591 48.286 105.21
0.1287 14.496 112.66
Exp 5
0.2467 27.902 113.09 29.069 0.2617 111.08
0.1269 15.423 121.52
0.3164 35.201 111.27
0.3568 37.751 105.82
Mean n=5 103.32
SD 7.2248
SEM 3.6124
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Table 4.6 Cell input resistance measurements from 
five separate experiments of tPKP2 cell monolayers
Cell input resistance measurements in tPKP2 cell monolayers from twenty-four 
individual cell recordings obtained in five separate experiments.
tPKP2 Cells Average Average Average
x value rfast rfast/x rfast x value rfast/x
Exp 1
0.0941 11.145 118.42 11.145 0.0941 118.44
Exp 2
0.2498 37.409 149.77 15.511 0.1399 110.87
0.1031 10.884 105.57
0.1518 17.331 114.19
0.0824 7.4428 90.361
0.1273 12.205 95.898
0.1191 11.258 94.526
0.1521 14.599 95.989
0.1341 12.955 96.607
Exp 3
0.1348 15.253 113.18 12.449 0.1069 116.45
0.1198 13.953 116.5
0.0991 12.432 125.45
0.0741 8.1568 110.08
Exp 4
0.3911 36.965 94.54 24.545 0.2641 92.938
0.1622 14.658 90.37
0.2373 22.024 92.83
0.2735 22.051 80.622
0.2461 21.113 85.825
0.1937 19.009 98.151
0.3187 33.326 104.58
0.2907 27.214 93.625
Exp 5
0.3101 33.357 107.6 27.934 0.2449 114.06
0.2471 28.947 117.19
0.1777 21.499 121.01
Mean n=5 110.55
SD 10.243
SEM 5.1184
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Figure 4.18 Comparative plot of average rfast versus 
average ? values extrapolated from measurements 
using five different experiments each of wPKP2 and 
tPKP2 stable cell monolayers
Graphical plot of rfast values versus x values obtained from five separate experiments 
of cell input resistance measurements in wPKP2 and tPKP2 monolayers (average rfast 
versus average x values plotted from Tables 4.5 and 4.6 respectively). Five data points 
in wPKP2 cells fit a regression line (y = 103.7x) while five data points in tPKP2 cells 
fit a regression line (y = 105.4x). Since only a modestly small reduction in the value 
of the slope was found in wPKP2 cells expressing Cx-43 gap junctions, this indicated 
there was little difference in the cell-cell coupling between wPKP2 cell clusters with 
cell membrane localized Cx-43 and tPKP2 cell clusters lacking cell membrane Cx-43.
Rfast versus tau plot for WPKP2 and tPKP2 cell clusters
Figure 4.19 Confocal microscopy determination of 
GJIC in tetracycline induced wPKP2 cells
Gap junction intercellular communication (GJIC) determined in tetracycline-induced 
wPKP2 following scrape loading of Lucifer yellow dye and determination of the 
extent of dye transfer by confocal microscopy. Stable cells (wPKP2) were cultured in 
P30 dishes in complete DMEM containing blasticidin, hygromycin and tetracycline to 
obtain induction of full-length PKP-2 for the full duration of culture until cells were 
highly confluent. A fine incision was made in a wPKP2 monolayer of cells followed 
by the addition of 5% Lucifer yellow dye for exactly 5 minutes. Following washing of 
excess dye in PBS the extent of Lucifer yellow dye transfer was assessed by confocal 
microscopy. Lucifer Yellow penetrated through a maximum of eight adjacent cell 
layers (each cell layer is identified relative to the positions of the nuclei indicated by 
the dark non-fluorescing area around the cytoplasm with a red bar in the image on the 
right hand side of the image on the left) measured relative from the scrape line 
(identified by white arrow) indicating that these cells were not particularly well 
coupled to each other. Confocal microscopy images (xlO objective used) are derived 
from four separate scrape loading dye transfer experiments in wPKP2 cells showing 
essentially a low penetration of Lucifer Yellow (3-8 cell layer deep). The white size 
bar in the image on the left (at the bottom right hand side) represents 8 pm.
G j p Junction Intercellular communication in tetracycline induced wPKP2 cells
8 layer transfer 3 layer transfer 5 layer transfer 4 layer transfer
4.5.5 Electron microscopy examination of 
desmosomes in Flp-ln T-Rex 293, wPKP2 and tPKP2 
cells
EM examinations of cell lines were performed by an electron microscopist (Peter 
Balson) at the Royal Free Hospital electron microscopy unit. The identities of all three 
cell lines analyzed by EM were revealed after completion of EM analysis and data 
interpretation. The gross morphology of non-transformed Flp-ln T-Rex HEK 293 
cells, tetracycline-induced wPKP2 cells, and tetracycline-induced tPKP2 cells 
examined by EM at x2000 magnification showed that all three cell preparations were
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viable with a good preservation of cellular ultrastructure (Figure 4.20). Examination 
of desmosomes at x70000 magnification (Figure 4.21) showed that desmosomes in 
Flp-ln T-Rex 293 cells were not well developed. Desmosomes in wPKP2 cells were 
undoubtedly more prominent showing electron dense plaques with dense filament 
associations. Desmosomes in tPKP2 cells, in contrast appeared to form intermittent 
DS coupling with pale plaques. Some desmosomes in induced tPKP2 cells had less 
prominent filament association (dashed arrow, Figure 4.21C) while other desmosomes 
present in these cells were devoid of any filaments (marked by asterisks, Figure 
4.21C). In some tPKP2 desmosomes in which filaments could be localized their 
organization was in a plane perpendicular with the length of the desmosome (two 
arrows in Figure 4.22B) while in wPKP2 desmosomes the filaments were organised in 
a plane parallel with the length of desmosomes (Figure 4.22A). Electron micrographs 
of tPKP2 and wPKP2 cellular junctions illustrated at lower magnification of x30000 
(Figure 4.23) further emphasize the observed difference between these two 
desmosomes. The arrows in figure 4.23 indicate the intermittent DS coupling with 
pale ODP whilst a desmosome with electron dense ODP is marked by an asterisk, 
albeit this desmosome lacks filament association; the presence of both types 
desmosomes in tPKP2 cells is not unexpected as over-expressed A733fsX740 PKP-2 
is present in conjunction with endogenous full length PKP-2 protein (Figure 4.5B). 
Although there was a visual suggestion on examination of serial section that the 
intermittent DS coupling in induced tPKP-2 cells may be shorter than found in control 
induced wPKP2 desmosomes, statistical analysis of mean desmosomal lengths in Flp- 
ln T-Rex 293 cells, induced wPKP2 cells and induced tPKP2 cells did not show a 
statistical difference in mean desmosomal length as pair-wise comparisons between 
the three groups showed that the p values were all >0.05 (Figure 4.24). All electron 
micrographs are representative of images analyzed in all three cell lines.
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Figure 4.20 Gross morphology of non-transformed Flp-ln T-Rex HEK 293 cells, 
tetracycline-induced wPKP2 cells, and tetracycline-induced tPKP2 cells
Gross morphology o f non-transfected Flp-ln T-Rex 293 control cells and o f wPKP2 and tPKP2 cells expressing full-length and 
A733fsX740 PKJP2 respectively. Cells cultured on Thermanox plastic coverslips in complete DMEM were induced where required, with 
0.1pg/ml tetracycline for 72 hours until they were confluent. Coverslips processed for electron microscopy (see section 2.7.4) were 
examined in a Philips 201 electron microscope at x 2000 magnification to examine the gross morphology o f these cells. All there 
preparations showed cell viability with good preservation o f ultrastructure. The size bar in each electron micrograph represents 10pm
BlO microns
10 microns
Tetracycline-induced tPKP2 cellsNon-transformed Flp-ln T-Rex HEK 293 cells Tetracycline-induced wPKP2 cells
Figure 4.21 Morphology of desmosomes formed in Flp-ln T-Rex HEK 293, wPKP2 and 
tPKP2 cells
Desmosome morphology in Flp-ln T-Rex 293 non-transfected control cell and in induced wPKP2 and tPKP2 ceils expressing full-length and 
A733fsX740 PKP-2 respectively. Cells cultured on Thermanox plastic cover slips in complete DMEM were induced where required in 
O.lpg/ml tetracycline for 72 hours until they were highly confluent. Coverslips processed for electron microscopy (see section 2.7.4) were 
examined in a Philips EM microscope at x 70000 magnification to examine desmosome morphology. Full-length PKP-2 expression resulted in 
formation of electron dense desmosomes with prominent filaments (arrows, B) in wPKP2 cells, while A733fsX740 PKP-2 expression resulted 
in the formation of pale repeated desmosomal couplings (asterisks, in C) with less prominent filament association (dashed arrow, C) or with 
absence of filament association (desmosomes marked by asterisks, C). Flp-ln T-Rex HEK 293 cells formed less prominent desmosomes (A) 
compared to wPKP2 cell desmosomes presumably due to low level of recruitment of endogenous desmosomal plaque proteins. The size bar in 
each electron micrograph represents 100 nm.
A) Flp-ln T-Rex 293 cells B) wPKP2 cells C) tPKP2 cells
Figure 4.22 Filament organization of desmosomes in induced wPKP2 and tPKP2 cells
Cells cultured on Thermanox plastic cover slips in complete DMEM were induced where required in O.lpg/ml tetracycline for 72 hours until they were highly 
confluent. Coverslips processed for electron microscopy (see section 2.7.4) were examined in a Philips EM microscope at x 70000 magnification to examine 
desmosome morphology. The filaments are organised in induced wPKP2 desmosomes running parallel with the length of the desmosomes, whereas in induced 
tPKP2 cells the two intermittent desmosomal couplings have filaments running perpendicular to the length of the desmosomes. The asterisk identifies a 
desmosome lacking filaments as seen in previous electron micrographs. The scale bars represent 100 nm.
A) Induced wPKP2 cells B) Induced tPKP2 cells
totou>
Figure 4.23 Lower magnification EM micrograph 
contrasting the differences of desmosomes formed in 
tPKP2 and wPKP2 cells
Examination of desmosomes in induced tPKP2 cells. This is a representative electron 
micrograph of desmosomes found in tPKP2 cells showing intermittent DS linkages with pale 
plaques. Inset shows desmosomes from induced wPKP2 cells at the same magnification for 
comparison. Tetracycline-induced tPKP2 and wPKP2 cells cultured on Thermanox 
coverslips for 72 hours were processed in situ for electron microscopy. Desmosomes were 
examined by transmission electron microscopy in a Philips 201 electron microscope at x 
30000 magnification. Arrows indicate short repeated DS linkages with a pale outer dense 
plaque. Asterisk indicates a DS with ‘normal’ electron dense outer dense plaque, 
desmosomes of induced tPKP-2 cells were largely devoid of filaments compared to those in 
induced wPKP-2 desmosomes, which showed electron dense plaques with prominent 
filaments (marked by two arrows, inset). The size bar represents 500 nm.
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Figure 4.24 Statistical analysis of desmosomal length in 
Flp-ln T-Rex HEK 293, wPKP2 and tPKP2 cells
Statistical analysis o f the lengths o f  desmosomes found in Flp-ln 293, wPKP2 and tPKP2 
stable cells. A minimum o f fourteen measurements o f desmosomal lengths (nm) were taken 
from electron micrographs o f desmosomes obtained from each o f the three cell types. Data 
were analyzed using Graph Pad Prism software using ANOVA analysis followed by 
Bonferroni post-test computation o f significance. The graph shows plots o f individual values 
in each group o f cells and the table below shows results o f the Bonferroni multiple 
comparison statistical test parameters between the three data sets from Graph Pad. Pair-wise 
analysis did not show statistically significant difference (p>0.05) in desmosomal length 
comparing either control Flp-ln or control wPKP2 desmosomes with tPKP2 desmosomes. 
Flp-ln desmosomal length were also not significantly different to those o f wPKP2 
desmosomes (p>0.05)
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90 0 -1
8 0 0 -
7 0 0 -
6 0 0 -
5 0 0 -
4 0 0 -
3 0 0 -
200-
100-
p>0.05
jfi
Parameter Flp-ln cells wPKP2 cells tPKP cells Data Set-D
Table Analyzed
Data 2
One-way analysis of variance
P value 0.3782
P value summary ns
Are means signif. different? (P < 0.05) No
Number of groups 3
F 0.9932
R squared 0 04139
Bartlett's test for equal variances
Bartlett's statistic (corrected) 14.46
P value 0.0007
P value summary ***
Do the variances differ signif. (P < 0.05) Yes
ANOVA Table SS df MS
Treatment (between columns) 62730 2 31360
Residual (within columns) 1453000 46 31580
Total 1515000 48
Bonferroni's Multiple Comparison Test Mean Diff. t P value 95% Cl of diff
Flp-ln cells vs wPKP2 cells -26.24 0.4192 P > 0.05 -181.8 to 129.3
Flp-ln cells vs tPKP cells 57.74 0.8878 P > 0.05 -103.9 to 219.3
wPKP2 cells vs tPKP cells 83.98 1.393 P > 0.05 -65.84 to 233.8
225
4.5.6 Endogenous plakoglobin co-localization with 
full-length and truncated PKP-2 in wPKP2 and tPKP2 
cells
Examination of immunofluorescence co-localized endogenous PG staining with 
truncated PKP-2 appeared weaker (Figure 4.25B) in cell-cell contacts of induced 
tKP2 cells compared to the co-localized endogenous PG staining with full-length 
PKP-2 in cell-cell contacts of induced wPKP2 cells (Figure 4.25A, representative of 
triplicate staining). Co-localization studies of endogenous p-catenin, DP, DSG-2 and 
DSC-2 with either full-length or truncated PKP-2 were not reproducible and therefore 
inconclusive (data not shown). A possible reason for the difficulty in obtaining 
reliable co-localization of these endogenous proteins with over-expressed full-length 
or S140F PKP-2 could be that these endogenous proteins are present in small 
amounts.
4.5.7 Verification of XPress-tagged A733fsX740 PKP-2 
and full-length PKP-2 expressions
Transient protein expressions of N-terminal XPress-tagged PKP-2 or A733fsX740 
PKP-2 proteins was confirmed in HEK 293T cells by staining using a mouse 
monoclonal anti-PKP-2 antibody and immunofluorescence confocal microscopy 
localization of these PKP-2 proteins forty eight hours after transfection with pcDNA4 
(Figure 4.26) vectors. The transient expressions of PKP-2 or A733fsX740 PKP-2 
proteins localized by immunofluorescence confocal microscopy in HEK 293T cells 
were also verified using a mouse monoclonal anti-XPress antibody, which gave an 
identical result (data not shown) as obtained using anti-PKP2 antibody staining. SDS 
PAGE/westem blotting analysis using anti-XPress and anti-PKP-2 antibodies verified 
expressions of PKP-2 proteins in soluble cell lysates. This revealed a full-length PKP- 
2 band (predicted and apparent SDS PAGE size 103.6 KD) and a truncated 
plakophilin-2 band (predicted and apparent SDS PAGE size 81 KD) in transfected 
HEK 293T cells forty-eight hours after transfection with pcDNA4 vectors (Figure 
4.27).
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4.5.8 Interaction of endogenous PG, p-catenin, DP, 
DSC-2 and DSG-2 with fuli-length or truncated PKP-2
Co-immunoprecipitation assays in transiently transfected HEK 293T cells showed 
reduced association of endogenous plakoglobin with truncated PKP-2 compared to its 
interaction with full-length PKP-2 (Figure 4.28, representative of triplicate assays). 
However, no differences were found in the levels of endogenous beta-catenin 
associating with either truncated or full-length PKP-2 (Figure 4.29, representative 
data of triplicate assays performed). Attempts to co-IP endogenous desmoplakin, 
desmocollin-2, and desmoglein-2 with either truncated or full-length PKP2 were 
unreliable resulting in variable immunoprecipitation of all three endogenous proteins 
(data not shown). This was probably because of insufficient extraction of these 
membrane-associated or cytoskeletal-associated proteins under the conditions 
employed.
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Figure 4.25 Co-localization of PKP-2s and PG in wPKP2 and tPKP2 cells
Confocal microscopy immunofluorescence co-localization of endogenous plakoglobin with either full-length PKP-2 or A733fsX740 PKP-2 in 
tetracycline-induced wPKP2 and tPKP2 cells respectively. DAPI nuclear staining produces a blue signal, rabbit anti-human PG followed by anti-rabbit 
Alexa-488 produces green signal localizing PG staining, mouse anti human PKP-2 followed by anti-mouse Alexa 546 produces red signal localizing 
PKP-2 and A733fsX740 PKP-2 in wPKP2 and tPKP2 cells respectively. Merged signals are obtained with all three composite signals superimposed. 
Images were obtained using x40 oil immersion objective. The size bar in each green channel represents 5 pm. This is a representative result of 
triplicate staining performed.
A) Endogenous PG/PKP-2 
co-localization in wPKP2 cells
Blue =  DAPI Green =  Plakoglobin
B) Endogenous PG/A730fsX740 PKP-2 
co-localization in tPKP2 cells
Blue =  DAPI Green = Plakoglobin
Red= PKP2 merged =  com posite Red= A 730fsX740 PKP2 merged = com posite
Figure 4.26 Confocal microscopy localization of PKP-2 and 
truncated PKP-2 in HEK293T cells transfected with pcDNA4 
vectors encoding these plakophilins
Verification o f the expressions o f either full-length PKP-2 or A733fsX740 PKP-2 in lx lO 5 HEK 
293T cells cultured on 13mm plastic coverslips transfected with lp g  pcDNA4 PKP2 or pcDNA4 
A733fsX740 PKP2 plasmids for forty-eight hours using lOpl Polyfect reagent. Following fixation 
of cells in 4% formaldehyde, permeabilization in 0.1% triton X-100 and blocking in 10%FBS, they 
were incubated with 1:200 dilution o f mouse monoclonal anti-PKP2 (610788, BD Bioscience) for 
lhr at room temperature. Cells were washed in PBS and incubated with 1:200 Alexa fluor 546 goat 
anti-mouse (Invitrogen) for lhr at room temperature. Following PBS washes cells were incubated 
with DAPI nuclear stain (Invitrogen) and mounted on glass slide. Control cells transfected with 
pcDNA4 (without an insert, A); pcDNA4 PKP2 transfected cells (B) and pcDNA4 A733fsX740 
PKP2 transfected cells (C). Blue fluorescence shows DAPI nuclear staining, red fluorescence shows 
PKP-2 or A733fsX740 PKP-2 staining (B and C respectively), and merged fluorescence shows 
composite signals. The size bar in each DAPI stained image on the left panels represents 10 pm.
DAPI PKP-2 or Merge
staining A733fsX740
PKP-2 
staining
Empty
pcDNA4
vector
transfected
HEK293T
B )
pcDNA4
PKP2
transfected
HEK293T
c )
pcDNA4
A733fsX740
PKP2
transfected
HEK293T4 i
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Figure 4.27 Verification of transient expressions of PKP2 and truncated PKP2 in HEK 
293T cells after transfection with pcDNA4 vectors encoding these plakophilins
N-terminal XPress-tagged full-length PKP2 and A733fsX740 PKP2 transient protein expressions obtained in HEK 293T cells following 
transfection with pcDNA4 PKP2 and pcDNA4 A733fsX740 PKP2 plasmids respectively. HEK 293T cell lysates of non-transfected 
(control), pcDNA4 PKP2 or pcDNA4 A733fsX740 transfected cell lysates were analyzed by Western blotting probed using anti-XPress 
(top) or anti-PKP-2 antibodies (bottom). Following transfection of 293T cells with lpg of each plasmid for 48 hours, cell lysates 
prepared in RIP A buffer (lOOpg protein per lane) were electrophoresed in 10% SDS PAGE and transferred using semi-dry transfer on 
Hybond ECL membrane. Blots were blocked in TBST/milk and incubated with mouse monoclonal (1:5000 anti-XPress or 1:500 anti- 
PKP-2) antibodies. Following washing of blots in TBST they were incubated in 1:3500 rabbit-anti-mouse HRP. Following TBST washes, 
the blots were incubated in ECL reagents and exposed to ECL Hyperfilm.
Control pcDNA4 PKP2 pcDNA4 A733fsX740 PKP2
K)
103.6 KD 
81 KD —» Anti-XPress
103.6 KD - »  
81 KD —> Anti-PKP-2
Figure 4.28 Co-IP analysis using anti-XPress binding 
of PKP-2 or truncated PKP-2 to endogenous PG
Co-immunoprecipitation of XPress-tagged full-length or A733fsX740 PKP-2 with 
endogenous plakoglobin performed in transfected HEK 293T cells. Forty-eight hours 
after transfection of 293T cells with pcDNA4 PKP2 or pcDNA4 A733fsX740 PKP2 
plasmids (4pg/P90 dish), cells were scrapped off P90 dishes in lysis buffer (10 mM 
Tris HC1 pH 7.6, 145 mM NaCl, 1 mM NasVO^ and 1% triton X-100 + protease 
inhibitors). Triton X-100 soluble cell lysates (3 mg) were pre-cleared with Protein G- 
Sepharose at 4°C for 30 minutes on rotator. Three microgram of anti-XPress (mouse 
monoclonal anti-XPress antibody, Invitrogen) was added to the pre-cleared fraction 
and incubated on a rotator at 4°C for three hours. Fifty microliters o f Protein G- 
Sepharose was added and incubation continued overnight at 4°C. Immuno-complexes 
were pelleted at lOOOOg for 0.5 minute and washed thrice in low stringency 
PBS/inhibitor followed by a single wash in lysis buffer. Immuno-complexes were 
denatured in 3x reducing Laemmli buffer followed by electrophoreses on a 10% SDS 
PAGE and immunoblotting analysis using either rabbit anti-PG antibody at 1:500 
dilution (Santa Cruz sc7900) and 1:5000 mouse anti-rabbit HRJP conjugate 
(Invitrogen) or 1:500 mouse anti-PKP2 and 1:5000 goat anti-mouse HRP conjugate 
followed by incubation in ECL reagents and exposure to ECL Hyperfilm.
A) Triton X-100 cell lysates (equal amount, 100pg) loaded on 10% SDS PAGE
A733fsX740 A733fsX740 A733fsX740
PKP-2 PKP-2 PKP-2 PKP-2
PG equal loading
B) IP Probed for plakoglobin association with PKP-2 or A733fsX740 PKP-2
A733fsX740 
No Anti 
body IP - 
control
PKP-2
Co-IP
Anti-
XPress
A733fsX740
PKP-2
Co-IP
Anti-
XPress
A733fsX740
PKP-2
Co-IP
Anti-
c-myc control
PG co-IP reactions
C) Probe to determine relative amounts of PKP-2 or A733fsX740 PKP2 
Co-IP in cell lysates of pcDNA4 PKP2 or pcDNA4 A733fsX740 PKP2 
transfected HEK 293T cells
A733fsX740 
PKP-2 PKP-2 PKP-2 co-IP reactions
<- 81 KD A7W sX740 PKP-2
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Figure 4.29 Co-IP analysis using anti-XPress binding 
of PKP-2 or truncated PKP-2 to endogenous (5-catenin
Co-immunoprecipitation of XPress-tagged full-length or A733fsX740 PKP-2 with 
endogenous (3-catenin performed in transfected HEK 293T cells. Forty-eight hours 
after transfection of 293T cells with pcDNA4 PKP2 or pcDNA4 A733fsX740 PKP2 
plasmids (4pg/P90 dish), cells were scrapped off P90 dishes in lysis buffer (10 mM 
Tris HC1 pH 7.6, 145 mM NaCl, 1 mM Na3V0 4 . and 1% triton X-100 + protease 
inhibitors). Triton X-100 soluble cell lysates (3mg) were pre-cleared with Protein G- 
Sepharose at 4°C for 30 minutes on rotator. Three micro gram of anti-XPress (mouse 
monoclonal anti-XPress antibody, Invitrogen) added to the pre-cleared fraction was 
incubated on a rotator at 4°C for three hours. Fifty microliters o f Protein G-Sepharose 
was added and incubation continued overnight at 4°C. Immuno-complexes were 
pelleted at 10,000g for 0.5 minute and washed thrice in low stringency PBS/inhibitor 
followed by a single wash in lysis buffer. Immuno-complexes were denatured in 3x 
Laemmli buffer followed by electrophoresis on a 10% SDS PAGE and 
immunoblotting analysis using either 1:500 rabbit anti-p-catenin antibody (Abeam, 
ab2982) and 1:5000 mouse anti-rabbit-HRP conjugate (Invitrogen) and 1:500 anti­
mouse PKP-2 and 1:5000 goat anti mouse HRP conjugate followed by incubation in 
ECL reagents and exposure to ECL Hyperfilm.
A) Triton X-100 cell lysates (equal amount, 50pg) loaded on 10% SDS PAGE
A733fsX740
PKP-2 PKP-2
A733fsX740 A733fsX740
PKP-2 PKP-2
p-catenin equal loading
B) IP Probed for (3-catenin association with PKP-2 & A733fsX740 PKP-2
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PKP-2
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P-catenin co-IP reactions
C) Probe to determine relative amounts of PKP-2 or A733fsX740 PKP2 
Co-IP in cell lysates of pcDNA4 PKP2 or pcDNA4 A733fsX740 PKP2 
transfected HEK 293T cells
PKP-2
A733fsX740
PKP-2 PKP-2 co-IP reactions
4.6 Discussion
Two stable cell lines were generated to examine the functional effect of expression of 
full-length and A733fsX740 PKP-2 proteins at a cellular level in Flp-ln T-Rex HEK 
293 cells. Reduced level of A733fsX740 PKP-2 protein relative to the endogenous 
PKP-2 protein observed in the membrane fraction of sub-cellular fractionated induced 
tPKP2 cells, suggested that A733fsX740 PKP-2 protein might incorporate less 
efficiently into cell-cell contacts. Localization studies of a different plakophilin (PKP- 
1) using transfection experiments in a PKP-1 null A431D derivative of a cervical 
squamous carcinoma cell line showed that over-expression of a PKP-1 protein lacking 
the final forty-one amino acid residues in the carboxy-terminus failed to localize this
999protem at cell-cell contacts in these transfected cells , implying that the last 41 
residues of PKP-1 are important for its insertion into cell-cell contacts. It is 
speculative whether an analogous region present in full-length PKP-2, but lacking in 
A733fsX740 PKP2 might affect the localization of the truncated PKP-2 at cell-cell 
contacts. The extent of incorporation of truncated versus full-length PKP-2 proteins 
into cell-cell contacts could be assessed using double cell line transfection 
experiments expressing a GFP-conjugated full-length PKP-2 protein and a FLAG- 
tagged truncated PKP-2 protein followed by localization of dual-colour immuno­
fluorescence signals in cultured cells.
Expression of either full-length or truncated plakophilin-2 did not affect the cellular 
proliferation rates of wPKP2 and tPKP2 cells respectively as regression analysis of 
the proliferation data gave comparable values of the slopes in these non-induced and 
tetracycline-induced cells. The initial cell-cell adhesion of labelled tPKP2 cells to a 
homologous cell monolayer was about 1.5-fold greater compared to initial cell 
adhesion of labelled wPKP2 cells to a homologous cell monolayer. The increased 
initial tPKP2 cell-cell adhesion was investigated by a different assay measuring the 
dissociation of induced highly confluent wPKP2 and tPKP2 monolayers by shear 
stress, which showed increased resistance to disruption of induced tPKP2 monolayers 
compared to induced wPKP2 monolayers. These two adhesion data suggests that 
tPKP2 are more adherent compared to wPKP2 cells, and these findings are supported 
by a consistently longer trypsinization required for induced tPKP2 compared to 
induced wPKP2 cells (data not shown, 5 minutes and 3 minutes required to release
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clusters of tPKP2 and wPKP2 cells respectively). The increased cell-cell adhesion of 
tPKP2 cells is an anomaly in regards to electron microscopy data, which showed 
abnormal cell-cell contacts in these cells compared to control wPKP2 cells. The 
mechanism responsible for increased cell-cell adhesion is not obvious. As far as the 
direct binding of plakophilins to intermediate filament proteins is concerned, both 
PKP-1 a as well as PKP-2a are known to strongly interact in vitro with cytokeratin IF 
proteins such as CK5, CK14 & CK18, and less so with CK8 and vimentin examined 
by blot overlay assays223. An over-expressed head fragment of PKP-1 a was reported 
to decorate and disrupt keratin filament network organization in certain transfected 
cells224. Although the interaction of A733fsX740 PKP-2 with IF proteins is unknown, 
it is speculated that insertion of this protein into cell-cell contacts may cause a 
dominant negative effect in tPKP2 cells resulting in intermittent DS coupling largely 
lacking filaments indicating inappropriate desmosomal coupling.
In vivo specific mechanisms are postulated to regulate binding of PKP-2 or PKP-1 to 
desmoplakin and intermediate filaments, where plakophilins are generally excluded 
from interacting directly with IF proteins . Desmoplakin is the main protein directly 
involved in the interaction with IF proteins. The evidence supporting this is firstly, an 
N-terminal truncated desmoplakin peptide transiently expressed in simple epithelial 
cells and fibroblasts show co-localization with IF fibrils resulting in gradual 
disruption of endogenous IF network132. Secondly, the last 68 amino acids of 
desmoplakin C-terminus are essential for its binding to IF proteins131, and this 
binding can be modulated indirectly, for instance, by site-specific phosphorylation of 
a specific serine residue225.
Cell-cell adhesion in epithelial cells such as primary keratinocytes has been shown to 
depend on PG where it accomplishes this role through the regulation of desmosome 
assembly and function , however very little is known about the mechanisms of cell­
cell adhesion in HEK 293T cells. Although HEK 293 cells adopt epithelial cell type of 
morphology, they are believed to be closely related to early differentiating neuronal 
cell lineages such as PC 12 and Ntera-2 cells as they express an array of different 
intermediate filament proteins resembling expression patterns in these cell types. HEK 
293 cells express large amounts of neurofilaments -M and -L (type IV IF proteins), 
smaller amounts of a-intemexin and neurofilaments -H (type IV IF proteins). HEK
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293 cells do not express desmin, GFAP and nestin, but they express vimentin (type III 
IF protein), keratin 8, and keratinl8 (type I IF proteins) in a heterogenous staining 
pattern227. Given this complex expression pattern of IF proteins in HEK 293 cells, it is 
plausible that the A733fsX740 PKP-2 might differentially affect these IF networks 
and tPKP2 cell-cell adhesion. The relevance of increased tPKP2 cell-cell adhesion is 
dubious in a cardiac context as desmin is the only IF protein expressed in 
cardiomyocytes. Irrespective of the underlying mechanism of increased cell-cell 
adhesion in tPKP2 cells, A733fsx740 PKP-2 protein insertion into tPKP2 
desmosomal cell-cell contacts appears to exert a dominant negative effect in these 
cells. Similarly, in the nucleus where A733fsX740 PKP-2 also localises, it may exert 
a dominant negative effect by interfering with presumed nuclear signalling function(s) 
of endogenous PKP-2. In contrast with other junctional plaque proteins such as p- 
catenin and plakoglobin, there is limited data available about the signalling pathways 
in which PKP-2 might integrate. One possible interaction of PKP-2 described was 
with endogenous P-catenin in transfected SW40 cells over-expressing PKP-2a causing 
the activation of p-catenin/T cell factor-signalling activity183.
Various studies have examined apoptotic cell death in ARVC shown to be associated 
with cardiomyocyte loss63,64,66'71, however, it was not clear from these studies whether 
apoptosis was causative for ARVC. One hypothesis is that weakened cell-cell 
adhesion between cardiomyocytes in ARVC arise presumably from dominant 
negative mutant cell adhesion protein insertion, and this may under inappropriate 
mechanical stress (for example during intense physical exercise), cause myocyte 
detachment with consequent replacement with fibrous and/or fatty tissue as myocytes 
have a limited capacity for cellular proliferation. Expression of truncated and full- 
length PKP-2 proteins in HEK 293 cells provided an opportunity to examine the 
response of tPKP2 and wPKP2 cell to mechanical cell-stretch and induced apoptosis. 
Caspase-3 activity measured in cells recovering from an exposure to mechanical cell- 
stretch showed presence of its activity in both wPKP2 and tPKP2 cells, but this was 
approximately two-fold higher in mechanical cell-stretched induced tPKP2 cells 
compared to mechanical cell-stretched tetracycline-induced wPKP2 cells. The 
intensities of active caspase-3 bands detected by SDS PAGE and western 
immunoblotting analysis in control wPKP2 or tPKP2 cells not exposed to cell-stretch 
was weak, but exposure to cell-stretch showed a dramatic increase in the intensities of
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active caspase-3 bands in both types of cells. This increase, however appeared to be 
greater in induced tPKP2 cells compared to induced wPKP2 cells. Taken together 
with the EM data showing abnormal cell-cell contacts in tPKP2 cells the mechanical 
cell-stretch data indicates that incorporation of A733fsX740 PKP2 into cell-cell 
contacts probably weaken these contacts, and therefore, tPKP2 cells presumably 
sustain increased cellular injury with marked activation of cellular apoptosis. The 
signalling pathways responsible for this response in tPKP2 cells was not investigated, 
but in the following paragraphs discussion relating to mechanical cell-stretch of 
cardiomyocytes provide some insight of the responses of these cells to mechanical 
cell-stretch Based on a proposed framework of mechanism linking contractile and 
electrical dysfunction in cell-cell junction cardiomyopathies50,228, A733fsX740 PKP-2 
protein expression in tPKP2 cell-cell junctions is envisaged to cause abnormal 
mechanical cell-cell coupling due to desmosomal instability resulting in cellular 
injury probably manifesting in enhanced apoptosis from intolerance to the applied 
mechanical cell stretch. In the following two paragraphs, a brief overview of 
apoptosis and current knowledge about effect of stretch on cardiomyocytes in vitro is 
described.
Apoptosis, generally is a tightly controlled programmed cell death process, which is 
characterized by cytomembrane overturn, DNA fragmentation, nuclear condensation
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and cell shrinkage . Two types of apoptosis pathways are recognised the 
mitochondria-dependent (intrinsic) pathway and a death receptor-dependent 
(extrinsic) pathway. Both types have been found in cardiomyocyte apoptosis230. In the 
intrinsic pathway various apoptotic factors such as cytochrome c, apoptosis inducing 
factor (AIF), Smac/DLABLO and endonuclease G are released into the cytoplasm 
when stimulated by intrinsic death signals. Once cytochrome c is released it rapidly 
activates caspase-9, which leads to activation of caspase-3 and execution of 
apoptosis ’ . Bcl-2 family of proteins are involved in regulating this process . In
the extrinsic pathway, apoptosis is initiated after binding of various ligands to their 
death receptors (DR) such as FasL to Fas, TNF-alpha to tumour necrosis factor 
receptorl (TNFR1), Apo3L to DR3, and TNF-related apoptosis-inducing ligand 
(TRAIL) to DR4 and DR5. Binding of ligands results in trimerization of DR, 
recruitment and activation of procaspase-8 through adaptor molecules such as Fas- 
associated protein with death domain (FADD). Active caspase-8 subsequently cleaves
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downstream caspases as well as other pro-apoptotic factors to initiate intracellular 
amplification of the apoptotic response.
Mechanical stretch activates multiple signalling pathways (MAPK, JAK/STAT & 
PKC) which in rat cardiomyocytes may be responsible for a hypertrophic or apoptosis 
response, depending on the system used and degree of stretch applied234. Based on in 
vitro studies, prolonged mechanical cell-stretch was reported to induce apoptosis in 
adult cardiomyocytes via enhancement of autosecretion of angiotensin II, which led to 
Bax expression and apoptosis in a p53 dependent manner235,236, although this view 
was challenged . Another report attributed mechanical cell-stretch induced 
apoptosis in cardiomyocytes to production of reactive oxygen species (ROS) during 
periodic stretch . Both Bax and ROS can influence in mitochondria, hence 
supporting the roles of mitochondria-dependent pathway in stretch-induced 
cardiomyocyte apoptosis. Further support for this pathway came from neonatal rat 
cardiomyocytes exposed to sustained stretch that undergo mitochondria-dependent 
apoptosis via cytochrome c and Smac/DIABLO release from mitochondria into 
cytosol accompanied by loss of mitochondrial membrane potential . A report 
describing the involvement of FADD-linked death receptor signalling in apoptosis of 
rat neonatal cardiomyocytes exposed to sustained stretch has been described240. 
Ventricular cardiomyocytes in vivo are exposed to continual mechanical cell-stretch 
due to the rhythmic contraction and cardiomyocytes must be able to endure normal 
level of mechanical cell-stretch, however, in ARVC it is believed that exposure to 
abnormal level of mechanical cell-stretch (degree and frequency of mechanical cell- 
stretch, for example during intense physical exertion) superimposed with abnormal 
mechanical junctions (weakened cell-cell contact between cardiomyocytes caused 
either by insertion of dominant negative proteins or by a lack of sufficient wild-type 
protein insertion due to haploinsufficiency) may result in cardiomyocytes sustaining 
cellular injury and increased programmed cell death. Although mechanical stretch 
activated pathways in cardiomyocyte apoptosis are described in vitro, no direct 
evidence in the literature exists to suggest that defective cell-cell mechanical coupling 
resulting from abnormal desmosomal protein insertion in vitro could enhance 
cardiomyocyte apoptosis in response to mechanical cell-stretch exposure. A recent 
study examining the expression of a defective PG protein (S39_40KinsS PG) in Flp- 
ln T-Rex HEK 293 stable cells not only demonstrated enhanced cellular proliferation
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but also reduced apoptosis levels in these cells compared to stable cells expressing 
wild type PG protein, however, the effect of mechanical cell stretch in these stable 
cells was not examined51. A cardiac restricted transgenic mice study expressing a 
mutant missense desmoplakin protein (R2834H DP transgenic mice) compared with 
control wild type transgenic mice expressing full-length DP showed evidence of ID 
remodelling (irregularly shaped ID with marked widening of gaps between adjacent 
anchoring sarcomeres affecting both AJ and DS junctions), increased cardiomyocyte 
apoptosis cardiac fibrosis, neutral lipid accumulation and aberrant desmin 
intermediate filament localization in vivo 163. These data therefore appear to be the 
first evidence linking defective cardiomyocyte mechanical junctions arising from an 
expressed mutant DP protein in the heart with apoptosis of these cardiomyocytes from 
exposure to normal mechanical cell-cell stretch (from rhythmic contraction) in vivo. 
HEK 293 stable cells cannot tolerate the high level of cellular stretch (up to 20%) that 
cardiomyocytes are able to endure in vitro, but the increased apoptosis of tPKP2 cells 
in response to mechanical stretch demonstrate that these cells can respond in a similar 
fashion to R2834H transgenic mice cardiomyocytes in vivo.
Although the loss of desmosomal integrity is known to disrupt mechanical junctions 
in hearts afflicted with ARVC, this does not directly explain the highly 
arrhythmogenic nature of the disease, particularly in cases in which life-threatening 
arrhythmias can occur in the absence of severely displaced fatty or fibro-fatty
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myocardium. Saffitz and colleagues ’ ’ recently proposed that disruption of 
mechanical coupling may lead to a loss of gap junction-mediated electrical coupling. 
Connexin-43 is the main cardiac gap junction protein important in ventricular 
conduction. This protein was examined in stable tPKP2 and wPKP2 cells. A strong 
expression of Cx-43 protein was found in soluble cell lysates of highly confluent non­
induced as well as tetracycline-induced wPKP2 and tPKP-2 cells. However, 
examination of Cx43 protein by confocal microscopy showed Cx-43 protein 
localization in cell-cell contacts of induced wPKP2 cells, but this Cx-43 protein 
localization pattern was consistently absent in induced tPKP2 cells. The absence of 
Cx-43 protein localizing at tPKP2 cell-cell contacts despite Cx-43 protein being 
present in the cytosol suggests a failure of incorporation of Cx-43 into cellular 
membrane of tPKP2 cells. It is possible that low amounts of Cx-43 protein 
incorporated into tPKP2 cell membrane will result in a diffuse staining pattern that is
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not detected by confocal microscopy. HEK 293 cells are excellent cells for plasmid 
vector transfection studies resulting in high expression of membrane bound proteins, 
however these cells suffer a drawback for localization of expression as nuclei of HEK 
293 cells occupy a significant proportion of the cell space and they lack a cubical 
geometry found in other epithelial cells (such as MDCK or A431). These factors 
might further hinder detection of small amounts of immuno-localized Cx-43 signals in 
induced tPKP2 cells due to the poor discrimination of weak signals by confocal 
microscopy. A likely explanation for the lack of detectable Cx-43 at cell-cell contacts 
of tPKP2 cells might be that Cx-43 protein assembly into gap junctions is disrupted 
because of destabilized abnormal tPKP2 cell-cell contacts formed by the insertion of 
A733fsX740 PKP-2; both the incorporation of A733fsX740 PKP-2 protein into 
cellular membrane and disruption of cell-cell contacts of induced tPKP2 cells were 
confirmed by sub-cellular fractionation/immunostaining and by electron microscopy 
examination respectively. Gap junctions in the cardiomyocyte ID are known to be 
located close to desmosomal contacts, which suggest that these mechanical junctions 
provide the stability at the plasma membrane for incorporation of these rigid gap 
junction assemblies. Precisely why Cx-43 protein expressed in tPKP2 cells fails to 
incorporate into functional gap junctions is not known, but the stability and turnover 
of this protein could be affected by multiple mechanisms (section 1.4).
Supportive data for a role of PKP-2 in the proper function and distribution of Cx-43 
gap junction protein was recently obtained in cultured rat neonatal ventricular 
cardiomyocytes transfected with adenoviral vector containing a specific silencer 
sequence construct for PKP-2. Transfection achieved loss of cell-cell contact 
immuno-localized PKP-2, a significant redistribution of Cx-43 (with fewer Cx-43 gap 
junctions being detected, instead Cx-43 was found mostly in the intracellular space),
01 ftand reduction in Lucifer Yellow dye transfer (GJIC) between cardiomyocytes . The 
data from these PKP-2 inhibition studies emphasize the importance of PKP-2 in 
proper assembly of Cx-43 gap junctions, and suggests a crosstalk between Cx-43 and 
PKP-2 proteins in which the presence of PKP-2 was essential for regulating and 
coordinating the formation of and interactions between mechanical and electrical 
junctional complexes. Immuno “pull-down” experiments showed Cx-43 and PKP-2 to 
be part of a common macromolecular complex in these studies. The data obtained 
from tPKP2 cells suggests that abnormal cell-cell contacts disrupt mechanical
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linkages affecting the assembly of Cx-43 protein into functional gap junctions. 
Additional supporting evidence suggesting the mechanism of arrhythmogenesis in 
ARVC might be linked by a crosstalk between structures involved in mechanical 
coupling with those that maintain electrical communication was obtained from a study 
in a spontaneous animal model of ARVC in Boxer dogs. Although the presumed gene 
mutations involved in this animal model of ARVC are still pending identification 
(mutations were not present in the coding regions of genes for DP, PG, PKP-2, DSC-2 
and Cx-4361’62), examination of ID in cardiac biopsy of afflicted dogs showed 
significant loss of Cx-43 gap junction protein in cardiac ID associated with severe 
remodelling of other intercalated disc structures61. Similarly, in human heart 
conditions myocyte gap junction remodelling was reported to cause alterations in the 
amount and distribution of Cx-43 protein in gap junctions seen in Caravajal 
syndrome43, Naxos disease42, and more recently in autosomal dominant ARVC caused 
by an in-frame insertion mutation in plakoglobin51. Thus, there is now an increasing 
body of evidence pointing to the disruption of Cx-43 gap junctions resulting from 
abnormal mechanical coupling. Furthermore, a recent study accentuated the critical 
function of PKP-2 in the formation, architectural organization, and stability of the 
junctions within the area composita of the ID of rat neonatal cardiomyocyte culture. 
In these studies, the prolonged siRNA-mediated reduction of cardiomyocyte content 
of PKP-2 showed progressive disintegration and the loss of the area composita with 
significant reduction in the number of cell-cell contacts between cardiomyocytes243.
Electrophysiological studies determining cell input resistances in induced tPKP2 cells 
and wPKP2 cells established the extent of current conduction in these cells. However, 
statistical analysis of calculated cell input resistance values indicated no significant 
statistical differences in these cells. This might probably be due to compensatory up- 
regulation of other connexin proteins in tPKP2 cells. This phenomenon can be 
observed in vitro during modulation of the expression of one connexin subtype244 
resulting in the upregulation of another connexin subtype. Analysis of wPKP2 and 
tPKP2 cell gap junction intracellular communication indicated that both cells were 
poorly coupled (maximum dye transfer across eight cell layers, but highly efficient 
cell-cell coupling would result in transfer of dye across twenty or more layers) to each 
other as a limited dye transfer was observed in these cells. Stable cell functional 
studies in wPKP2 and tPKP2 cells showed the limitations of HEK 293 cell system in
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performing complex analysis of the inter-relationship of expression of defective cell­
cell adhesion protein and the effect on mechanical junction stability and influence on 
gap junction protein functionality. Although Cx-43 was demonstrated in wPKP2 cell­
cell contacts, this does not demonstrate the state of functionality of these gap 
junctions in these cells as the gating properties of these gap junctions can be 
modulated in vivo. Other cellular systems such as isolated rat neonatal ventricular 
cardiomyocytes are probably a more relevant system for examining the effect of 
abnormal cell-cell junction protein on electrical and mechanical dysfunction in a 
cardiac context. Recent studies examining the area composita in the ID of 
cardiomyocytes in vitro demonstrated the utility of this culture system137,138,245,246 in 
evaluating the functional contributions of various cell-cell adhesion proteins in the ID.
The antibody reactive to PKP-2 (BD Bioscience, P63420) was used for confirming the 
expression of A733fsX740 PKP-2 expression by SDS PAGE and western 
immunoblotting and confocal microscopy immuno-localization analysis of tPKP2 
cells, but this antibody was not suitable for immuno-localizing truncated PKP-2 into 
desmosomes by electron microscopy as the antibody recognizing an N-terminal 
epitope reacts with all PKP-2 proteins (endogenous PKP-2 and over-expressed PKP- 
2a as well as A733fsX740 PKP-2). Tagged-truncated PKP-2 expression in stable cells 
is necessary for a definitive localization of truncated PKP2 into desmosomes.
Although the localization studies of truncated PKP2 into desmosomes are not 
available, desmosomes in control non-transfected Flp-ln, induced wPKP2 and tPKP2 
cells showed marked differences in morphology with wPKP2 cells forming prominent 
desmosomes with electron dense plaques and filament association while tPKP2 cells 
formed intermittent DS coupling with pale plaque region, and which largely appeared 
to lack extensive filament association; when filaments could be localized in tPKP2 
desmosomes their morphological organization appeared to be different from filaments 
found in induced wPKP2 desmosomes. Low level of recruitment of desmosomal 
plaque proteins or their reduced expressions in non-transformed Flp-ln T-Rex HEK 
293 cells might be responsible for the lack of conspicuous desmosomes.
There could be two reasons for prominent desmosomes in wPKP2 cells, firstly over­
expressed PKP-2a could bind to endogenous desmosomal proteins, targeting them to
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the plasma membrane, and thereby dramatically increase their stability. Secondly, 
over-expressed PKP-2a may directly be involved in regulating the synthesis of other 
desmosomal proteins in the nucleus; the induction of desmosomes would then depend 
on a putative signalling function of PKP2a. However, since PKP2a localised in the 
membrane as well as in the nucleus, both of these mechanisms might contribute to the 
recruitment of endogenous desmosomal proteins. If indeed there was an upregulation 
of desmosomal components by over-expressed PKP-2a then this could be tested by 
examining the expression of mRNA encoding other desmosomal proteins by RT-PCR 
or by examining the endogenous proteins levels in these cells by western 
immunoblotting analysis.
In common with mutations in the gene encoding human PKP-1 that lead to impaired 
association of keratin intermediate filaments with the plasma membrane in 
keratinocytes, lack of PKP-2 in mouse cardiomyocytes also causes intermediate 
filaments to retract from the membranes190. Thus, both PKP-1 and PKP-2 play 
essential roles in mediating desmoplakin association with desmosomes in the 
epidermis and heart respectively. In contrast with mouse cardiomyocytes lacking PG
1 8Awhere DP remains firmly associated with the plaques of adhering junctions , DP was 
no longer associated with cardiomyocyte junctions in the absence of PKP-2, 
suggesting that PKP-2, possibly together with PG might be essential for fixing DP to 
the junctional plaques of cardiomyocytes190. It is believed that PKP-2 is important in 
recruiting DP to the plaque and for stabilizing lateral connections in the desmosomes 
through its interactions with other plaque proteins via its head domain183,184, while PG 
is thought to be important for clustering DP to desmosomal cadherins. Precisely why 
tPKP2 cell desmosomes possess little or no filaments might be explained by recent 
studies examining the role of PKP-2 in DP assembly dynamics. The functional 
requirement of PKP-2 in the formation and translocation of DP particles to cell-cell 
contacts was demonstrated in a study tracking fluorescent DP-GFP in SCC9 cells in 
which PKP-2 was found to co-localize with assembly competent DP-GFP particles in 
the cytoplasm and into nascent desmosomes at sites of cell-cell contacts216. 
Furthermore, it is now known that PKP-2 affects DP assembly by scaffolding a DP- 
PKP-2-PKCa protein complex247. In this study siRNA mediated reduction of PKP-2 
protein expression in SCC9 and A431 cells showed an impaired DP localization at 
sites of cell-cell contacts. In SCC9 cells PKP-2 was shown to regulate PKC signalling
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by recruiting it to DP. PKP-2 deficient SCC9 cells showed increased phosphorylation 
of myristolylated alanine rich PKC substrates, and a reduction in the amount of DP 
co-immunoprecipitated in complex with PKCa247. The association of PKCa with the 
assembly competent DP particle regulates DP assembly into desmosomes possibly 
through modulation of serine phosphorylation at position 2849 which regulates the 
association of DP with intermediate filaments199,225. As previously discussed, DP is 
essential for recruiting IF filament into desmosomes, and it is speculative whether 
A733fsX740 PKP-2 might alter assembly dynamics of DP by affecting the availability 
of PKCa required for the appropriate assembly of intermediate filament binding. 
Additionally, since reduced amounts of endogenous PG associates with A733fsX740 
PKP-2 this may also affect the clustering of desmoplakin into cell-cell junctions as PG 
serves as a linker between cadherins and DP via its binding to the N-terminal domain 
of DP.
A suitable antibody facilitating the immunoprecipitation of full-length PKP-2 as well 
as A733fsX740 PKP-2 in wPKP2 and tPKP2 cells was not commercially available. 
Thus, DNA encoding full-length or truncated PKP-2 was cloned in pcDNA4 plasmid 
vector and this was used to transfect HEK 293T cells for obtaining transient protein 
expressions of N-terminally XPress-tagged full-length or truncated PKP-2 proteins. 
The reduced interaction of A733fsX740 PKP-2 (three ARM repeats missing) with PG 
was unexpected as previous studies had shown that the head domain of PKP2 was 
primarily involved in its interaction with PG183. However, the relative importance of 
the PKP-2 ARM repeats in binding to PG was emphasized in that study where a 
reduced association of a PKP-2 protein fragment lacking all ARM with PG was 
shown, however comparatively, the association of PG with a PKP-2 protein fragment 
including all ARM repeats but lacking the head domain was even more reduced 183. 
These domain specific studies of PKP-2a expression in vitro suggests that the head 
domain as well as the ARM repeats of PKP-2 may co-operatively modulate the 
binding of PG. The binding of endogenous p-catenin with truncated PKP-2 in IP 
assays occurred at a level comparable to the interaction of P-catenin with full-length 
PKP-2, and this was consistent with a previous finding confirming that PKP-2a 
interacted with p-catenin mainly through its N-terminus head domain183.
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Both isoform of endogenous DP proteins were expressed in wPKP2 and tPKP2 stable
cells (data not shown), however the immunoprecipitation of full-length PKP-2 and
truncated PKP-2 proteins using anti-XPress antibody co-immunoprecipitated variable
amounts of DP, as well as DSG-2 and DSC-2 in wPKP2 and tPKP2 Triton X-100
soluble cell lysates (data not shown). It is arguable that the location of the epitope tag
in the expressed PKP-2 might be important for obtaining successful
immunoprecipitation of endogenous DP, DSG-2, and DSC-2 proteins that were poorly
immunoprecipitated in this study. The XPress tag on PKP-2 in this study was N-
terminally located, however, in a study examining over-expressed C-terminus FLAG
tagged PKP-2a in SCC9 cells it was reported that endogenous desmoplakin was
1 8^variably immunoprecipitated using an anti-FLAG antibody . Thus, poor cellular 
extraction of these protein complexes rather than the location of the tag seem 
plausible explanation for the difficulty of obtaining reliable immunoprecipitation of 
these proteins and the inefficient transfer of large proteins by semi-dry transfer 
method might be an additional factor contributing to the variable amounts of co-IP of 
these endogenous proteins. The immunoprecipitation of Desmoglein-2 was reported 
to be problematic in SCC9 cells expressing C-terminal FLAG-tagged PKP-2a which 
failed to immuno-precipitate endogenous DSG-2 using an anti-FLAG antibody, 
however, DSG-3 also expressed in these cells was successful immunoprecipitated183. 
The immunoprecipitation of endogenous DSC-2 with C-terminal FLAG-tagged PKP- 
2a in SSC9 cells has not been reported in a previous study183. Cell membrane and 
cytoskeleton localized DP, DSG-2, and DSC-2 proteins may inefficiently extract into 
solution and other buffer systems (for example, RIPA buffer, and using a different 
detergent such as NP40) may be required to obtain sufficient amounts of complexes of 
these endogenous proteins with either full-length or truncated PKP-2 proteins. 
Although the precise amino-acid residues responsible for the interaction of PKP-2 
with PG, DP, DSG-2, P-catenin, and DSC-2 are unknown all these inter-protein 
interactions are believed to occur via the head domain of PKP-2183.
It is not known whether A733fsX740 PKP-2 protein is indeed expressed or 
incorporated into cardiac desmosomes of patients affected with the 
c.2197_2202_delCACACCinG PKP-2 gene mutation, as it was not possible to obtain 
heart tissue sample from any individuals in the three families examined by pedigree 
studies. Availability of tissue sample would allow verification of the presence of
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mRNA encoding a truncated protein by reverse transcription polymerase chain 
reaction, or by examining the presence of A733fsX740 PKP-2 truncated protein in 
diseased heart lysates by western immunoblotting analysis, or by immuno-electron 
microscopy to localize expression of a truncated PKP-2 protein in cardiac ID.
4.7 Summary of the main findings of the study
DNA encoding full-length and c.2197_2202_delCACACC_insG PKP-2 was cloned in 
pcDNA5 and pcDNA4 plasmid vectors. Using pcDNA5 vectors encoding full-length 
or truncated PKP-2 (p.A733fsX740 PKP-2), two stable cell lines were established 
using Flp-ln T-Rex HEK 293, one of these cell lines, wPKP2, expressed full-length 
PKP2, and a second cell line, tPKP2, expressed truncated PKP-2.
A strong tetracycline-induced expression of full-length PKP2 (with a predicted and 
apparent SDS PAGE migration size of 98.7 KD) occurred in wPKP2 cells that was 
localised at cell-cell contacts and in the cell nuclei by confocal immunofluorescence 
staining. Sub-cellular protein fractionation of induced wPKP2 cells followed by 
Western immunoblotting analysis confirmed a predominant expression of PKP2 in the 
cytoplasm, membrane, and cytoskeletal protein fractions, while some PKP2 was 
associated with the nuclear protein fraction.
A strong tetracycline-induced expression of A733fsX740 plakophilin-2 (predicted and 
apparent SDS PAGE migration size of 77.1 KD) occurred in tPKP2 cells, which 
localized at cell-cell contacts and in the cell nuclei by confocal immunofluorescence 
staining. Sub-cellular protein fractionation of induced tPKP2 cells followed by 
western immunoblotting analysis indicated a strong expression of the truncated 
plakophilin-2 in the cytoplasm and cytoskeletal fractions, where roughly equal 
amount of both the endogenous plakophilin-2 and the mutant protein 
compartmentalized in the later fraction. The membrane fraction showed expression of 
both truncated and endogenous plakophilin-2, but the amount of endogenous 
plakophilin-2 protein appeared to be greater than that of the truncated PKP-2 protein. 
Both endogenous and truncated plakophilins were present in roughly equal amounts in 
the nuclear fraction.
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Induced wPKP2 and tPKP2 cells proliferated at similar rates to non-induced wPKP2 
and tPKP2 cells. The initial cell-cell contact adhesion of induced wPKP2 and tPKP2 
cells showed statistically significant increased adherence of tPKP2 cells compared to 
wPKP2 cells when assessed by plating of these Calcein-labelled cells to homologous 
monolayer of cells cultured induced on coverslips. Adhesive strengths of confluent 
monolayers of induced wPKP2 and tPKP2 cells assessed by monolayer Dispase-based 
dissociation adhesion assays showed significantly increased resistance to 
fragmentation of sheared tPKP2 monolayer compared to those of wPKP2 monolayer. 
Tetracycline-induced wPKP2 and tPKP2 cells recovering from exposure to 
mechanical stretch showed statistically significant increased apoptosis (approximately 
two-fold) in tPKP2 cells compared to wPKP2 cells. Whole cell lysate western blot 
analysis of induced wPKP2 and tPKP2 cells showed that whilst Connexin-43 protein 
was strongly detected in both induced wPKP2 and tPKP2 cells only the localization of 
Cx-43 protein to cell-cell junctions of wPKP2, but not in tPKP2 cells was found by 
confocal microscopic examination of these induced cells. Cell input resistance 
measurements did not show significant differences to pulse current conduction within 
monolayer of induced wPKP2 and tPKP2 cells. Scrape-loading Lucifer Yellow dye 
transfer experiment indicated in wPKP2 cells that these did not couple particularly 
well to one another as dye transferred poorly in these cells. Examination of Flp-ln T- 
Rex HEK 293, wPKP2, and tPKP2 cells showed that whilst desmosomes formed in 
Flp-ln cells these were not as conspicuous as those formed in wPKP2 cells expressing 
full-length PKP-2 showing dense plaque and filament attachment. In contrast, 
however, desmosomes in tPKP2 cells compared to those in wPKP2 cells formed 
intermittent DS couplings with pale plaque region and largely lacking filaments; these 
filaments when present were observed to be organized differently compared to those 
found in induced wPKP2 cells. Overall, the measured desmosomal lengths in Flp-ln, 
wPKP2 and tPKP2 cells were not statistically different from one another. Reduced 
localization of endogenous plakoglobin was observed at the cell-cell contacts of 
induced tPKP2 cells compared to wPKP2 cells.
N-terminally tagged transient protein expression of full-length (predicted and apparent 
SDS PAGE size 103.6 KD) and truncated (predicted and apparent SDS PAGE size 81 
KD) plakophilin-2 obtained in HEK 293T cells obtained 48hour after transfection of 
pcDNA4 vectors showed reduced association of truncated PKP-2 with PG by
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immunoprecipitation studies. Beta-catenin appeared to associate to the same extent 
with both truncated and full-length plakophilin-2
4.8 Future Studies
Flp-ln T-Rex HEK 293 stable cells expressing truncated PKP2 and PKP2 provided a 
practical model system for assessing the functional impact of cell membrane 
incorporated PKP-2 proteins. However, these stable cells have obvious limitations in 
studying PKP-2 mutations in a cardiac setting. In this context, isolated rat neonatal 
ventricular cardiomyocytes is an appropriate model system to examine the effects of 
A733fsX740 PKP-2 protein expression. Isolated neonatal rat cardiomyocytes are 
widely used to examine transient protein expressions and mechanical cell-stretch 
studies; these primary cells are relatively easy to isolate and can be maintained in 
culture for up to twelve days duration in spite of having limited capacity for cellular 
proliferation246. Although a human cardiomyocyte cell line is available248, it is not 
possible to examine the effect of A733fsX740 PKP-2 protein expression in this cell 
line using pcDNA5 A733fsX740 plasmid vector because of poor 
transfection/expression obtained using plasmid vectors (personal communications 
with the author). However, it might be possible to use human cardiomyocyte cell line 
for examining the effects of A733fsX740 PKP-2 protein expression using a different 
vector delivery system, such as an adenoviral vector. A mouse model describing a 
cardiac restricted expression of mutant cell-cell adhesion protein is an elegant 
system allowing the role of mutant cell adhesion proteins to be evaluated in the ID in 
vivo, however it is by no means an easy system due to the high level of technical 
expertise required in establishing genetically engineered transgenic mice. It may be 
possible to determine the incorporation of A733fsX740 PKP-2 into tPKP2 cell 
desmosomes using an epitope-specific antibody raised against the last eight amino 
acids in A733fsX740 PKP-2 fragment, which are novel to the truncated PKP-2. The 
reduced filament association seen in tPKP2 cells must be examined by confocal 
immuno staining localization studies to demonstrate the disruption of intermediate 
filament protein network (for example, vimentin) in these cells. Immuno-localization 
studies also need to be performed to determine whether there is an altered localization 
of DP into tPKP2 cell-cell junctions, which might explain the reduced intermediate 
filament association in these cells. Examination of levels of PKCa in immuno
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complex with A733fsX740 PKP-2-DP in induced tPKP2 cells compared to levels PKPCa 
in immuno-complex with PKP-2-DP in induced wPKP2 cells may shed light on a possible 
mechanism explaining the lack of filaments in induced tPKP2 cells. Although over­
expressions of PKP-2 and A733fsX740 PKP-2 proteins in Flp-ln T-Rex HEK 293 cells 
have shown an effect on desmosome morphology and endogenous PG localization, these 
studies must be confirmed in other cell systems such as MDCK or A431 cells that form 
robust desmosomes in vitro and permit better co-localization of desmosomal proteins to 
confirm observations from the present studies. Since p.A733fsX740 PKP-2 appears to be 
a recurrent mutation, it might be possible to obtain heart tissue from affected individuals 
in the future to verify the presence of A733fsX740 PKP-2 protein in cardiac tissue to 
support a possible dominant negative effect of the protein or to exclude this possibility 
because of NMD mechanisms causing haploinsufficiency. The reduced association of PG 
in desmosomes of tPKP2 cells may imply a possible signalling function of PG in tPKP2 
cells, which requires investigation in future studies. The absence of cell membrane 
localized Cx-43 protein in induced tPKP2 cell-cell contacts requires further investigation 
particularly to examine the phosphorylation and ubiquitination status of Cx-43 protein as 
these are important in the targeting of Cx-43 to cell membranes and turnover of the 
protein. Optimization of co-IP reactions using different combination of buffers and 
detergents are required for obtaining sufficient cellular extraction of immuno-complexes 
containing endogenous DP, DSG-2, and DSC-2 formed with over-expressed either full- 
length or truncated PKP-2 proteins. The co-IP of full-length and truncated PKP-2 with 
endogenous Cx-43 protein need to be examined further because of the apparent lack of 
incorporation of Cx-43 protein in tPKP2 cells and evidence in the literature supporting the 
importance of PKP-2 in proper function and distribution of Cx-43 gap junctions and the 
coexistence of PKP-2 and Cx-43 as a macromolecular complex present at cell-cell 
contacts. The co-IP data has to be verified with confocal microscopy localization studies, 
the failure to obtain reliable co-localization of other endogenous proteins such as p- 
catenin, DP, DSG-2, and DSC-2 with either full-length or truncated PKP-2 may be a 
limitation of HEK 293 stable cells as they are not the best cell line for localization studies 
and some of these endogenous proteins may be expressed in small amounts, but it should 
be possible using double plasmid co-transfection transient expressions of either over­
expressed tagged full-length PKP-2 or over-expressed tagged truncated PKP-2 together 
with each of these different epitope-tagged plasmids encoding p-catenin, DP, DSG-2 and 
DSC-2 to alleviate the problem of low amounts of endogenous protein co-localization.
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Chapter 5 
Functional Studies of S140F 
Plakophilin-2 protein expression in mPKP2 cells
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5.1 Introduction
Genetic screening of an ARVC cohort and pedigree analysis of family G (section 3.42 
part 2.5) showed an autosomal dominant mode transmission of ARVC caused by 
PKP-2 gene mutation (c.C1604T) resulting in a missense sequence change p.S140F in 
the PKP-2 protein. (Table 3.4, Figure 3.2). This mutation described previously by 
Gerull40 et al, results in the substitution of a serine residue relatively conserved in 
different species (human, cat and mouse PKP-2), but functional study of the missense 
PKP-2 protein was not performed in that study. The interactions of PKP-2 protein 
with other desmosomal proteins have been reported to depend critically on the head
• 1 f i 'J  •domain (first 348 amino acid residues) of PKP-2 . A novel association of PKP-2 
with (3-catenin demonstrated by yeast two-hybrid assay, IP analysis of transient 
transfected human tongue squamous cell carcinoma SCC9 cell line, and in co-IP
1 83analysis of transient transfected COS cells showed that p-catenin specifically co- 
immuno precipitated with both PKP-2 and its head domain but only weakly with the 
ARM repeat domains of PKP-2. This novel association of PKP-2 with p-catenin 
raised the possibility that PKP-2 might participate in the cross-talk between adherens 
and desmosomal junctions and signal transduction pathways via Wnt-signalling183.
5.2 Experimental approach to investigate functional 
effect of S140F PKP-2 protein expression
The S140F PKP-2 protein formed was predicted tolerant and benign by SIFT and 
Polyphen analysis (section 3.4.1 parti.7), however pedigree analysis established a 
clear association of the inheritance of the genetic defect (cC1604T) with expression of 
ARVC. The cC1604T gene mutation in exon 3 of PKP-2 was shown to reside on a 
SC35 protein recognition exon splice enhancer sequence, however, ESE finder 
computer program algorithm analysis of the wild type and mutant PKP-2 exon 3 
sequences showed that the C>T nucleotide substitution does not abolish the splice 
enhancer sequence (section 3.4.1 part 1.8a), hence no effect on the splicing of PKP-2 
protein was predicted. Serine residues phosphorylation site predictions in PKP-2 
protein indicated that serine residue at position 140 might be a potential 
phosphorylation site involved in a putative signalling function of the protein (section
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3.4.1 part 1.8b and Table 3.6). A stable cell line expressing missense PKP-2 protein 
was established to investigate its functional effect at a cellular level.
Cloning of DNA encoding S140F PKP-2 was performed in pcDNA5 and pcDNA4 
vectors that permit stable cell line to be established and inter-protein interaction to be 
examined using an anti-XPress immunoprecipitation approach using these two vectors 
respectively. Using pcDNA5 PKP2 and pcDNA5 S140F PKP2 plasmids, Polyfect- 
mediated cationic transfection allowed selection of stable clones expressing either full 
length or missense PKP-2 proteins in an established tet-on system in Flp-In T-Rex 
HEK 293 cells. Several studies were performed using stable cells expressing full- 
length (designated wPKP2 cells) and missense PKP-2 (designated mPKP2 cells) 
proteins:
1) Expressions of full-length or truncated PKP-2 proteins were confirmed by 
confocal microscopy and western immunoblotting in wPKP2 and mPKP2 
cells. The distribution of full-length and missense PKP-2 proteins expressed in 
wPKP2 and mPKP2 cells were examined in different cellular compartments 
(in cytosol, membrane, nuclear, and cytoskeletal fractions) using a Qiagen cell 
compartment fractionation kit.
2) Properties of wPKP2 and mPKP2 cells were examined to compare cellular 
proliferation rate and initial cell-cell contact adhesion with commercial kits 
described previously in chapter 4. Another assay measured confluent 
monolayer adhesive strengths of wPKP2 and mPKP2 cells using a Dispase- 
based monolayer dissociation assay.
3) Stable cells exposed to controlled mechanical cell stretch were allowed to 
recover for a short time. Non-induced and tetracycline-induced wPKP2 and 
mPKP2 cells treated in this manner were compared for their response to 
specific apoptosis activity measured using a CaspACE assay kit. This 
procedure measures the extent of apoptosis in wPKP2 and mPKP2 cells 
subjected to mechanical cell-stretch to determine whether expression of the 
missense PKP-2 influenced the degree of mPKP2 cell apoptosis.
4) Cx-43 protein a major connexin expressed in the heart ventricle was 
examined in triton X-100 soluble cell lysates of non-induced and tetracycline- 
induced wPKP2 and mPKP2 cells and the localization of cell membrane 
bound Cx-43 protein was compared in tetracycline-induced wPKP2 and
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mPKP2 cells using western immunoblotting and confocal microscopy analysis 
respectively.
5) Desmosomes formed in vitro in tetracycline-induced wPKP2 and mPKP2 
cells examined by electron microscopy were compared with desmosomes 
formed in control non-transfected Flp-In T-Rex HEK 293 cells to determine 
the effect of missense PKP-2 protein expression on the morphology of 
desmosomes.
Lastly, using pcDNA4 vectors HEK 293 T cells were transfected to obtain transient 
expressions of full-length and S140F PKP-2 N-terminally XPress epitope tagged 
proteins. These PKP-2 proteins were immunoprecipitated using a mouse monoclonal 
antibody reactive to the XPress epitope allowing the comparison of interaction of 
these two PKP-2 proteins with other endogenous desmosomal proteins.
5.3 Experimental Aims
Six overall objectives were set in this part of the study. The first was to make 
expression mutant S140F PKP2 plasmid in pcDNA5/FRT/TO/TOPO/TA using site 
directed mutagenesis of +2301ApcDNA5 plasmid. The second was to make a stable 
cell line in Flp-In TRex HEK 293 and verify the expression of S HOF plakophilin-2 in 
this cell line. The third was to examine the proliferation rates, initial cell-cell contact 
adhesion, Dispase-based monolayer adhesion strength, and the effect of mechanical 
cell stretch on the measured apoptosis of mPKP2 stable cell line. The fourth was to 
examine Cx-43 protein expression at sites of cell-cell contacts in stable cell lines 
expressing PKP-2 and S140F PKP-2. The fifth was to examine desmosomes formed 
in non-transfected Flp-In T-Rex HEK293 and in tetracycline-induced wPKP2 cells 
and mPKP2 stable cells. The sixth was to clone S140F PKP-2 into 
pcDNA4/XPress/TOPO/TA expression vector for transient transfection expression of 
XPress-tagged S140F PKP-2 in HEK 293T cells to determine the degree of 
interaction of S140F PKP-2 protein with other desmosomal proteins using co-IP with 
an anti-XPress antibody and comparing with co-IP of XPress-tagged full-length PKP- 
2 with other desmosomal proteins.
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5.4 Materials and Methods
Plasmid +2301 pcDNA5 was prepared as previously described in chapter 4. Flp-In-T-Rex 
HEK 293 cell line, all antibiotics, and media supplies were purchased from Invitrogen, UK. 
Quick-Change site directed mutagenesis kit was purchased from Stratagene, UK
5.4.1 SDM to obtain S140F PKP2 DNA encoded in 
pcDNA5/FRT/TO/TOPO/TA
Site-directed PCR mutagenesis (section 2.3) of +2301 pcDNA5 plasmid was performed 
using mutagenic primers (Table 5.1) to incorporate the C.C1604T nucleotide change in PKP- 
2 DNA encoded within +2301 pCDNA5 plasmid to obtain a plasmid (S140F pcDNA5) 
encoding the S140F PKP-2 mutation.
5.4.2 Cloning of S140F PKP2 in pcDNA4/XPress /TOPO/TA
An amplimer (2522bp) of S140F PKP-2 obtained by PCR using S140F pcDNA5 as template 
and XPress primers was cloned into pcDNA4 plasmid vector using vector-based 
topoisomerase cloning (Table 5.2).
5.4.3 Establishing stable transfected cell lines
Stable cell lines were established in Flp-In T-Rex HEK293 cells using pcDNA5 PKP2 and 
pcDNA5 S140F PKP2 plasmids according to procedure described previously (section 2.5.4) 
to obtain full-length PKP-2 and S140F PKP2 protein expression upon tetracycline-induction. 
Five separate clones of each stable cell line established were selected and clonally expanded, 
and the clone showing strong stable tetracycline-induced protein expression by western 
blotting (section 2.6.2) and immunofluorescence staining (section 2.7.2) was examined in 
functional study. Two stable cell line clones were selected for functional studies based on the 
above criteria: clone wPKP2 expressed full-length PKP-2 (identical clone as the one that 
was used previously in Chapter 4) and clone mPKP2 expressed S140F PKP-2 under 
tetracycline-induction.
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Table 5.1 SDMI to obtain pcDNA5 encoding full-length and missense S140F PKP-2
Site-directed PCR mutagenesis to obtain +2301A pcDNA5 and S140F pcDNA5 plasmids which are suitable for in vitro transfection in 
Flp-In T-Rex HEK 293 cells to obtain stable cell tetracycline-induced expression of either full-length PKP-2 or S140F PKP-2 proteins 
respectively. Plasmid -2301A pcDNA5 containing an out-of-frame coding sequence of PKP2a (Table 4.1) was mutated by site directed 
mutagenesis to obtain +2301A pcDNA5 plasmid (previously described, section 4.4.2) that correctly encoded the full-length PKP2a 
coding sequence. Plasmid S140F pcDNA5 containing the nucleotide coding sequence for the mutant S140F PKP-2a was generated from 
+2301A pcDNA5 by site directed mutagenesis using the primers shown. Resulting plasmids obtained were sequenced to verify the entire 
protein encoding nucleotide sequences in these plasmids.
P u rp ose o f  S ite  
D irected  
M u tagen esis
F orw ard  prim er  
S equence (5 ’-3 ’)
R everse p rim er  
S equence (5 ’-3 ’)
P lasm id
M utated
R esu ltin g
p lasm id
O btained
Create a wild plasmid 
expressing full-length 
PKP-2a in pcDNA5
PKP2 Mut2301A for
TTGGTGACCCAAGTGTGAAAAAGACA
GCCATCTCGCTGCTGAG
PKP2 Mut2301A rev
CTCAGCAGCCAGATGGCTGTCTTTTT
CACACTTGGGTCACCAA
-2301A 
pcDNA5
+2301A pcDNA5
Create a plasmid 
expressing S140F 
plakophilin-2a in 
pcDNA5
PKP2 S140F for
TCCGTGGAAGAAAGGTTCTTGAGGCAT
CCTCTG
PKP2 S140F rev
CAGAGGATGCCTCAAGAACCTTTCTT
CCACGGA
+2301A 
pcDNA5
S140F pcDNA5
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Table 5.2 Cloning of S140F PKP-2 in pcDNA4/XPress/TOPO/TA
Cloning of either full-length PKP-2 or S140F PKP-2 DNA in pcDNA4/XPress/TOPO/TA vector suitable for in vitro transfection studies 
to obtain XPress-tagged expressions of either full-length or S140F PKP-2 proteins in HEK 293T cells. S140F PKP-2 PCR fragment 
obtained using S140F pcDNA5 as template DNA and PKP2 XPress for and PKP XPress rev primers was cloned in pcDNA4 plasmid 
vector. Transient expression of these XPress-tagged PKP-2 proteins in HEK293T transfected cells were co-immunoprecipitated using an 
anti-XPress antibody. Plasmids +2301 pcDNA5 and S140F pcDNA5 (described in Table 5.1) were used as PCR templates with EXL 
DNA polymerase to obtain amplimers that were cloned in pcDNA4/XPress/TOPO/TA. The Primer pairs PKP2 XPress for and PKP2 
XPress rev amplified PCR fragments encoding either full-length PKP-2 or S140F PKP-2 DNA that was cloned in 
pcDNA4/XPress/TOPO/TA preceded by vector encoded sequences for poly-histidine and an XPress tag (amino acid sequence: 
DLYDDDK). The cloned PKP-2s maintained the proper reading frame for protein translation with an ATG translation start site used from 
the host vector. A stop codon for protein translation termination was contained in the amplified cloned DNA inserts. PKP-2 or S140F 
PKP-2 proteins expressed in HEK 293T transfected cells contained N-terminal fused 6XHis tag and an XPress epitope adding 3.9 KD to 
the size of each PKP2 protein that was expressed.
Primer
Pairs
Sequence (5’-3’) PCR size 
(bp)/ 
Enzyme 
used/ 
Template
Destination 
vector PCR 
product cloned 
into
Plasmid obtained
PKP2 XPress for ATGGCAGCCCCCGGCGCC
CCAGCT
2522*
/EXL/**
pcDNA4/XPress/
TOPO/TA
pcDNA4 PKP2, 
pcDNA4 
S140F PKP2PKP2 XPress rev GCTCTAGATCAGTCTTTA
AGGGAGTGGTAGGC
*  Both full-length PKP2 and S140F PKP2 PCR fragment sizes were 2522bp long 
* *  Templates used +2301A pcDNA5 and S140F pCDNA5 respectively.
5.5 Results
5.5.1 Characterization of S140F PKP-2 expression in 
mPKP2 stable cells
Missense PKP-2 was expressed in tetracycline-induced mPKP2 stable cells that 
localized as punctate staining at cell-cell contacts (Figure 5.IB), and this was detected 
as a strongly induced 98.7 KD band (Figure 5.2B) by SDS PAGE/ western 
immunoblotting analysis, which correlated with the predicted size of PKP-2a protein. 
Using confocal microscopy examination of PKP-2 staining (protocol omitting 
detergent treatment step) that preserved nuclear staining, but not of membrane PKP- 
2182, induced S140F PKP-2 was found to be present in the nucleus (Figure 5.3B) of 
tetracycline-induced mPKP2 cells. Sub-cellular distribution in induced mPKP2 cells 
(Figure 5.4B) showed that missense plakophilin-2 localized predominantly in the 
cytoskeletal compartment, with some protein also present in the cytoplasm. Missense 
PKP-2 protein was found to be distributed in the membrane and nuclear 
compartments in equal amounts.
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Figure 5.1 Immuno-localisation of full-length and S140F PKP-2 
in wPKP2 and mPKP2 cells by confocal microscopy
Localization of expressions of full-length PKP-2 and S140F PKP-2 to the cell membranes of 
tetracycline-induced wPKP2 and mPKP2 stable cell lines respectively. Immunofluorescence images 
showing blue fluorescence signal resulting from DAPI nuclear staining, green fluorescence 
resulting from FM 1-^13FX membrane dye staining, red fluorescence resulting from full-length 
PKP-2 or A733fsX740 PKP-2 staining with anti-PKP-2 antibody (610788, BD Bioscience) and 
merge representing composite staining (all panels on the far right) with all three signals 
superimposed. A punctate staining of each plakophilin examined indicates a staining reminiscent of 
desmosomal reactivity. The white size bar on each image in the green channel represents 8pm.
A) wPKP2 cells non-induced
DAPI M em brane PKP-2 Merge
wPKP2 cells tetracycline-induced
DAPI M em brane PKP-2 Merge
n I p P *  |  li
B) mPKP2 cells non-induced
DAPI M em brane PKP-2 Merge
11
mPKP2 cells tetracycline-induced
DAPI M em brane PKP-2 M erge
Figure 5.2 Western blot analysis of the expressions of 
PKP-2 & S140F PKP-2 in wPKP2 & mPKP2 cells
Analysis of expressions of full-length PKP-2 and S140F PKP-2 in non-induced (NI) 
or tetracycline-induced (IND) wPKP2 (A) and mPKP2 (B) stable cells determined by 
western blotting technique. A mouse monoclonal antibody to human PKP-2 (1:500 
dilution, BD Bioscience, product 610788) was used followed by a goat anti-mouse 
HRP conjugate (1:5000, Abeam). Blots were exposed to ECL reagents (GE 
Healthcare) and developed using Kodak reagents. The migration of protein markers 
(Precision Plus protein standards, BioRad Laboratories, UK) are indicated on the left 
hand side of the blots
A -  wPKP2 cells B -  mPKP2 cells
NI IND NI IND
150 KD-»
100 KD->
75 KD->
37 KD-»
50 KD->
< r  98.7 KD 
PKP-2a
<- 98.7 KD
S140F PKP-2a
PKP-2
and endogenous
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Figure 5.3 Demonstration of nuclear presence of full- 
length and missense PKP-2 in wPKP2 and mPKP2 
induced cells
Nuclear staining of full-length PKP-2 and S140F PKP-2 demonstrated in tetracycline- 
induced wPKP2 and mPKP2 stable cells respectively using confocal microscopy. 
Cells were cultured on glass coverslips in the presence of O.lpg/ml tetracycline to 
induce the expressions o f the respective PKP-2 isoforms in each stable cell line. 
Seventy-two hours after induction, cells were fixed in -20°C methanol for five 
minutes followed by incubation in acetone for 30 seconds. After rinsing the cells in 
PBS, they were incubated in 10% FBS/PBS solution for thirty minutes, followed by 
incubation in 1:200 dilution of mouse anti-plakophilin-2 (BD Bioscience, 610788) for 
thirty minutes at room temperature. Coverslips were washed gently twice in PBS and 
incubated in 1:200 dilution of goat anti-mouse Alexa fluor-546 antibody for one hour 
at room temperature. Coverslips were washed in PBS followed by mounting on glass 
slide in Glycerol/PBS solution and observation of fluorescence in a laser scanning 
confocal microscope. Under this detergent-free staining conditions, membrane 
staining of plakophilin-2 is abrogated, but exclusive intense nuclear staining is
991 •seen , probably due to masking of the plaque-bound form. The red 
immunofluorescence signal localized each PKP-2 staining inside the spherical nuclei 
(where the presence o f dark outline of nucleoli can be seen inside some of these 
nuclei). The presence of missense PKP-2 in the nuclear protein fraction was 
confirmed in sub-cellular fraction studies (Figure 5.4B). The size bar represents 5pm.
A) Induced wPKP2cells B) Induced mPKP2 cells
Figure 5.4 Sub-cellular localization of full-length and 
missense PKP-2 in wPKP2 and mPKP2 cells
Sub-cellular distribution of A) induced PKP2, or B) induced S140F PKP2 in cytosolic 
(CYT), membrane (MEM), nuclear (NUC) and cytoskeletal (CSK) protein fractions in 
tetracycline-induced (48 hrs) wPKP2 or mPKP2 stable cells respectively. Sub-cellular 
protein fractions were obtained from 5xl06 cells using the Qproteome cell 
compartment kit (Qiagen). Each protein fraction was precipitated in 4 volumes of ice- 
cold acetone and the pellet was resuspended in lOOpl RIPA containing protease 
inhibitor cocktail (Roche). l/5 th of each protein fraction was electrophoresed in a 10% 
SDS PAGE and transferred to a Hybond ECL membrane. Following blocking of blot 
in TBST/5% milk, blot was incubated with 1:500 mouse monoclonal anti-PKP-2 
(610788, BD Bioscience) for one hour in TBST/5% milk at room temperature. 
Following washing of the blots in TBST, they were exposed to 1:3500 dilution of 
anti-mouse HRP conjugate in TBST/5% milk for one hour at room temperature. 
Following washing of the blots in TBST they were incubated in ECL reagents (GE 
Healthcare) and exposed to ECL Hyperfilm (GE Healthcare).
A -Induced wPKP2 cells
CYT MEM NUC CSK
98.7 KD endogenous 
PKP-2 + over-expressed
PKP-2a
B -  Induced mPKP2 cells
CYT MEM NUC CSK
<- 98.7 KD endogenous
PKP-2 + S140F  
PK P2a
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5.5.2 Properties of mPKP2 stable cells
Cellular proliferation of wPKP2 and mPKP2 cells did not appear to be substantially 
altered by the expressions of full-length or truncated PKP-2 respectively as 
comparable values of the slopes were obtained by regression analysis of the data in 
tetracycline-induced cell lines (Figure 5.5). Calcein-AM labelled induced mPKP2 or 
wPKP2 cells did not show a statistically significant difference in initial cell-cell 
contact adherence of these two cell lines to homologous monolayer of cells 
established on coverslips (Figure 5.6). The adhesive strengths of induced mPKP2 and 
wPKP2 monolayers measured using a Dispase-based cell dissociation assay did not 
show any differences in resistances to shear stress-induced fragmentation as both 
monolayers formed comparable fragment sizes assessed visually (Figure 5.7) 
indicating that S140F PKP-2 probably did not affect the adhesive strength of mPKP2 
monolayer. Stable wPKP2 and mPKP2 cells subjected to mechanical cell-stretch and 
then allowed to recover for a short while did not show statistical difference in the 
specific apoptosis activity in these cells (Figure 5.8). Analysis of non-induced and 
tetracycline-induced wPKP2 and mPKP2 highly confluent monolayer NP-40 
detergent-soluble cell lysates by western immunoblotting showed strong Cx-43 
protein bands under both conditions in each stable cell line (Figure 5.9 representative 
data of triplicate experiments). Examination of tetracycline-induced wPKP2 and 
mPKP2 cells by confocal microscopy confirmed strong Cx-43 protein localization to 
cell-cell contacts of both cells under tetracycline-induced conditions (Figure 5.10, 
representative of triplicate experiments).
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Figure 5.5 Proliferation of wPKP2 and mPKP2 cells
Cellular proliferation of stable wPKP2 and mPKP2 cells expressing full-length PKP-2 
and S140F PKP-2 respectively. 15,000 cells per well were plated in a twenty-four 
well plate and allowed to attach overnight. Cell proliferation was measured 
spectrophotometrically at 490nm by measuring the reduction of Cell Titer AQ One 
solution (Promega, UK) after incubation of substrate with cells for exactly one hour. 
The six data points obtained in each treatment were fitted to a linear tread line using 
Microsoft Excel software. The values of the slopes were: 0.0101, 0.0111, 0.0104, and 
0.0108 for wPKP2NI, wPKP2 IND, mPKP2 NI and mPKP2 IND cells respectively.
Cellular proliferation of wPKP2 and mPKP2 cells
Linear (mPKP2 NI)
 Linear (wPKP2 IND)
—  — Linear (mPKP2 IND) 
 Linear (wPKP2 NI)
S 0.5
*  0.4
10 20 30 40 50 60
Time after plating (hrs)
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Figure 5.6 Initial cell-cell contact adhesion assay of
wPKP2 and mPKP2 cells
Initial cell-cell contact adhesion measured in wPKP2 and mPKP2 stable cell lines 
expressing full-length PKP-2 and S140F PKP-2 respectively. Both cell lines were 
cultured under tetracycline-induced conditions on 13 mm plastic coverslips to obtain a 
uniform highly confluent monolayer of cells. Separate suspension aliquots (1 x 106) of 
each tetracycline-induced cells previously pre-incubated in lOpM Calcein AM dye were 
allowed to adhere to the homologous unlabelled confluent monolayer of cells growing on 
coverslips conditions for five hours at 37°C/5%C02- Coverslips were carefully washed 
four times in complete DMEM medium. Coverslips were fixed in 4%  
formaldeheyde/PBS, stained with DAPI, and mounted on glass slides, followed by 
examination in a confocal microscope (images shown using xlO objective lens) to co- 
localise the green and blue fluorescence. The number of calcein AM-labelled (cells 
fluorescing green) versus the total number of cells labelled with DAPI (all cells 
fluorescing blue) was expressed as a percentage to quantify the percentage initial cell-cell 
contact adhesion of each monolayer. No statistical difference (student’s paired t-test p 
value = 0.5387) o f % mean initial cell-cell contact adhesion between wPKP2 or mPKP2 
cells was found. A p-value of <0.05 was considered statistically significant.
Induced wPKP2 cells Induced mPKP2 cells
Green = calcein labelled cells Green = calcein labelled cells
retained on adherent retained on adherent
monolayer, Blue = DAPI monolayer, Blue = DAPI
staining o f all cells staining o f all cells
% wPKP2 initial cell­
cell adhesion
% mPKP2 initial cell­
cell adhesion
Experiment 1 20.7 29.4
Experiment 2 23.3 29.7
Experiment 3 24.4 27.6
Experiment 4 25.4 24.1
Experiment 5 29.3 29.4
Experiment 6 35.4 27.9
Total number of cells examined 3000 3000
Mean 26.417 28.017
SD 5.225 2.107
SEM 2.133 0.860
p value (paired student’s t-test) p= 0.5387
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Figure 5.7 Dispase-based induced wPKP2 and mPKP2 
monolayer dissociation adhesion assay
Monolayer adhesive strength of tetracycline-induced wPKP2 and mPKP2 confluent 
monolayers measured using a Dispase-based cell dissociation assay212. Each cell line 
was cultured in P6o Nunc brand plastic culture dishes in penicillin, streptomycin, 
foetal calf serum, blasticidin and hygromycin supplemented DMEM (Invitrogen 
19308-025) in the continued presence of O.lpg/ml tetracycline until cells were highly 
confluent. Medium was decanted from each dish and the cell monolayer was carefully 
washed in PBS. One ml of 2.4U/ml Dispase II (Roche, Cat No 10295835001) was 
added to the dishes followed by incubation at 37°C for 30 minutes. The entire intact 
monolayer lifted off the plastic cell culture dish by enzyme treatment was carefully 
rinsed in PBS and resuspended in five ml of PBS. The cell monolayer was subjected 
to shearing for exactly ten rotations on a rocking tabletop platform. Sheared 
monolayer was photographed under Epi-white light illumination in BioRad Gel 
Documentation system (gel doc XR) using quantity one version 4.6 software for 
image analysis. Comparable level o f monolayer fragmentation resulted in sheared 
mPKP2 and wPKP2 monolayers after ten rotations indicating that S140F PKP-2 
expression does not influence cell-cell adhesion.
Control wPKP2 stable cells expressing full-length PKP-2
mPKP2 stable cells expressing S140F PKP-2
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Figure 5.8 Effect of mechanical cell stretch on apoptosis of
wPKP2 and mPKP2 stable cells
Effect of mechanical cell-stretch on the measured apoptosis determined in wPKP2 and 
mPKP2 stable cells. Apoptosis levels are mean values o f n = 6 experiments ±  standard 
deviations. The CaspACE assay system (Promega, UK) was used to measure the specific 
caspase-3 activity in cell lysates o f cells subjected to mechanical stretch using the Flexer cell- 
stretch apparatus with 4% cell-stretch applied at a frequency of 1Hz for 4.0 hours followed by 
recovery of cells for 3 hours prior to assessing apoptosis. Cells were plated at a density o f 0.5 
x 106 cells/six well plate and cultured for 48 hours prior to exposure to mechanical stretch. 
Induced cells were cultured in presence o f O.lpg/ml tetracycline. Statistical analysis using 
paired student’s t-test showed that there were no differences in the mean apoptosis o f wPKP2 
or mPKP2 cells with all p values >0.05.
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Figure 5.9 Western blot analysis of whole cell lysates 
of wPKP2 and mPKP2 cells to measure Cx-43 and 
plakophilins
Connexin-43 protein levels in wPKP2 and mPKP2 cells analyzed by western blotting 
analysis. The top panel shows the levels o f Cx43 protein, middle panel shows PKP-2 
and S140F PKP-2 protein induction and bottom panel shows p-actin protein levels as 
loading controls. Stable wPKP2 and mPKP2 cells were cultured in the absence (NI) or 
presence of O.lpg/ml tetracycline (IND) for 72 hrs until cells were fully confluent. 
Detergent-soluble cell lysates were prepared in RIPA buffer and equal amounts of 
protein (100 microgram protein) were separated on a 10% SDS PAGE system. Gels 
were blotted onto ECL Hybond membrane and blots were blocked in TBST/milk 
followed by incubation in 1:2000 rabbit anti-connexin-43 (GJA1, Abeam ab-113700), 
or 1:500 mouse anti-human PKP2 (610788, BD Bioscience), or 1:2000 rabbit anti-P- 
actin (loading control, Abeam, ab-8227). Following washing of blots in TBST they 
were incubated in either 1:5000 anti-mouse HRP or 1:5000 anti-rabbit HRP. Blots 
were washed in TBST and incubated in ECL reagents (GE Healthcare) followed by 
exposure to ECL Hyperfilm and development with Kodak photographic reagents.
Connexin-43
wPKP2 NI WPKP2 IND mPKP2 NI mPKP2 IND
PKP-2 and S140F PKP-2
PKP-2 S140F PKP-2
wPKP2 NI wPKP2 IND mPKP2 NI mPKP2 IND
<- 98 7 KD 
PKP-2 or S140F 
PKP-2
P-actin
WPKP2NI wPKP2 IND mPKP2 NI mPKP2 IND
a*IMP <— 42 KD (3-actin
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Figure 5.10 Localization of Cx-43 protein in wPKP2 and mPKP2 cells
Localization o f Connexin-43 expression determined by immunofluorescence staining and confocal microscopy examination o f wPKP2 (A) and mPKP2 
(B) tetracycline-induced cells. Blue channel records DAPI nuclear staining, green channel records cell membrane staining with FM 1-43FX dye, red 
channel records connexin-43 staining, and the merge channel shows composite signals. Images were obtained using x40 objective oil immersion lens. 
The size bar in the green channel represents 5 pm.
A -  induced wPKP2 B -  induced mPKP2 cells
DAPI Membrane DAPI M embrane
the co-localized staining intensity of full-length PKP-2 and endogenous PG p 
wPKP2 cells (Figure 5.11, representative of triplicate staining). Results of co-loca 
endogenous P-catenin, DP, DSG-2 and DSC-2 with either full-length or S140F PI 
not reproducible and therefore these studies were inconclusive (data not shown), i  
reason for the difficulty in obtaining reliable co-localization of these endogenou 
with over-expressed full-length or S140F PKP-2 could be that these endogenou 
might be present in small amounts.
5.5.4 Examination of desmosome morphology in mPK 
stable cells
The gross morphology of non-transformed Flp-In T-Rex HEK 293 cells, tetracyclin 
wPKP2 cells, and tetracycline-induced mPKP2 cells were examined by electron m 
at x2000 magnification in a Philips 201 transmission electron microscope. The ident 
three cell lines were revealed after completion of data analysis. All of these cell pn 
were viable with a good distribution of sub-cellular organelles (Figure 5.12). Induce 
and mPKP2 cells and control non-transfected Flp-In T-Rex HEK 293 cells cu 
Thermanox coverslips were examined by transmission electron microscopy to deten 
desmosome morphology. Whilst desmosomes formed in non-transfected cells, they 
particular well developed, presumably due low level of recruitment of endogenous d< 
plaque proteins, induced wPKP2 cells on the other hand showed very prominent des 
with electron dense plaques (Figure 5.13 A and B respectively). Induced S14C 
expression resulted in considerably longer desmosomes in mPKP2 cells (Figure 
Examination of serial EM sections suggested that the longer desmosomes formed ii 
cells might be due to fusion of adjacent desmosomes (Figure 5.13C, inset). Exceptioi 
desmosomes exist in tetracycline-induced mPKP2 cells as demonstrated by
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desmosome measuring nearly 1300 nm in length present in serial sections (Figure 5.14) of 
these cells. Such large desmosomes were not present in either wPKP2 or Flp-In T-Rex 
HEK293 cells; the mean desmosomal length o f wPKP2 cells was 325 nm. Thus, desmosomes 
in mPKP2 cells can be up to four-times longer compared to desmosomes found in control 
cells. Statistical analysis of desmosomal lengths in Flp-In T-Rex HEK 293, wPKP2 and 
mPKP2 cells by ANOVA analysis followed by Bonferroni post-test correction and multiple 
comparison between these three groups o f desmosomes showed a significant difference 
(p<0.001) in desmosomal lengths between either Flp-In and mPKP2 or wPKP2 and mPKP2 
desmosomes (Figure 5.15). Although a formal analysis of the % area of the cell membrane 
that desmosomes occupy was not performed, it was evident from electron micrographs that 
desmosomes in induced mPKP2 cells occupied a larger area of the cell membrane compared 
to those of induced wPKP2 cell desmosomes (compare Figures 5.13B and 5.13C), indicating 
there might be fewer desmosomes per unit length in induced mPKP2 cells.
5.5.5 Verification of XPress-tagged S140F PKP-2 and full- 
length PKP-2 expressions
Transient protein expressions of N-terminal XPress-tagged PKP-2 or S140F PKP2 proteins 
was confirmed in HEK 293T cells by immunofluorescence staining confocal microscopy 
localization of these PKP-2 proteins forty eight hours after transfection with pcDNA4 (Figure 
5.16) vectors. The transient expressions of PKP-2 or S I40 PKP-2 proteins (Figure 5.16) were 
verified using a mouse monoclonal anti-PKP-2 antibody (reactive near the N-terminus of 
PKP-2), however, an identical result was obtained using monoclonal anti-XPress antibody 
staining and confocal microscopy localization of these PKP-2 protein expressions in 
transfected HEK 293T cells (data not shown). SDS PAGE/westem blotting analysis of soluble 
cell lysates ffom pcDNA4 PKP2 or pcDNA4 S140F PKP2 transfected HEK293T cells was 
performed to confirm full-length or S140F PKP-2 proteins using both anti-XPress and anti- 
PKP-2 (reactive near the N-terminus o f PKP-2) antibodies which revealed identical bands for 
both full-length and missense PKP-2 proteins (predicted and apparent SDS PAGE size of
103.6 KD, Figure 5.17).
269
Figure 5.11 Co-locaiization of PKP-2s in induced mPKP2 and wPKP2 with endogenous PG
Confocal microscopy immunofluorescence co-localization of endogenous plakoglobin with either full-length PKP-2 or S140F PKP-2 in tetracycline- 
induced wPKP2 and mPKP2 cells respectively. DAPI nuclear staining produces a blue signal, rabbit anti-human PG followed by anti-rabbit Alexa-488 
produces green signal localizing PG staining, mouse anti-human PKP-2 followed by anti-mouse Alexa 546 produces red signal localizing PKP-2 and 
S140F PKP-2 respectively. Merged signals represent composite signals superimposed. Images were obtained using x40 oil immersion objective. The 
size bar in each green channel represents 7pm.
A) Endogenous PG/PKP-2 co-localization in B) Endogenous PG/S140F PKP-2 co-localization
wPKP2 cells in mPKP2 cells
B l u e  =  D A P I G r e e n  =  P l a k o g l o b i n B l u e  =  D A P I G r e e n  =  P l a k o g l o b i n
R e d  =  P K P -2 M e r g e d  =  c o m p o s i t e R e d  = SI40F  P K P -2 M e r g e d  =  c o m p o s i t e
Figure 5.12 Gross morphology of non-transformed Flp-In T-Rex HEK 293 cells,
tetracycline-induced wPKP2 cells, and tetracycline-induced mPKP2 cells
Gross morphology of non-transfected Flp-In T-Rex 293 control cells and of stable wPKP2 and mPKP2 cells expressing full-length and 
S140F PKP-2 respectively. Cells cultured on Thermanox plastic coverslips in complete DMEM were induced where required, with 
O.lpg/ml tetracycline for 72 hours until they were confluent. Coverslips processed for electron microscopy (section 2.7.4) were examined 
in a Philips 201 electron microscope at x 2000 magnification to examine the gross morphology of these cells. The bar on each electron 
micrograph represents 10pm
Non-transformed Flp-In T-Rex HEK 293 cells Tetracycline-induced wPKP2 cells Tetracycline-induced mPKP2 cells
Figure 5.13 Morphology of desmosomes formed in Flp-In T-Rex HEK 293, wPKP2 and
mPKP2 tetracycline-induced cells
Desmosome morphology in non-transformed Flp-In T-Rex 293 control cells and in stable tetracycline-induced wPKP2 and mPKP2 cells expressing 
full-length and S140F PKP-2 respectively. Cells cultured on Thermanox plastic cover slips in complete DMEM were induced in O.l pg/ml tetracycline 
for 72 hours until they were confluent. Coverslips processed for electron microscopy (section 2.7.4) were examined in a Philips EM microscope at x 
70000 magnification to examine desmosome morphology. The bar on each electron micrograph represents lOOnm. Induced expression o f full-length 
PKP-2 in wPKP2 cells resulted in formation o f prominent electron dense desmosomes (B), while SI40 PKP-2 expression in mPKP2 cells resulted in 
the formation o f significantly longer desmosomes, which appeared to result from fusion o f adjacent desmosomes (C, inset, top left comer).). Flp-In T- 
Rex HEK 293 cells formed less prominent desmosome (A) compared to wPKP2 cell desmosomes presumably due to low endogenous level of  
recruitment o f endogenous desmosomal plaque proteins. Dense filament associations were present in both wPKP2 and mPKP2 cells.
C) mPKP2 cellsB) wPKP2 cells
Figure 5.14 High magnification electron micrograph of a 
single desmosome in tetracycline-induced mPKP2 cell
Examination of a desmosome at a high magnification in induced mPKP2 cells. This is a 
representative electron micrograph of an exceptionally long desmosome obtained in induced 
mPKP2 cells. Tetracycline-induced mPKP2 cells cultured on Thermanox coverslips for 72 
hours were processed in situ for electron microscopy. A single desmosome examined by 
transmission electron microscopy at x 70000 magnification shown here was nearly 1300 nm 
in length compared with a mean value of 325 nm for desmosomes found in wPKP2 cells. 
Examination of serial sections of mPKP2 cells showed presence of such long desmosomes 
with dense filament association.
Figure 5.15 Statistical analysis of desmosomal length in Flp- 
In T-Rex HEK 293, wPKP2 and mPKP2 induced cells
Statistical analysis of desmosomal lengths in Flp-In 293, wPKP2 and mPKP2 stable cells (the 
later two were tetracycline-induced). A minimum of fourteen measurements of desmosomal 
lengths (nm) were taken from electron micrographs o f desmosomes obtained from each of these 
three cells. Data were analyzed using Graph Pad Prism software using non-parametric ANOVA 
analysis followed by Bonferroni post-test computation of significance. The graph shows plots of 
individual values in each group of cells and the table below shows results of the Bonferroni 
multiple comparison statistical test parameters between the three data sets from Graph Pad. Pair­
wise analysis showed a significant difference (p<0.001) in desmosomal length comparing either 
control Flp-In or control wPKP2 desmosomes with mPKP2 desmosomes. Flp-In desmosomal 
length were not significantly different from those of wPKP2 desmosomes (p>0.05).
Comparison of desmosomal lengths of 
Flp-In HEK 293, wPKP2 and mPKP2 cells
p>0.05 p<0.001
1000
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Parameter Flp-In cells WPKP2 cells mPKP2 cells Data Set-D
Table Analyzed
Data 1
One-way analysis of variance
P value 0.0002
P value summary ***
Are means signif. different? (P < 0.05) Yes
Number of groups 3
F 10.52
R squared 0.3235
Bartletts test for equal variances
Bartlett's statistic (corrected) 1.386
P value 0.5000
P value summary ns
Do the variances differ signif. (P < 0.05) No
ANOVA Table SS df MS
Treatment (between columns) 874300 2 437100
Residual (within columns) 1828000 44 41550
Total 2703000 46
Bonferroni's Multiple Comparison Test Mean Diff. t P value 95% Cl of diff
Flp-In cells vs wPKP2 cells -26.24 0.3655 P > 0.05 -204.9 to 152.5
Flp-In cells vs mPKP2 cells -312.4 4.055 P < 0.001 -504.2 to -120.6
wPKP2 cells vs mPKP2 cells -286.2 3.985 P < 0.001 -464.9 to -107.4
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Figure 5.16 Confocal microscopy localization of PKP-2 and 
missense PKP-2 in HEK293T cells transfected with pcDNA4 
vectors encoding these plakophilins
Verification PKP-2 and S140F PKP-2 protein expression in 1x10s HEK 293T cells cultured on 
13mm plastic coverslips and transfected with lpg  pcDNA4 PKP2 or pcDNA4 S140F PKP2 
plasmids for forty eight hours using lOjil Polyfect reagent. Following fixation of cells in 4% 
formaldehyde, permeabilization in 0.1% triton X-100 and blocking in 10% FBS, they were 
incubated in 1:200 mouse monoclonal anti-PKP-2 (610788, BD Bioscience) for lhr at room 
temperature. Cells were washed in PBS and incubated in 1:200 Alexa fluor 546 goat anti-mouse 
(Invitrogen) for lhr at room temperature. Following PBS washes of coverslips, they were 
incubated in DAPI nuclear stain (Invitrogen) and mounted on glass slide. Control cells 
transfected with pcDNA4 (without an insert, A); pcDNA4 PKP2 transfected cells (B) and 
pcDNA4 S140F PKP2 transfected cells (C). Blue fluorescence shows DAPI nuclear staining, 
red fluorescence shows PKP-2 or S140F PKP-2 staining (B and C respectively), and merge 
shows composite signals. The size bar in each DAPI stained image on the left panels represents 
10 pm.
DAPI PKP-2 or Merge
S140F PKP-2
Empty
pcDNA4
vector
transfected
HEK293T
B )
pcDNA4 
PKP2 
transfected 
HEK 293T 
cells
pcDNA4 
S140F PKP2 
transfected 
HEK 293T 
cells
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Figure 5.17 Verification of transient expressions of PKP-2 and missense PKP-2 in HEK 
293T cells transfected with pcDNA4 vectors encoding these plakophilins
XPress-tagged full-length PKP-2 and S140F PKP-2 transient protein expressions obtained in HEK 293T cells following transfection with 
pcDNA4 PKP2 and pcDNA4 S140F PKP2 plasmids respectively. HEK 293T cell lysates of non-transfected (control), pcDNA4 PKP2 or 
pcDNA4 S140F PKP2 transfected cell lysates were analyzed by Western blotting probed using anti-XPress (top) or anti-PKP-2 
antibodies (bottom). Following transfection of 293T cells with 1 fig of each plasmid for forty eight hours, soluble cell lysates prepared in 
RIP A buffer (1 OOjug protein per lane) were electrophoresed in 10% SDS PAGE and transferred using semi-dry transfer on Hybond ECL 
membrane. Blots were blocked in TBST/milk and incubated with mouse monoclonal (1:5000 anti-XPress, Invitrogen or 1:500 anti-PKP- 
2, BD Bioscience, 610788) antibodies. Following washing of blots in TBST they were incubated in 1:3500 rabbit-anti-mouse HRP. 
Following TBST washes, the blots were incubated in ECL reagents and exposed to ECL Hyperfilm.
Control pcDNA4 PKP2 pcDNA4 S140F PKP2
103.6 KD -» mxrnAnti-Xpress
103.6 KD
Anti-PKP-2
5.5.6 Interaction of endogenous PG, p-catenin, DP, 
DSC-2 and DSG-2 with PKP-2 or missense PKP-2
The interaction o f endogenous plakoglobin in mPKP2 cells with over-expressed 
S140F PKP-2 appeared to be similar to its interaction with full-length PKP-2 in 
wPKP2 cells (representative of triplicate co-IP, Figure 5.18). The interaction of p- 
catenin however, appeared significantly reduced with S140F PKP-2 compared to its 
interaction with full-length PKP-2 (representative of triplicate co-IP, Figure 5.19). 
The co-immunoprecipitation of endogenous desmoplakin, desmoglein-2, and 
desmocollin-2 using anti-XPress antibody was unreliable resulting in variable 
immunoprecipitation o f all three endogenous proteins (data not shown). This was 
probably because of insufficient extraction of these membrane-associated or 
cytoskeletal-associated proteins under the conditions employed.
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Figure 5.18 Co-IP analysis using anti-XPress binding
of PKP-2 or missense PKP-2 to endogenous PG
Co-immunoprecipitation of XPress-tagged full-length PKP-2 or S140F PKP-2 with 
endogenous plakoglobin performed in transfected HEK 293T cells. Following 48 
hours after transfection of HEK 293T cells with pcDNA4 PKP2 or pcDNA4 S140F 
PKP2 plasmids (4pg/P90 dish), cells were scrapped off P90 dishes in lysis buffer 
(lOmM Tris HC1 pH 7.6, 145mM NaCl, 1 mM Na3V 0 4, and 1% triton X-100 + 
protease inhibitors). Soluble cell lysates (3mg) were taken for IP, with a prior pre­
clearing with Protein G-Sepharose at 4°C for 30 minutes on rotator. Three microgram 
of anti-XPress (mouse monoclonal anti-XPress antibody, Invitrogen) was added to the 
pre-cleared fraction and incubated on a rotator at 4°C for three hours. Fifty microliters 
of Protein G-Sepharose was added and incubation continued overnight at 4°C. 
Immuno-complexes were pelleted at 10,000g for 0.5 minute and washed thrice in low 
stringency PBS/inhibitor followed by a single wash in lysis buffer. Immuno- 
complexes were denatured in 3x Laemmli buffer followed by electrophoreses on a 
10% SDS PAGE and immunoblotting analysis using either 1:500 rabbit anti- 
plakoglobin antibody (Santa Cruz sc7900) and a 1:5000 mouse anti-rabbit-HRP 
conjugate (Invitrogen, UK) or 1:500 goat anti-human PKP-2 (reactive to a PKP-2 
peptide near the C-terminus, Insight Biotechnology, sc-18976) and 1:5000 rabbit anti­
goat HRP conjugate (Insight Biotechnology, BP5000) followed by incubation in ECL 
reagents and exposure to ECL Hyperfilm.
A) Triton X-100 cell lysates (equal amount, lOOpg) loaded on 10% SDS PAGE
S140F S140F S140F
PKP-2 PKP-2 PKP-2 PKP-2
PG equal loading
B) IP Probed for plakoglobin association with PKP-2 & S140F PKP-2
S140F PKP-2 SI40F S140F
No Anti Co-IP PKP-2 PKP-2
body IP - Anti- Co-IP Co-IP
control XPress Anti- Anti-
XPress c-myc control
PG co-IP reactions
C) Probe to determ ine relative amounts of PKP-2 or S140F PKP-2 
co-immunoprecipitated by anti-XPress antibody in cell lysates of 
pcDNA4 PKP2 and pcDNA4 S140F PKP2 transfected HEK 293T cells
PKP-2
S140F
PKP-2
PKP-2 co-IP reactions
103.6 KD full-length PKP-2 
or S140F PKP-2
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Figure 5.19 Co-IP analysis using anti-XPress binding
of PKP-2 or missense PKP-2 to endogenous p-catenin
Co-immunoprecipitation of XPress-tagged full-length or S140F PKP-2 with 
endogenous p-catenin performed in transfected HEK 293T cells. Following 48 hours 
after transfection o f 293T cells with pcDNA4 PKP2 or pcDNA4 S140F PKP2 
plasmids (4pg/P90 dish), cells were scrapped off P90 dishes in lysis buffer (lOmM 
Tris HC1 pH 7.6, 145mM NaCl, 1 mM NasVO^ and 1% triton X-100 + protease 
inhibitors). Soluble cell lysates (3mg) were taken for IP, with a prior pre-clearing with 
Protein G-Sepharose at 4°C for 30 minutes on rotator. Three microgram of anti- 
XPress (mouse monoclonal anti-XPress antibody, Invitrogen) was added to the pre­
cleared fraction and incubated on a rotator at 4°C for three hours. Fifty microliters of 
Protein G-Sepharose was added and incubation continued overnight at 4°C. Immuno- 
complexes were pelleted at 10,000g for 0.5 minute and washed thrice in low 
stringency PBS/inhibitor followed by a single wash in lysis buffer. Immuno- 
complexes were denatured in 3x Laemmli buffer followed by electrophoreses on a 
10% SDS PAGE and immunoblotting analysis using either 1:500 rabbit anti-p-catenin 
antibody (Abeam, ab2982) and 1:5000 mouse anti-rabbit-HRP conjugate (Invitrogen, 
UK) or 1:500 goat anti-human PKP-2 (reactive to a PKP-2 peptide near the C- 
terminus, Insight Biotechnology, sc-18976) and 1:5000 rabbit anti-goat HRP 
conjugate (Insight Biotechnology, BP5000) followed by incubation in ECL reagents 
and exposure to ECL Hyperfilm.
A) Triton X-100 cell lysates (equal amount, lOOpg) loaded on 10% SDS PAGE
S140F S140F S140F
PKP-2 PKP-2 PKP-2 PKP-2
|3-catenin equal loading
B) IP Probed for P-catenin association with PKP2 & S140F PKP2
S140F PKP-2 S140F S140F
No Anti Co-IP PKP-2 PKP-2
body IP - Anti- Co-IP Co-IP
control XPress Anti- Anti-
XPress c-myc control
P-catenin co-IP
C) Probe to determine relative amounts of PKP-2 or S140F PKP-2 
co-immunoprecipitated by anti-XPress antibody in cell lysates of 
pcDNA4 PKP2 and pcDNA4 S140F PKP2 transfected HEK 293T cells
PKP-2
S140F
PKP-2
PKP-2 co-IP reactions
<- 103.6 KD full-length PKP-2 
or S HOF PKP-2
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5.6 Discussion
Stable cell lines expressing S140F PKP-2 and full-length PKP-2 were analyzed by 
functional studies. Although the missense protein was expressed in tetracycline- 
induced mPKP2 cells, no significant differences were found in their proliferation, 
cell-cell adhesion, induced apoptosis to mechanical cell stretch and expression o f 
connexin-43 gap junctions compared to tetracycline-induced wPKP2, indicating that 
these cellular functions/processes were not disrupted by the expression of S140F 
PKP-2.
S140F PKP-2 was expressed in tetracycline-induced mPKP2 cells localizing at both 
the cell-cell contacts and within the nucleus in a pattern that was similar to that o f 
full-length PKP-2 in wPKP2 cells. The relative amounts of S140F PKP-2 and o f 
endogenous PKP-2 in sub-cellular protein fractions o f tetracycline-induced mPKP2 
cells could not be distinguished based on size alone using a monoclonal antibody 
raised against a sequence near the N-terminus of PKP-2 (BD Bioscience, P63420) as 
this antibody recognized both proteins with an identical molecular weight. The 
epitope of this monoclonal antibody is located between amino acid residues 19 to 183 
o f PKP-2 (BD Bioscience technical information). It is not known whether the S140F 
PKP-2 substitution affected the epitope recognition of this antibody, as fine amino 
acid residue mapping studies were not available to define its epitope (technical 
information, BD Bioscience). It seems unlikely however, that S140F substitution in 
PKP-2 protein affects the recognition of this protein using the BD Bioscience anti- 
PKP-2 antibody as pcDNA4 S140F PKP2 vector transient transfection o f HEK 293T 
cells and IP of this soluble cell lysate using anti-XPress antibody showed that the 
XPress-tagged S140F PKP-2 protein also reacted with an anti-PKP-2 polyclonal 
antibody (reactive to a human PKP-2 peptide near the C-terminus) correlating with 
the expected migration position of S140F PKP-2 in SDS PAGE immunoblotting 
analysis (Figures 5.18C and 5.19C).
A highly striking effect of S140F PKP-2 protein expression on desmosome 
morphology occurred in tetracycline induced mPKP2 cells with formation of 
extremely long desmosomes that ostensibly appeared to develop by fusion of 
neighbouring desmosome to form large intercellular junctions; such large intercellular 
junctions were absent in tetracycline-induced wPKP2 cells. Thus, S140F substitution
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in PKP-2 appears to cause a gain o f  function as formation of these long desmosomal 
structures in tetracycline-induced mPKP2 cells would implicitly activate/disrupt a 
signalling pathway involving PKP-2. The mechanism of the formation of these large 
intercellular junctions in induced mPKP-2 cells has not been investigated in the 
present studies however; it seems probable that the loss of a putative phosphorylation 
site on serine residue number 140 in the PKP-2 protein may affect a signalling role of 
this protein. Evidence in the literature suggests that amongst the plakophilins, a strong 
expression o f PKP-1 in the suprabasal layers o f epidermal keratinocytes correlates 
with an increase in desmosome stability, number and size, this role of PKP-1 was 
highlighted by mutations in PKP-1 gene resulting in the loss of PKP-1 protein 
expression in ectodermal dysplasia/skin fragility where desmosome numbers and size 
are reduced compared to those in normal individuals. This suggests a function for 
PKP-1 in regulating desmosome size and functional integrity222; PKP-2 is not known 
to influence the size o f desmosomes, and therefore, it is likely that the effect of S HOF 
PKP-2 on desmosome size in induced mPKP2 cells is mediated by an effect of this 
protein via protein-protein interactions essential for assembly of the desmosomal 
plaque components; this probably involves disruption/activation of a signalling 
function of PKP-2. PG is also known to regulate the size of desmosomes as 
expression of a PG protein truncated in the final ninety-two amino acids of the C- 
terminus causes formation o f extremely long junctions or groups of tandemly linked 
desmosomes in A431 cells249, similar to those found in tetracycline-induced mPKP2 
cells. The interaction between p0071/PKP-4 and the C-terminus of PG is thought to 
regulate the size of desmosomes . Thus, the formation of long desmosomes may be 
linked with the interference of any of a number of different types of proteins involved 
in the assembly of the desmosomal plaque, resulting in the disruption of a common 
signalling pathway.
The question also arises whether the large intercellular junctions seen in tetracycline- 
induced mPKP2 cells might be “mixed-type” junctions as cross-talk between adherens 
junctions and desmosomes exists to ensure their appropriate assembly and segregation 
at sites of cell-cell contacts. Several lines of evidence suggests that formation of
1 0 / »  1 1 1 C  i
adherens junctions is functionally linked to desmosome assembly ’ ’ ’ .
Blockade of adherens junction formation by an anti-E-cadherin antibody inhibits the 
formation of desmosomes in MDCK cells suggesting a cross-talk between adherens 
junctions and desmosomes251. A431D cells, a clonal variant of A431 epithelial cells,
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express the requisite desmosomal protein components, but lack a classical cadherin or 
a-catenin and are unable to assemble desmosomes. Re-expression of E-cadherin in 
A431D cells was insufficient to trigger desmosome assembly, but reintroduction of 
PG or an E-cadherin-PG chimera led to desmosome formation in these cells, 
suggesting that E-cadherin-PG complex may be important in the assembly of these
17Sjunctions . Formation of desmosome-like structures in the skin of PG knockout 
mice, however suggests that other proteins besides PG might be involved in the cross- 
talk affecting the dynamics of desmosome assembly . Other proteins such as 
p0071/PKP-4 (localized in the area composita of human ID137), P-catenin and PKP-2 
may compensate for this function of PG as all of these proteins have been shown to 
associate with proteins present in both adherens and desmosomal junctions ’ . The
regulated expression of p0071/PKP-4 is thought to important as this influences the 
size and number of the desmosomal and adherens junctions249.
The marked reduction in the interaction of endogenous P-catenin with S140F PKP-2 
in pcDNA4 S140F transfected HEK 293T soluble cell lysate raises the question 
whether P-catenin could be involved in signalling cross-talk between AJ and DS 
adhering junctions in induced mPKP-2 cells. Such a role for P-catenin was supported 
by a study showing that FLAG-tagged PKP-2a transiently expressed in SCC9 cells 
was associated with two of the endogenous adherens junction components, P-catenin
1113and E-cadherin . It is tempting to speculate that the reduced association of P-catenin 
with S140F PKP-2 might probably interrelate with the formation of long desmosomal 
junctions seen in tetracycline-induced mPKP2 cells, however further studies are 
needed to clarify this association in other cellular systems. The association between p- 
catenin and PKP-2 proteins seen in wPKP2 and mPKP2 induced cells seem especially 
pertinent in a cardiac context as large polar arrays of closely spaced or fused 
composite, plaque-bearing adhering junctions (the area composita) comprising of 
nearly 90% of the total ID area shows a strong co-localization of most protein 
components belonging to both assemblies of adhering junctions, as indeed, that which 
occurs between p-catenin and PKP-2137. The in vitro disruption of PKP-2 expression 
in the area composita of cardiomyocyte ID using siRNA-mediated reduction of PKP-2 
cardiomyocyte content242 highlights the central role of PKP-2 in the organization, 
formation, stabilization, and functions of the area composita, and of the ID, which
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undergoes structural remodelling in human arrhythmogenic right ventricular 
cardiomyopathy46.
Bioinformatics computer algorithms predict potential phosphorylation sites based on 
the consensus recognition sequence of known protein kinases, or based on the known 
phosphorylation sites in a homologous protein. The predicted sites are then verified by 
mutational analysis (genetic approach) or by immunological methods with antibodies 
that specifically recognise the predicted phosphorylation site. Unfortunately, the 
consensus recognition sites o f most protein kinases are not stringent enough to be very 
useful in predicting phosphorylation sites. Since protein kinases most likely recognize 
three-dimensional structures instead o f linear sequences in their substrates, a 
bioinformatics approach based on structural information is needed to accurately 
predict phosphorylation sites in proteins. NetPhos software predicted a potential 
phosphorylation site at serine residue number 140 in PKP-2 (section 3.4.1 part 1.8b) 
and although the relevance of this predicted post-translational modification of PKP-2 
is not known because modification at this serine residue has not been reported in the 
literature, it seems highly likely that phosphorylation predicted at this site might be of 
functional significance based on data derived from a genetic approach showing 
significantly reduced binding o f S140F PKP-2 with P-catenin by co-IP analysis, and 
the dramatic morphological change in desmosomes from tetracycline-induced mPKP2 
stable cells.
The cell-cell adhesion data obtained by measuring contact adhesion of labelled 
mPKP2 cells with homologous non-labelled cells cultured on coverslip and using the 
Dispase-based monolayer dissociation assay o f mPKP2 cells is an anomaly with 
respect to electron microscopy data, which showed presence of significantly longer 
desmosomes with dense filament association. As previously discussed (section 4.6), 
very little is known about cell-cell adhesion in HEK 293 cells and these cells express 
several different intermediate filament proteins resembling a cell line of an early 
neuronal lineage. The relevance of the apparent normal cell-cell adhesion of 
tetracycline-induced mPKP2 cells in the face o f abnormally long desmosomes in a 
cardiac context seems dubious as unlike in cardiomyocytes where desmin 
intermediate filament protein is expressed this is not the case in HEK 293 cells.
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It is not known whether the S140F PKP-2 protein is indeed expressed or incorporated 
into cardiac desmosomes o f patients affected with the C.C1604T PKP-2 gene mutation 
as heart tissue sample was not available from affected individuals in family G (section 
3.4.1 part 2.5). Based on the results o f the analysis of the exon 3 nucleotide sequences 
o f wild type and mutant PKP-2 by ESE finder (section 3.4.1 part 1.8a), it seems 
unlikely that an mRNA transcript encoding the S140F substitution would undergo 
NMD as an ESE element identified was not abolished by the sequence change. Hence, 
there was no predicted effect on the splicing of the mRNA transcript. Since C.C1604T 
PKP-2 gene mutation is a recurrent mutation it is possible that in future ARVC 
genetic screening heart tissue sample will become available from an affected 
individual. This will allow detection o f mRNA encoding the missense protein by 
reverse transcription polymerase chain reaction and the presence of S140F PKP-2 
protein in diseased heart lysate can be determined by western immunoblotting 
analysis. The incorporation o f S140F PKP-2 into the ID structures can be examined 
and its effect on the ultrastructure of desmosomes can be determined. The co­
localization and interaction o f S140F PKP-2 with other desmosomal and adherens 
junction proteins, including p-catenin can be performed to determine the 
characteristics o f cross-talk between these junctions.
5.7 Summary of main findings of the study
The cloning of S140F plakophilin-2 into pcDNA5 and pcDNA4 plasmid vectors is 
described utilizing the topoisomerase catalyzed reaction in the plasmid vector. Using 
S140F plakophilin cloned into a pcDNA5 vector, a stable cell line, mPKP2, was 
established in Flp-In T-Rex HEK 293 cells and the effect of expression of S140F 
plakophilin-2 in mPKP2 cells was characterized by the addition of tetracycline to 
overcome tet-repression.
Strong induction of full-length PKP2 (size 98.7 KD) was reported previously in 
wPKP2 cells (Chapter 4) with its expression localised to cell-cell contacts and in 
nucleus by confocal immunofluorescence staining. Sub-cellular protein fractionation 
of induced wPKP2 cells followed by Western immunoblotting analysis confirmed a 
predominant expression o f PKP2 in the cytoplasm, membrane, and cytoskeletal 
fractions, while some PKP2 associated with the nuclear protein fraction (Chapter 4).
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S140F PKP-2 (size 98.7 KD) was induced in mPKP2 cells and its expression 
localized to cell-cell contacts and in the nucleus by confocal immunofluorescence 
staining. Sub-cellular protein fractionation o f induced mPKP2 cells followed by 
Western immunoblotting analysis indicated strong association of missense 
plakophilin-2 in the cytoskeletal fractions and presence of this protein in the 
cytoplasm fraction. Equal amounts of S HOF PKP-2 compartmentalized in membrane 
and nuclear fractions.
Stable wPKP2 and mPKP2 cells proliferated to the same extent and expression of 
either full-length or missense plakophilin-2 did not affect their proliferation rates. The 
initial cell-cell adhesion of wPKP2 and mPKP2 cells showed no statistically 
significant difference when Calcein-labelled cells were allowed to adhere to 
homologous cell monolayer cultured on coverslips. Adhesive strengths of confluent 
monolayers of induced wPKP2 and mPKP2 cells assessed by Dispase-based cell 
dissociation assay did not show any difference in resistance to fragmentation based on 
visual assessment o f fragment sizes produced in sheared mPKP2 monolayer compared 
to those of wPKP2 monolayer. Mechanically stretched tetracycline-induced wPKP2 
and mPKP2 cells recovering from stretch exposure did not show a statistically 
significant difference in the induced apoptosis o f these cell lines. Triton X-100 soluble 
cell lysate western blot analysis o f wPKP2 and mPKP2 cells showed that Connexin- 
43 protein was strongly detected in non-induced and tetracycline-induced mPKP2 
cells and wPKP2 cells. Confocal microscopy examination of these induced cells 
confirmed localization of Connexin-43 to cell-cell contacts of both tetracycline- 
induced wPKP2 cells and mPKP2 cells. Examination o f Flp-In T-Rex HEK 293, 
tetracycline-induced wPKP2, and tetracycline-induced mPKP2 cells by transmission 
electron microscopy showed formation o f desmosomes in Flp-In T-Rex HEK 293 
cells, but these were not particularly robust. Desmosomes in tetracycline-induced 
wPKP2 were prominent (with dense plaque and filament association) however, whilst 
desmosomes in tetracycline-induced mPKP2 cells also appeared to be prominent and 
with dense filament association, the mean desmosomal length of these cells was 
statistically significantly longer compared to either Flp-In T-Rex HEK 293 or 
tetracycline-induced wPKP2 cells. Endogenous plakoglobin co-localization with 
S140F PKP-2 in cell-cell contacts o f tetracycline-induced mPKP2 cells was not
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significantly different to its co-localization with full-length PKP-2 in tetracycline- 
induced wPKP2 cells.
XPress-tagged transient protein expression o f full-length (size 103.6 KD) and 
missense (size 103.6 KD) PKP-2 in HEK 293T cells was obtained 48 hour after 
transfection with pcDNA4 vectors. Immunoprecipitation studies showed no 
differences in the amounts of plakoglobin associating with either missense PKP-2 or 
PKP-2. P-catenin however, showed significantly reduced association with missense 
PKP-2 compared to its association with PKP-2. Other endogenous desmosomal 
proteins such as DP, DSG-2, and DSC-2 did not co-IP reproducibly with the anti- 
XPress antibody and therefore the effects o f binding of these proteins to missense 
PKP-2 could not be determined.
5.8 Future Studies
Both the bioinformatics approach and a genetic approach strongly suggests that the 
S140F substitution probably affects a putative signalling function of PKP-2 hence a 
definitive confirmation of the phosphorylation o f the affected serine residue needs to 
be obtained by phosphopeptide analysis and Edman degradation of the labelled 
protein. Although the cellular characteristics of mPKP2 cells appeared not to be 
altered relative to those o f wPKP2 cells, the dramatic effect on desmosome formation 
in tetracycline-induced mPKP2 cells was unexpected. This effect of S140F PKP-2 
must be examined in other cell systems, such as SSC9, MDCK, and A431 cells, which 
would permit better quality co-localization data to be obtained by 
immunofluorescence confocal microscopy, verify the effect of S140F PKP-2 on the 
ultrastructure of desmosomes robustly formed in these cell lines, and allow protein- 
protein interactions to be examined between S140F PKP-2 and proteins present in the 
adherens junction.
The significance o f the reduced association of p-catenin with S140F PKP-2 needs to 
be examined in induced mPKP2 cell immunofluorescence staining confocal 
microscopy analysis to determine whether the co-localization of these two proteins is 
affected compared to the co-localization of p-catenin and full-length PKP-2 in 
induced wPKP2 cells. In order to overcome limitations of co-localizing missense and 
full-length PKP-2 proteins with potentially low endogenous amounts of P-catenin, co­
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transfection with plasmids encoding PKP-2 proteins and P-catenin in HEK 293T cells 
may be required. The co-localization o f S140F PKP-2 with other desmosomal 
proteins in induced mPKP2 cells as well as the co-IP o f the missense PKP-2 protein 
with other desmosomal proteins requires optimization using modified staining and co- 
IP protocols incorporating different detergent and/or buffers.
Isolated neonatal rat ventricular cardiomyocytes maintained in culture for up to 12 
days continue to synthesize myocardium-specific proteins, and remarkably most of 
the plaque proteins including DP, PG, PKP-2, p i 20, a-catenin, and P-catenin can still 
be localized at membrane structures showing a high degree o f co-localization in the 
area composita o f cardiomyocyte ID found in situ246. Transfection of rat 
cardiomyocyte cultures with plasmid or viral encoded S140F PKP-2 should allow the 
interaction of this protein with p-catenin and its consequence on the organization of 
the area composita at the ID to be determined in an in vitro relevant cardiac system.
A transgenic mouse model with a cardiac restricted expression of mutant desmosomal 
protein163 would be a useful in vivo approach to examine o f the effects of S HOF PKP- 
2 protein within the ID o f cardiomyocytes to determine the relevance of the in vitro 
data obtained from induced mPKP2 cells. Although the transgenic mouse model is a 
technically demanding system it offers several benefits allowing the effect of 
missense PKP-2 to be investigated within the area composita in a milieu of the 
molecular complexity o f this unique structure, examination of the effect of the 
missense protein on the ultrastructure o f area composita within the ID, and 
examination o f the cross-talk between different junctional protein components.
Immunoelectron microscopy using gold-conjugated antibodies against proteins 
specific for desmosomes and adherens junctions would be required to determine 
whether the long intercellular junctions in induced mPKP2 cells might be “mixed- 
type” junctions.
A working hypothesis has emerged from functional studies undertaken in mPKP2 
cells suggesting that substitution of serine amino acid residue at position 140 with the 
loss of a putative phosphorylation could be related to the formation o f abnormal long 
desmosomes with prominent filament association. The weak association o f missense 
PKP-2 protein with p-catenin may participate in a speculated cross-talk between
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adherens junctions and desmosomes in mPKP2, which seems relevant in polar 
epithelial cells where AJ and desmosomes are present as discreet junctions however, 
in cardiomyocyte ID such a molecular cross-talk may be of a greater relevance 
because of the intimate association of these protein assemblies along the area 
composita246. Non-cadherin bound P-catenin can participate in the Wnt-signalling 
pathway through the interaction of TCF/Lefl transcription factors176 and since PKP-2 
co-precipitates a non-cadherin pool of p-catenin, it raised the possibility that PKP-2 
might be involved in regulating p-catenin/TCF signalling. Evidence for this role of 
PKP-2 was obtained in a human colon carcinoma cell line with constitutive p- 
catenin/TCF transcription activity in which over-expression of PKP-2 strongly 
elevated activation of TOPFLASH reporter compared to reporter plasmid only 
control; the activation of TOPFLASH was also shown to be competitively abolished 
with simultaneous over-expression o f both PKP-2 and E-cadherin183. Future studies in 
mPKP-2 and w PKP-2 cells should include determination of the roles of over­
expressed full-length and missense PKP-2 on Wnt-signalling.
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Chapter 6 
Functional Studies of Q273fsX288 
Desmoplakin protein expression in tDP cells
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6.1 Introduction
Genetic screening of the ARVC cohort identified two separate DP gene mutations that 
caused reading ffame-shifts resulting in the truncation of translated DP proteins in the 
SR4 spectrin repeat of the plakin domain o f DP (Table 3.4). One of these mutations 
c.818_819insA (p.Q273fsX288 DP) showed incomplete penetrance with variable 
clinical ARVC expression (family I, Chapter 3). Expression of a DP polypeptide with a 
predicted size of about 33KD might form in patient heart if an mRNA transcribed from 
the mutant DP gene was translated. Additionally, both full-length DP and Q273fsX288 
may be present in patient tissue sample as only one allele was affected by the 
c.818_819insA mutation. The Q273fsX288 DP polypeptide encodes a small part of the 
N-terminal domain of DP while the rod region, intermediate filament-binding plakin 
repeats (A, B and C), and a glycine-serine-arginine rich domain (GSR) are missing.
An mRNA transcribed from a DP gene carrying the c.818_819insA mutation is rather 
likely to undergo NMD resulting in DP haploinsuffrciency. Heterozygous mouse 
models with a cardiac-restricted over-expression o f a mutated desmosomal gene would 
be especially suitable for studying frame-shift mutations that undergo NMD, but such a 
study was not feasible under this project proposal. However, as small amounts of the 
affected DP transcript might escape NMD surveillance this could result in the formation 
of a severely truncated DP polypeptide. The study described in this chapter examines 
the effect of truncated Q273fsX288 DP polypeptide expression on cellular 
characteristics of Flp-In HEK 293 stable cells.
6.2 Experimental approach to investigate functional 
effect of Q273fsX288 DP protein expression
Cloning of DNA fragment encoding a small fragment of the DP gene incorporating the 
final codon for W at position 358 and o f a DNA encoding full-length DP was performed 
in pcDNA5 vector. SDM of pCDNA5 vector incorporating the small DP DNA fragment 
was performed to obtain pcDNA5 vector encoding the sequence for Q273fsX288 DP 
polypeptide. Polyfect-mediated cationic transfection of pcDNA5 plasmids allowed 
selection of stable cell clones to express either full length or truncated DP proteins 
under the control o f an established tet-on system in Flp-In T-Rex HEK 293 cells.
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Several studies were performed using stable cells expressing full-length (designated 
wDP cells) and truncated DP (designated tDP cells):
1) Expressions of full-length or truncated DP proteins were confirmed by confocal 
microscopy and western immunoblotting analysis in wDP and tDP cells. The 
distribution of full-length and truncated DP proteins were examined in different 
cellular compartments o f induced wDP and tDP cells (in cytosol, membrane, 
nuclear, and cytoskeletal fractions) using a Qiagen cell compartment kit.
2) Properties of wDP and tDP cells were examined to compare cellular 
proliferation rates using a colorimetric assay and their response to induced 
apoptosis under mechanical cell-stretch using a CaspACE assay system.
3) The co-localizations o f endogenous PKP-2 and PG with either full-length or 
truncated DP were examined by confocal microscopy analysis of tetracycline- 
induced wDP and tDP stable cells respectively.
4) The interaction o f either full-length DP or truncated DP with endogenous PG 
and PKP-2 proteins was determined by immunoprecipitation analysis of 
detergent solubilised cell lysates o f induced wDP and tDP stable cells using a 
polyclonal antibody directed against an N-terminus sequence of DP.
5) The sub-cellular distribution of endogenous PG and PKP-2 proteins were 
determined in tetracycline-induced wDP and tDP cells to establish whether these 
protein distributions in different fractions were altered by the expression of a 
truncated DP polypeptide.
6) Desmosomes in tetracycline-induced wDP and tDP cells were examined by 
transmission electron microscopy and compared with desmosomes in control 
non-transfected Flp-In T-Rex HEK 293 cells to determine whether DP 
polypeptide protein expression affected the morphology of these desmosomes
7) The strength of cell-cell adhesion in tetracycline-induced wDP and tDP 
monolayers were assessed using an established Dispase-based monolayer 
dissociation assay212 to determine if  this was altered by the expression of a DP 
polypeptide.
8) The vimentin intermediate filament network was examined in tetracycline- 
induced wDP and tDP stable cells by immunofluorescence staining and confocal 
microscopy analysis to determine if  the organization of this cytoskeletal protein 
was altered by expression of DP polypeptide.
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6.3 Experimental Aims
Eleven overall objectives were set in this part o f the study. The first was to construct a 
pcDNA5/FRT/TO/TOPO/TA plasmid encoding a DP DNA fragment of Q273fsX288 
DP using site directed mutagenesis of a cloned 1094 bp partial DP DNA fragment in 
pcDNA5 plasmid. The second was to clone a PCR fragment encoding full-length DP in 
pcDNA5 vector. The third was to establish stable cell lines in Flp-In TRex HEK 293 
that express Q273fsX288 DP and full-length DP under the control of a tet-on system. 
The fourth was to verify the expressions o f Q273fsX288 DP and full-length DP in these 
stable cell lines using immunofluorescence staining confocal microscopy analysis and to 
determine the distribution o f full-length or truncated DP in sub-cellular fractions of 
these stable cells using a cell compartment kit. The fifth was to examine the 
proliferation rates o f these stable cell lines and to determine their response to induced 
apoptosis upon mechanical cell-stretch. The sixth was to determine the 
immunofluorescence co-localization of endogenous PG and PKP-2 proteins with either 
full-length or truncated DP in stable cells. The seventh was to determine the interactions 
o f either endogenous PG or PKP-2 with full-length or truncated DP proteins using co- 
immunoprecipitation analysis. The eighth was to determine the sub-cellular distributions 
o f endogenous PG and PKP-2 proteins in induced wDP and tDP cells. The ninth was to 
examine desmosomes in non-transfected Flp-In T-Rex HEK293 and in induced wDP 
and tDP stable cells. The tenth was to determine the Dispase-based monolayer 
dissociation adhesion strengths of these induced stable cell lines. The eleventh was to 
examine the vimentin IF network in wDP and tDP stable cell lines.
6.4 Materials and Methods
A goat anti-human DP polyclonal antibody was purchased from Santa Cruz 
Biotechnology (product sc-18082). All other reagents including cell culture media, 
supplements, and antibiotics were purchased from Invitrogen, UK. Low melting point 
agarose was purchased from Sigma Aldrich, UK.
6.4.1 Cloning of DP and Q273fsX288 DP in 
pcDNA5/FRT/TO/TOPO/TA
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A plasmid, PI 140 (map shown in Figure 6.1), containing a cloned desmoplakin DNA 
with an 5’ UTR ( a gift kindly provided by Professor Kathleen Green, Department of 
Pathology, Dermatology and RH Lurie Cancer Centre, Northwestern University, USA) 
was used for obtaining DP DNA sequences by PCR. PI 140 was used as a template 
DNA in EXL DNA polymerase reaction (primer sequences in Table 6.1) to generate a 
DP PCR fragment, 8.633kbp in length, which contained a Kozak recognition sequence 
before the ATG start site and a TGA stop codon. The amplified DP PCR fragment 
lacked the untranslated UTR sequence found in PI 140. This DP PCR fragment was 
cloned into pcDNA5/FRT/TO/TOPO/TA (section 2.2.1) to generate plasmid pcDNA5 
DP. An another DP PCR fragment was generated by EXL DNA polymerase using the 
plasmid PI 140 as template, this PCR product incorporated the ATG start site preceded 
by the Kozak recognition sequence and flanked on the 3’ site by a triplet nucleotide 
sequence completing the encoding o f amino acid W at position 358 (Ensemble 
transcript ID: ENST0000021199). The PCR product (1094bp) also contained Kpnl and 
Bam HI restriction nucleotide sequences incorporated at the 5’ and 3’ positions 
respectively. The 1094bp DP PCR product was cloned into 
pcDNA5/FRT/TO/TOPO/TA utilising the topoisomerase-catalyzed reaction to generate 
plasmid pcDNA5 1094 DP.
6.4.2 Site-directed mutagenesis to obtain Q273fsX288 
DP encoded in pcDNA5/FRT/TO/TOPO/TA
Plasmid pcDNA5 1094 DP was used as a template in SDM (section 2.3) using 
mutagenic primers (Table 6.1) to generate plasmid pcDNA5 1094 mutA DP that 
contained an insertion of an Adenosine residue c.818 819 insA (accession number 
NM 004415) predicted to cause a reading frame-shift resulting in a predicted truncation 
o f the translated DP polypeptide (Q273fsX288 DP). Plasmids pcDNA5 DP, pcDNA 
1094 DP and pcDNA5 1094 mutA DP were sequenced to verify the cloned desmoplakin 
DNA sequence orientations and to confirm the reading frames in plasmids pcDNA5 DP 
and pcDNA5 1094 mutA DP.
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6.4.3 Establishing stable cell lines expressing full- 
length DP and Q273fsX288 DP
Stable cell lines were established in Flp-In T-Rex HEK293 cells using pcDNA5 DP and 
pcDNA5 1094 mutA DP plasmids according to procedures described (section 2.5.4) to 
obtain full-length DP and Q273fsX288 DP protein expressions upon tetracycline- 
induction. At least five different clones o f each stable cell line established were selected 
and clonally expanded, and a stable cell clone characterized with strong tetracycline- 
induced protein expression by immunofluorescence staining (section 2.7.2) and western 
blotting (section 2.6.2) was selected for functional studies. Based on these criteria two 
stable cell clones were selected: clone wDP expressed full-length DP and clone tDP 
expressed Q273fsX288 DP.
294
Figure 6.1 Map of plasmid P1140 encoding full-length 
DP
Plasmid PI 140 was kindly supplied by Professor Kathleen Green (Northwestern 
University, Illinois, USA). It contained a full-length desmoplakin coding sequence 
preceded by a 5’ UTR sequence of DP. A FLAG epitope was incorporated at the end of 
the C-terminus of desmoplakin. The plasmid DNA was sequenced to verify that the 
entire desmoplakin-coding region was free of nucleotide errors. The plasmid was 
utilized as a template in a PCR reaction to obtain an 8633 bp amplicon that was cloned 
into a pcDNA5 plasmid expression vector (Table 6.1), which was used for establishing 
stable cells expressing DP used as a control for functional studies of Q273fsX288 DP 
expression. Plasmid map was reproduced courtesy of Professor Kathleen Green 
(Northwestern University, Illinois, USA).
P - 1 1 4 0
AMP
£MW EcoRl (920)
DP insert 5' utr
BsKI  (10369)
p l l 4 0  DP.FLAG
13593 bp
Kpii (9900) 
£coRI (9828)
CM (7743) DPI Code
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Table 6.1 Cloning in pc DNA5/FRT/TO/TOPO/TA of full-length DP and a fragment of 1094 bp 
DP to obtain pcDNA5 e ncoding Q273fsX288 DP by site-directed PCR mutagenesis
Cloning of full-length desmoplakin and a 1094 bp desmoplakin fragment into pcDNA5/FRT/TO/TOPO/TA vector and SDM to obtain a 
pcDNA5 plasmid encoding the desmoplakin mutation Q273fsX288. PCR primers DSP for and DSP rev were used to generate an 8633bp 
fragment using PI 140 as a tem plateThis desmoplakin PCR fragment encoded the entire full-length desmoplakin sequence lacking the 5’ UTR. 
It contained a Kozak recognition ssquence preceding the ATG translation start site. A termination stop codon, TGA, was incorporated in the 
reverse primer. The resulting plasmid obtained designated pcDNA5 DP was sequenced to confirm nucleotide sequence of the encoded DP DNA 
insert. A 1094 bp fragment of desmoplakin was amplified using primers shown with PI 140 as a template. This 1094 bp fragment was cloned in 
pcDNA5/FRT/TO/TOPO/TA to give a plasmid pcDNA5 1094 DP. Plasmid pcDNA5 1094 DP was used a template in a SDM reaction using 
primers shown which incorporated the insertion of a single Adenosine residue in the plasmid obtained (pcDNA5 1094 mutA DP) encoding a 
frame-shift in the translated desmoplakin polypeptide resulting in the expression of a 33KD Q273fsX288 desmoplakin fragment. Plasmids 
pcDNA5 DP and pcDNA5 1094 mutA DP were used for establishing stable cell lines in Flp-In HEK 293 cells permitting the over-expression of 
DP and Q273fsX288 DP in a tetracycline-inducible culture system.
Primer Sequence (5’-3’) PCR size (bp)/ Destination vector PCR 
product cloned into
Plasmid
obtainedPairs Enzyme used/ Template
DSP for GGTACCGAAATGGGCTGCAACGGAGGCTCC 8633/ 
ACCUTAQ/ P1140 pcDNA5/FRT/TO/TOPO/TA pcDNA5 DP
DSP rev GCGGCCGCCTAGTGCCCAAT AGAACTACTGC
1094 
DSP for
CGGGGTACCGAAATGGGCTGCAACGGAGGCT 1094/ 
EXL/P1140 pcDN A5/F RT/T O/T O PO/TA pcDNA5 1094 
DP
1094 
DSP rev
CGCGGATCCCACT GCGT CT G CAGAGT GTCC
1094 
mutA 
DSP for
GGATCACCTGCGACAGCTGCAAGAACATCATTCAGGCCACGTC 1094/
EXL/1094 pcDNA5 pcDNA5/FRT/TO/TOPOyTA pcDNA5 1094 
mut A DP
1094
mutA DSP 
rev
GACGTGGCCT GAATGAT GTT«3TT GCAGCT GTCGCAGGT GATCC
6.5 Results
6.5.1 Cloning of DP in pcDNA5/FRT/T0/T0P0/TA
Cloning o f desmoplakin full-length PCR fragment into pcDNA5 was a particularly difficult 
procedure because the PCR fragment encoding full-length DP was a large amplimer (~8.7Kb) 
which easily fragmented during cloning. Multiple steps were followed for successfully 
cloning o f ftdl-length DP DNA. The PCR fragment obtained using high fidelity AmpliTaq LA 
DNA polymerase was electrophoresed in a low melting temperature agarose gel (Sigma 
Aldrich, UK) without the use o f ethidium bromide staining and exposure to ultraviolet light to 
minimise photolysis o f the amplified PCR fragment. The low melting point agarose facilitated 
the release o f the PCR fragment into solution without the use of gel purifications kits ensuring 
that further handling o f the PCR product was avoided. The solubilised PCR fragment obtained 
from a low melting point agarose gel slice was used directly in the pcDNA5 cloning reaction. 
The ratio o f purified DP PCR fragment: plasmid vector was meticulously optimized for 
successful insertion o f the full-length DP fragment into pcDNA5 T/A cloning site. Very large 
numbers o f isolated recombinant plasmids had to be screened because partial DP PCR 
fragments cloned more efficiently and plasmid re-circularization without an insert occurred 
frequently. The sequence o f the cloned full-length DP had to be checked to verify that this 
was free from PCR derived errors, a task that was not trivial given the large size of the 
nucleotide sequence encoding full-length DP.
6.5.2 Characterization of DP and Q273fsX288 DP 
expressions in stable cell lines
Stable wDP and tDP cells expressed endogenous DP I and II (DP II lacks most of the 
dimerization coiled-coil rod DP domain) proteins constitutively. However, upon tetracycline 
induction o f wDP cells, full-length DP I was over-expressed localizing at a sub-membranous 
location (Figure 6.2A) within these cell-cell contacts by immunofluorescence staining 
confocal microscopy analysis (consistent with the location of DP at the juncture between 
intermediate filament network and the cytoplasmic tail of the transmembrane desmosomal 
cadherins, Figure 1.6d) and detected as a strongly induced band o f 250 KD (predicted size 
based on protein sequence was 330KD) by SDS PAGE analysis (Figure 6.3A). The Plakin 
family o f proteins are all known to run aberrantly on SDS PAGE gels with their size estimates
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being significantly lower than the predicted molecular weight based on cDNA sequence data131. 
The DP I isoform was chosen to be over-expressed in wDP cells as only this isoform was able to 
form a DP protein dimer. In tetracycline-induced tDP cells, Q273fsX288 DP was over-expressed 
localizing as punctate staining by immunofluorescence staining confocal microscopy analysis 
suggesting a membrane localization of the induced DP polypeptide (Figure 6.2B). Q273fsX288 
DP was detected as a strongly induced band o f 33 KD by SDS PAGE immunoblotting analysis 
(Figure 6.3B), which correlated with the predicted size o f the DP polypeptide. Tetracycline 
induction o f tDP cells did not appear to significantly alter the amount of endogenous DP I and II 
proteins (Figure 6.3B).
6.5.3 Sub-cellular localization of DP and Q273fsX288 DP in 
induced wDP and tDP stable cell lines
Sub-cellular fractions obtained from induced wDP cells showed that over-expressed DP I was 
primarily found in the cytoskeletal protein fraction with presence of endogenous DP I and II 
proteins in the cytoplasm protein fraction; over-expressed DP I was not present in either the 
membrane (confirming the sub-membranous immuno-localization of DP 1 by IF, Figure 6.2A) or 
nuclear protein fractions of induced wDP cells (Figure 6.4A). In tetracycline-induced tDP cells 
endogenous DP I and DP II proteins constitutively expressed were present in the cytoplasm and 
the cytoskeletal protein fractions, but not in the membrane or nuclear protein fractions. Over­
expressed Q273fsX288 DP (the band present in all four fractions on the bottom part of Figure 
6.4B) however, was present in the cytoplasm, membrane, cytoskeletal, and surprisingly, also in 
the nuclear fraction of induced tDP cells. A bioinformatics program, Predict NLS online 
(http://cubic.bioc.columbia.edu/cgi/var/resonline.pB analysis o f the polypeptide sequence of 
Q273fsX288 DP did not reveal presence o f known nuclear localization signals in this polypeptide 
(data not shown). However, the presence of this polypeptide in the nuclear protein fraction of 
induced tDP cells does not appear to be an artefact resulting from a significant cross­
contamination with the membrane fraction because assessment o f the purity of each of these four 
protein fractions using specific protein marker distribution showed minimal cross-contamination 
(Figure 6.5). The sub-cellular fractionation was carried out according to the Qproteome 
recommended protocol (section 2.5.7, Qproteome handbook available online), which was 
reportedly tested and shown to give reliable separation of protein fractions in cell compartments 
derived from a wide variety o f cells including, HeLa, Jurkat, NIH-3T3, COS as well as HEK 293 
cells (references to publications contained in Qiagen Qproteome handbook).
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Figure 6.2 Immuno-localisation of full-length DP and 
Q273fsX288 DP in wDP and tDP cells by confocal microscopy
Localization of protein expression of full-length DP and Q273fsX288 in non-induced and 
tetracycline-induced wDP (A) and tDP (B) stable cell lines respectively. Immunofluorescence 
images showing blue fluorescence signal resulting from DAPI nuclear staining, green fluorescence 
resulting from FM 1-^3FX membrane dye staining, red fluorescence resulting from 
Q273fsX288DP or full-length DP staining with 1:200 goat polyclonal antibody to human 
desmoplakin reactive to a region near the N-terminus of the molecule (Santa Cruz, sc-18082) and an 
Alexa fluor-546 conjugated donkey anti-goat antibody (Invitrogen) and merge representing 
composite signals. The white size bar on each image in the green channel represents 8pm.
A) wDP cells non-induced
DAPI M em brane DP Merge
wDP cells tetracycline-induced 
DAPI M em brane DP Mergemm1Hi
B) tDP cells non-induced
DAPI Membrane DP Merge
ifll
tDP cells tetracycline-induced 
DAPI M em brane DP Merge
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Figure 6.3 Western blot analysis of the expressions of 
full-length DP and Q273fsX288DP in wDP & tDP cells
Analysis o f  expressions o f  full-length DP and Q273fsX288 DP in non-induced (NI) or 
tetracycline-induced (IND) wDP (A) and tDP (B) triton X-100 soluble stable cell 
lysates determined by western blotting technique. A goat polyclonal antibody to 
human desmoplakin (1:500 dilution, Santa Cruz, sc-18082) was used followed by a 
rabbit anti-goat HRP conjugate (1:5000 dilution, Insight Biotechnology, BP5000). 
Blots were exposed to ECL reagents (GE Healthcare) and developed using Kodak 
reagents. The migration o f  protein markers (Precision Plus protein standards, BioRad 
Laboratories, UK) are indicated on the right hand side o f the blots. The apparent SDS 
PAGE migration sizes o f endogenous DP protein bands in non-induced wDP cells are 
smaller than the predicted protein sizes.
A) wDP Cells B) tDP cells
<-33 KD Q273fsX288 DP
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Figure 6.4 Sub-cellular localization of full-length and 
Q273fsX288 DP in wDP and tDP cells
Sub-cellular distribution o f over-expressed full-length DP I and over-expressed 
Q273fsX288 DP in cytosolic (CYT), membrane (MEM), nuclear (NUC) and 
cytoskeletal (CSK) protein fractions determined by SDS PAGE and immunoblotting 
analysis these fractions derived from tetracycline-induced (O.lpg/ml, 72hrs) wDP (A) 
or tDP (B) stable cells respectively. Sub-cellular protein fractions were obtained from 
5x l06 cells using the Qproteome cell compartment kit (Qiagen, UK). Each protein 
fraction was precipitated in 4 volumes of acetone (-20°C) and the pellet was 
resuspended in 100 pi RIP A containing cocktail o f protease inhibitors (Roche). 175th 
o f each protein fraction was electrophoresed in a 10% SDS PAGE gel and transferred 
onto a Hybond ECL membrane. Following blocking of blot in TBST/5% milk, it was 
incubated with 1:500 goat anti-human Desmoplakin I/II (Santa Cruz Biotechnology, 
sc-18082) at 4°C overnight. Blot was washed in TBST followed by incubation in 
1:5000 rabbit anti-goat HRP conjugate (Insight Biotechnology, BP5000). After 
washing the blot in TBST, it was exposed to ECL reagents (GE Healthcare) and 
developed using Kodak reagents.
A) Induced wDP cells B) Induced tDP cells
CSK NUC MEM CYT CSK NUC MEM CYT
r -
301
Figure 6.5 Assessment of purities of protein fractions 
of cytoplasmic, membrane, nuclear and cytoskeletal 
obtained from tetracycline-induced tDP cells using the 
Qproteome cell compartment kit
Assessment o f purities o f  fractionated sub-cellular protein fractions obtained from 
tetracycline-induced tDP cells using the Qproteome cell compartment kit (Qiagen, 
UK). 5 xlO6 cells were fractionated according to the manufacturer’s protocol. Each 
protein fraction was precipitated by the addition o f four volumes of acetone (-20°C), 
and following precipitation the pellet was resuspended in an equal final volume o f 100 
pi in RIP A buffer. l/5 th o f  each protein fraction was separated under reducing and 
denaturing conditions in a 10% SDS PAGE system. Proteins were blotted from the 
gels onto ECL Hybond membranes using semi-dry transfer method in TGM transfer 
buffer. Blots were blocked in TBSTM buffer and incubated for one hour in 1:1000 
mouse anti-human a-tubulin (Sigma Aldrich, T5168), or 1:500 dilution of the 
following antibodies: mouse anti-human N cadherin (Zymed, 33-3900), or mouse 
anti-human cyclin D1 (Abeam, ab6152), or mouse anti-human cytokeratin-18 (Santa 
Cruz Biotechnology, sc-6259). Following washing o f the blots in three changes of  
TBST buffer for 20 minutes each, blots were incubated for one hour in 1:5000 rabbit 
anti-mouse-HRP. Blots were washed in three changes of TBST buffer and incubated 
in ECL reagents followed by exposure to ECL Hyperfilm and development using 
Kodak reagents. Fractions analyzed were: cytoplasm (CYT), membrane (MEM), 
nuclear (NUC), and cytoskeletal (CSK).
CYT M EM  NUC CSK
a-tubulin  50 KD
N-Cadherin 127 KD
Cyclin D1 32 KD
Cytokeratin-18 45KD
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6.5.4 Cellular proliferation and effect of mechanical
stretch on wDP and tDP cells
Cellular proliferation of wDP and tDP cells did not appear to be substantially altered 
by the expressions o f full-length or Q273fsX288 DP respectively as comparable 
values of the slopes were obtained by regression analysis of the data in tetracycline- 
induced cell lines (Figure 6.6). Stable wDP and tDP cells subjected to mechanical 
cell-stretch and then allowed to recover for a short while did not show statistical 
differences in the induced specific apoptosis activity of these cells (Figure 6.7). The 
magnitude o f applied mechanical cell stretch in wDP and tDP cells was slightly higher 
(5%) compared to 4%  stretch used in mechanical stretch experiments chapters 4 and 5 
because the Flexer cell apparatus relies on a tight vacuum seal being established, 
introducing a variation in the actual recorded mechanical stretch achieved. A 
marginally longer duration of stretch (four hours) and a higher cell plating density 
(1.5X106) o f wDP and tDP cells was used in these stretch experiments compared to 
stretch experiments in chapters 4 and 5.
6.5.5 Immuno-staining co-localization of PG or PKP-2 
with DP or Q273fsX288 DP
Immunofluorescence staining confocal microscopy co-localization of endogenous PG 
with DP and Q273fsX288 DP in induced wDP and tDP cells respectively showed that 
PG co-localized in these cells to a similar extent (Figure 6.8A & B). The co­
localization of endogenous PKP2 with DP and Q273fsX288 DP occurred to a similar 
extent in induced wDP and tDP cells (Figures 6.8C & D).
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Figure 6.6 Proliferation of wDP and tDP cells
Cellular proliferation o f stable cell lines wDP and tDP over-expressing full-length and 
truncated DP proteins respectively. 60,000 cells were plated in a twenty-four well 
plate and allowed to attach overnight. Cell proliferation was measured 
spectrophotometrically at 490nm by measuring the reduction o f Cell Titer AQ One 
solution (Promega Corporation, UK) after incubation with cells for exactly one hour. 
The measured cell growth indicated no significant differences in the proliferation rates 
o f non-induced or induced wDP and tDP cells. The values o f the slopes were: 0.0134, 
0.0137, 0.0131, and 0.0139 for wDP NI, wDP IND, tDP NI and tDP IND cells 
respectively.
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Figure 6.7 Effect of mechanical cell stretch on
apoptosis of wDP and tDP stable cells
Effect o f mechanical cell stretch on measured apoptosis of recovering wDP and tDP 
stable cells expressing DP or Q273fsX288 DP. Apoptosis levels are mean values of n 
= 6 experiments + standard deviations. The CaspACE assay system (Promega, UK) 
was used to measure the specific caspase-3 activity in cell lysates of cells subjected to 
mechanical stretch using the Flexer cell-stretch system with 5% cell-stretch applied at 
a frequency of 1Hz for 4 hours. Paired student’s t test p values comparing mean 
apoptosis were: wDP NI versus wDP IND, p=0.502; tDP NI versus tDP IND, 
p=0.826; wDP IND versus tDP IND, p=0.951. Cells were allowed to recover for 3 
hours prior to measuring caspases-3 activity. Initial cell plating density was 1.5 xlO6 
cells/six well plate and cells were cultured for 48 hours.
Susceptibility of wDP and tDP cells to apoptosis 
following 5.0*» cell-stietch foi 4his at 1Hz
1Q00 | p= 0-502 | _________ |p -0 .S 2 6  |
900
wDPM wDPIND tDP NI tDP ND 
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Figure 6.8 Co-localization of PG or PKP-2 with full-length DP and Q273fsX288 DP in
induced wDP and tDP cells
Confocal microscopy co-localization of PG and PKP-2 in tetracycline-induced wDP and tDP cells over-expressing full-length DP and 
Q273fsX288 DP respectively. A) & B) shows endogenous plakoglobin co-localization with desmoplakin proteins while C) & D) shows 
endogenous plakophilin-2 co-localization with desmoplakin proteins. Images were obtained using x40 oil immersion objective lens.
A) Full-length DPI endogenous PG co-localization in induced wDP cells
Green= full-length DP Red= Plakoglobin Overlay = merged____
u>
o
ON
B) Q273fsX288 DP/endogenous PG co-localization in induced tDP cells
Green= Q277fsX288DP Red= Plakoglobin Overlay = merged
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Figure 6 . 8  c o n t in u e d
C) Full-length DP/endogenous PKP-2 co-localization in induced wDP cells
Green= full-length DP Red= Plakophilin-2 Overlay = merged________
D) Q273fsX288 DP/endogenous PKP-2 co-localization in induced tDP cells
Green= Q273fsX288 DP Red= Plakophilin-2 Overlay = merged
6.5.6 Interaction of endogenous PG or endogenous 
PKP-2 with DP or Q273fsX288 DP
The amount of endogenous plakoglobin interacting with full-length DP and 
Q273fsX288 DP did not appear to be significantly different in wDP and tDP cell 
lysates respectively (Figure 6.9) even though the amount of DP and Q273fsX288 DP 
that was immunoprecipitated by the goat-anti DP antibody from wDP and tDP cell 
lysates were comparable. The amount of endogenous PKP-2 interacting with full- 
length DP and Q273fsX288 DP did not seem to be significantly different in induced 
wDP and tDP cell lysates (Figure 6.10), albeit comparable amounts of full-length DP 
and Q273fsX288 DP were immunoprecipitated by the goat-anti DP antibody from 
wDP and tDP cell lysates. The lack of a difference in the binding of PG and PKP-2 
with either DP or Q273fsX288 DP suggests that the truncated DP polypeptide retains 
the binding sites for both PG and PKP-2, which is in agreement with EM data (section 
6.5.8) suggesting that Q273fsX288 DP is able to form normal ODP in desmosomes of 
induced tDP cells.
6.5.7 Distribution of PG and PKP-2 in sub-cellular 
fractions of induced wDP and tDP cells
Sub-cellular fractions of induced wDP and tDP cells obtained using the Qproteome 
cell compartment kit (Qiagen, UK) were analyzed by western immunoblotting 
analysis to determine the distribution of endogenous either PG or PKP2 in each of the 
four sub-cellular fractions obtained from these cells. Plakoglobin distribution (Figure 
6.11) did not appear to be significantly different in any of the four sub-cellular 
fractions (cytoplasm, membrane, nuclear and cytoskeletal) derived from either induce 
wDP or induced tDP cells. The distribution of PKP-2 (Figure 6.12) also did not 
appear to be significantly different in any of the four sub-cellular fractions derived 
from either induced wDP or induced tDP cells
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Figure 6.9 Co-IP analysis using goat anti-human DP
binding of DP or truncated DP to endogenous PG
Co-immunoprecipitation of full-length DP or Q273fsX288 DP with endogenous PG 
performed in tetracycline-induced wDP and tDP cell lysates. Following induction of 
expression of respective desmoplakin protein over-expression, stable cells were 
scrapped off P90 dishes in lysis buffer (lOmM Tris HC1 pH 7.6, 145mM NaCl, and 
1% triton X-100 + protease inhibitors). Soluble cell lysates (3mg) were taken for IP, 
with a prior pre-clearing with Protein G-Sepharose at 4°C for 30 minutes on rotator. 
Twelve microgram o f sc 18082 (goat anti-human DP antibody) was added to the pre­
cleared fraction and incubated on a rotator at 4°C for three hours. Fifty microliters o f 
Protein G-Sepharose was added and incubation continued overnight at 4°C. Immuno- 
complexes were pelleted at 10,000g for 0.5 minute and washed thrice in low 
stringency PBS/inhibitor followed by a single wash in lysis buffer. Immuno- 
complexes were denatured in 3x Laemmli buffer followed by electrophoreses on a 
10% SDS PAGE and immunoblotting analysis using an anti-plakoglobin antibody at 
1:500 dilution (Santa Cruz sc7900) and a goat anti-rabbit-HRP conjugate at 1:5000 
dilution (Invitrogen) followed by incubation in ECL reagents and exposure to ECL 
Hyperfilm.
A) Triton X-100 cell lysates (equal amount, lOOpg) loaded on 10% SDS PAGE 
tDP wDP tDP wDP
PG equal loading
B) IP Probed for plakoglobin association with DP & Q273fsX288 DP
tDP wDP tDP wDP
No Anti­ Co-IP Co-IP Co-IP
body IP Anti- Anti- Anti-
control DP DP c-myc control
PG co-IP reactions
C) Probe to determine relative amounts of DP I/II or Q273fsX288 DP 
coimmunoprecipitated by scl8082 antibody in tetracycline-induced wDP or tDP 
cell lysates
wDP tDP DP & Q273fsX288 
DP co-IP reactions
<-250 KD DP I 
<-210 KD DP II
<- 33 KKD Q273 fsX288 DP
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Figure 6.10 Co-IP analysis using goat anti-human DP
binding of DP or truncated DP to endogenous PKP-2
Co-immunoprecipitation of full-length DP or Q273fsX288 DP with endogenous PKP- 
2 performed in tetracycline-induced wDP and tDP cell lysates. Following induction of 
expression of respective desmoplakin protein over-expression, stable cells were 
scrapped off P90 dishes in lysis buffer (lOmM Tris HC1 pH 7.6, 145mM NaCl, and 
1% triton X-100 + protease inhibitors). Soluble cell lysates (3mg) were taken for IP, 
with a prior pre-clearing with Protein G-Sepharose at 4°C for 30 minutes on rotator. 
Twelve microgram of sc 18082 (goat anti-human DP antibody) was added to the pre­
cleared fraction and incubated on a rotator at 4°C for three hours. Fifty microliters of 
Protein G-Sepharose was added and incubation continued overnight at 4°C. Immuno- 
complexes were pelleted at 10,000g for 0.5 minute and washed thrice in low 
stringency PBS/inhibitor followed by a single wash in lysis buffer. Immuno- 
complexes were denatured in 3x Laemmli buffer followed by electrophoreses on a 
10% SDS PAGE and immunoblotting analysis using an anti-Plakophilin-2 antibody at 
1:500 dilution (catalogue no. 610788, BD Bioscience,) and a rabbit anti-mouse-HRP 
conjugate at 1:5000 dilution (Invitrogen) followed by incubation in ECL reagents and 
exposure to ECL Hyperfilm.
A) Triton X-100 cell lysates (equal am ount, lOOpg) loaded on 10% SDS PAGE 
tDP wDP tDP tDP
PKP-2 equal loading
B) IP Probed for plakophilin-2 association with DP & Q273fsX288 DP
tDP wDP tDP tDP
No Anti­ Co-IP Co-IP Co-IP
body IP Anti- Anti- Anti-
control DP DP c-myc control
PKP-2 co-IP reactions
C) Probe to determine relative am ounts of DP I/II or Q273fsX288 DP 
coimmunoprecipitated by scl8082 antibody in tetracycline-induced wDP or tDP 
cell lysates
wDP tDP DP & Q273fsX288 
DP co-IP reactions
<-250 KD DP I 
<-210 KD DP II
33 KD Q273 fsX288 DP
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Figure 6.11 Sub-cellular distribution of endogenous
PG in induced wDP and tDP cells
Sub-cellular distribution of endogenous PG in tetracycline-induced wDP and tDP 
cells determined using the Qproteome cell compartment kit (Qiagen, UK). Cells were 
cultured in 0.1 pg/ml tetracycline for seventy-two hours in DMEM supplemented with 
10% FBS, penicillin/streptomycin, blasticidin and hygromycin. Protein fractions 
enriched in cytoplasm, membrane, nuclear and cytoskeletal were obtained from 5 x 
106 of each cell line using the Qproteome cell compartment according to the 
manufacturer’s instruction. Each protein fraction was precipitated by the addition of 
four volumes of -20°C acetone and resuspended in a final equal volume of 100 pi in 
RIPA buffer. l/5th of each protein fraction was separated in a 10% SDS PAGE gel 
under reducing condition. The semi-dry transfer in Tris-glycine methanol transfer 
buffer transferred proteins to ECL Hybond membrane. The blot was blocked in 
TBST/milk followed by incubation in 1:500 rabbit anti-human PG (Santa Cruz, sc- 
7900) at 4°C overnight. Blot was washed in TBST followed by incubation in 1:5000 
goat anti-rabbit HRP conjugate (Invitrogen). Blot was exposed to ECL reagents (GE 
Healthcare) and developed using Kodak reagents. Key to sub-cellular fractions: CYT 
= cytosolic, MEM = membrane, NUC = nuclear, and CYK = cytoskeletal.
Induced wDP cell fractions Induced tDP cell fractions
CYT MEM NUC CYK CYT MEM NUC CYK
81 KD PG
Figure 6.12 Sub-cellular distribution of endogenous
PKP-2 in induced wDP and tDP cells
Sub-cellular distribution of endogenous PKP-2 in tetracycline-induced wDP and tDP 
cells determined using the Qproteome cell compartment kit (Qiagen, UK). Cells were 
cultured in 0.1 pg/ml tetracycline for seventy-two hours in DMEM supplemented with 
10% FBS, penicillin/streptomycin, blasticidin and hygromycin. Protein fractions 
enriched in cytoplasm, membrane, nuclear and cytoskeletal were obtained from 5 x 
106 of each cell line using the Qproteome cell compartment kit according to the 
manufacturer’s instruction. Each protein fraction was precipitated by the addition of 
four volumes of -20°C acetone and resuspended in a final equal volume of 100 pi in 
RIPA buffer. 1 /5th of each protein fraction was separated in a 10% SDS PAGE gel 
under reducing condition. The semi-dry transfer in Tris-glycine methanol transfer 
buffer transferred proteins to ECL Hybond membrane. The blot was blocked in 
TBST/milk followed by incubation in 1:500 mouse anti-human PKP-2 (BD 
Bioscience, 610788) at 4°C overnight. Blot was washed in TBST followed by 
incubation in 1:5000 rabbit anti-mouse HRP conjugate (Invitrogen). Blot was exposed 
to ECL reagents (GE Healthcare) and developed using Kodak reagents. Key to sub- 
cellular fractions: CYT = cytosolic MEM = membrane, NUC = nuclear, and CYK = 
cytoskeletal.
Induced wDP cell fractions Induced tDP cell fractions
CYT MEM NUC CYK CYT MEM NUC CYK
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6.5.8 Examination of Desmosomes in tetracycline
induced wDP and tDP cells
The gross morphology o f non-transformed Flp-In T-Rex HEK 293 cells, tetracycline- 
induced wDP cells, and tetracycline-induced tDP cells were examined by electron 
microscopy at various magnifications in a Philips 201 transmission electron 
microscope. The identities of all three cell lines were revealed after completion of 
data analysis. All three cell preparations were viable with a good distribution of sub- 
cellular organelles (Figure 6.13). Non-transfected Flp-In T-Rex HEK 293, wDP, and 
tDP cell desmosomes were examined by transmission electron microscopy (Figure 
6.14) at a magnification of x70000. Desmosomes in Flp-In T-Rex HEK 293 cells were 
not well developed as noted previously. Desmosomes in tetracycline-induced wDP 
cells (Figure 6.14B) showed electron dense plaques with highly extensive filament 
condensation in the IDP, which can extend beyond the length of the desmosome. In 
contrast, while some desmosomes in induced tDP cells appeared to have developed 
ODP, they lacked the extensive filament association in the IDP compared to induced 
wDP cell desmosome (Figure 6.14C) The results o f the widths rather than the length 
of desmosomes are presented here to emphasize the effect of filament condensation in 
desmosomes from induced tDP cells (desmosomal lengths of induced wDP and tDP 
cells analyzed however, were not statistically different, p>0.005, data not shown). 
Differences between wDP and tDP desmosomes were illustrated further in low 
magnification (x 15000) electron micrograph (Figure 6.15) which showed wDP 
desmosomes with extensive filament associations (identified by arrows), that were 
noticeably absent in tDP desmosomes (identified by asterisks). Using the desmosomal 
width measurements described (Figure 6.14) statistical pair wise analysis of 
desmosomal widths in these cells was performed by ANOVA followed by Bonferroni 
post-test correction (Figure 6.16). This showed highly significant statistical 
differences in desmosomal widths in these cells. Desmosomes in tetracycline-induced 
tDP showed highly significant statistical reduction in the mean junctional plaque 
width compared to induced wDP desmosomes (p <0.001). The mean junctional 
plaque widths o f either induced wDP or tDP desmosomes showed highly significant 
statistical increase compared to the mean junctional plaque width of control 
desmosomes present in Flp-In T-Rex HEK 293 cells indicating that Flp-In T-Rex
313
HEK 293 cell desmosomes are probably not efficient at recruiting filaments to their 
desmosomal plaques as these desmosomes are generally not well developed.
Comparisons of desmosomes in induced wPKP2 cells (Chapter 4, figure 4.2IB) with 
those formed in induced wDP cells (Figure 6.14B) showed that whilst both 
desmosomes were prominent in terms o f their ODP, the striking difference between 
wDP cell desmosomes and those in wPKP2 cells was that there was a much denser 
filament association in wDP desmosomes compared to those in wPKP2 cells. This 
was supported by desmosomal width measurements indicating a larger width of wDP 
desmosome (Figure 6.14B, measured width = 440nm, versus Figure 4.2IB, 
desmosome in bottom left hand side width = 250nm). This suggests that DP over- 
expression probably increases the amount o f DP protein recruited into the 
desmosomal plaque with increased condensation of intermediate filaments.
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Figure 6.13 Gross morphology of non-transformed Flp-In T-Rex HEK 293 cells,
tetracycline-induced wDP cells, and tetracycline-induced tDP cells
Examination o f gross morphology o f non-transfected Flp-In T-Rex HEK 293 control cells, and o f  stable wDP and tDP cells expressing 
full-length and Q273fsX288 DP respectively. Cells cultured on Thermanox plastic coverslips in complete DMEM were induced where 
required, with O.lpg/ml tetracycline for 72 hours until they were confluent. Coverslips processed for electron microscopy (section 2.7.4) 
were examined in a Philips 201 electron microscope at x 2000 magnification to examine the gross morphology o f these cells. The bar on 
each electron micrograph represents 10 pm
10 m icro n s
Non-transformed Flp-In T-Rex HEK 293 cells Tetracycline-induced wDP cells Tetracycline-induced tDP cells
Figure 6.14 Morphology of desmosomes formed in Flp-In T-Rex HEK 293, wDP and tDP cells
Electron micrographs of representative desmosomes found in highly confluent non-transfected Flp-In T-Rex HEK 293 and in tetracycline-induced 
wDP and tDP cells. Cells cultured on coverslips were fixed in Kamovsky style of fixative for twenty-four hours at room temperature. Ultra-thin 
sections (nominal 70 nm) were processed for electron microscopy (section 2.7.4) and were examined in a Philips electron microscope. All 
micrographs are at the same magnification (x 70000) and the size bar on each micrograph represents 100 nm. Desmosomes in induced wDP cells (B) 
were highly prominent with dense ODP and extensive filament association, while desmosomes in tDP cells (C) although these had developed ODP 
they showed less extensive filament association resulting in reduced desmosomal width. Non-transfected cells had less prominent desmosomes 
probably due to low level of desmosomal plaque protein recruitment. The desmosomal width measurements in Flp-In, wDP, and tDP cells is 
illustrated here with the widths between the two red dots in A, B, and C measured to give values of 118, 440, and 200 nm respectively. Statistical 
analysis of further desmosomal width measurements of these cells is shown in Figure 6.16.
u>
On A) Flp-In T-Rex HEK 293 cells B) Induced wDP cells C) Induced tDP cells
Figure 6.15 Lower magnification EM micrograph 
contrasting the differences of desmosomes formed in 
wDP and tDP cells
Examination o f desmosomes in induced wDP cells. This is a representative electron 
micrograph o f desmosomes found in wDP cells showing electron dense DS plaques 
with extensive filament associated in the IDP. Inset shows desmosomes from induced 
tDP cells at the same magnification for comparison, these desmosomes did not show 
the filament associations (marked by asterisks) seen in wDP desmosomes (indicated 
by the two arrows). Tetracycline-induced wDP and tDP cells were cultured on 
Thermanox coverslips for 48 to 72 hours and cells were processed in situ for electron 
microscopy. Desmosomes were examined by transmission electron microscopy in a 
Philips 201 electron microscope at x 15000 magnification.
Induced wDP desmosomes
T
Induced tDP desmosomes 
▼
Figure 6.16 Statistical analysis of desmosomal widths in Flp-In 
T-Rex HEK 293 and induced wDP and tDP cells
Statistical analysis of desmosomal widths (plaque width) in Flp-In T-Rex HEK 293 and in induced 
wDP and induced tDP cells expressing DP and Q273fsX288 DP. Measurements of desmosomal 
widths (nm) were taken from electron micrographs of desmosomes obtained from each of these 
cells. Data were analyzed using Graph Pad Prism software using non-parametric ANOVA analysis 
followed by Bonferroni post-test computation of significance. The graph shows plots of individual 
values in each group o f cells and the table below it shows results of the Bonferroni multiple 
comparison statistical test parameters between the three data sets obtained from Graph Pad. Pair­
wise analysis showed significant differences in desmosomal widths comparing control Flp-In 
desmosomes with either induced wDP or induced tDP desmosomes. Desmosomal plaque width of 
tDP desmosomes was significantly reduced compared to wDP desmosomes. Pair wise significance 
levels were all at p < 0.001.
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F 81 .01
R squared 0.7941
EJartletf s test for equal variances
Bartlett's statistic (corrected) 5.781
P value 0.0555
P value summary ns
Do the variances differ signif. (R < 0.05) No
ANOMA Table SS df MS
Treatment (between columns) -43-4700 2 21 7400
Residual (within columns) 112700 42 2683
Total 547-400 44
Bonferroni's Multiple Comparison Test Mean Diff. t R value 05% Ol of diff
Flp-In cells vs wDP cells -238 Q 1 2.58 R c  0 .001 -285 .2 to -190.8
Flp-In cells vs tDP oells -1 50.5 7.955 P < 0 .001 -197 .6 to -103.3
vsrfDP cells vs tDP cells 87 53 4.628 R ■< 0 .001 40 .37 to 134.7
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6.5.9 Dispase-based cell dissociation assay of induced 
wDP and tDP monolayers
Highly confluent monolayers o f tetracycline-induced wDP and tDP cells cultured in P6o 
culture dishes were enzymatically released from the plastic dish using Dispase II, which 
released intact monolayer without dissociating individual cells and these were then subjected 
to trituration for exactly six times. Using induced wDP and tDP monolayers handled in an 
identical manner described, clusters o f cells in each cell line were examined photographically 
to assess the sizes of fragments obtained from the two groups of cell. Larger fragments were 
obtained in induced wDP monolayers than from induced tDP monolayers (Figure 6.17). The 
number of clusters with > 100cells/ffagment were counted (using a dissecting microscope) in 
each cell type and analysed by student’s t-test. This showed that there was a statistical 
difference (p <0.0001) in the mean number o f clusters > 1 0 0  obtained in induced wDP and 
tDP cells illustrated graphically and with tabulated result (Figure 6.18) of the statistical 
analysis using Graph Pad.
6.5.10 Confocal microscopy analysis of vimentin filament in 
wDP and tDP cells
Vimentin immunofluorescence staining confocal microscopy analysis o f tetracycline induced 
wDP and tDP cells (representative data from triplicate staining, Figure 6.19) showed that 
whereas vimentin filament networks were present in both induced wDP and tDP cells, the 
vimentin filaments localized extensively between induced wDP cells (Figure 6.19A). In 
induced tDP cells however, vimentin filaments appeared to be associated within individual 
cells, but did not appear to connect with adjacent tDP cells (Figure 6.19B).
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Figure 6.17 Dispase-based induced wDP and tDP
monolayer dissociation adhesion assay
Adhesive strength o f tetracycline-induced wDP and tDP confluent monolayers measured 
using a Dispase-based cell dissociation assay212. Each cell line was cultured in 60 mm Nunc 
plastic culture dishes in penicillin, streptomycin, fetal bovine serum, blasticidin and 
hygromycin supplemented DMEM (Invitrogen 19308-025) in the presence o f O.lpg/ml 
tetracycline until cells were highly confluent. Medium was decanted from each dish and the 
monolayer was gently rinsed in 5 ml PBS. One ml of 2.4U/ml Dispase II (Roche, Cat No 
10295835001) was added to the dishes followed by incubation at 37°C for 30 minutes. The 
released monolayer released was carefully rinsed in PBS without agitation and one ml o f PBS 
was added. The monolayer was subjected to shear stress by trituration (six times) through a 
PI000 (one ml pipette tip). The triturated cell monolayer sample was photographed under 
Epi-white light illumination in BioRad Gel Documentation system (gel doc XR) using 
quantity one version 4.6 image analysis software. Triturated tDP monolayer resulted in 
significantly decreased number o f cell clusters (>100 cells) compared to those obtained in 
triturated wDP cell monolayer indicating that tDP cells were prone to increased fragmentation 
resulting in smaller fragments after shearing compared to those seen in wDP cells.
A) T riturated tetracycline-induced wDP monolayer -> forms larger fragments
No o f  cell clusters> lOOcells/0.15ml sample (triplicate counts/sample):
95,93,97 105,109,110 117,113,115
B) T riturated tetracycline-induced tDP monolayer -> forms smaller fragments
No o f  cell clusters> 100cells/0.15ml sample (triplicate counts/sample):
10,11,9 13,15,16 19,19,18
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Figure 6.18 Analysis of Dispase-based wDP and tDP
monolayer dissociation adhesion assay
Data obtained in figure 6.15 was analyzed using Graph Pad and is illustrated graphically 
(mean + SD). Statistical student’s t-test analysis showed significant reduction in the mean 
value of clusters >100 cells in induced tDP cells compared with the mean value obtained in 
induced wDP cells (p<0.0001) as shown in the table.
Dispase-based wDP and tDP monolayer 
dissociation assay
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Figure 6.19 Examination of Vimentin intermediate filament 
network in wDP and tDP cells by confocal microscopy
Confocal microscopy examination of tetracycline-induced wDP and tDP stable cells stained 
for vimentin. Cells were cultured on plastic coverslips in the presence of tetracycline 
(O.lpg/ml) to induce over-expression of full-length and Q273fsX288 DP. Cells were cultured 
for forty-eight hours and fixed in 4% formaldehyde/PBS for ten minutes. Following washing 
of the cells, they were permeabilised in 0.1 % triton X-100 for five minutes and then blocked 
in 10 % fetal bovine serum in PBS for thirty minutes. Cells were incubated in 1:200 mouse 
monoclonal anti-vimentin (Santa Cruz Biotechnology, sc-6260) for one hour. Following 
washing o f cells in TBST buffer they were incubated in DAPI solution to stain nuclei. 
Coverslips were mounted on glass slides in glycerol/PBS and examined in a confocal 
microscope. Blue channel records nuclear staining, red channel records the vimentin network 
staining and overlay channel records the composite staining. The vimentin filament network 
in tDP cells does not appear to connect between adjacent cells, whilst in wDP cells there is an 
extensive localization o f vimentin filaments between cells.
A) Vimentin network of induced wDP cells
Blue = DAPI Red = Vimentin Overlay = merged
I S
B) Vimentin network of induced tDP cells
Blue = DAPI Red = Vimentin Overlay = merged
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6.5 Discussion
Three lines of experimental evidence indicated that localization and interaction of either 
endogenous PG or PKP-2 with truncated DP was not adversely affected at the site of induced 
tDP cell-cell contacts. Firstly, the immunofluorescence staining co-localization of either 
endogenous PG or PKP-2 with either DP or Q273fsX288 DP in induced wDP or tDP cells did 
not appear to be significantly different in these cells. Secondly, IP analysis of detergent 
soluble cell lysates from wDP and tDP cells did not show significant differences in the 
amounts of either endogenous PG or PKP-2 interacting with either DP or Q273fsX288 DP, 
although it could be argued that endogenous DP I and DP II proteins expressed at basal levels 
in induced tDP might conceal differences in binding of endogenous PKP-2 or PG to 
Q273fsX288 DP alone. However, immunoprecipitation of induced wDP and tDP soluble cell 
lysate with goat anti-DP antibody showed that DP immunoprecipitated in lysates from 
induced wDP cells, but in induced tDP cell lysates the antibody predominantly 
immunoprecipitated Q273fsX288 DP rather than endogenous DP, suggesting that immuno- 
complexes formed between either PG or PKP-2 with Q273fsX288 DP might be present in a 
greater amount than the immuno-complexes formed by endogenous DP either because of 
reduced recruitment o f endogenous DP into plaques o f induced tDP cells (probably resulting 
from a dominant negative effect of Q273fsX288 DP) or less likely because of reduced 
solubility o f larger complexes formed by endogenous DP proteins. Therefore, the 
immunoprecipitated endogenous PG and PKP-2 in induced tDP cell lysates probably 
represent interactions mainly with the DP polypeptide. Thirdly, in each of the four protein 
fractions enriched for cytoplasm, membrane, nuclear and cytoskeletal compartments obtained 
from induced wDP and tDP cells there were no significant differences in the amounts of 
either endogenous PG or PKP-2 associating in any o f these four fractions from induced tDP 
cells relative to induced wDP cells.
Endogenous DP (DPI/II) proteins are expressed constitutively in wDP and tDP stable cells 
and these DP proteins are present together with over-expressed DP I and Q273fsX288 DP in 
tetracycline induced wDP and tDP cells respectively. It was not possible to determine the 
extent of incorporation o f endogenous DP and truncated DP into desmosomes of tDP cells by 
immuno-electron microscopy using a goat polyclonal antibody (Santa Cruz Biotechnology, 
sc-18082) directed against a twenty amino acid sequence near the N-terminus of DP as the
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antibody reacts with both endogenous DP and truncated DP. A tagged expression of DP 
polypeptide might discriminate the relative incorporation of this DP polypeptide and 
endogenous DP proteins present. The relative incorporation of DP polypeptide into cell-cell 
contacts of induced tDP cells should determine the extent of displacement of endogenous DP 
in induced tDP cells, however, although this was not examined in this study, it was evident 
that expression of truncated DP in induced tDP cells caused a dom inant negative effect on 
desmosome morphology, as these desmosomes lacked the extensive filament association 
found in control induced wDP cell desmosomes. The smaller widths of induced tDP cell 
desmosomes relative to induced wDP desmosomes appear to reflect a varying degree of 
disruption of IF assembly in the IDP of desmosomes formed between induced tDP cells 
probably resulting from a displacement of endogenous DP assembly. The mechanism for the 
dominant negative effect o f Q273fsX288 DP expression in induced tDP cells might involve 
the preferential recruitment o f the small DP polypeptide, which might be present in molar 
excess in this induced cell expression system compared to endogenous DP protein (assuming 
Q273fsX288 DP does not affect the expression level o f the endogenous DP proteins). The 
preferential recruitment o f Q273fsX288 DP into desmosomes might also result from the loss 
of adjacent N-terminal sequence found in full-length DP, which might influence the insertion 
of the DP polypeptide into desmosomes. Q273fsX288 DP is deficient in the coiled-coil rod 
and the plakin repeat domains, and therefore, this polypeptide cannot directly support the 
assembly and attachment o f intermediate filaments. The coiled-coil rod of DP is important for 
DP dimerization and also stabilizing interactions with vimentin intermediate filament 
proteins, whilst the plakin repeat domains of DP are important in determining the specificities 
of IF protein binding to desmoplakin in different cells.
As discussed in the previous two chapters, several different intermediate filament proteins are 
expressed in HEK 293 cells, but desmin a cardiac IF protein was absent. HEK 293 cells 
express abundant amount o f vimentin IF protein227; this protein can be recruited into the IDP 
of desmosomes via its interaction with the C-terminus PRD in DP and robust alignment of DP
1 ^ 1  i
with vimentin IF networks in transient transfection assays requires DP rod domain ’ , 
suggesting that the interaction of full-length DP and vimentin may be strengthened 
considerably by the formation of DP coiled-coil dimer. Examination of vimentin IF protein 
network in induced wDP and tDP cells by immunofluorescence staining confocal microscopy 
revealed that whereas this IF network was present in both induced wDP and tDP cells, it was
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extensively localized between induced wDP cells, but not between induced tDP cells. 
Although the clustering o f desmosomal cadherins in induced tDP cell-cell contacts is assumed 
to occur normally in induced tDP cell-cell contacts (these are promoted by PG mediated 
interactions with the cytoplasmic tail o f desmoglein-desmocollin heterodimers252, Figure 
1.6d), the incorporation and assembly of Q273fsX288 DP polypeptide into the cytoplasmic 
plaque appears to uncouple vimentin filament attachment at sites of induced tDP cell-cell 
contacts whilst maintaining apparently normal interactions between either PG or PKP-2 and 
this DP polypeptide.
The role of IF network assembly in regulating the cell-cell adhesive strength has been 
demonstrated in an inducible stable cell variant o f A431 expressing a FLAG-tagged truncated 
N-terminus 584 amino acid DP polypeptide, which led to dissociation of Kertin8/18 IF from 
the junctional plaque212. These induced A431 cells readily dissociated in Dispase-based 
monolayer dissociation assays, suggesting that loss o f proper IF assembly affects tissue 
integrity. The vimentin IF network in induced tDP cells may not be completely uncoupled 
(for example, in the electron micrograph of Figure 6.14C some filament association is seen in 
the IDP of an induced tDP desmosome). This could be because some endogenous DP present 
in these cells could either assemble in competition with Q273fsX288 DP into induced tDP 
desmosomes or other accessory proteins known to interact with IF proteins in vitro, such as 
PKP-2, might augment the recruitment o f vimentin in the absence of full-length DP 
incorporation into desmosomes. Using the Dispase-based monolayer dissociation assays the 
fragmentation of tDP and wDP monolayers were examined after shearing. This resulted in 
formation o f smaller fragments in induced tDP cells while larger fragments formed in induced 
wDP cells, this together with the data obtained from vimentin filament organization in 
induced tDP cells provides supportive evidence suggesting that disrupted vimentin-IF 
network in induced tDP cells compromise their adhesive strength.
The extent o f interference from endogenous DP proteins in co-IP reactions of induced tDP 
cell lysates for determining interactions o f Q273fsX288 DP with either endogenous PG or 
PKP-2 proteins appears to be small, but theoretically, this problem can be avoided by the use 
of tagged Q273fsX288 DP expression in cell lines. However, the cloning of DP into a tagged 
expression vector was not performed because o f technical problems with cloning of full- 
length DP DNA. Plasmid PI 140 contained nucleotide sequence encoding a FLAG epitope
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located at the C-terminal end o f the cloned DP gene and this plasmid could allow examination 
of FLAG-tagged DP pull down assays in HEK 293T cells using an anti-FLAG antibody. 
However, it was not possible to obtain a plasmid encoding truncated DP with a C-terminal 
FLAG tag directly from plasmid PI 140 using SDM PCR as the nucleotide sequence for the 
FLAG tag is situated downstream o f the nucleotide sequence encoding the ffame-shift, which 
therefore, would not lead to the translation of Q273fsX288 DP containing a FLAG tag at the 
C-terminal end o f the DP polypeptide. Other plasmid vectors with a C-terminal FLAG tag 
were not commercially available, however vectors containing a FLAG tag located at the N- 
terminus of a multiple cloning site were available and it would have been relatively easy to 
clone in a DNA fragment encoding Q273fsX288 DP, but this approach was impractical as a 
FLAG epitope located at the N-terminal end of desmoplakin or its fragments disrupt 
important protein-protein interactions (personal communication, Lisa Godsel, Northwestern 
University, USA) o f these proteins. Therefore, for the purpose of this study, stable wDP and 
tDP cells were used for examining interactions o f either full-length or truncated DP with 
either endogenous PG or PKP-2 with an antibody directed against DP suitable for immuno- 
precipitation studies.
Early studies using ectopic expression of DP I carboxy terminus alone or in combination with
the rod domain showed that these DP polypeptides co-aligned with and disrupted the IF
network in COS-7 and NIH 3T3 cells, but neither of these polypeptides appeared to
incorporate into desmosomes suggesting that 1056 amino acid (90 KD) N-terminal globular
head domain of DP (Figure 1.10) could be necessary for the localization of DP into the 
1desmosomal plaque . The role of the DP N-terminus in targeting DP to the desmosomal 
plaque was investigated by studies showing that the expression of the first 584 amino acid 
fragment of DP (DP-NTP, 70 KD) co-localized this DP polypeptide at A431 cell-cell contacts 
with PG, DSC-2 and DSG217,252; and in COS-7 cells DP-NTP was shown to co-localise with 
PKP-1 including its head domain wherein these interactions were confirmed by yeast two 
hybrid analysis . Additionally, the ectopic expression of N-terminal DP polypeptides in 
COS-7 cells using plasmids encoding N-terminal deletions of DP demonstrated that the first 
194 amino acids in DP N-terminus were essential for integrating DP into the desmosomal 
plaque131. Fine mapping studies of amino acid sequences within DP N-terminal subsequently 
revealed that amino acid residues between 86 to 176 are essential for efficient desmosomal 
recognition of DP in keratinocytes, with the first 29 residues being critical254 for this function.
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These studies support the contention that Q273fsX288 DP should contain the requisite sites 
for desmosomal targeting. The data obtained from studies with Q273fsX288 DP suggests that 
this DP polypeptide can co-localize with PG and PKP-2 plaque proteins in the ODP of 
induced tDP cell-cell desmosomal contacts and that the DP polypeptide can interact normally 
with these two plaque proteins as shown by co-IP studies. The recruitment and insertion of 
Q273fsX288 DP, however, appears to disrupt vimentin intermediate filament condensation 
within the inner plaque region of induced tDP desmosomes. This implies that Q273fsX288 
DP acts in a dominant negative manner disrupting the assembly and linking of the 
intermediate filament network between neighbouring induced tDP cells.
Stable A431 epithelial cell lines fortuitously expressing DP-NTP showed this polypeptide 
assembled together with other desmosomal proteins into distinct junctions at cell-cell 
contacts, but severely dissociated endogenous DP binding to cell-cell contacts with associated 
loss o f keratin intermediate filament attachment217. Ultrastructure of desmosomes in these 
cells showed that they possessed a central dense stratum and an ODP, but the associated 
filaments present in the IDP of normal desmosomes were absent. This study supported the 
proposal that DP-NTP acted in a dominant negative manner interfering with assembly of 
endogenous DP in A431 cell-cell contacts shown to be disrupted by cellular localization and
• •  17biochemical analysis . A range o f junctional structures were reported to coexist in these 
A431 stable cells, ranging from oversized desmosomes containing large amounts of 
endogenous DP and associated IF bundles to structures containing DP-NTP but little 
endogenous DP and largely lacking IF coupling217. The data obtained from induced tDP stable 
cell line are in agreement with data from A431 cells in so far as showing disruption of the 
vimentin filament network in tDP cells (versus disruption of keratin filaments in A431), and 
desmosome ultrastructure of tDP cells suggesting that not only were some desmosomes 
deficient in filament association in the IDP, but also that some desmosomes appeared to 
incorporate filaments to a varying extent as indicated by the distribution of desmosomal 
widths in induced tDP cells and their differences with the desmosomal widths of induced 
wDP cells. Induced tDP desmosomes, however, appeared to differ from A431 desmosomes, 
as oversized desmosomes were not observed in induced tDP stable cells. Evidence supporting 
the displacement of endogenous DP in desmosomal plaque of tDP cells has not been obtained, 
but the disruptive effect on vimentin filament network with the associated effect on 
desmosomal widths in these cells is highly suggestive.
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An association o f DP-NTP with adherens junction proteins reported in A431 cells217 
suggested lateral co-assembly of DS and AJ junctions. The interaction of E-cadherin, a - 
catenin and p-catenin with Q273fsX288 DP was not examined in induced tDP cell lysates and 
therefore, it remains unknown whether the segregation of DS and AJ junctions of tDP cells 
could be affected; this however seems unlikely as ”mixed-type” or oversized cell-cell 
junctions were not observed by transmission electron microscopy examination of induced tDP 
cells. In support of this observation in induced tDP cells, a study previously described using a 
Tet-On A431 inducible stable cell expression o f FLAG-tagged DP-NTP 212 showed that 
“hybrid junctions” with the intermingling o f AJ and DS junctions did not occur in these cells .
Interestingly another mutation 40 amino acids downstream of Q273fsX288 DP (i.e. p.W233X 
DP, c.699G>A DP) found in an ARVC patient from a North American ARVD registry 
showed that an mRNA encoding this truncation was not present in cDNA amplified from 
lymphocytes from the affected patient suggesting that the mRNA transcript probably 
undergoes NMD. Expression of W233X DP protein in a desmosome forming human tongue 
squamous carcinoma cell line showed the formation of perinuclear aggregates of this protein, 
but it neither localised at cell-cell contacts nor was it present diffusely in the cytoplasm163. 
Q273fsX288 DP also was associated with the nuclear protein fraction in induced tDP; this 
might suggest a probable localization of the DP polypeptide around the nuclei of induced tDP 
cells.
6.6 Summary of main findings of the study
Plasmids encoding full-length DP DNA and Q273fsX288 DP DNA were prepared in 
pcDNA5 vectors. Using pcDNA5 plasmids, two stable cell lines were established using Flp-In 
T-Rex HEK 293, one o f these cell lines, wDP, expressed full-length DP, and a second cell 
line, tDP, expressed truncated DP.
A strong tetracycline-induced expression of full-length DP (with a predicted size of 331.8 KD 
and apparent SDS PAGE migration size of 250 KD) occurred in wDP cells that was localised 
at sub-membranous sites of cell-cell contacts by confocal immunofluorescence staining. Sub- 
cellular protein fractionation o f induced wDP cells followed by western immunoblotting
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analysis confirmed that full-length DP was primarily found in the cytoskeletal protein 
fractions.
A strong tetracycline-induced expression of Q273fsX288 DP (predicted and apparent SDS 
PAGE migration size of 33 KD) occurred in tDP cells, which localized in a punctate staining 
pattern at sites of cell-cell contacts by confocal immunofluorescence staining. Sub-cellular 
protein fractionation of induced tDP cells followed by western immunoblotting analysis 
indicated presence o f Q273fsX288 DP in cytoplasm, membrane, nuclear and cytoskeletal 
protein fractions. The localization o f Q273fsX288 DP differed from that of full-length DP as 
the former was associated in the cytoskeletal and the membrane, but the later was primarily 
found in the cytoskeletal fraction protein fraction. The presence of Q273fsX288DP in the 
nuclear protein fraction suggests that this DP polypeptide might be present in the perinuclear 
region.
Induced wDP and tDP cells proliferated at similar rates to non-induced wDP and tDP cells. 
Tetracycline-induced wDP and tDP cells recovering from exposure to mechanical stretch 
showed no statistically significant difference in induced apoptosis. These data indicated that 
cell proliferation and the apoptosis were not affected by the expression of the truncated DP 
polypeptide.
No apparent differences in the immunofluorescence staining co-localization of either 
endogenous PG or PKP-2 proteins with DP and Q273fsX288 DP were observed in induced 
wDP and induced tDP cells respectively. Immunoprecipitation analysis showed no significant 
differences in the interactions of either endogenous PG or PKP-2 proteins with DP and 
Q273fsX288 DP in cell lysates obtained from induced wDP and tDP cells respectively; and 
analysis of sub-cellular protein fractions obtained from induced wDP and tDP cells supported 
these findings as the distributions of either endogenous PG or PKP-2 did not appear to be 
altered significantly in the cytoplasm, membrane, nuclear and cytoskeletal compartments of 
these induced cells.
Examination of vimentin filament network in induced tDP and wDP cells showed that while 
these were developed in both cell types, vimentin filaments appeared to connect extensively 
neighbouring cells in induced wDP cells but this was not the case in induced tDP cells.
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Examination of Flp-In T-Rex HEK 293, induced wDP and induced tDP cells showed that 
whilst desmosomes formed in Flp-In cells these were not prominent. Desmosomes in induced 
wDP were highly prominent with dense plaques and extensive filament localization affecting 
their plaque widths. The filament organization in desmosomes from induced wDP cells can 
extend beyond the length of the desmosomes. In contrast, however, desmosomes in tDP cells 
compared to those in wDP cells had varying desmosomal plaque widths including many 
desmosomes with little or no filament condensation; this affected their measured plaque 
widths. The measured desmosomal plaque widths of Flp-In T-Rex HEK 293, induced wDP, 
and induced tDP cells showed highly significant statistical differences (p value < 0.0001) with 
mean desmosomal width of wDP cells being greater than the mean value in tDP cells, while 
the mean widths of wDP and tDP desmosomes were each greater than the mean value in Flp- 
In T-Rex HEK 293 non-transformed cells.
Consistent with the observed disruption o f vimentin filament network in induced tDP cells, a 
Dispase-based monolayer dissociation assay showed a statistically significant increased 
fragmentation of sheared induced tDP2 monolayer compared to those of induced wPKP2 
monolayer.
6.7 Future Studies
The effects of Q273 fsX288 DP should be examined in other cell systems, such as SSC9, 
MDCK, and A431 cells, which allow better morphological co-localization data to be obtained 
by immunofluorescence confocal microscopy. These cells form robust desmosomes and 
comparison between non-transfected and transfected cells should allow the effect of 
Q273fsX288 DP on the ultrastructure of desmosomes to be verified in these cells. SSC9, 
MDCK and A431 cells express different intermediate filament protein from vimentin 
expressed in tDP cells, therefore examination of the effect of Q273fsX288 DP on other IF 
protein assembly (for example, keratin) in these cells may support the findings in tDP cells. 
Rat neonatal cardiomyocytes may be used to assess the significance of the findings from tDP 
cells in a cardiac relevant cell culture model; this may however, require expression of full-
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length DP and truncated DP using viral vector expression systems to obtain optimum 
expression of these proteins.
Q273fsX288 DP appears to exert a dominant negative effect in induced tDP cells, sharing 
similarities with an inducible A431 cell line expressing a 70 KD fragment of DP-NTP. The 
apparently normal interaction of Q273fsX288 DP with PG and PKP-2 in induced tDP cells 
needs to be verified by yeast two hybrid studies. The assumed displacement of endogenous 
DP in desmosomal plaques o f induced tDP cells should be examined by several approaches: 
firstly a biochemical approach should allow the relative amounts of Q273fsX288 DP and 
endogenous DP to be determined, and if  needed this might be modulated by changing the 
concentration of tetracycline used during induction of tDP cells, secondly, an 
immunofluorescence staining confocal microscopy examination of the localization of 
endogenous DP and Q273fsX288 DP in induced tDP cells must be carried out using 
differential staining using anti-DP antibodies directed against the N-terminus, C-terminus and 
the rod domains (for example, antibodies NW161, NW6 and DP2.15 respectively can be
*717used ) to determine the extent o f endogenous DP displacement in these cells, thirdly, an 
immuno staining electron microscopy examination would verify the extent of redistribution of 
endogenous DP in these cells, with non-induced tDP cells serving as an appropriate control 
for immunoelectron microscopy studies. The final fourteen amino acid residues in truncated 
DP are unique (peptide sequence in Q273fsX288 DP: EHHSGHVQGDHVDQ, sequence in 
full-length DP: NIIQATSREIMWIN) and this might make it feasible to raise monoclonal 
antibodies allowing the differential recognition of truncated DP and endogenous DP binding. 
Using different sized gold particle-conjugated to these monoclonal antibodies specific for 
these peptide sequences the localization of Q273fsX288 DP by immunoelectron microscopy 
and determination of the relative extent o f endogenous DP displacement within desmosomes 
of induced tDP cells might be possible. The staining for cortical actin using rhodamine- 
conjugated phalloidin needs to be performed in induced tDP cells and non-induced tDP cells 
as a control to determine whether there might be an alteration in the cortical actin 
microfilament system of cells expressing Q273fsX288 DP.
It is not known whether c.818_819insA DP gene mutation found in family I (section 3.4.1 
part 2.7) causes haploinsufficiency resulting from nonsense mediated degradation of mRNA 
transcript encoding the truncated DP polypeptide, this seems quite likely as many mRNA
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transcripts encoding frameshift are efficiently targeted by the NMD machinery. The 
c.818_819insA DP gene mutation has not been reported in further patients in different cohorts 
examined, however further cascade screening of family I, may in the future, provide sample 
of cardiac tissue from an affected individual that would allow protein and cDNA studies to 
examine whether NMD with haploinsufficiency is a plausible mechanism for the 
cardiomyopathy seen in affected patients. A heterozygous transgenic mouse model encoding 
the c818-819ins A DP would be a feasible in vivo model system to examine the effect of 
expression of mutant DP protein from one defective copy of the DP gene.
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Chapter 7 
Discussion and future direction
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7.1 Compare and contrast molecular roles of PKP-1 and 
PKP-2 in desmosomes
PKP-2 is a predominant plakophilin isoform expressed in the human heart (p0071/PKP-4 is 
also present, but its role in the heart is not clear), however because of the similarities 
(structural homology and conserved functions) with PKP-1, the role of PKP-1 in desmosomes 
is first discussed. The general structure of PKP-1 and PKP-2 is identical consisting of a basic 
charged head domain, which is considerably larger in PKP-2, but shares only a 25% sequence 
identity apart from a bipartite HR2 element at the very end of the N-terminus221,255. This is 
followed by successive ARM repeats forming a superhelix of helices consisting of positively 
charged grove, and a very short carboxy-terminal extension. The ARM repeat domains are 
composed of ten repeat units one of which is a large insert producing a characteristic kink 
resulting in a sickle shape in these proteins184. PKP-1 and PKP-2 share 42% overall identity 
with each other however, the homology in their ARM domains is high (70%)255.
The last 40 amino acids in the carboxyl terminus of PKP-1 are required for its localization in 
the plasma membrane while residues at the very beginning of the N-terminal are necessary for 
recruiting DP to the membrane and desmosome assembly222. PKP-1 is strongly expressed 
localizing in desmosomes found in the suprabasal layer of stratified epithelia, certain complex 
epithelia, and the urothelium. PKP-1 promotes lateral clustering of desmosomal protein
7^ 7complex, provides stability to the structure and controls desmosome size by binding 
tightly to desmoplakin to augment desmoplakin recruitment to sites of cell contact258. Genetic 
defect in PKP-1 reduces desmosome stability and size in the skin and increased keratinocytes 
migration259. PKP-1 acts co-operatively with plakoglobin to promote clustering of 
desmosomal plaque complexes at cell-cell contacts . A study examining the contribution of 
different domains of PKP-1 proteins binding to desmosomes in HaCaT cells showed that the 
head domain was essential for targeting it to desmosomes and enhancing recruitment of 
desmoplakin, desmoglein, desmocollin, and plakoglobin. While the ARM domain of PKP-1 
can associate with actin microfilaments, full-length PKP-1 preferentially localizes to 
desmosomes257.
PKP-2 is found in desmosomes of virtually all cell types, including simple one-layered 
epithelia and non-epithelial tissues such as the myocardium and Purkinje fibres of the heart
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and the dendritic reticulum of lymphatic system. It is also present in basal proliferative cells 
of most multilayered epithelia such as the mucosal lining of stomach, oesophagus, and vagina 
and in comifying stratified squamous epithelium of the skin. PKP-2 has a broad repertoire of 
binding partners of desmosomal as well as non-desmosomal origin. Proteins which have been 
reported to interact with PKP-2 include DSG-1, DSG-2, DSC2a, PG, DP, p0071/PKP-4, p- 
catenin, aT-catenin, and E-cadherin PK Ca183’246’249’260, but PKP-2 is less efficient than PKP-1 
at recruiting DP and other desmosomal proteins to cell membranes183,260. PKP-2 is not known 
to increase DP content or affect desmosomal size, but it appears to be important in trafficking 
DP to the plasma membrane via non-membranous assembly-competent particles formed in 
close association with keratin filaments216. Although the ARM repeats of PKP-2 shares 
structural homology with the ARM repeats in pl20ctn and PG no binding partners have been 
identified for these repeats in PKP-2. All the inter-protein interactions involving PKP-2 
appears to occur via its globular head domain184.
PKP-2 as well as PG, DP, DSC2 and DSG2 appear to co-localise at desmosomal and adherens 
junctions in the ID of cardiomyocytes as shown by recent immunoelectron microscopy studies 
revealing that, at ID, desmosomes and facia adherentes structures form a highly integrated 
system called the area composita. The exclusive localization of proteins specific only for
I  I Q A A
desmosomes and adherens junctions is largely lost ’ ’ in this structure. In the area 
composita cardiomyocytes form multiple interactions between protein assemblies belonging 
to classical desmosomal and adherens junction origins -  resulting in a complex and 
interlinked association between different molecular components that is different and 
distinctive from polar epithelial cells that possess discrete and separate entities of these two 
adhering type of junctions. The complex intermolecular interactions in the area composita are 
believed to be superimposed by a unique interaction between PKP-2 and a-T-catenin which 
has been proposed to bridge the actin microfilaments and desmin intermediate filament
*)fS\
networks . PKP-2 also associates with p-catenin, a protein normally associated only in 
adherens junction, and this potentially might influence p-catenin signalling or the assembly of 
cell-cell junctions183.
PKP-2 has a fundamental function in desmosome assembly and maintenance of tissue
integrity. The importance of PKP-2 in heart morphogenesis was demonstrated in PKP-2 null-
mice which showed lethal cardiac damage190 at mid-gestation resulting in absence of
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desmoplakin from virtually all cell-cell junctions, thus emphasizing that PKP-2 was important 
in the assembly of junctional proteins in the ID. PKP-1 mutations manifest in cutaneous 
defects, but PKP-2 mutations cause a r v C40,41’^ ’107,108,110,112^ 07,262 associated with fibro-fatty 
replacement of cardiomyocytes, ventricular tachyarrhythmias and sudden cardiac death 
(section 1.1.1), but these mutations do not manifest cutaneous defects presumably due to 
redundant functions of these plakophilin proteins in the skin. Mutations in PKP-2 appear to be 
the most common amongst the five major desmosomal proteins (section 1.8.3 and Table 1.5) 
and are linked to ARVC with a propensity for early onset of symptoms and arrhythmias108. In 
the genetic screening of the ARVC cohort mutations were found in eight out of one hundred 
(8%, section 3.4.1 part 1.4) patients. It has been speculated that lack of PKP-2 resulting from 
haploinsufficiency and the insertion of a mutant PKP-2 protein into cardiac desmosomes 
could impair cell-cell adhesion by loss of function of PKP-2 protein, resulting in disruption of 
adjacent cardiomyocyte cell-cell junctions particularly in response to inappropriate 
mechanical stress (for e.g. during intense competitive sports). However, direct evidence 
supporting this concept is lacking and functional studies performed (Chapters 4, 5, and 5) 
have attempted to shed light on how expressions of three different mutant proteins could be 
linked with changes observed in desmosomes and cellular functions.
7.2 Lessons learned from plakophilin-2 mutant protein 
expression functional studies
PKP-2 gene mutations c.2197-2202_delCACACC_insG and C.C1604T resulting in protein
truncation p.A733fsX740 PKP-2 and formation of a missense p.S140F PKP-2 protein each
caused autosomal dominant ARVC in affected patients. These mutant PKP-2 proteins were
expressed in stable HEK 293 cells under tetracycline-induced condition and the effect of each
mutant protein expression was examined in vitro to provide functional evidence linking
defects in these PKP-2 proteins with alteration in desmosomal structure and/or cell function.
Both PKP-2 proteins affected desmosomes, but produced different structural changes as well
as functional effects at a cellular level because o f domain specific alterations in these mutant
PKP-2 proteins (Table 3.4). Altered desmosomal structures and cellular characteristics seen in
induced cell lines may offer possible mechanisms to explain the cardiomyopathy seen in
affected individuals. Although A733fsx740 PKP-2 expression can exert dominant negative
effects on desmosomes in vitro, it is possible that the c.2197-2202_delCACACC_insG PKP-2
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gene mutation may cause haploinsufficiency due to NMD of the transcript formed by PKP-2 
gene expression from the affected allele, and this might be a predominant mechanism for the 
cardiomyopathy in affected patients. The lack of Cx-43 gap junction protein localization 
within cell-cell contacts of induced tPKP2 cells provides a potential mechanism for the 
arrhythmia seen in ARVC and is supported by recent studies defining the roles of PKP-2 in 
maintaining the structures at the ID242 and coordinating the assembly of Cx-43 gap junction 
protein at sites of cell-cell contacts61,218.
Functional studies of tetracycline-induced tPKP2 cells showed that A733fsX740 PKP-2 
protein appeared to be inserted competitively into cell membrane fraction together with 
endogenous PKP-2 and this caused dominant negative effects resulting in intermittent 
desmosomal linkages with pale plaques that largely lacked filaments. The lack of Cx-43 
protein localized at the cell-cell contacts, enhanced apoptosis of induced tPKP2 cells 
subjected to mechanical cell stretch. Induced tPKP2 cells also showed increased cellular 
adhesion measured by two different assays, but the significance of this data is not clear, as it 
does not reconcile with the EM data showing abnormal DS linkages. Mechanical cell stretch 
of stable HEK 293 cells resulted in apoptosis of these cells, and although the mechanism was 
not investigated, it is possible that apoptosis in HEK 293 stable cells might occur by 
mechanisms similar to those in mechanical stretched rat neonatal cardiomyocytes in 
vitro234’237’238. xhe abnormal DS linkages in induced tPKP2 cells are believed to augment the 
level of cellular injury in these cells enhancing the apoptosis response of these cells compared 
to control induced wPKP2 cells expressing normal DS linkages. This assumption is in 
agreement with in vivo data obtained from cardiomyocytes of R2834H DP cardiac restricted 
transgenic mice showing increased apoptosis o f these cells due to abnormalities in mechanical 
junctions assembled in these mice163. Strong adhesions are required in the ID of 
cardiomyocytes to prevent fragmentation as this structure, which is under continuous stress.
The lack of detectable signal by immuno-fluorescence staining confocal microscopy 
examination of Cx-43 protein localization at cell membranes of induced tPKP2 cells suggests 
that A733fsX740 PKP2 insertion into cell membranes might destabilise mechanical junctions 
preventing formation of Cx-43 gap junctions as a direct consequence of impaired cell-cell 
junctions found by EM examination of these cells. The dependence of mechanical junction 
stability in promoting gap junction formation is recognised49,228,241 and supported by several
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lines of evidence. For instance, gap junctions were known to associate into macromolecular 
complexes containing cell adhesion molecules263,264 and interference with N-cadherin 
expression prevented gap junction formation265. Cardiac-specific loss of N-cadherin gene in 
mice also led to significant decrease in the amount of connexin found in gap junctions with 
ensuing slowing o f ventricular conduction velocity48. Furthermore, in three cardiomyopathies 
(Carvajal Syndrome, Naxos disease and autosomal dominant ARVC) caused by defective 
linkage between adhesive junctions the remodelling of gap junctions was observed42,43,51. The 
absence of Cx-43 at plasma membranes of tPKP2 cells is an important finding as a reduction 
in Cx-43 protein immuno-histochemical staining at cell membrane is implicated as a possible 
mechanism for arrhythmogenesis. Expression of Connexin-43 protein alone appears not to be 
sufficient for the assembly o f functional gap junctions as PKP-2 has been shown to play an 
essential role in regulating and coordinating the formation and interactions between 
mechanical junctions and electrical junctional complexes in cardiac cells using siRNA 
mediated inhibition studies of PKP-2 expression 218.
Comparison of cell input resistance measurements of induced wPKP2 cells (expressing Cx-43 
at cell membranes) and in induced tPKP2 cells (not expressing Cx-43 at cell membranes) did 
not show a statistical difference in the conduction of pulsed current between these two cell 
types. Possible explanations for this might be that as a compensatory mechanism other 
Connexin subtypes might be expressed, or that although Cx-43 protein was not detected in 
induced tPKP2 cell membrane, this might be below the threshold detection level by confocal 
microscopy. If this was the case, then it could be possible that small amount of Cx-43 present 
at cell membrane would be sufficient to permit normal current conduction. It is known from 
transgenic mice models that the magnitude o f Connexin 43 protein reduction required for 
ventricular arrhythmia is large (86-95%)266. Furthermore, computer modelling studies predict 
that reductions of up to 40% in gap junction content (without change in junction size) would 
be unlikely to have a major impact on conduction velocity267. Also, the total Connexin levels 
are shown to be indicators of potential capacity for cell-to-cell communication, but this does 
not provide information on the quantity of functional channels open .
The most striking feature of desmosomes in induced tPKP2 cells appear to be their 
intermittent coupling (indicating inappropriate assembly o f the junction) with pale plaque 
(indicating reduced content of plaque proteins), predominant absence of filament association
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in these desmosomes and altered alignment of filaments compared to induced wPKP2 cells. 
These dominant negative effects of A733fsX740 PKP-2 may be related to the reduced 
interaction of truncated PKP-2 with endogenous PG (this presumably result in reduced 
clustering of desmosomal proteins at the ODP); and the altered intermediate filament 
organization presumably result from disruption of the recruitment of endogenous DP by 
A733fsX740 PKP-2 into induced tPKP2 cell desmosomes. PKP-2 is important in recruiting 
DP to the desmosomal plaque216,247 and reduced interaction of PG in immuno-complex with 
A733fsX740 PKP-2 may affect the intermediate filament organization in desmosomes as a 
recent study using electron tomography and immuno-labelling of keratinocytes from PG null 
mice (-/- PG) highlights an essential role of PG for the effective intermediate filament 
anchorage to desmosomes269.
Functional studies examining the effects of S140F PKP-2 protein expression did not show 
substantial effects on cellular properties of induced mPKP2 cells. Expression of S HOF PKP-2 
appear to cause a gain o f function in induced mPKP2 cells manifesting a striking effect on 
desmosome size and interaction of missense PKP-2 with p-catenin. The presence of extremely 
long desmosomes (seemingly formed by lateral fusion of adjacent desmosomes) in induced 
mPKP2 cells might not be caused by a direct effect of missense PKP-2 as PKP-2 per se is not 
known to control desmosome size. Either the loss of a serine residue and a putative 
phosphorylation site in S140F PKP-2 may directly affect the binding of PKP-2 to p-catenin 
by disrupting a domain important in this interaction or a signalling role of PKP-2 may be 
affected via altered protein-protein mediated interactions. The significantly reduced 
interaction of S140F PKP-2 with P-catenin may be one possible mechanism influencing the 
cross talk between adherens and desmosomal junctions, which seems particularly pertinent in 
the area composita o f the ID in human cardiomyocytes where these proteins are intimately 
localized. This might explain the cardiomyopathy seen in patients carrying the C.C1604T 
PKP-2 gene mutation as the missense PKP-2 protein is quite likely to be incorporated into the 
area composita. Additionally it seems reasonable to suppose that PKP-4/p0071 might also 
mediate the cross-talk with PKP-2 in the area composita where these two proteins are 
intimately associated137 and their interactions in vitro250 can occur.
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7.3 Insights into the role of desmoplakin in cell-cell 
adhesion
The desmosomal cadherin-plakoglobin complex is coupled to the IF network by desmoplakin, 
a member o f the spectra-plakin family of proteins197,270’271. The amino terminus of DP binds 
to PG and plakophilins, whereas the carboxy-terminus interacts with i f 126,272. Desmoplakin is 
expressed ubiquitously in all tissues possessing desmosomes. The importance of DP in vivo is 
supported by findings showing that DP-null mice die just after implantation at E6.5 owing to 
defects of the extraembryonic endoderm. These mice had significantly fewer desmosomes 
than wild-type mice187, and the few desmosomes present were not attached to keratin 
intermediate filaments. These DP-null mice also revealed a role of DP in tissue 
morphogenesis as the embryos failed to undergo the massive cellular proliferation observed at 
E5-6. Furthermore, chimeric morulae expressing DP in extraembryonic tissues do not survive 
beyond E9.5 as a result of defects in the developing epidermis, neuroepithelium, and heart
1 fifi 1 COassociated with disorganized desmosome assembly and severing of IF attachment .
7.4 Lessons learned from desmoplakin mutant protein 
expression functional study
Q273fsX288 DP polypeptide expression can exert a dominant negative effect on desmosomes 
of induced tDP cells; they lack the extensive filament association seen in desmosomes of 
induced wDP cells expressing full-length DP. This affects the adhesive strength of induced 
tDP monolayer, which is reduced compared to the adhesion of induced wDP monolayer; this 
might be caused by a lack of attachment of desmosomes to vimentin intermediate filaments 
resulting in a reduction in the width of the junctional plaques in induced tDP cells. Although 
expression o f a truncated DP polypeptide showed an effect on desmosomes, it is quite likely 
that the c.818_819insA DP gene mutation may cause haploinsufficiency due to NMD of the 
transcript formed from the DP null allele. In humans, the recruitment of desmoplakin into 
desmosomes decreases when one of the allele is null, resulting in formation of rudimentary 
desmosomes with reduced IF attachment154,155.
Previous mapping studies of amino acid residues in the N-terminal of DP131,254 suggested that 
Q273fsX288 DP probably retains the sequence information important for desmosomal
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targeting, but it lacks the domains essential for DP oligomerization and intermediate filament 
protein attachment. Functional study of Q273fsX288 DP expression showed that this protein 
was competitively inserted into induced tDP cell membranes, and possibly into induced tDP 
cell-cell contacts. Q273fsX288 DP appeared to interact normally with endogenous PG as well 
as PKP-2 and the content of these two armadillo proteins in various sub-cellular fractions or 
their cellular immuno co-localization with Q273fsX288 DP appeared not be significantly 
different when compared with induced wDP cells expressing full-length DP. However, 
although the extent of incorporation o f endogenous DP into desmosomes of these cells was 
not examined, a striking absence of the extensive filament attachment to cell-cell junctions 
identified ultrastructurally suggested that the intermediate filament network was disrupted.
997Vimentin, one of several abundant IF proteins expressed in HEK 293 cells was examined 
by immuno-staining localization in induced wDP and tDP cells as this protein together with 
desmin and keratin IF proteins are known to interact directly with desmoplakin in 
desmosomes. This showed that vimentin connected extensively with neighbouring cells in 
induced wDP cell clusters, but this was not the case in induced tDP cell clusters. Lack of an 
extensive vimentin network and ultrastructurally identifiable filaments in induced tDP cells 
was supported by examination o f the adhesive strength of tDP monolayers, which showed that 
these fragmented readily when subjected to shearing. However, no effects on cellular 
proliferation or on the measured apoptosis following mechanical cell-stretch of these cells 
were observed. Induced tDP stable cells are similar in three respects with another inducible 
Tet-On system in A431 stable cell line expressing a 584 amino acid DP-NTP polypeptide. 
Firstly, as with to vimentin filament disruption in tDP cells, A431 cells dissociate Kertin8/18 
intermediate filaments from their junctional plaques. Secondly, in induced A431 cells the total 
or cell surface distribution of desmosomal proteins was unaltered as was the case with the 
distribution of endogenous PG and PKP-2 in all cellular fractions and at the cell surface of 
induced tDP cells. Thirdly, both induced A431 cells and tDP cells were readily dissociated in 
Dispase-based monolayer dissociation assays.
7.5 Ultrastructure studies of cell-cell junctions in ARVC
In all three functional studies ultrastructurally identifiable changes in cell-cell junctions were 
observed, affecting desmosomes in induced tPKP2, mPKP2 and tDP cells in a different
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manner. In induced tPKP2 cells, intermittent DS coupling with pale plaques and sparse 
filaments with abnormal orientations occurred. In induced mPKP2 significantly longer 
desmosomes were formed presumably by fusion of adjacent desmosomes, these had normal 
ODP and the expected association of filaments aligned normally as found in control induced 
wPKP2 cells. In induced tDP cells whilst desmsomes had apparently normal electron dense 
ODP, their filaments were localized to varying extent, affecting their desmosomal widths with 
many desmosomes lacking filament association altogether. Thus the effects of of these mutant 
desmosomal protein expression on desmosomes seem to be linked with separate functions of 
these desmosomal proteins explaining the differences in desmosomal lengths or widths; in 
the case of PKP-2 mutant protein expressions, distinct changes in desmosome morphology 
seem to be linked to domain specific effects caused by expression of PKP-2 mutant proteins, 
which might be modulated by disruption or activation of signalling functions of this molecule.
Literature review suggests that mutations in genes encoding DP, PKP-2 and DSG-2 can also 
lead to similar effects in desmosomes as found in induced tPKP2, mPKP2 and tDP cells. For 
example, a quantitative morphometric study of ARVC endomyocardial biopsies obtained 
from patients without any identified gene mutations and with some ten patients with 
mutations in DP, PKP-2 and DSG-2 genes analyzed by transmission electron microscopy46 
found that overall, mean desmosomal length and desmosomal percent length were both 
significantly higher in ARVC patients with these mutations. Desmosome number per unit 
length was significantly lower in ARVC patients with these mutations, whilst desmosomal 
gap was widened. In addition to these changes abnormally located long desmosomes, 
dissarranged filaments, abnormally small junction with intermitent DS couplings and pale 
plaques in the presence of a normal ID convolution index were observed. This study provided 
ultrastructural evidence of ID remodelling in ARVC patients in both genotype positive 
(carrying mutations in any of five known desmosomal genes) as well as genotype negative 
ARVC patients (lacking mutations in the coding regions of the five desmosomal genes), and 
confirmed earlier EM studies showing pale structures and flattened convolutions with rare or 
small desmosomes and decreased filaments272,273. Abnormal small junctions with series of 
intermittent repeated desmosomal couplings and elongated long desmosomes have been 
observed in ARVC, and these have similarly been observed in Carvajal syndrome caused by a 
recessive desmoplakin mutation159. Also PG-null mouse embryos showed decreased myofibril 
compliance and reduced cell-cell adhesion resulting from reduced desmosome numbers and
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1altered structure . The ID o f R2834H DP transgenic mice showed widening gaps and 
absence of desmsosmes163. Many of the ultrastructural features (such as intermittent 
desmosomal coupling, pale plaques, long desmosomes, and disruption to filaments) reported 
in the literature in ARVC46,104 were also observed in EM analysis of cell-cell junctions in 
induced tPKP2, mPKP2, and tDP cells, this therefore raises the question whether the resulting 
desmosomal phenotypes are solely because of physical disruption of cell-cell adhesion or 
whether these are coupled with signalling mechanisms that influence additional cellular 
processes. The observed ultrastructural changes in HEK 293 cells would need to be examined 
in other cell systems to determine the relevance in a cardiac context.
7.6 Cardiomyocyte cell culture for investigating cell-cell 
adhesion
HEK 293 cells while being amenable to high plasmid transfection rates and offers ease of 
establishing stable cell constructs with an inducible system for mutant desmosomal protein 
expression, have an obvious limitation for studying the effects of these proteins in a cardiac 
context. In a recent study246 rat neonatal cardiomyocytes were examined during 2 weeks in 
culture to assess their suitability as models cell systems for looking at perturbation at the ID. 
The ID is a very large, myocardium-specific and functionally sensitive structure. The 
importance of this structure is evident from a number of deletions or mutations in genes 
encoding ID p ro te jn sW M M o o -.o ^ .o w u .iu ^ ,* ^* . Cultures of rat neonata,
cardiomyocytes when compared with cardiomyocytes in situ revealed that while these cell 
cultures are useful as limited models for myocardiac structure and function, they represent 
only incomplete albeit progressively deteriorating pathogenic copies of the natural 
cardiomyogenesis program. However, remarkably most of the plaque proteins examined (DP, 
PG PKP2, p i20, a -  and P-catenin) were localized at membrane structures in cardiomyocyte 
cultures. Neonatal rat ventricular cardiomyocytes cultures (NRVC) may therefore be a 
suitable in vitro model for assessing the loss of function of proteins involved in the adhering 
junctions at the area composita of the ID. NRVC can be problematic as low transfection 
efficiency could result in low expression of transfected gene products, but cloning into viral 
vectors should overcome this drawback.
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7.7 Animal studies investigating mechanism of ARVC
As haploinsufficiency appears to be one of several mechanisms in cardiomyopathy seen in 
affected ARVC patients, animal models involving heterozygous gene expression (+/-) in a 
cardiac restricted pattern are especially suitable for examining frameshift mutations that 
undergo NMD to evaluate the in vivo effects of haploinsufficiency. NRVC obtained from 
transgenic mice expressing a mutant desmosomal protein (+/-) should also be a useful 
approach for future studies to examine the effects of a functional null allele. Several animal 
models have shed new light on the possible mechanisms of ARVC. A study in ten month old 
heterozygous PG deficient (PG +/-) mice examined the effect of a reduced PG expression in 
cardiac defects in these mice275. Isolated perfused plakoglobin (+/-) hearts had spontaneous 
ventricular tachycardia of right ventricular origin and prolonged right ventricular conduction 
times compared to wild-type hearts. Exercise training accelerated development of right 
ventricular dysfunction and arrhythmias in plakoglobin (+/-) mice. Histology and 
ultrastructure examination did not identify right ventricular abnormalities in affected animals. 
Thus, it was concluded that heterozygous plakoglobin deficiency provoked ARVC and 
accelerated manifestation of the phenotype in effort-induced training. The effect of effort 
induced studies in PKP-2 deficient (+/-)mice have not been reported, such a study may 
provide important clues about the loss of function of this protein in vivo, as PKP-2 gene 
mutations causing reading frame shift are by far the most predominant types of mutations in 
ARVC (Table 1.5)
In another study56 using atrial myocyte cell lines expressing siRNA against DP, suppression 
of DP expression led to nuclear localization of plakoglobin, with a two-fold reduction in 
canonical Wnt/beta-catenin signalling through Tcf/Lefl transcription factors. Increased 
expression of adipogenic and fibrogenic genes and accumulation of fat droplets were 
observed in these cell lines. Furthermore, a cardiac-restricted deletion of DP impaired cardiac 
morphogenesis with high embryonic lethality resulting in the homozygous (DP -/-) mice. 
Heterozygous (+/-) DP-deficient mice exhibited excess adipocytes and fibrosis in the 
myocardium, increased myocyte apoptosis, cardiac dysfunction, and ventricular 
arrhythmias56, which seemed to recapitulate ARVC in human.
344
A transgenic mouse cardiac restricted over-expression model examining missense DP
1affecting the DP tail domain showed that whereas mice over-expressing wild type DP had 
no detectable histologic, morphological, or functional cardiac changes, a transgenic mouse 
with R2834H DP over-expression showed increased cardiomyocyte apoptosis, cardiac 
fibrosis, and lipid accumulation, along with ventricular enlargement and cardiac dysfunction 
in both ventricles. Disruption of desmin-DP interactions were also seen in the ID of these 
mice and irregularly shaped ID with widening gaps affecting both AJ and desmosomes were 
identified ultrastructurally. Transgenic R2834H DP mice showed dissociation of a number of 
junctional proteins from cell-cell junctions (increased expression and redistribution of PG, 
PKP2 and p-catenin, and redistribution of Cx-43). The authors believed that these changes in 
various junctional complexes were probably secondary to DP-desmin disruption. The failure 
of desmin to localise with DP at ID of R2834H DP transgenic mice by IHC was a feature that 
was also noted in Carvajal syndrome43. Disruption in the desmin-DP interaction was 
suggested to lead to instability of desmosomes, resulting in a reduced resistance to the 
constant mechanical stress experienced by cardiomyocytes. Gross widening of junctions in 
the ID in R2834H transgenic mice reminiscent of human ARVC supported this contention.
The above genetically manipulated models of ARVC suggested that these animal models are 
important tools in assessing the molecular defects of cell-cell adhesion proteins providing 
insights on mechanisms of ARVC. However, there are also spontaneous models of ARVC 
described in the domestic cat276 and boxer dogs60, which might be useful for analyzing how 
genetic defects might cause ARVC. The canine model in this respects could be useful as it 
shows familial transmission of ARVC, and although screening of coding sequence of genes 
encoding desmosomal proteins have not as yet shown any defects in these genes61,62, the 
model would appear to be useful in targeting the discovery of further unidentified genes 
involved in ARVC. The future studies from this work would be to test heterozygous 
mutations in cardiomyocyte cell cultures or in animal models where one affected allele (+/- 
system) encoding a mutant cell adhesion molecule is expressed in a cardiac restricted manner 
allowing the molecular defects of these proteins to be examined in the ID.
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7.8 Genetic screening of ARVC cohort - Pitfalls
Although PKP-2 gene mutations result in missense, nonsense, frameshift, splice site 
mutations there are some apparently silent (synonymous) amino acid changes that can give 
rise to cryptic splicing in the PKP-2 mRNA, resulting from the loss of ESE elements or the 
creation of ESS elements in an exon sequence. One such change, involves a synonymous 
amino acid change (p.gly828) in an ARVC patient who had a homozygous mutation in PKP-2 
(c.[2484C>T]+[2484C>T]), which caused predominantly cryptic splicing (resulting from 
creation of a novel splice donor site), with a 7 nucleotide deletion in exon 12 
(r.[2483_2489del]). This caused a frame shift disrupting the last 54 amino acids of PKP2 
resulting in extension of reading frame by 145 nucleotides (48 amino acids) into the 
3’UTR113. A second alternatively spliced PKP2 form present in the proband and one of his 
children showed retention of intron 13-14 with proper splicing at other exon junctions, 
resulting in the addition of three additional nucleotide residues after exon 13 followed by 
premature termination with loss of 21 amino acids encoded by exon 14. Thus, the possibility 
of cryptic or alternative splicing should be considered in apparently synonymous amino acid 
substitutions found in ARVC. Other problems in genetic screening of ARVC cohorts include 
low frequencies of some ARVC mutations, some intronic nucleotide changes may be difficult 
to assign as mutations, and effect of modifier genes or presence of mutations in more than one 
gene can complicate the screening. An absence of mutation in any of the five known 
desmosomal genes277 does not rule out ARVC, as mutations might be present in non- 
desmosomal genes58,59 or in other unidentified genes. Rare polymorphisms may be difficult to 
distinguish from mutations, and assigning pathogenicity to missense sequence changes 
requires exhaustive literature searches, bioinformatics approach, and further genetic studies in 
an individual family to classify a sequence variant of unknown clinical significance. 
Screening of all five desmosomal genes implicated in ARVC is labour intensive and requires 
immense resources; some large genes, such as desmoplakin, pose a technical challenge for 
sequencing, but new sequencing technologies may alleviate these difficulties
7.9 Domain specific effects of DP mutations
Figure 1.10 shows the locations of twenty four DP mutations reported in the literature to date 
(June 2008) as well as the locations of three DP mutations identified from the present genetic
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screening work. Why some missense mutations in the PRD of DP affect only the heart 
(p.R2834H DP) and others only the skin (p.R2336C DP) can be explained molecularly by the 
different binding sites for desmin (cardic IF) or keratin (skin IF) binding sites that are 
disrupted in the PRD by these mutations. Nonetheless, the effect of the vast majority of the 
missense and nonsense mutations in this region on the binding of desmin and keratin IFs to 
desmosomes is not different; they all produced both an abnormal skin and heart phenotype 
due to reduced attachment of desmosomes to IF proteins157,161. Missense mutations in the 
plakin domain that affect both the heart and the skin have also been found160. These defects 
are most likely associated with a failure of desmoplakin to bind to plakoglobin since 
mutations in plakoglobin cause a very similar disorder in both humans and mice, i.e. skin 
defects associated with developmental anomalies of the hair and cardiomyopathy38,186. Why 
some of the missense mutations in the plakin domain only affect the heart, while others affect 
both the heart and the skin is an open question, but it is clear that the different clinical 
manifestations cannot be explained by the failure of desmoplakin to bind to either plakoglobin 
or plakophillin-2.
7.10 Conclusions from studies undertaken
Inclusion of genetic screening of mutations in genes frequently mutated in ARVC would 
clearly improve the clinical criteria from a simply diagnostic standpoint; however, given that 
ARVC is a genetically heterogenous disease, with incomplete penetrance, with presence of 
frequent ‘private family’ mutations, and a disease where the possiblity of further unidentified 
gene mutations is high and existing screening already involves the coverage of a large 
genomic region of approximately 40Kb -  these factors would weigh down on the cost benefit 
for population based screening/diagnosis of this disease using a genetic approach.
The confirmation of an abnormal genotype, particularly in family members, could identify
carriers at risk for transmitting ARVC to offsprings and who might potentially develop
clinical manifestations of ARVC. Conversely, the absence of a particular genotype identified
in a family would greatly argue against ARVC, especially in asymptomatic individuals. The
presence alone o f an abnormal genotype may not predict high risk in an individual, but it
should prompt vigilant care. In an individual with boderline clinical findings, an abnormal
genotype may aid in securing an ARVC clinical diagnosis, although perhaps such an
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individual may be at a lower risk than an individual with overt clinical manifestations. Recent 
studies have shown that the type of gene mutation in ARVC is also important. For example, 
patients with ARVC due to PKP-2 mutations were found to have propensity for earlier
1 A Oarrhythmias than patients who met Task Force criteria but did not carry PKP-2 mutations . 
Genetic screening of human ARVC cohort showed mutations affecting various parts of the 
plakophilin-2 and desmoplakin protein domains, and by far, the most frequent mutations, 
were found to reside in the plakophilin-2 gene with all domains of the protein molecule 
appearing to be affected.
The Flp-In T-Rex HEK 293 cell line is a useful in vitro model system allowing the role of 
mutant PKP-2 and DP proteins to be investigated at the level of desmosomes and cellular 
functions. The Flp-In T-Rex HEK293 cell model has been used successfully to examine the 
Ryanodine receptor2 protein mutations in vitro to determine the effect of C terminal 
mutations in storage-overload-induced Ca2+ release 278. This showed the versatility of the Flp- 
In cell sytem as RyR2 is fairly large protein molecule to express and assemble appropriately 
in these cells for functional analysis.
The value of the work performed is to show that ARVC is a genetic disease of the 
desmosomes, affecting the genes encoding PKP-2 and DP, and in out of a total of eleven 
mutations found, seven were novel mutations, and with gene mutations being inherited in 
families in an autosomal dominant manner with incomplete pentrance due to age and sex of 
the individual. Three separate mutations affecting at the protein level: p.S140F PKP-2, 
p.A733fsX740 PKP-2 and p.Q2273fsX288 DP were examined in stable HEK 293 cells using 
protein expression studies, cellular assays and analysis of desmosomes in cell lines 
expressing these mutant proteins. S140F PKP-2 caused a gain of function with formation of 
long desmosomes and reduced interaction with p-catenin, suggesting that loss of a putative 
serine phosphorylation site in PKP-2 may possibly be involved in signal transduction and the 
changes observed ultrastructurally in desmosomes. Expression of A733fsX740 PKP-2 and 
Q273fsX288 DP proteins each caused distinct dominant negative effects on desmosome 
morphology and in cellular functions specific to the roles of these two proteins; the effect of 
A733fsX740 PKP-2 also revealed a dominant negative effect on Cx-43 protein localization at 
cell-cell contacts and enhanced apoptosis of cells expressing this truncated plakophilin-2; the 
dominant negative effects in cells expressing A733fsX740 PKP-2 may be caused by the
348
reduced interaction of expressed A733fsX740 PKP-2 protein with PG. Disparate effects on 
cell-cell adhesion and desmosome morphology were observed in stable cells expressing 
S140F PKP-2 and A733fsX740 PKP-2 proteins, but these effects may be due to a complex 
expression pattern of various IF proteins in HEK 293 cells that might modulate cell-cell 
adhesion in a different manner. These functional studies have provided important mechanisms 
to explain the cardiomyopathy and arrhythmogenesis seen in patients inheriting these gene 
mutations in PKP-2 and DP, and a framework for further future studies (see chapters 4, 5, and 
6 under ‘Future Studies’) using cardiac relevant cell culture systems and mice models to 
investigate how gene mutations might be linked to the observed changes in ARVC in vivo. 
While many of the features of ARVC can be explained by functional studies in HEK 293 
cells, recent studies have also postulated molecular mechanisms for adipogenesis56,59 to 
explain the fatty or fibrofatty replacement of cardiomyocytes occurring in ARVC.
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